anastrozole and triazoles

anastrozole has been researched along with triazoles in 1246 studies

Research

Studies (1,246)

TimeframeStudies, this research(%)All Research%
pre-19906 (0.48)18.7374
1990's63 (5.06)18.2507
2000's644 (51.69)29.6817
2010's526 (42.22)24.3611
2020's7 (0.56)2.80

Authors

AuthorsStudies
Demers, L; Dowsett, M; Dyroff, M; Plourde, PV; Webster, A; Yates, R1
Dukes, M; Dyroff, M; Plourde, PV1
Dowsett, M; Fisher, GV; Selen, A; Wyld, PJ; Yates, RA1
Azab, M; Blomqvist, C; Buzdar, A; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Plourde, PV; Vogel, CL; Webster, A; Wolter, JM1
Castiglione-Gertsch, M1
Azab, M; Blomqvist, C; Eiermann, W; Hellmund, R; Howell, A; Jonat, W; Lundgren, S; Mauriac, L; Roche, H; Tyrrell, C; Winblad, G1
Buzdar, AU; Hortobagyi, GN; Plourde, PV1
Dowsett, M; Geisler, J; King, N; Kormeset, PO; Lundgren, S; Lønning, PE; Ottestad, L; Walton, P1
Boyle, T; Dukes, M; Edwards, PN; Large, M; Smith, IK1
Buzdar, AU; Jones, SE; Plourde, P; Vogel, CL; Webster, A; Wolter, J1
Hannaford, M1
Dyroff, MC; Grimm, SW1
Cala, KM; Landrum, DP; Mahendroo, MS; Russell, DW1
Dowsett, M3
Spencer, CM; Wiseman, LR1
Durgam, VR; Tekmal, RR1
Buzdar, AU; Howell, A; Jonat, W; Plourde, PV1
Buzdar, AU; Roseman, BJ; Singletary, SE1
Blamey, RW; Cheung, KL; Ellis, IO; Elston, CW; Nicholson, RI; Pinder, SE; Robertson, JF; Willsher, PC1
Bara, I; Bock, MJ; Dyroff, M; LeDonne, N; Martz, A1
Goss, PE; Tye, LM1
Dukes, M1
Dowsett, M; Lønning, PE1
Jonat, W1
Aparicio, LA; Carrion, RP; Dodwell, DJ; Dowsett, M; Kleeberg, UR; Robertson, JF; Vorobiof, DA1
Ashby, J; Lefevre, PA1
Flanagan, AM; Lea, CK1
alKhouri, N; Higa, GM1
Buzdar, AU15
Bulun, SE; Carr, BR; Gunby, RT; Sasano, H; Takayama, K; Zeitoun, K1
Harvey, HA1
Brodie, A; Liu, Y; Long, B; Lu, Q; Wang, JP; Yue, W1
Buzdar, AU; Hortobagyi, GN1
Blomqvist, CP; Buzdar, AU; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Lee, D; Steinberg, M; Vogel, CL; Webster, A; Wolter, JM1
Lønning, PE3
Kurokawa, K; Mamiya, Y; Okazaki, H; Ono, Y; Onuma, E; Suzuki, K; Suzuki, T; Takanashi, H; Yamanaka, H1
Dowsett, M; Geisler, J; Lønning, PE1
Brodie, A; Liu, Y; Long, B; Lu, Q; Wang, J; Yue, W1
Adkins, JC; Wiseman, LR1
Brodie, AM; Grigoryev, DN; Long, BJ; Thiantanawat, A; Tilghman, SL; Yue, W1
Flanagan, AM; Lea, CK; Sarma, U1
Baum, M; Blackman, GM; Dowsett, M; Howell, A; King, N; Ponzone, R; Tobias, JS; von Euler, M; Welch, H1
Hamilton, A; Piccart, M1
Lund, SA; Murdoch, J; Murdoch, WJ; Van Kirk, EA1
Blijham, GH; de Jong, PC1
Benson, S; Cella, D; Fallowfield, LJ; Howell, A; Leaity, SK1
Coombes, RC; Harper-Wynne, C1
Colciago, A; Motta, M; Negri-Cesi, P; Poletti, A1
Bonneterre, J; Feutrie, ML1
Calvo, L; Clack, G; Dodwell, DJ; Dowsett, M; Kleeberg, UR; Perez-Carrion, R; Robertson, JF; Vorobiof, DA1
Brodie, A; Gimbel, M; Grigoryev, D; Liu, Y; Long, BJ; Lu, Q1
Bland, KI; Buzdar, AU1
Bland, KI1
Atanassova, N; Morley, M; Sharpe, RM; Swanston, ID; Turner, KJ1
Buzdar, A; Howell, A; Lee, D; Robertson, JF; von Euler, M1
Bellamy, C; Cameron, DA; Dixon, JM; Leonard, RC; Love, CD; Miller, WR; Renshaw, L1
Smith, IE2
Harvey, HA; Santen, RJ1
Bajetta, E; Bichisao, E; Pozzi, P; Toffolatti, L; Zilembo, N1
Berntsen, H; Geisler, J; Lonning, PE1
Bellamy, C; Dixon, JM; Hoctin-Boes, G; Miller, WR; Renshaw, L; Stuart, M1
Hayes, V; Klein, KO; Mauras, N; O'Brien, KO1
Donaldson, K; Dowsett, M; Tsuboi, M; Wong, J; Yates, R1
Bulun, SE; Sasano, H; Takayama, K; Zeitoun, KM1
Bell, J; Brunetto, VL; Lee, RB; Rose, PG; VanLe, L; Walker, JL1
Fujiwara, K; Hohjoh, T; Ikeda, T; Kawaguchi, M; Kitajima, M; Masamura, S; Matsui, A; Mitsui, Y; Takayama, S; Tokura, H1
Boepple, PA; Crowley, WF; Decruz, S; Hayes, FJ; Seminara, SB2
Perey, L1
Sonoo, H1
Attolico, M; Crucitta, E; De Lena, M; Lorusso, V; Mazzei, A; Sambiasi, D1
Dranitsaris, G; Leung, P; Mather, J; Oza, A1
Buzdar, A2
Bonneterre, J; Koralewski, L; Krzakowski, M; Mauriac, L; Robertson, J; Steinberg, M; Thürlimann, B; Vergote, I; von Euler, M; Webster, A1
Bonneterre, J; Koralewski, P; Krzakowski, M; Mauriac, L; Robertson, JF; Steinberg, M; Thürlimann, B; Vergote, I; von Euler, M; Webster, A1
Burton, G; Buzdar, A; Harwin, W; Mangalik, A; Nabholtz, JM; Pollak, M; Steinberg, M; von Euler, M; Webster, A1
Fujita, T; Kaiho, S; Kuwabara, K; Ogata, E; Oizumi, I; Okazaki, T; Tanaka, Y1
Sonoo, H; Watanabe, T1
Howell, A4
Cattel, F; Messori, A; Trippoli, S; Vaiani, M1
Ashby, J; Joiner, R; Odum, J; Tinwell, H; Van Miller, J1
Baum, M; Thornton, H; Tobias, JS1
Cohen, MH; Flamm Honig, S; Hirschfeld, S; Ibrahim, A; Johnson, JR; O'Leary, JJ; Pazdur, R; White, RM; Williams, GA1
Arosio, M; Faglia, G; Porretti, S1
Bulun, SE; Takayama, K1
Murdoch, WJ; Van Kirk, EA1
Auvray, P; Bichat, F; Genne, P1
de Crémoux, P1
Kerbrat, P; Lefeuvre, C1
Mokbel, K3
Tsukagoshi, S1
Panasci, LC1
Bagley, CM; Rowbotham, RK1
Bolton, M; Copur, MS; Ledakis, P; Muhvic, J; Norvell, M1
Tonkin, K1
Costa, SD; Kaufmann, M1
Berntsen, H; Detre, S; Dowsett, M; Einstein Lønning, P; Geisler, J; Lindtjørn, B; Ottestad, L1
Cameron, DA; Donnellan, PP; Douglas, SL; Leonard, RC1
Bray, MJ; Schnorr, JA; Veldhuis, JD1
Clive, JM; Fall, PM; Kennedy, DG; Raisz, LG; Taxel, P; Willard, AK1
Bergmann, L1
März, W; Merz, M; Nauck, M; Seiberling, M; Wong, J; Yates, RA1
Tominaga, T1
Cuzick, J; Dowsett, M; Howell, A; Jackson, I1
Hamilton, A; Volm, M1
Buzdar, A; Howell, A1
Cohen, RB; Fisch, MJ; Myers, CE; Petroni, GR; Santen, RJ; Theodorescu, D1
Burstein, HJ; Winer, EP1
Murray, R1
Boeddinghaus, I; Dixon, M; Dowsett, M; Ebbs, S; Gui, G; Harper-Wynne, C; Hills, M; Sacks, N; Salter, J; Smith, I1
Bonneterre, J; Buzdar, A; Nabholtz, JM; Robertson, JF; Sahmoud, T; Steinberg, M; Thürlimann, B; von Euler, M; Webster, A1
An, FR; Chen, J; Ge, SR; Liang, JY; Shi, AG; Wang, PQ; Yuan, J1
Feng, F; Jiang, Z; Xu, B1
Nabholtz, JM; Reese, DM1
Bando, H; Saji, S; Toi, M1
Raman, JD; Schlegel, PN1
Anker, G; Dowsett, M; Geisler, J; Haynes, B; Lønning, PE1
Carlini, P; Casali, A; Cognetti, F; De Marco, S; Fabi, A; Frassoldati, A; Nardi, M; Paoloni, F; Papaldo, P; Ruggeri, EM1
Dixon, JM; Miller, WR1
Anderson, TJ; Cameron, DA; Dixon, JM; Miller, WR1
Junker, A; Possinger, K; Wiedemann, GJ1
Cortvrindt, R; Hu, Y; Smitz, J1
Sledge, GW1
Baum, M4
Chaudhuri, G; Dinh, H; Mukherjee, TK; Nathan, L1
Cohen, Y; Geffen, DB; Lavrenkov, K; Man, S1
Buzdar, A; Johnson, PE1
Goss, PE1
Nicholls, H1
Soudon, J1
Bajetta, E; Bombardieri, E; Buzzoni, R; Catena, L; Celio, L; Ferrari, L; Gattinoni, L; La Torre, I; Martinetti, A; Pozzi, P; Seregni, E; Vitali, M; Zilembo, N1
Jones, SE1
Casper, RF; Mitwally, MF1
Benedetto, C; De Nicola, B; Ferraris, F; Genta, F; Piccinno, R; Porpiglia, M; Vicelli, R1
Buzdar, AU; Giordano, SH; Hortobagyi, GN; Valero, V1
Alba, E; Colla, F; Farina, C; Mazzoleni, A; Ragonesi, G1
Lynn, J1
Bajetta, E; Bichisao, E; Zilembo, N1
Ravdin, P1
Baum, M; Budzar, AU; Cuzick, J; Forbes, J; Houghton, JH; Klijn, JG; Sahmoud, T1
Ingle, JN6
Köberle, D; Thürlimann, B2
Goss, PE; Smith, RE1
Cummings, FJ1
Assikis, VJ; Buzdar, A1
Braun, S; Browman, GP; Burstein, HJ; Chlebowski, RT; Cobleigh, MA; Edge, SB; Goldstein, LJ; Gralow, J; Hudis, C; Ingle, JN; Langer, AS; Mamounas, EP; Perotti, J; Powles, TJ; Pritchard, KI; Whelan, TJ; Winer, EP1
Bajetta, E; Bombardieri, E; Ferrari, L; La Torre, I; Longarini, R; Martinetti, A; Pozzi, P; Salvucci, G; Seregni, E; Zilembo, N1
Burton, G; Buzdar, A; Come, S; Dimery, I; Elledge, R; Ellis, M; Gertler, SZ; Jones, SE; May, JT; Morris, C; Osborne, CK; Parker, LM; Pippen, J; Webster, A1
Aschermannova, A; Erikstein, B; Howell, A; Kleeberg, UR; Mauriac, L; Morris, C; Quaresma Albano, J; Robertson, JF; Vergote, I; Webster, A1
Anderson, TJ; Dixon, JM; Miller, WR; Sahmoud, T; Stuart, M1
Nabholtz, JM; Reese, D1
Albers, N; Freiberg, C; Roth, C; Zappel, H1
Ashby, J; Deghenghi, R; Odum, J; Owens, W1
Bramwell, V; Vandenberg, T; Winquist, E1
Duan, G; Liang, J; Zuo, M1
Enomoto, K; Kinoshita, T; Nishimura, M; Okamura, Y; Oura, S; Sakurai, T; Yokochi, H1
Freed, DJ; Gillam, MP; Middler, S; Molitch, ME1
Bruntsch, U1
Buzdar, AU; Eiermann, W; Nabholtz, JM; Robertson, JF1
Beat, T1
Vergote, I1
McClellan, MB1
Faulds, DM; Wellington, K1
Basu, S; Last, A; Shinkfield, M1
Dixon, JM; Miller, WR; Sahmoud, T; Stuart, M1
Gluck, S2
Mokbel, K; Singh-Ranger, G2
Hakamata, Y; Hozumi, Y; Nagai, H; Ogura, S; Sasanuma, H1
Robertson, JF1
Jordan, VC2
Stasi, R; Terzoli, E1
Thornton, H3
Chiba, N; Mori, K; Yamamoto, Y; Yonekawa, H1
Eastell, R; Finkelstein, JS; LeBlanc, KM; Leder, BZ; Schoenfeld, DA1
Coleman, RE1
Aumiller, J3
Davidson, NE; Visvanathan, K1
Martín de Vidales, C; Pérez-Torrubia, A; Zapatero, A1
Bryant, M; Bulun, SE; Hsu, WT; Neely, K; Schultz, RA; Sebastian, S; Shozu, M; Takayama, K1
Miyoshi, Y; Noguchi, S; Taguchi, T; Tamaki, Y1
Okamura, Y; Sakurai, T; Shimizu, Y; Suzuma, T; Umemura, T; Yang, QF; Yoshimura, G1
Campos, SM; Winer, EP1
Gertler, SZ; Mauriac, L; Osborne, CK; Pippen, JE; Quaresma Albano, J1
Brown, P; Wu, K1
Dranitsaris, G; Trudeau, M; Verma, S1
Casanovas, J; Milla, L; Milla-Santos, A; Pons, M; Portella, J; Puig-Gali, M; Rallo, L; Rodes, E1
Dimmer, C; Goodare, H; Page, K1
Burton, G; Kleeberg, U; Mauriac, L; Osborne, CK; Robertson, JF; Vergote, I1
Höffken, K; Sayer, HG1
Buzdar, A; Come, SE; Ellis, M; Gertler, S; Howell, A; Jones, SE; Kleeberg, UR; Mauriac, L; Morris, C; Osborne, CK; Robertson, JF; Vergote, I; Webster, A1
Baum, M; Buzdar, A1
Rocchi, A; Verma, S2
Bonneterre, J; Buzdar, A; Nabholtz, JM; Robertson, JF; Thürlimann, B2
Rose, C2
Brodie, AH; Mouridsen, HT1
Thomas, R1
Cuzick, J5
Dixon, JM; Jackson, J; Miller, WR1
Cohen, PG; Holbrook, JM1
Carlini, P; Cognetti, F; Colella, E; Di Cosimo, S; Fabi, A; Ferretti, G; Frassoldati, A; Papaldo, P; Romiti, A; Ruggeri, EM; Tomao, S; Tonachella, R1
Eckhardt, S1
BEVERLEY-BURTON, M1
MOLTZ, H; ROSENBLUM, LA1
Cuzick, J; Forbes, J; Howell, T; O'Neill, C1
AKESTER, AR1
GOMOT, L; LUTZ-OSTERTAG, Y1
BUTLER, DG; HOLMES, WN; PHILLIPS, JG1
Hazini, A; Pietropaolo, M; Repetto, L; Rosso, R; Sestini, A; Vannozzi, O1
Lønning, P; Martoni, A; Pfister, C; Zamagni, C1
Gershanovich, M; Mouridsen, H1
Kmietowicz, Z1
Aapro, MS; Forbes, JF1
Carlson, RW; Henderson, IC1
Hortobagyi, GN1
Baird, A; Bross, PF; Chen, G; Jee, JM; Lostritto, RT; Morse, DE; Pazdur, R; Rahman, A; Rosario, LA; Williams, G; Williams, GM; Yang, P1
Ben Ayed, F; Burdette-Radoux, S; Caicedo, JJ; Chaudri-Ross, HA; Davidson, N; Gershanovich, M; Gervasio, H; Johnson, S; Lang, R; Manikhas, G; Pluzanska, A; Rose, C; Thomas, R; Vtoraya, O1
Gerber, B1
Fleming, GF1
Baum, M; Buzdar, A; Cuzick, J; Forbes, J; Houghton, J; Howell, A; Sahmoud, T1
Dawood, T; Komesaroff, P; Lew, R; Sudhir, K; Williams, M1
Baum, M; Buzdar, A; Howell, A1
Geisler, J2
Dixon, JM; Jackson, J; Miller, WR; Renshaw, L1
Nabholtz, JM2
Fallowfield, L; Howell, T; Jenkins, V; Shilling, V1
Davidson, NE; Emens, L; Visvanathan, K1
Pritchard, KI1
Brodie, AH; Mouridsen, HT; Rose, C; Smith, IE1
Bianco, AR; Clack, G; Coibion, M; Cuzick, J; Duffy, S; Jackson, TL; Lansdown, M; Philips, K; Pollard, S; Wells, M1
Campos, S; del Carmen, MG; Duska, LR; Fuller, AF; Goodman, A; Horick, NK; Matulonis, U; Penson, R; Roche, M; Seiden, MV1
Gezgin, T; Gul, N; Ozer, S; Soysal, ME; Soysal, S1
Buzdar, A; Jones, D; Simons, WR1
Howell, A; Robertson, JF; Vergote, I1
Howell, A; Mauriac, L; Osborne, CK1
Goss, PE; Strasser-Weippl, K1
Fallowfield, L; Howell, A; Hutton, S; Jenkins, V; Shilling, V1
Aihara, T; Morino, H; Munakata, S; Takatsuka, Y1
Cheung, KL; Forward, DP; Jackson, L; Robertson, JF1
KOMIYA, Y; KONDO, S1
Morgentaler, A; Rhoden, EL1
Kammerer, S1
Eiermann, W1
Domont, J; Khayat, D; Namer, M; Spano, JP1
Wilkinson, K1
Kawakami, M; Saji, S; Toi, M1
Gallo, J; Leder, BZ; Longcope, C; Rohrer, JL; Rubin, SD1
Curran, MP; McKeage, K; Plosker, GL1
Baron, M; d'Anjou, J; Dessogne, P1
Campos, SM1
Arora, A; Potter, JF1
Baum, M; Bianco, R; Buzdar, A; Coleman, R; Constenla, M; Cuzick, J; Distler, W; Dowsett, M; Forbes, J; Guastalla, JP; Houghton, J; Howell, A; Locker, G; MacKey, J; Sainsbury, R; Tobias, J; Williams, N1
Chaudri-Ross, HA; Mouridsen, HT1
Guo, KJ; Guo, Y; Huang, L; Li, X; Tong, XG1
Aebi, S; Ballabeni, P; Goldhirsch, A; Hess, D; Köberle, D; Pagani, O; Perey, L; Rochlitz, C; Senn, I; Thürlimann, B1
Shippen, ER; West, WJ1
Al-Hadithi, N; Al-Omari, WR; Sulaiman, WR1
Clemons, M; Coleman, RE; Verma, S1
Sainsbury, R1
Aglietta, M; Cirillo, S; Gatti, M; Martincich, L; Montemurro, F; Regge, D; Russo, F1
Christopoulos, S; Rivera, JA; Small, D; Trifiro, M1
Aebi, S; Baumann, ChK1
Baus, I; Krone, N; Partsch, CJ; Riepe, FG; Sippell, WG; Wiest, S1
Howell, A; Tobias, JS1
Blanchard, R; Hamid, AM; Leiser, AL1
Cuzick, J; Locker, GY; Sainsbury, JR1
Tobias, JS2
Boccardo, F2
Amezcua, C; Bahador, A; Burnett, AF1
Megahed, M; Reifenberger, J; Schulte, KW; Sonntag, M1
Backeljauw, PF; Bercu, BB; Desrochers, PE; Diamond, FB; Jou, HC; Plourde, PV; Reiter, EO; Rubin, SD1
Hillner, BE1
Altundag, K; Buzdar, AU; Hortobagyi, G; Morandi, P; Rouzier, R; Theriault, RL1
Abou-Jawde, RM; Alemany, CA; Budd, GT; Choueiri, TK1
Bloomfield, D; Godward, S; Makris, A; Moody, AM; Thomas, R; Williams, M1
Ameye, L; Carbonez, A; Christiaens, MR; Morales, L; Neven, P; Paridaens, R; Timmerman, D; Van Huffel, S; Van Limbergen, E; Vergote, I1
Hirono, M; Ikeda, M; Kurebayashi, J; Nakashima, K; Nomura, T; Okubo, S; Sonoo, H; Tanaka, K; Udagawa, K1
Fuchimoto, S; Inagaki, M; Miyoshi, K; Nakagawa, T; Ohsaki, T; Ohtsuka, S; Yumura, M1
Bianco, AR; Clack, G; Coibion, M; Duffy, S; Jackson, TL; Lansdown, M; Philips, K; Pollard, S; Wells, M2
Cella, D; Cuzick, J; Fallowfield, L; Francis, S; Howell, A; Locker, G1
Caruggi, M; Colombo, G; Marchetti, M1
Hiura, M; Nogawa, T; Oshita, T; Yokoyama, T1
Johnston, S; Stebbing, J1
Bessho, T; Hirai, I; Kinoshita, T; Kokawa, Y; Nishida, M; Nishimura, O; Okamura, Y; Oura, S; Sakurai, T; Sasaki, R; Tanino, H; Yokochi, H; Yoshimas, T1
Anderson, TJ; Cameron, DA; Dixon, JM; Dowsett, M; Hills, M; Jackson, J; Miller, WR; Renshaw, L1
Cheng, CW; Cheung, MN; Chow, LW; Loo, WT; Tse, EY1
Casper, RF; Diamond, MP; Mitwally, MF1
Buraglio, M; Denton, G; Hemsey, G; Tredway, DR1
Duffy, SR; Taylor, L1
Bajetta, E; Bombardieri, E; Del Vecchio, M; Ferrari, L; La Torre, I; Longarini, R; Martinetti, A; Paleari, D; Seregni, E; Toffolatti, L; Zilembo, N1
Buzdar, A; Macahilig, C1
de Cremoux, P; Diéras, V; Fourquet, A; Magdelénat, H; Pierga, JY; Poupon, MF; Sigal-Zafrani, B1
Harwood, KV1
Klein, KO; Mauras, N; Rini, A; Welch, S1
Fentiman, IS1
Agorastos, T; Bontis, JN; Efstathiadis, E; Pantazis, K; Vaitsi, V; Vavilis, D1
Travis, K1
Barlow, DH; Kennedy, S1
Ahmed, S; Amory, JK; Bremner, W; Cherrier, MM; Craft, S; Johnson, M; Matsumoto, AM; Peskind, ER; Raskind, MA1
Dougherty, RH; Hayden, D; Leder, BZ; Rohrer, JL; Rubin, SD1
Battaglia, M; Bertaccini, A; Boccardo, F; Comeri, G; Conti, G; Di Tonno, P; Durand, F; Ferraris, V; Galassi, P; Macchiarella, A; Manganelli, A; Martorana, G; Montefiore, F; Muscas, G; Potenzoni, D; Rubagotti, A; Selvaggi, FP; Siragusa, A; Zattoni, F1
Gallo, J; Morris, T; Saltzstein, D; Sieber, P1
Beex, L; Come, SE; Jones, SE; Kaufmann, M; Makris, A; Nortier, JW; Possinger, K; Robertson, JF; Rutqvist, LE1
Ashley, S; Boeddinghaus, I; Detre, S; Dixon, JM; Dowsett, M; Ebbs, SR; Francis, S; Griffith, C; Hills, M; Salter, J; Skene, A; Smith, IE; Walsh, G2
Clemons, MJ; Freedman, OC; Verma, S2
Miller, DS; Rao, GG1
Michaud, LB1
Mouridsen, HT2
Bershtein, LM; Kovalevskii, AY; Poroshina, TE; Semiglazov, VF; Tsyrlina, EV; Zhil'tsova, EK; Zimarina, TS1
Kaplow, R1
Ayaori, M; Hiraide, H; Kusuhara, M; Mochizuki, H; Ohsuzu, F; Sato, K; Sawada, S; Tamaki, K; Yonemura, A1
Angeles Victoria, L; Basavilvazo Rodríguez, MA; Castelazo Rico, G; Hernández Valencia, M; Molotla Xolalpa, D; Zárate, A1
Deguchi, Y; Kamimura, K; Kaneko, I; Kii, E; Murata, T; Nonogaki, H; Tanaka, T; Tsubono, M; Yasumizu, R1
Jakesz, R2
Bundred, N1
Chen, S; Itoh, T; Karlsberg, K; Kijima, I; Smith, D; Ye, J; Yuan, YC1
Geisler, J; Lønning, PE3
Boccardo, F; Conti, G; Del Monaco, D; Manganelli, A; Potenzoni, D; Rubagotti, A1
Baker, MA; Chettle, C1
Ejlertsen, B; Joensuu, H; Lønning, PE; Rutqvist, LE1
Katsumine, Y; Noda, N; Osawa, I; Uehara, S; Yuasa, H1
Beaton, EA; deCatanzaro, D1
Caraglia, M; Cigolari, S; Colucci, G; Del Prete, S; Fanelli, F; Febbraro, A; Ferrari, E; Formato, R; Gebbia, V; Giotta, G; Iaffaioli, RV; Ianniello, G; Incoronato, P; Manzione, L; Marano, O; Marzano, N; Nasti, G; Pappagallo, G; Pedicini, T; Pezzella, G; Pisano, A; Pisconti, S; Pizza, C; Quattrin, S; Tortoriello, A1
Finkelstein, JS; Leder, BZ1
Gradishar, WJ; Sahmoud, T1
Jones, SE; Pippen, J1
Brown, P; Kalidas, M1
Delozier, T; Khayat, D; Spano, JP1
Dodwell, D; Vergote, I1
Karatza, EC; Manquez, ME; Shields, CL; Shields, JA1
Ali, S; Barrett, N; Beresford, E; Coombes, RC; Hadjiminas, D; Jiang, J; Mansi, JL; Morrison, K; Peston, D; Polychronis, A; Shivapatham, D; Shousha, S; Singhal, H; Sinnett, HD; Slade, MJ; Vigushin, D1
Come, SE; Elledge, RM; Howell, A; Jones, SE; Mauriac, L; Osborne, CK; Pippen, J; Robertson, JF; Vergote, I1
Ingle, JN; Suman, VJ1
Cilaker, S; Karaer, O; Koyuncu, MF; Oruç, S; Ozbilgin, K; Vatansever, HS1
Ponzone, R; Sismondi, P1
Hamilton, AL; Nordman, IC; Spillane, AJ1
Ashley, SE; Blohmer, JU; Boeddinghaus, I; Dixon, JM; Dowsett, M; Ebbs, SR; Francis, S; Skene, A; Smith, IE; Walsh, G1
Anderson, TJ; Dixon, JM; Evans, D; Krause, A; Larionov, A; Miller, WR; Murray, J; White, S1
Bell, J; Mauras, N; Snow, BG; Winslow, KL1
Amadori, D; Amoroso, D; Benedetto, C; Boccardo, F; Buzzi, F; Distante, V; Fini, A; Franchi, R; Guglielmini, P; Massidda, B; Mesiti, M; Paladini, G; Porpiglia, M; Puntoni, M; Restuccia, N; Rinaldini, M; Romeo, D; Rubagotti, A; Scali, S; Sismondi, P1
Børresen-Dale, AL; Frigessi, A; Geisler, J; Glad, I; Harada, N; Kristensen, VN; Linegjaerde, OC; Lønning, PE; Sørlie, T; Yoshimura, N1
Banerjee, S; Barker, P; Dowsett, M; Folkerd, L; Iqbal, J; Smith, IE1
Amsterdam, LL; Bulun, SE; Gentry, W; Jobanputra, S; Rubin, SD; Wolf, M1
Gradishar, WJ3
Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E1
Kopans, DB; Ryan, PD; Sgroi, DC1
Thönnessen, D; Wenz, F1
Aghi, M; Brisman, JL; Kiehl, TR1
Glassman, R; Stebbing, J1
Chowdhury, S; Ellis, PA1
Chen, V1
Ando, M; Matsuyama, Y; Ooi, Y; Rai, Y; Sagara, Y; Takahama, T1
Jiang, ZF; Song, ST1
Doody, D; Dowsett, M; Folkerd, E; Haynes, B1
Dickler, M1
Grimm, C; Hefler, LA; Nagele, F; van Trotsenburg, M1
Esteva, FJ; Hortobagyi, GN1
Attilakos, G; Fox, R1
Baum, M; Cuzick, J; Dowsett, M; Houghton, J; Howell, T; Wale, C1
Dowsett, M; Johnston, SR; Martin, LA1
Abram, P; Vergote, I1
Hoffman, MA; Khan, A1
Chen, S; Itoh, T; Kijima, I1
Howell, A; Locker, GY1
Denes, AE1
Bolat, F; Erkanli, S; Haberal, A; Kayaselcuk, F; Kuscu, E; Sakalli, H1
Haberstich, R; Rodier, JF; Tuech, JJ; Wilt, M1
Dubinett, SM; Fishbein, MC; Garban, HJ; Goodglick, L; Marquez-Garban, DC; Pietras, RJ; Weinberg, OK1
Demonty, G1
Norjavaara, E; Reiter, EO1
Bardi, M; Barrett, GM; Guillén, AK; Mori, A; Shimizu, K1
Mouridsen, HT; Robert, NJ1
Noguchi, S; Okishiro, M; Taguchi, T; Tamaki, Y; Tanji, Y; Yoneda, K1
Bertelli, G; Bertolotti, L; Castiglione, F; Del Mastro, L; Fusco, O; Garrone, O; Leonard, RC; Merlano, M; Occelli, M; Pepi, F1
Sereda, D; Werth, VP1
Tuma, RS1
Clapper, JA; Hilleson-Gayne, CK1
Adamsbaum, C; Bougnères, P; Bouvattier, C; Carel, JC; Lahlou, N; Lefevre, H1
Rennie, I; Rundle, P1
A'Hern, R; Ashley, S; Boeddinghaus, I; Detre, S; Dixon, JM; Dowsett, M; Ebbs, SR; Francis, S; Griffith, C; Hills, M; Salter, J; Skene, A; Smith, IE; Walsh, G1
Buzdar, AU; Cuzick, J1
Shan, ZZ; Shen, KW; Wang, LP1
Gerber, B; Janni, W; Krause, A; Kundt, G; Makovitzky, J; Mylonas, I; Reimer, T1
Gltick, S1
Abrial, C; Cabrespine, A; Chollet, P; Cure, H; Durando, X; Ferriere, JP; Kwiatkowski, F; Leheurteur, M; Mouret-Reynier, MA; Penault-Llorca, F1
Bunck, MC; Gooren, LJ; Lips, P; Toorians, AW1
Bines, J; Buzdar, AU; Cataliotti, L; de Oliveira, CT; Dube, P; Noguchi, S; Petrakova, K; Takatsuka, Y1
Langenegger, T; Schiesser, D; Thürlimann, B; Wahl, P1
Nakagawa, Y; Ohzeki, T1
Fujii, S; Fukui, A; Kimura, H; Mizunuma, H1
Grana, G1
Geyer, H; Guddat, S; Haenelt, N; Koch, A; Kohler, M; Mareck, U; Opfermann, G; Schänzer, W; Thevis, M1
Dowsett, M; Hayes, D; Lønning, PE; Santen, RJ; Smith, IE; Walsh, G; Yap, YS1
Cummings, MH; Jackson, A; Knight, JS; Satchidanand, RY; Yiangou, C1
Beer, TM; Deloughery, TG; Luoh, SW; Lycette, JL1
Canorea, F; Del Castillo, A; Gil, JM; González, P; Rubio-Terrés, C1
Ballester Navarro, I; Carrato Mena, A; Maciá Escalante, S; Pons Sanz, V; Rodríguez Lescure, A1
Amadori, D; Benedetto, C; Boccardo, F; Buzzi, F; Distante, V; Fini, A; Franchi, R; Guglielmini, P; Massidda, B; Mesiti, M; Paladini, G; Porpiglia, M; Restuccia, N; Rinaldini, M; Rubagotti, A; Scali, S; Sismondi, P1
Duffy, MJ1
Brown, MM; Manquez, ME; Shields, CL; Shields, JA1
Buzdar, AU; Cuzick, J; Guastalla, JP; Nabholtz, JM1
Giordano, SH; Hortobagyi, GN1
Adams, JE; Clack, G; Cuzick, J; Dowsett, M; Eastell, R; Hannon, RA1
Freeman, SA; Modesitt, SC1
Buzdar, A; Cuzick, J; Distler, W; Hoctin-Boes, G; Houghton, J; Howell, A; Locker, GY; Nabholtz, JM; Wale, C1
Alran, S; Campana, F; de Cremoux, P; Languille, O; Malka, I; Rosty, C; Salmon, RJ; Sigal-Zafrani, B1
Dewar, R; Rayson, D; Skedgel, C; Younis, T3
Borstnar, S; Cufer, T; Mrhar, A; Piskur, P; Sonc, M1
Inoue, K; Nagamoto, N; Nakahara, O; Ohsako, T; Sakamoto, N; Yoshida, Y1
Rustad, R1
Delameter, P; Hochberg, Z; Kreher, NC; Pescovitz, OH; Tiulpakov, A1
El-Hajj, II; El-Saghir, NS; Makarem, JA; Otrock, ZK1
Dodwell, D; Pippen, J1
Barker, P; Cella, D; Cuzick, J; Fallowfield, L; Howell, A; Locker, G1
Ioannidis, JP; Mauri, D; Pavlidis, N; Polyzos, NP1
Davis, WA; Maifeld, M; Sipe, CS; Van Voorhis, BJ1
Annemans, L; Moeremans, K1
Fathollahi, Y; Moradpour, F; Naghdi, N1
Brueggemeier, RW1
Habib, MJ; Hammad, MA; Hussain, MD; Khan, MA; Megrab, NA; Sammour, OA; Zidan, AS1
Bujanda, L; Piérola, A; Zapata, E; Zubiaurre, L1
Goodwin, GM1
Ballerini, G; Cavalli, F; Conti-Beltraminelli, M; Forni, V; Goldhirsch, A; Graffeo, R; Mainetti, C; Pagani, O; Pianca, S; Richetti, A; Ruggeri, M; Schönholzer, C1
Monnier, A1
DiLeonardo, M; Gibbons, G; Resnik, KS1
Chien, AJ; Goss, PE1
Dexter, DT; Dhankot, A; Gillies, GE; McArthur, S; Murray, HE1
Boccardo, F; Gnant, M; Greenwood, M; Jakesz, R; Jonat, W; Kaufmann, M; Rubagotti, A; Zuna, I1
Carlini, P; Ciccarese, M; Cognetti, F; Fabi, A; Felici, A; Ferretti, G; Milella, M; Nuzzo, C; Papaldo, P; Ruggeri, EM1
Galid, A; Gnant, MF; Grampp, S; Hausmaninger, H; Jakesz, R; Kaessmann, H; Luschin-Ebengreuth, G; Menzel, C; Mittlboeck, M; Mlineritsch, B; Piswanger-Soelkner, JC; Schmid, M1
Chu, QD; Li, BD; McDonald, JC1
Kaya, U; Kuscu, E; Oktem, M; Ozen, O; Zeyneloglu, HB1
de la Cruz, L; Herrerias-Gutierrez, JM; Jiménez-Sáenz, M; Padron, JR; Romero-Vazquez, J1
Endo, W; Fujie, Y; Fukunaga, H; Hojo, S; Maeura, Y; Okada, Y; Ota, H; Yoshioka, S1
Inoue, K; Nagamoto, N; Ohsako, T; Tanaka, E; Yoshida, Y1
A'Hern, R; Detre, S; Dixon, JM; Dowsett, M; Ebbs, SR; Hills, M; Salter, J; Skene, A; Smith, IE; Walsh, G1
Lewis, S1
De Nucci, G; Hamamoto, D; Ilha, J; Mendes, GD; Pereira, Ados S1
Imai, H; Kuroi, K; Ohsumi, S; Ono, M; Shimozuma, K1
Cella, D; Dobrez, D; Gandhi, SK; Locker, GY; Mansel, R; Sorensen, S1
Ellis, MJ; Rigden, CE1
Eisner, A; Falardeau, J; Samples, JR; Toomey, MD; Vetto, JT1
Carmona-Bayonas, A1
Cianfrocca, M; Wolff, AC1
Nortier, JW; Seynaeve, C; van de Velde, CJ; van Nes, JG1
Akçali, Z; Boğa, S; DemIrhan, B; Karakuş, S; Sahin, FI; Yilmaz, Z1
Budd, GT; Margolis, R; Singh, AD1
Chishima, T; Ichikawa, Y; Inui, K; Ishikawa, T; Matsumoto, C; Momiyama, N; Shimada, H; Togo, S1
Azim, AA; Costantini-Ferrando, M; Lostritto, K; Oktay, K1
Draxler, W; Gnant, M; Haider, K; Hammer, J; Handl-Zeller, L; Hofbauer, F; Jakesz, R; Kapp, K; Kwasny, W; Luschin-Ebengreuth, G; Pakisch, B; Pöstlberger, S; Pötter, R; Reiner, G; Rottenfusser, A; Schmid, M; Sedlmayer, F; Stierer, M; Taucher, S; Tausch, C1
Jonat, W; Mundhenke, C1
Barnes, L; Crowley, V; Daly, P; Darby, C; Roche, M1
Akashi-Tanaka, S; Ando, M; Fujiwara, Y; Fukutomi, T; Hasegawa, T; Kinoshita, T; Omatsu, M; Seki, K; Shien, T; Shimizu, C; Terada, K1
Lian, ZQ; Yang, MT1
Hou, KY; Ji, JF; Jia, TZ; Li, HP; Wang, MP; Wang, YF; Xiao, Y; Zhao, HM1
Aapro, M; Cannon, H; Georgiou, V; Leto di Priolo, S; Wengström, Y1
Abrams, JS; Cameron, DA; Castiglione, M; Davidson, NE; Goss, PE; Ingle, JN; Livingston, RB; Martino, S; Muss, HB; Norton, L; Palmer, MJ; Pater, JL; Perez, EA; Piccart, MJ; Pritchard, KI; Robert, NJ; Shepherd, LE; Tu, D1
Alimonti, A; Bria, E; Carlini, P; Cognetti, F; Cresti, N; Di Cosimo, S; Fabi, A; Ferretti, G; Giannarelli, D; Michelotti, A; Milella, M; Papaldo, P; Pellegrini, M; Ricci, S; Ruggeri, EM; Salesi, N1
Cheng, ML; Hsieh, JN; Wang, NM; Wu, HH1
Baydal, R; Blanes, MD; Chirivella, I; Colio, JM; De-la-Morena, E; Laforga, J; Lluch, A; Perez-Fidalgo, JA; Roselló, S1
Kafy, S; Tulandi, T1
Bell, R; Lewis, J1
Berstein, LM; Bozhok, AA; Dashyan, GA; Ivanov, VG; Kletzel, A; Melnikova, OA; Paltuev, RM; Semiglazov, VF; Semiglazov, VV; Ziltsova, EK1
Ashworth, A; Dexter, T; Dixon, JM; Dowsett, M; Drury, S; Evans, DB; Fenwick, K; Larionov, A; Mackay, A; Miller, WR; Urruticoechea, A; White, S; Young, O1
Lin, NU; Winer, EP1
Eidtmann, H; Gademann, G; Hilfrich, J; Jonat, W; Kaufmann, M; von Minckwitz, G; Zuna, I1
Gralow, JR1
Barghout, V; Delea, T; Karnon, J1
Carroll, C; De Nigris, E; Hind, D; Simpson, E; Ward, S; Wyld, L1
Brun, J; Confavreux, CB; Delmas, PD; Fontana, A; Guastalla, JP; Munoz, F1
Benedict, A; Fallowfield, L; Jones, D; Locker, G; Mansel, R1
Gallagher, J; Habin, K; Winters, L1
Bruno, V; Caruso, A; Matrisciano, F; Melchiorri, D; Molinaro, G; Motolese, M; Nicoletti, F; Orlando, R; Togna, G1
Burnett, AF; Hardman, MP; Roman, JJ; Santin, AD1
Basso, AD; Black, S; Kirschmeier, P; Liu, G; Liu, M; Long, BJ; Marrinan, CH; Robert Bishop, W; Taylor, SA1
Clark, E; Detre, S; Dowsett, M; Llombart, A; Magill, P; Mayordomo, JI; Salter, J; Skene, A; Smith, IE; Walsh, G1
Badawy, A; Mosbah, A; Shady, M1
Abreu, P; Banke-Bochita, J; Goss, PE; Hadji, P; Subar, M; Thomsen, T1
Martens, HA; Posthumus, MD; Schröder, CP; van der Eerden, PJ; Willemse, PH1
Chander, SK; Jackson, T; Potter, BV; Purohit, A; Reed, MJ; Trusselle, MN; Woo, LW2
Makedos, GA; Papanicolaou, AN; Varelas, FK; Vavatsi-Christaki, N; Vlassis, GD1
Douchi, T; Iwamoto, I; Kosha, S; Rai, Y; Sagara, Y; Yonehara, Y1
Kamby, C; Lindberg, H; Nielsen, DL; Tuxen, M1
Cufer, T1
Fabian, CJ1
O'Shaughnessy, J1
Perez, EA1
Altundag, K; Dede, D; Gullu, I; Harputluoglu, H1
Barton, JC; Bertoli, LF1
Jahanzeb, M1
Schagen, SB; Schilder, CM1
Graham, PH1
Borg, S; De Lafontan, B; Laroche, M; Lassoued, S; Roché, H1
Gurates, B; Kumru, S; Sandal, S; Yildiz, AA; Yilmaz, B1
Antoni, G; Bollet, MA; Campana, F; Cottu, P; Dendale, R; Fourquet, A; Kirova, YM; Laki, F; Pierga, JY; Salmon, R; Sigal-Zafrani, B1
Bershteĭn, LM; Bozhok, AA; Damenia, AO; Dashian, GA; Donskikh, RV; Ivanov, VG; Klettsel', AA; Kochetova, IA; Krivorot'ko, PV; Mel'nikova, OA; Paltuev, RM; Semiglazov, VF; Semiglazov, VV; Tonuzov, EE; Voskresenskiĭ, DA; Zernov, KIu; Zhil'tsova, EK1
Cooper, BC; Stilwill, SE1
Clack, G; Eastell, R; Finkelman, RD; Fraser, WD; Hannon, RA; Lakner, G; McCloskey, EV; Miyamoto, A1
Altundag, K; Dizdar, O; Harputluoglu, H1
Buxeraud, J; Chulia, AJ; Fagnere, C; Pouget, C; Yahiaoui, S1
Kotsis, L; Kovács, O; Krasznai, G1
Balme, B; Cavailhes, A; Skowron, F; Trancart, M1
Brodie, AM; Buzdar, AU; Come, SE; Coombes, RC; Goss, PE; Ingle, JN; Johnston, SRD; Miller, WR; Pritchard, KI; Winer, EP; Zujewski, JA1
Prowell, TM; Stearns, V1
Dadak, C; Gnant, M; Greil, R; Hofbauer, F; Jakesz, R; Kubista, E; Kwasny, W; Mlineritsch, B; Renner, K; Rücklinger, E; Samonigg, H; Schmid, M; Stierer, M; Tausch, C1
Akiyama, F; Ikeda, T; Imoto, S; Inaji, H; Kurosumi, M; Noguchi, S; Sakamoto, G; Takatsuka, Y; Tsuda, H; Watanabe, T1
Wengström, Y1
Baum, M; Buzdar, A; Cuzick, J; Forbes, JF; Howell, A; Tobias, JS1
Eisen, A; Messersmith, H; Pritchard, KI; Shelley, W; Trudeau, M1
Bishop, K; Desrosiers, P; Gonzalez de Pijem, L; Hsiang, HY; Klein, KO; Mauras, N; Miyamoto, A; Rapaport, R; Schwartz, ID; Singh, RJ1
Abdel Aal, I; Abulatta, M; Badawy, A1
Miller, WR1
Toi, M1
Akcali, C; Demirtas, OC; Inaloz, S; Karakok, M; Kirtak, N1
Asnis-Alibozek, A; LaFountain, A; Mayer, E; Partridge, AH; Taylor, BS; Winer, E1
Allred, C; Bishop, H; Buzdar, A; Carder, P; Cussac, AL; Cuzick, J; Dowsett, M; Ellis, I; Forbes, J; Houghton, J; Knox, F; Knox, J; Larsimont, D; Mallon, E; Quinn, E; Salter, J; Sasano, H; Speirs, V; Wale, C; Williams, N1
Baracat, EC; Borsari, R; Bozzini, N; Hilário, SG1
Kodama, H; Matsumoto, M; Nakatani, K; Nishioka, A; Ogawa, Y; Sasaguri, S; Tanaka, Y; Ue, H1
Blackwell, KL; Herold, CI2
Ikeda, M; Kurebayashi, J; Miyake, A; Nakashima, K; Nomura, T; Shiiki, S; Sonoo, H; Tanaka, K; Yamamoto, Y1
Carpenter, R1
Adams, JE; Beckmann, MW; Clack, G; Coleman, RE; Cuzick, J; Eastell, R; Hannon, RA; Howell, A; Mackey, JR1
Chaigneau, L; Demarchi, M; Lorgis, V; Maurina, T; Meaux-Ruault, N; N'guyen, T; Pivot, X; Stein, U; Thiery-Vuillemin, A; Villanueva, C1
Aapro, M1
Pennery, E1
Ucci, G1
Coates, A; Mouridsen, H; Thürlimann, B1
A'Hern, RP; Cameron, DA; Dixon, JM; Dowsett, M; Folkerd, E; Macaskill, EJ; McHugh, M; Murray, J; Renshaw, L; Young, O1
Alkasi, O; Beckmann, MW; Fasching, P; Jonat, W; Maass, N; Meinhold-Heerlein, I; Zaki, R1
Habib, MJ; Hammad, MA; Khan, MA; Megrab, NA; Sammour, OA; Zidan, AS1
Diedrich, K; Griesinger, G; Schröer, A; Schultze-Mosgau, A; von Otte, S1
Eugster, EA; Lowe, ES; Mieszczak, J; Plourde, P1
Kihara, M; Miyauchi, A1
Dixon, JM; Dowsett, M; Evans, DB; Murray, J; Renshaw, L; Thomas, JS; White, S; Williams, L; Young, OE1
Brodie, A; Goloubeva, OG; Macedo, LF; Sabnis, GJ1
A'hern, R; Banerjee, S; Dowsett, M; Ghazoui, Z; Martin, LA; Pancholi, S; Smith, IE1
Eisner, A; Falardeau, J; Toomey, MD; Vetto, JT1
Adrover, E; Barnadas, A; Calvo, L; de la Haba, J; Estevez, LG; Gil, M; Llombart, A; Sánchez-Rovira, P1
Fields, MM; Mellington, TE1
Gligorov, J; Nabholtz, JM1
Andersen, AN; Andersen, CY; Bangsbøll, S; Freiesleben, NL; Loft, A; Lossl, K1
Akgul, B; Camci, C; Kalender, ME; Karakok, M; Sevinc, A; Turk, HM1
Doggrell, SA1
Amory, JK; Page, ST; Roth, MY1
Narahara, H; Nasu, K; Takai, N; Tsuno, A1
Plosker, GL; Sanford, M1
Kurmann, PT; Nemitz, N; Van Linthoudt, D1
Bellone, S; McKenney, JK; Santin, AD; Shah, HR; Stone, PJ1
Chen, S; Lui, K; Mori, T; Tamura, T; Zhou, D1
Bohrer, J; Chen, CC; Falcone, T1
Bogliolo, S; Costantini, S; Dugnani, MC; Ferrero, S; Moioli, M; Papadia, A; Valenzano Menada, M1
Burnett-Bowie, SA; Dere, ME; Leder, BZ; Lee, H; Roupenian, KC1
Grossman, J; Hahn, BH; La Cava, A; Wong, M1
Nagykálnai, T1
Kahán, Z1
Apostolou, C; Dotsikas, Y; Kousoulos, C; Loukas, YL1
Kamiura, S; Masuhara, K; Takeda, T1
Chen, S; Lui, K; Masri, S; Phung, S; Wang, X; Ye, J; Zhou, D1
Vestergaard, P1
Bianco, AR; Buzdar, AU; Cuzick, J; Eastell, R; Forbes, JF; Sapunar, F; Sestak, I1
Eisner, A; Falardeau, J; Thielman, EJ; Vetto, JT1
Bjelic-Radisic, V; Dubsky, P; Fitzal, F; Gnant, M; Greil, R; Jakesz, R; Kainberger, F; Kässmann, H; Kubista, E; Luschin-Ebengreuth, G; Marth, C; Menzel, C; Mittlböck, M; Mlineritsch, B; Piswanger-Sölkner, JC; Ploner, F; Samonigg, H; Seifert, M; Steger, G; Wohlmuth, P1
Gibson, K; O'Bryant, CL1
Chlebowski, RT2
Sarkar, K; Yang, H1
Ambroisine, LM; Atkins, L; Cuzick, J; Fallowfield, LJ; Howell, A; Jenkins, VA1
Chlebowski, RT; Col, N1
Gurwitz, D; Newman, W1
A'Hern, R; Bhatnagar, AS; Chaudri Ross, HA; Dowsett, M; Eiermann, W; Ellis, MJ; Evans, DB; Luo, J; Miller, WR; Smith, I; Tao, Y; von Kameke, A1
Boyle, F; Butow, P; Coates, A; Forbes, JF; Juraskova, I; Lopez, A; McCarthy, N; Reaby, L; Seccombe, M1
Janowsky, JS; Neiss, MB; Roselli, CE; Samuels, MH; Siegel, JA; Young, LA1
Aas, T; Duong, NK; Ekse, D; Evans, DB; Geisler, J; Helle, H; Lønning, PE; Nordbø, Y1
Brown, JE; Coleman, RE; Dodwell, D; Ellis, SP; Gutcher, SA; Hannon, RA; Horsman, JM; Lester, JE; Purohit, OP; Thorpe, R1
Bienkiewicz, A; Cialkowska-Rysz, A; Gora, E; Gottwald, L; Jesionek-Kupnicka, D; Korczynski, J; Morawiec, Z; Piekarski, JH; Sowa, P1
Hashida, S; Hirano, Y; Iga, K; Inukai, M; Ito, M; Kanaya, Y; Maruyama, S; Shimo, T; Yokoyama, N1
Cella, D; Cuzick, J; Fallowfield, L; Sestak, I1
Baum, M; Cuzick, J; Distler, W; Duffy, SR; Howell, A1
Aloisi, AM; Ceccarelli, I; Fiorenzani, P; Pessina, F; Sgaragli, G; Valeri, A1
Kim, SJ; Noguchi, S; Okishiro, M; Shimazu, K; Taguchi, T; Tamaki, Y; Tanji, Y1
Needleman, SJ; Tobias, JS1
Berga, SL1
Bielajew, C; Collins, B; Mackenzie, J; Stewart, A; Verma, S1
Cheung, KL; Haynes, AP; Wood, JP1
Abdelhady, H; Allam, AF; Badawy, A; Shokeir, T1
Callam, M; Glen, J; Thomas, RJ; Williams, M1
Albert, US; Hadji, P; Holzhauer, W; Kalder, M; Wagner, U; Ziller, M; Ziller, V1
Eyssette-Guerreau, S; Le Merrer, M; Pinto, G; Polak, M; Sultan, A; Sultan, C1
Bjelic-Radisic, V; Dubsky, P; Eidtmann, H; Fitzal, F; Fridrik, M; Gnant, M; Greil, R; Hubalek, M; Jakesz, R; Kwasny, W; Luschin-Ebengreuth, G; Marth, C; Menzel, C; Mlineritsch, B; Pöstlberger, S; Rücklinger, E; Samonigg, H; Schippinger, W; Seifert, M; Steger, G; Stierer, M; Tausch, C1
Konje, JC; Verma, A1
Adamicova, K; Kajo, K; Kubatka, P; Nosalova, G; Ostatnikova, D; Sadlonova, J; Sadlonova, V1
Brodie, A; Macedo, LF; Sabnis, G1
Andersen, AN; Andersen, CY; Bangsbøll, S; Freiesleben, NL; Hartwell, D; Loft, A; Lossl, K; Pedersen, AT1
Alacacioğlu, A; Bilgi, O; Erikçi, AA; Kandemir, EG; Karagöz, B; Ozgün, A; Sayan, O1
Furukawa, T; Manabe, S; Matsuyama, T; Saitoh, W; Sakurai, K; Sanbuissho, A; Shirai, M; Teranishi, M1
Nothnick, WB; Zhang, X1
Abreu, P; Cameron, DA; Campos, SM; Guastalla, JP; Subar, M; Winer, EP1
Barker, LC; Brand, IR; Crawford, SM1
Azria, D; Belkacémi, Y; Gligorov, J; Jacot, W; Ozsahin, M; Romieu, G; Zaman, K1
Cobb, P; Henry, D; Houts, AC; Kulig, K; Schwartzberg, LS; Senecal, F; Stepanski, EJ; Walker, MS1
Bandou, H; Inaki, N; Kadoya, S; Kotake, M; Kurokawa, M; Morita, K; Murata, T; Takayanagi, T; Yamada, T; Yamamoto, M; Yoshino, H1
Akashi-Tanaka, S; Ando, M; Fujiwara, Y; Hojo, T; Katsumata, N; Kinoshita, T; Kouno, T; Shibata, T; Shien, T; Shimizu, C; Terada, K; Yoshida, M; Yoshimura, K1
Al-Sukhun, S; Chollet, P; Durando, X; Ferriere, JP; Mouret-Reynier, MA; Nabholtz, JM; Van Praagh, I1
Chen, Y; Gonzalez-Angulo, A; Guggisberg, N; Hennessy, B; Jorda, M; Mills, GB; Slingerland, JM; Tan, CK1
Jinta, E; Sakurai, T; Shimizu, S; Suzuma, T; Umemura, T; Yoshimura, G1
Agbo, F; Bishop, K; Emeribe, U; Lowe, E; Mauras, N; Merinbaum, D1
Wenz, F1
Aebi, S; Gelber, RD1
Calabrich, A; Katz, A; Saad, ED1
Gerber, B; Reimer, T1
Berruti, A; Buttigliero, C; Dogliotti, L1
Dong, PW; Li, LN1
Aloisi, AM; Ceccarelli, I; Maddalena, M; Rossi, A; Weber, E1
Agrawal, A; Aleskandrany, M; Cheung, KL; Ellis, IO; Green, AR; Hassell, K; Morgan, DA; Okunade, G; Paish, EC; Winterbottom, L; Ying, M1
Ando, M; Baba, S; Dokiya, F; Douchi, T; Kosha, S; Matsuyama, Y; Ohi, Y; Rai, Y; Sagara, Y; Tamada, S1
Fischgräbe, J; Götte, M; Kiesel, L; Radke, I; Smollich, M; Wülfing, P1
Bharathi, DV; Nagaraju, B; Nandan, SR; Rao, VS; Ravindranath, LK; Reddy, SS; Reddy, YR1
Ayata, A; Bilgi, O; Kandemir, EG; Karagöz, B; Ozgün, A; Türken, O; Unal, M; Uzun, G1
Barisik, NO; Bilici, A; Gumus, M; Salepci, T; Salman, T; Seker, M; Ustaalioglu, BB; Yaylaci, M1
Barbara, G; Berlanda, N; Crosignani, PG; Fedele, L; Somigliana, E; Vercellini, P1
Beiner, M; Ben-Baruch, G; Davidzon, T; Fridman, E; Korach, J; Perri, T1
Bershteĭn, LM; Danilova, MA; Gershfel'd, ED; Kovalevskiĭ, AIu; Maksimov, SIa; Meshkova, IE; Poroshina, TE; Tsyrlina, TE; Turkevich, EA1
Bachleitner-Hofmann, T; Blaha, P; Dubsky, P; Fitzal, F; Gnant, M; Jakesz, R; Steger, G1
Dewar, J; Ellis, MJ; Feltl, D; Lindemann, J; Llombart-Cussac, A; Macpherson, E; Robertson, JF; Rolski, J1
Amakye, D; Bauerfeind, I; Buzdar, A; Chia, S; Chlebowski, R; Cutuli, B; Cuzick, J; Hadji, P; Linforth, R; Maass, N; Noguchi, S; Robidoux, A; Verma, S1
Kaide, A; Kodama, K; Matsuoka, J; Ootawa, Y; Ootsuka, N; Watanabe, N1
Amir, E; Clemons, M; Cole, DE; Dowsett, M; Dranitsaris, G; Folkerd, E; Freedman, OC; Hanna, W; Kahn, H; O'Malley, F; Verma, S1
Cuzick, J; Sapunar, F; Sestak, I1
Gobello, C; Gonzalez, G; Guendulain, C; Maffrand, C1
Noguchi, S; Taguchi, T1
Blinman, P; Tattersall, MH1
Baselga, J; Cortes, J1
Bapsy, PP; Clemens, MR; Feyereislova, A; Jahn, M; Jones, A; Kaufman, B; Lehle, M; Mackey, JR; Révil, C; Tjulandin, S; Vaid, A; Wardley, A1
Barañao, RI; Bilotas, M; Meresman, G; Stella, I; Sueldo, C1
Burnett-Bowie, SA; Leder, BZ; Lee, H; McKay, EA1
Lazarus, P; Sun, D1
Kameda, N; Nihon-Yanagi, Y; Okazumi, S; Ueda, T1
Doyen, J; Ferrero, JM; Fontana, X; Italiano, A; Largillier, R; Thyss, A1
Bonanni, B; Cassano, E; Cazzaniga, M; Decensi, A; Gandini, S; Guerrieri-Gonzaga, A; Johansson, H; Lien, EA; Luini, A; Macis, D; Oldani, S; Pelosi, G; Serrano, D1
Chen, S; Masri, S; Phung, S; Wang, X1
El-Mardenly, G; Ezzat, Y; Gheita, TA; Hammam, W; Sayed, S1
Brites, MM; Figueiredo, A; Frutuoso, C; Saleiro, S; Santiago, F1
Bremec, T; Demsar, J; Luzar, B; Pavlović, MD1
Berberoglu, M; Bilir, P; Engiz, O; Ocal, G; Siklar, Z1
Jangid, AG; Joshi, SS; Pabrekar, PN; Pudage, AM; Tale, RH; Vaidya, VV1
Hirose, T; Honda, J; Kira, M; Nagao, T; Nakamura, Y; Sasa, M; Takahashi, M; Tangoku, A; Zembutsu, H1
Badawy, AM; Dritsas, C; Mauri, D; Polyzos, NP; Tzioras, S; Valachis, A1
Dixon, JM; Hannon, R; Macaskill, EJ; McCaig, FM; McHugh, M; Murray, J; Renshaw, L; Williams, L; Young, O1
Baumann, CK; Castiglione-Gertsch, M1
Brodie, A; Chen, S; Fischgräbe, J; Götte, M; Kiesel, L; Macedo, LF; Radke, I; Smollich, M; Wülfing, P1
Auboire, L; Landy, S; Le Hello, C; Maïza, D; Perrot, JY1
Khosla, S1
Aldemir, M; Altuğ, U; Cakan, M; Topcuoglu, M1
Inaji, H; Ishitobi, M; Komoike, Y; Koyama, H; Motomura, K; Nishiyama, K1
Bastit, L; Briot, K; Kloos, I; Roux, C; Tubiana-Hulin, M1
Kubota, K; Kuwayama, T; Nakagawa, T; Sato, T; Sugihara, K; Suzuki, S1
Enomoto, T; Hayashi, K; Kondou, Y; Kosaka, Y; Kuranami, M; Sengoku, N; Sugiyama, N; Watanabe, M1
Batteux, F; Chapron, C; Chéreau, C; Leconte, M; Ngô, C; Nicco, C; Weill, B1
Apffelstaedt, JP; Barlow, D; Campone, M; Clack, G; Eastell, R; Hannon, RA; Mackey, JR; Makris, A; Van Poznak, C1
Bromfield, EB; Drislane, FW; Dworetzky, BA; Farina, EL; Fowler, KM; Herzog, AG; Schomer, DL; Smithson, SD1
A'hern, R; Anderson, H; Crowder, RJ; Dowsett, M; Dunbier, AK; Ellis, MJ; Folkerd, EJ; Ghazoui, Z; Hoog, J; Nerurkar, A; Osin, P; Parker, JS; Perou, CM; Smith, IE1
Fang, L; He, Z; Liu, J; Mu, L; Sun, L; Xi, H; Yang, Y; Zhao, D; Zhao, N; Zhao, Y; Zheng, N1
Arnould, L; Coudert, B; Favier, L; Fumoleau, P; Guiu, S1
Beriwal, S; Bhargava, R; Dabbs, DJ; O'Connor, SM1
Nothnick, WB2
Altintas, D; Cetinkaya, MB; Kandemir, B; Kokcu, A; Tosun, M1
Baehner, FL; Baum, M; Bugarini, R; Buzdar, A; Cuzick, J; Dowsett, M; Dunbier, A; Forbes, J; Howell, A; Mallon, EA; Quinn, E; Salter, J; Shak, S; Wale, C1
Anderson, E; Arena, FP; Bacus, S; Cora, EM; Cristofanilli, M; Curcio, E; Kroener, JF; Magill, PJ; Mangalik, A; Rabinowitz, I; Royce, M; Valero, V; Watkins, C1
Bowers, CY; Iranmanesh, A; Veldhuis, JD1
Adamietz, B; Beckmann, MW; Buchholz, S; Dall, P; Dilbat, G; Fasching, PA; Haeberle, L; Hein, A; Heinrich, S; Heusinger, K; Jud, SM; Lex, B; Loehberg, CR; Rauh, C; Reichler, B; Rix, N; Schulz-Wendtland, R1
Maidment, SL1
Lteif, A; Mitre, N1
Crossley, M; Lejbak, L; Vrbancic, M1
Batzler, A; Buzdar, AU; Desta, Z; Flockhart, DA; Goetz, MP; Ingle, JN; Northfelt, DW; Olson, JE; Perez, EA; Robson, ME; Schaid, DJ; Weinshilboum, RM; Weintraub, RA; Williard, CV1
Ikeda, Y; Kawana, K; Kozuma, S; Nakagawa, S; Oda, K; Shoji, K; Takazawa, Y; Taketani, Y; Yasugi, T1
Fadeeva, EP; Fedosenko, KV; Lisianskaia, AS; Manikhas, GM; Tapil'skaia, NI1
Cai, RG; Li, Q; Ma, F; Wang, JY; Xu, BH; Yao, SY; Yuan, P; Zhang, P1
Beckmann, MW; Benedict, A; Buchholz, S; Distler, W; Hadji, P; Harbeck, N; Jonat, W; Kaufmann, M; Kreienberg, R; Kreif, N; Lux, MP; Possinger, K; Raab, G; Schneeweiss, A; Tesch, H; Weyers, G; Wöckel, A1
Abe, H; Aihara, T; Aogi, K; Hisamatsu, K; Hozumi, Y; Imoto, S; Ito, T; Iwata, H; Masuda, N; Mitsuyama, S; Mukai, H; Nakagami, K; Ogino, N; Ohashi, Y; Ohsumi, S; Shimizu, C; Takatsuka, Y; Tamura, M; Tanaka, S; Watanabe, T; Yamaguchi, T1
Antonopoulou, Z; Dafni, U; Gogas, H; Kalogerakos, K; Koukouras, D; Lazarou, S; Markopoulos, C; Misitzis, J; Papadiamantis, J; Polychronis, A; Sarantopoulou, A; Siasos, N; Tzoracoleftherakis, E; Venizelos, B; Xepapadakis, G; Zobolas, V1
Fox, KR1
Baiardi, P; Chiorino, G; Costa, A; Da Prada, GA; Fregoni, V; Ghimenti, C; Grosso, E; Marsoni, S; Mello-Grand, M; Miller, WR; Regolo, L; Scatolini, M; Singh, V; Villani, L; Zambelli, A1
Devine, S; Sedjo, RL1
Amonkar, MM; Forbes, CA; Kessels, A; Kleijnen, J; Lykopoulos, K; Rea, DW; Riemsma, R1
Cuzick, J; Distler, W; Dowsett, M; Forbes, JF; Howell, A; Sestak, I1
Goodwin, PJ; Pritchard, KI1
Baylis, C; Beinder, E; Santmyire, BR; Venkat, V1
Bertolini, E; Letho-Gyselinck, H; Prati, C; Wendling, D1
Kaminsky, A; Khalid, MK; Labban, G; Parda, D; Trombetta, MG; Valakh, V; Werts, ED1
He, J; Li, F; Qin, F; Xiong, Z; Yu, J; Zhang, Y1
Beckmann, MW; Gnant, M; Jonat, W; Kreienberg, R; Lux, MP; Reichelt, C; Thiel, FC; Wallwiener, D1
Alexandrou, P; Dimitroulis, D; Kostakis, A; Kykalos, S; Mantas, D1
Chen, LR1
Bender, C; Blair-Belansky, H; Moore, PJ; Terhorst, L1
Arun, B; Carlson, RW; Chiv, VY; Chung, CT; Dice, K; Green, M; Phan, SC; Rivera, E; Schurman, CM; Theriault, R; Valero, V1
Li, A; Wang, Y; Xu, XY1
Agrawal, K; Mortimer, JE; Onami, S; Pal, SK1
Balja, MP; Knezević, F; Sitić, S; Stanec, M; Supić, DK; Vrdoljak, DV1
Bianco, AR; Clack, G; Duffy, S; Jackson, TL; Lansdown, M; Philips, K; Wells, M1
Eugster, EA; Fuqua, JS; Lenz, AM; Lewis, KA; Pescovitz, OH; Rahhal, S; Shulman, D1
Karato, M; Matsui, K; Nagata, T; Shimada, Y; Tazawa, K; Tsukada, K1
Markopoulos, C1
Beer, B; Hubalek, M; Meraner, V; Oberacher, H; Oberguggenberger, A; Schubert, B1
Delea, TE; Guo, A; Lipsitz, M1
Abe, M; Kiniwa, M; Matsuo, K; Nakagawa, F; Noguchi, S; Nukatsuka, M; Saito, H; Shibata, J; Uchida, J1
Dixon, JM; Dixon, OM; Fallowfield, LJ; Langridge, C; Macaskill, EJ; McCaig, F; McHugh, M; Murray, J; Renshaw, L; Williams, L; Young, OE1
Avellar, MC; Fernandes, SA; Gomes, GR; Lazari, MF; Porto, CS; Siu, ER; Yasuhara, F1
Agrawal, A; Cheung, KL; Dowsett, M; Folkerd, E; Robertson, JF; Winterbottom, L1
Adachi, JD; Gordon, C; Papaioannou, A; Szabo, KA; Tozer, R; Webber, CE1
Batzler, A; Chapman, JA; Ellis, MJ; Flockhart, DA; Goetz, MP; Goss, PE; Ingle, JN; Jenkins, GD; Kubo, M; Liu, M; Mushiroda, T; Nakamura, Y; Pater, J; Pritchard, KI; Rohrer, DC; Schaid, DJ; Shepherd, L; Stearns, V; Wang, L; Weinshilboum, RM1
Mylander, WC; Rosman, M; Tafra, L1
Ewart, EK; Krell, J; Stebbing, J1
Amant, F; Berteloot, P; Blomme, C; De Jonge, E; Depypere, H; Neven, P; Timmerman, D; Van Calster, B; Van de Putte, G; Van den Broecke, R; Van Ginderachter, J; Van Huffel, S; Vergote, I; Vlaemynck, G; Vlasselaer, J1
Facina, G; Gebrim, LH; Logullo, AF; Mattar, A; Nonogaki, S; Soares, FA1
Buzdar, AU; Kelly, CM2
Adams, J; Beckmann, MW; Clack, G; Coleman, RE; Cuzick, J; Eastell, R; Howell, A; Mackey, J1
Chen, Z; Feng, J; Gu, K; Jiang, Z; Shao, Z; Song, S; Wang, C; Wang, J; Xu, B; Yang, J; Yu, S; Zhang, F; Zhang, Y1
Chung, GG; Cohen, P; Creswell, K; Eng-Wong, J; Herbolsheimer, P; Isaacs, C; Liu, MC; Novielli, A; Ottaviano, Y; Slack, R; Smith, KL; Warren, R; Wilkinson, M1
Tang, SC1
Inaji, H; Ishitobi, M; Komoike, Y; Koyama, H; Motomura, K; Nagase, H; Noguchi, S1
Baum, M; Buzdar, A; Cuzick, J; Dowsett, M; Forbes, JF; Howell, A; Sestak, I1
Dobbins, TA; Drew, AK; Harris, CA; Pearson, S; Ward, RL1
Gnant, M1
Amrhein, J; Armstrong, J; De Luca, F; Kulshreshtha, B; Mauras, N; McCormick, K; Melezinkova, H; O'Brien, S; Reiter, EO1
Fujimoto, A; Goto, K; Ichinose, Y; Kobayashi, T; Sasaoki, T; Uchida, S1
Borgia, JA; Mufson, EJ; Overk, CR1
Cochrane, RA; Davie, MW; Powell, DE1
Desta, Z; Flockhart, DA; Jeter, S; Kadlubar, SA; Kamdem, LK; Liu, Y; Ogburn, E; Ramirez, J; Ratain, MJ; Shahverdi, K; Stearns, V; Ward, BA1
Kawachi, H; Kubota, K; Kuwayama, T; Nakagawa, T; Oda, G; Sato, T; Sugihara, K; Yamamoto, K1
Christiaens, MR; De Smet, L; Dieudonné, AS; Henry, NL; Leunen, K; Lintermans, A; Morales, L; Neven, P; Pans, S; Paridaens, R; Timmerman, D; Van Calster, B; Van Hoydonck, M; Vergote, I; Verhaeghe, J; Verschueren, K; Westhovens, R; Wildiers, H1
Inaji, H; Ishitobi, M; Komoike, Y; Koyama, H; Motomura, K; Nakahara, S1
Aihara, T; Hozumi, Y; Masuda, N; Ohashi, Y; Ohsumi, S; Saito, T; Suemasu, K; Takehara, M; Takei, H2
Järhult, J1
Bock, D; Diamond, MP; Hemsey, G; Schertz, JC; Tredway, D2
Anderson, H; Buffa, FM; Detre, S; Dexter, T; Dowsett, M; Dunbier, AK; Ghazoui, Z; Harris, AL; Salter, J; Smith, IE1
Cirillo, G; Coppola, F; del Giudice, EM; Grandone, A; Perrone, L; Santarpia, M1
Anderson, H; Arteaga, CL; Balko, JM; Dowsett, M; Dunbier, A; Ghazoui, Z; González-Angulo, AM; Miller, TW; Miller, WR; Mills, GB; Shyr, Y; Wu, H1
Aihara, T; Hozumi, Y; Mukai, H; Ohashi, Y; Ohsumi, S; Shimozuma, K; Shinji, M; Takatsuka, Y1
Schertz, JC; Tredway, DR1
Doughty, JC1
Tannock, IF1
Candeloro, G; Desideri, G; Necozione, S; Piazze, J; Rea, S; Recchia, CO; Recchia, F1
Deshpande, PB; Karthik, A; Kumar, AR; Nayak, UY; Reddy, MS; Shavi, GV; Udupa, N1
Arun, B; Brown, PH; Castiglione, M; Cuzick, J; DeCensi, A; Dunn, B; Forbes, JF; Glaus, A; Howell, A; Vogel, V; von Minckwitz, G; Zwierzina, H1
Anderson, H; Dowsett, M; Dunbier, AK; Ghazoui, Z; Parker, JS; Perou, CM; Salter, J; Smith, IE1
Bagalà, C; Barone, C; Basso, M; Cerchiaro, E; D'Argento, E; Inno, A; Marsico, VA; Vecchio, FM1
Buzdar, AU; Cuzick, J; Dowsett, M; Forbes, J; Howell, A; Mallon, E; Pineda, S; Salter, J; Zabaglo, L1
Chu, L; Fu, Y; Ji, DS; Liu, L; Shang, R1
Dowsett, M; Dunbier, A; Ghazoui, Z; Johnston, S; Martin, LA; Pancholi, S; Weigel, MT1
Baigent, A; Lashen, H1
Coombes, RC; Dowsett, M; Folkerd, EJ; Palmieri, C; Purohit, A; Reed, MJ; Stanczyk, FZ; Stanway, SJ; Ward, R1
Bjelic-Radisic, V; Dubsky, P; Fesl, C; Gnant, M; Greil, R; Königsberg, R; Marth, C; Mlineritsch, B; Pfeiler, G; Pöstlberger, S; Samonigg, H; Seifert, M; Singer, CF; Steger, GG; Stoeger, H; Taucher, S1
Allred, DC; Babiera, GV; DeSchryver, K; Ellis, MJ; Esserman, LJ; Guenther, JM; Hoog, J; Hunt, K; Leitch, M; Lin, L; Luo, J; Marcom, PK; Margenthaler, J; Olson, JA; Parker, JS; Prat, A; Snider, J; Suman, VJ; Unzeitig, GW; Watson, MA1
Zhang, B1
Landherr, L; Mészáros, E; Nagykálnai, T1
Anan, K; Doihara, H; Ikeda, T; Kimura, M; Komaki, K; Kusama, M; Mitsuyama, S; Yanagita, Y1
Bauernhofer, T; Dubsky, P; Eidtmann, H; Eiermann, W; Fesl, C; Forsthuber, EP; Gnant, M; Greil, R; Heck, D; Hochreiner, G; Hubalek, M; Jakesz, R; Kwasny, W; Luschin-Ebengreuth, G; Menzel, C; Mlineritsch, B; Pristauz, G; Seifert, M; Steger, G; Stoeger, H1
Buś-Kwaśnik, K; Ksycińska, H; Rudzki, PJ; Szlagowska, A1
Gallicchio, L; Helzlsouer, KJ; Macdonald, R; Rushovich, E; Wood, B1
Flynn, ER; Manigrasso, MB; Marbury, DC; Maric, C; Sawyer, RT1
Ji, HY; Lee, HS; Sohn, JH1
Arrowsmith, E; Barton, J; Burris, HA; Clark, BL; Hainsworth, JD; Rubin, M; Shipley, D; Yardley, DA1
Chen, X1
Albertelli, MA; Feldman, D; Jensen, K; Krishnan, AV; Peng, L; Swami, S; Wang, JY1
Armamento-Villareal, R; Ellis, MJ; Gao, F; Jamalabadi-Majidi, S; Napoli, N; Rastelli, AL; Taylor, ME1
Ferrero, S; Gillott, DJ; Remorgida, V; Venturini, PL1
Alés-Martínez, JE; Alvarez, I; Andrés, R; Antolín, S; Antón, A; Barnadas, A; Cámara, C; Carrasco, E; Casas, I; García Saenz, JA; Lao, J; Llombart-Cussac, A; Martín, M; Ruiz, A1
Allawi, Z; Baum, M; Cuzick, J1
Andrade, VP; Arroyo, CD; Brogi, E; King, TA; Mo, Q; Morrogh, M; Morrow, M; Patil, AJ; Qin, LX; Sakr, R1
Beyer, A; Cai, WY; Elledge, R; Fuqua, S; Hilsenbeck, S; Huang, J; Massarweh, S; Rimawi, M; Sexton, K; Tham, YL; Tsimelzon, A; Weiss, H1
Chiesa, M; Di Nardo, G; Ferrero, VE; Giamello, E; Gilardi, G; Maurelli, S; Van Doorslaer, S1
Glück, S; Gorouhi, F1
Armstrong, DK; Blackford, AL; Byrne, C; Davidson, NE; Donehower, MG; Dowsett, M; Emens, LA; Fetting, JH; Folkerd, E; Garrett-Mayer, E; Jeter, SC; Khouri, NF; Powers, PP; Prowell, TM; Skaar, TC; Stearns, V; Tarpinian, KS; Wolff, AC; Wright, LA1
Reddy, BN; Rupakula, R; Sitaram, C1
Ciruelos Gil, EM; Fernández Martínez, R; Fernández Pérez, I; Garcerá Juan, S; Illarramendi Mañas, JJ; Iranzo González Cruz, V; Lao Romera, J; Peláez Fernández, I; Puertolas Hernández, TJ; Sampedro Gimeno, T1
Cruz Jurado, J; Fernández Martínez, R; Galve Calvo, E; García Mata, J; García Palomo, A; Murillo Jaso, L; Peláez Fernández, I; Polo Marqués, E; Richart Aznar, P; Sampedro Gimeno, T1
Alba Conejo, E; Bayo Calero, J; de la Cabeza Lomas Garrido, M; de la Haba Rodríguez, J; de Toro Salas, R; González Mancha, R; Martínez Guisado, A; Ruíz Borrego, M; Sánchez Muñoz, A1
Champ, C; Gower-Thomas, K; Jones, M; Osborn, G; Vaughan-Williams, E1
Choi, J; Lu, PY; Mufson, EJ; Overk, CR; Shaw, JW; Thatcher, GR; Wang, YT1
Atilgan, D; Boztepe, O; Erdemir, F; Markoc, F; Sahin, S; Suha-Parlaktas, B1
Honda, J; Kanematsu, M; Morimoto, M; Nagao, T; Nakagawa, M; Sasa, M; Takahashi, M; Tangoku, A1
Hurria, A1
Baum, M; Buzdar, A; Cuzick, J; Dowsett, M; Forbes, JF; Howell, A; Ring, A; Sestak, I1
Bago-Horvath, Z; Böhm, G; Dubsky, P; Filipits, M; Gnant, M; Greil, R; Gruber, C; Haid, A; Jakesz, R; Jasarevic, Z; Jelen, A; Kemmerling, R; Pöstlberger, S; Rudas, M; Singer, CF1
Schmidt, C1
Hutschemaekers, S; Nieuwenhuijzen, GA; Roukema, JA; Tjan-Heijnen, VC; van der Sangen, MJ; Voogd, AC; Wink, CJ; Woensdregt, K1
A'Hern, R; Anderson, H; Bliss, J; Dowsett, M; Dunbier, A; Evans, A; Ghazoui, Z; Iskender, A; Johnson, L; Pinhel, I; Robertson, J; Robison, L; Salter, J; Skene, T; Smith, I; Wilcox, M1
Fiore, L; Lala, R; Matarazzo, P; Mussa, A; Tessaris, D; Tuli, G; Verna, F1
Chino, A; Hirasaki, Y; Namiki, T; Ogawa, K; Okamoto, H; Ueda, K1
Bao, T; Blackford, AL; Stearns, V1
Cai, RG; Li, Q; Lu, HH; Wang, JY; Xu, BH; Yuan, P; Zhang, P1
Brito, LG; Candido-dos-Reis, FJ; Magario, FA; Sabino-de-Freitas, MM1
Akar, U; Arun, B; Brewster, A; Buzdar, AU; Esteva, FJ; Green, M; Gutierrez-Barrera, A; Hortobagyi, GN; Liu, D; Rivera, E; Sneige, N; Valero, V1
Burkemper, NM; Crockett, JS1
Daru, J; Kereszturi, A; Koloszar, S; Pal, A; Pal, Z; Vajda, G1
Akiyama, F; Fujiwara, Y; Ikeda, T; Imoto, S; Inaji, H; Iwata, H; Mitsuyama, S; Miyoshi, K; Noguchi, S; Takatsuka, Y; Tamura, M1
Hawkins, N; Veenstra, D; Woods, B1
Armstrong, A; Bagust, A; Blundell, M; Boland, A; Davis, H; Dickson, R; Dundar, Y; Fleeman, N; Moonan, M; Oyee, J; Thorp, N1
Basso, U; Berton, L; Brunello, A; Coin, A; Falci, C; Manzato, E; Monfardini, S; Perissinotto, E; Pintore, G; Sergi, G; Veronese, N1
Costantino, JP; Goss, PE; Ingle, JN; Jenkins, GD; Kubo, M; McDonnell, SK; Schaid, DJ; Sinnwell, JP; Weinshilboum, RM; Wickerham, DL1
Cuzick, J; Howell, A; Mesher, D; Richmond, B; Singh, S1
Hozumi, Y; Ohashi, Y; Ohsumi, S; Shimozuma, K; Suemasu, K; Takehara, M; Takei, H1
Frederix, GW; Hövels, AM; Raaijmakers, JA; Schellens, JH; Severens, JL1
Iwase, H; Iwata, H; Kamigaki, S; Kinoshita, T; Masuda, N; Nakamura, S; Nishimura, R; Noguchi, S; Sagara, Y; Takei, H; Yanagita, Y1
Amory, JK; Heinecke, JW; Hoofnagle, AN; Page, ST; Rubinow, KB; Snyder, CN; Tang, C1
Burstein, HJ; Griggs, JJ1
Bartsch, R; Dubsky, PC; Filipcic, L; Fitzal, F; Gnant, M; Greil, R; Haider, K; Jakesz, R; Kwasny, W; Luschin-Ebengreuth, G; Mlineritsch, B; Pöstlberger, S; Rudas, M; Samonigg, H; Sevelda, P; Singer, CF; Steger, GG; Stierer, M; Stöger, H; Taucher, S; Tausch, C1
Carro, G; Harper, A; Hui, W; Lawton, J; Menas, P; Merkel, D1
Bae, KS; Cho, SH; Choe, S; Ghim, JL; Jin, SJ; Jung, JA; Kim, UJ; Ko, YJ; Lim, HS; Noh, YH; Park, HJ; Song, GS1
Flynn, ER; Hutchens, ZM; Manigrasso, MB; Maric-Bilkan, C; Sawyer, RT1
Burkard, ME; Crone, E; Davis, LA; Gogineni, J; Hansen, KE; Shafer, MM; Tevaarwerk, A; Wisinski, KB1
Bergh, J; Brattström, D; Eiermann, W; Henriksson, R; Jönsson, PE; Lidbrink, EK; Lindemann, JP; Trudeau, M; Wiklund, F1
Cuzick, J; Dowsett, M; Drury, S; Hayes, DF; Haynes, BP; Rae, JM; Salter, J; Sestak, I; Stearns, V; Thibert, JN1
Punith, R; Seetharamappa, J1
Bershteĭn, LM; Boiarkina, MP; Danilova, MA; Gershfel'd, ÉD; Khadzhimba, AS; Kovalevskiĭ, AIu; Maksimov, SIa; Meshkova, IE; Turkevich, EA1
Badve, SS; Carlson, RW; Gomez, HL; O'Neill, A; Sledge, GW; Vidaurre, T1
Hikino, H; Koike, M; Mukai, T; Murata, Y1
Boronat, M; García-Delgado, Y; López-Plasencia, Y; Marrero, D; Nóvoa, FJ; Nóvoa, Y1
Brown, M; Cuzick, J; Dowsett, M; Howell, A; Landberg, G; Lundgren, K; Pineda, S; Salter, J; Zabaglo, L1
Chamniansawat, S; Chongthammakun, S1
Cao, MZ; Gu, L; He, PQ; Jiang, ZF; Li, B; Li, HY; Liu, GY; Liu, JP; Liu, YH; Lou, LH; Ma, LW; Shao, ZM; Shen, ZZ; Su, FX; Sun, SR; Tang, JH; Tang, LL; Wang, S; Wang, SM; Wang, X; Wang, XJ; Yu, KD; Zhang, HW; Zhang, QY; Zheng, H; Zhou, Y1
Di Leo, A; Malorni, L1
Gogas, H; Koukouras, D; Markopoulos, C; Misitzis, J; Tzoracoleftherakis, E; Venizelos, B; Xepapadakis, G; Zobolas, V1
Bakas, P; Creatsa, M; Creatsas, G; Gregoriou, O; Grigoriadis, C; Hassiakos, D1
Cuzick, J; Dowsett, M; Forbes, JF; Harvie, M; Howell, A; Sestak, I1
Dowsett, M; Dunbier, A; Ghazoui, Z; Martin, LA; Pancholi, S; Weigel, MT1
Katano, M; Kubo, M; Kuroki, S; Ogawa, T; Okido, M; Onishi, H; Shimada, K; Tanaka, M; Umeda, S; Yokohata, K1
Kalyan, CS; Naresh, B; Pawar, SC; Priyamvada Devi, A; Setti, A; Venugopal Rao, V1
Allred, DC; Babiera, GV; Ballman, K; Bose, R; Chang, LW; Chen, K; Crowder, R; Demeter, R; DeSchryver, K; Ding, L; Dooling, DJ; Du, F; Elhammali, A; Ellis, MJ; Esserman, L; Fulton, LL; Fulton, RS; Goiffon, RJ; Goldstein, TC; Guenther, JM; Harris, CC; Harrison, M; Hoog, J; Hunt, K; Kandoth, C; Koboldt, DC; Leitch, M; Ley, TJ; Lin, L; Lu, C; Luo, J; Maher, CA; Marcom, PK; Mardis, ER; Margenthaler, J; McDonald, S; McLellan, MD; McMichael, JF; Miller, CA; Ng, S; Oberkfell, B; Olson, J; Ota, D; Piwnica-Worms, D; Piwnica-Worms, H; Schierding, WS; Shen, D; Snider, J; Stuart, JM; Suman, VJ; Tao, Y; Unzeitig, G; Van Tine, BA; Vickery, TL; Wallis, JW; Watson, M; Weber, J; Wendl, MC; Wilson, RK1
Campelo, AE; Cutini, PH; Massheimer, VL1
Altman, AD; Chu, P; Ghatage, P; Nation, J; Nelson, GS1
Abdul Munem, A; Al-Bahrani, B; Kamona, A; Mehdi, I; Nadas, AM1
Barlow, DH; Clack, G; Eastell, R; Makris, A; Van Poznak, C1
Brooks, JD; Dickler, MN; Goldfarb, SB; Jozefara, JE; King, V; Morris, EA; Nulsen, BF; Pike, MC; Sung, JS1
Alves, C; Silva, SF1
Mewar, D; Michael, B; Tunn, E; Williams, S1
A'Hern, RP; Dixon, JM; Dowsett, M; Folkerd, EJ; Renshaw, L1
Ligibel, JA; Winer, EP1
Albain, KS; Barlow, WE; Dakhil, SR; Gralow, JR; Hayes, DF; Hortobagyi, GN; Lew, DL; Livingston, RB; Mehta, RS; Tirumali, NR; Vandenberg, TA1
Cunningham, DE; Dacic, S; Keohavong, P; Land, SR; Rothstein, ME; Siegfried, JM; Stabile, LP1
Acar, H; Ata, O; Toy, H; Yavas, C; Yavas, G; Yuce, D1
Gelber, RD; Goldhirsch, A1
Moore, KA; Potter, JE1
Hammersmith, KM; Nagra, PK; Nottage, JM; Rapuano, CJ; Turaka, K1
Hayashi, N; Iwase, H; Iwata, H; Kamigaki, S; Kinoshita, T; Masuda, N; Nakamura, S; Nishimura, R; Noguchi, S; Sagara, Y; Takei, H; Tsuda, H; Yanagita, Y1
Chen, Z; Li, Z; Liao, M; Lu, S; Niu, X; Shen, L; Shen, S; Yu, Y1
Bachner, M; Brase, JC; Dietze, O; Dubsky, P; Filipits, M; Gehrmann, MC; Gnant, M; Greil, R; Jakesz, R; Klug, E; Kronenwett, R; Luisser, I; Mayr, D; Petry, C; Rudas, M; Schmidt, M; Sedivy, R; Singer, CF; Weber, KE1
Dean, A; Dewar, J; Ellis, MJ; Emerson, L; Feltl, D; Lindemann, JP; Llombart-Cussac, A; Robertson, JF; Rolski, J1
Beer, B; Gamper, E; Giesinger, J; Holzner, B; Hubalek, M; Kemmler, G; Marth, C; Meraner, V; Oberacher, H; Oberguggenberger, AS; Schubert, B; Sperner-Unterweger, B; Sztankay, M1
Magee, PJ; Rowland, I1
Aksoy, S; Altundag, K; Sendur, MA; Zengin, N1
Inaji, H; Ishitobi, M; Komoike, Y; Nakahara, S; Ohsumi, S; Suzuki, O; Tomita, Y; Yagi, T; Yoshinami, T1
Katz, DP; Sample, CH; Swithers, SE1
Barañao, RI; Bilotas, MA; Meresman, GF; Olivares, CN; Ricci, AG1
Bell, R; Bell, RJ; Chirgwin, J; Cicuttini, F; Davies-Tuck, M; Davis, SR; Hanna, F; Wang, Y1
De, G; Diener, M; Namjoshi, M; Wu, EQ; Xie, J; Yang, H1
Garcia, PL; Gomes, FP1
Singh, AK; Singh, R1
Horváth, Z1
Keshavarao, KP; Satyanarayana, DA1
Aomatsu, N; Asano, Y; Hirakawa, K; Ishikawa, T; Kashiwagi, S; Kawajiri, H; Morisaki, T; Nakamura, M; Onoda, N; Takashima, T1
Clarke Hillyer, G; Crew, KD; Danaceau, J; Hershman, DL; Kalinsky, K; Maurer, MA; Neugut, AI; Rotsides, DZ1
Futsuhara, K; Kai, T; Kojima, M; Tabei, T; Takei, H; Takeuchi, H; Yoshida, T1
Glück, S; Untch, M; von Minckwitz, G1
Ansari, RH; Budd, GT; Chalchal, H; Chapman, JA; D'Souza, DP; Elliott, C; Ellis, MJ; Gelmon, KA; Goss, PE; Ingle, JN; Johnson, DB; Lang, I; Liedke, PE; Perez, EA; Pritchard, KI; Rabaglio, M; Shepherd, LE; Sledge, GW; Spadafora, S; Stearns, V; Tozer, R1
Tung, N1
Boysen, G; Dhakal, IB; Edavana, VK; Kadlubar, S; Penney, R; Williams, S; Yao-Borengasser, A1
Blettner, M; Hadji, P; Harbeck, N; Jackisch, C; Kreienberg, R; Lück, HJ; Windemuth-Kieselbach, C; Zaun, S1
Bong, JG; Jeong, YJ; Kwon, HJ; Park, SH; Park, YS; Shin, IH1
Fujiki, K; Fujimoto, T; Inoue, F; Ishikawa, H; Maruyama, N; Nakano, T; Nakatani, K; Oka, H; Ueshima, K; Yoshimoto, S1
Kaur, J; Tikoo, K; Vekariya, KK1
Boccardo, F; Bordonaro, R; Fini, A; Guglielmini, P; Massidda, B; Orzalesi, L; Porpiglia, M; Roagna, R; Rubagotti, A; Serra, P; Ucci, G1
Hadji, P; Hars, O; Kalder, M; Knöll, D; Kyvernitakis, I; Ziller, V1
Anan, K; Higaki, K; Mase, T; Nishimura, R; Ohno, S; Sagara, Y; Shibuta, K; Tanaka, M; Teramukai, S; Tsuyuki, S; Yamamoto, Y1
Cleeland, CS; Giordano, SH; Lu, H; Malveaux, D; Saleeba, AK; Shi, Q1
Aapro, M; Bartlett, JM; Coleman, RE; Markopoulos, C; Putter, H; van de Velde, CJ1
A'hern, R; Anderson, H; Dowsett, M; Dunbier, AK; Ghazoui, Z; Miller, WR; Nerurkar, A; Osin, P; Salter, J; Smith, IE1
Channon, E; Dixon, JM; Ellis, IO; Gee, JM; Hyman-Taylor, P; Jahan, A; Nicholson, RI; Robertson, JF; Sibbering, DM1
Goto, N; Hashimoto, M; Hatori, S; Inari, H; Iwasaki, H; Tanabe, H; Uesugi, K1
Brodie, A; Golubeva, O; Kazi, A; Sabnis, GJ; Shah, P1
Haaland, B; Lopes, G; Montero, AJ; Tan, PS1
Chandrashekar, K; Juncos, LA; Liu, R; Maranon, R; Reckelhoff, JF; Ruiz, AL; Soljancic, A1
Bachelot, T; Ben Larbi, S; Cohen, PA; Corbo, L; Ghayad, SE; Grisard, E; Heudel, PE; Treilleux, I; Vendrell, JA; Villedieu, M; Vilquin, P1
von Minckwitz, G1
Akiyoshi, T; Asayama, T; Hiura, S; Kato, H; Masuda, S; Ohtani, H; Okamoto, Y; Shimomura, Y1
Alberto, R; Furger, E; Tran, MT1
Banerjee, M; Gersch, C; Giacherio, D; Hayes, DF; Henry, NL; McConnell, D; Partridge, AH; Pearlman, M; Schott, AF; Stearns, V; Xia, R1
Augustine, TN; Gil, JF; Hosie, MJ1
Hosoya, T; Kusuhara, H; Miyajima, M; Sugiyama, Y; Takahashi, K; Takashima, T; Watanabe, Y1
Hashigaki, S; Hiraoka, M; Iwata, H; Masuda, N; Morimoto, T; Nishizawa, Y; Noguchi, S; Ohno, S; Ohsumi, S; Rai, Y; Saeki, T; Sasano, H; Sato, Y1
Hamilton, J; Kamiya-Matsuoka, C; Kumar, VA; Kurzrock, R; Langford, LA; Moulder, S; Munoz, J; Pasche, LJ; Taggart, MW; Tummala, S1
Kuranishi, F; Ohno, T1
Bauer, M; Hadji, P; Hars, O; Kalder, M; Kyvernitakis, I; Ziller, V1
Cowens, JW; Cuzick, J; Dowsett, M; Dunbier, AK; Ferree, S; Lopez-Knowles, E; Schaper, C; Sestak, I; Sidhu, K; Storhoff, J1
Bolyakov, A; Mehta, A; Paduch, DA; Roosma, J; Schlegel, PN1
Afentakis, M; Buzdar, A; Cuzick, J; Dowsett, M; Forbes, J; Howell, T; Salter, J; Sestak, I1
Cataldo, C; D'Andrea, F; De Francesco, F; del Giudice, EM; Di Grezia, G; Ferraro, GA; Gatta, G; Grandone, A; Nicoletti, G; Perrone, L; Romano, T1
Balic, M; Dubsky, P; Fesl, C; Fitzal, F; Gnant, M; Greil, R; Jakesz, R; Kwasny, W; Mlineritsch, B; Pfeiler, G; Samonigg, H; Seifert, M; Steger, G; Stierer, M; Stöger, H1
Kumar, A; Sawant, KK1
Bliss, JM; Braybrooke, JP; Brunt, AM; Cameron, D; Cheung, KL; Coombes, G; Dodwell, D; Dowsett, M; Ellis, P; Folkerd, E; Hayward, L; Howell, A; Im, YH; Johnston, SR; Jyothirmayi, R; Kilburn, LS; Robinson, A; Sergenson, N; Sin, HJ; Wardley, AM; Wheatley, D1
Oates, RD1
D'Andrea, F; Grella, E; La Padula, S; Nicoletti, GF; Romanucci, V1
Mehta, A; Paduch, DA; Schlegel, PN1
Dressel-Ban, G; Dubsky, P; Exner, R; Fitzal, F; Gnant, M; Hadji, P; Königsberg, R; Maroske, M; Pfeiler, G; Seifert, M; Singer, C; Zellinger, J1
Critchley, HO; Gibson, DA; McInnes, KJ; Saunders, PT1
Ganjekar, S; Kilara, N; Mahendra, JV; Manjunatha, N; Srinivasa, R1
Dimitrakakis, C; Glaser, RL2
Cuzick, J; Dowsett, M; Dunbier, A; Erlander, MG; Goss, PE; Lopez-Knowles, E; Schnabel, CA; Schroeder, B; Sestak, I; Sgroi, DC; Sidhu, K; Zhang, Y1
Gebrim, LH; Logullo, AF; Madeira, M; Mattar, A; Soares, FA1
Bell, MJ; Bender, CM; Terhorst, L1
Bai, YX; Huang, P; Li, YJ; Liu, L; Sui, H; Sun, XW; Wang, JX; Wei, XL; Xie, R; Yuan, HH; Zhang, QY; Zhang, TT; Zhang, WJ; Zhao, S; Zhou, JH1
Bode, AM; Ghazoui, Z; Grubbs, CJ; Liu, P; Lu, Y; Lubet, RA; Vedell, PT; Wen, W; You, M1
Duffy, SR; Hewitt, MJ; Quinton, ND; Thangavelu, A1
Anandappa, G; Turner, NC1
Frankel, J; McCullough, A; Mechlin, CW1
Bachner, M; Brase, JC; Dietze, O; Dubsky, P; Filipits, M; Fisch, K; Gehrmann, MC; Gnant, M; Greil, R; Jakesz, R; Klug, E; Kronenwett, R; Luisser, I; Mayr, D; Petry, C; Rudas, M; Schmidt, M; Sedivy, R; Singer, CF; Weber, KE1
Awang, K; Fadl-Elmula, I; Hasima, N; Idris, OF; In, LL; Ismail, AM; Mustafa, AH; Syamsir, DR; Tasyriq, M1
Conners, W; Kacker, R; Morgentaler, A; Zade, J1
Mehta, A; Tripathy, D1
Aebli, N; Baur, M; Bertolo, A; Ferguson, SJ; Stoyanov, J1
Bulun, SE; Khan, SA; Lin, Z; Moy, I; Rademaker, AW; Reierstad, S1
Frederix, GW; Hövels, AM; Huitema, AD; Raaijmakers, JA; Schellens, JH; Severens, JL; van Hasselt, JG1
Bauer, T; Hadji, P; Hars, O; Knöll, D; Kyvernitakis, I; Struck, M1
Akçay, HT; Bayrak, R1
Cameron, DA1
Bonanni, B; Cawthorn, S; Cuzick, J; Dowsett, M; Forbes, JF; Howell, A; Knox, J; Mansel, RE; Palva, T; Roche, N; Saunders, C; Sestak, I; von Minckwitz, G1
Allehmazedeh, K; Coviello, AD; Herbst, KL; Juang, PS; Peng, S; Shah, A1
Bago-Horvath, Z; Balic, M; Bartsch, R; Cowens, JW; Dubsky, P; Ferree, S; Fesl, C; Filipits, M; Fitzal, F; Gnant, M; Greil, R; Jakesz, R; Knauer, M; Kwasny, W; Liu, S; Mlineritsch, B; Nielsen, TO; Ressler, S; Rudas, M; Schaper, C; Singer, C; Steger, G; Stoeger, H; Storhoff, J1
Blettner, M; Bolten, W; Hadji, P; Harbeck, N; Hindenburg, HJ; Jackisch, C; Klein, P; König, K; Kreienberg, R; Rief, W; Wallwiener, D; Zaun, S1
Boyle, F; Bulsara, M; Holman, CD; Kemp, A; Malacova, E; Preen, DB; Roughead, EE; Saunders, C1
Cutress, RI; Layfield, DM; Mohamud, M; Odofin, O; Royle, GT; Walsh, C1
Alexandre, J; Bigenwald, C; Deval, B; Nogales, FF; Rousset, P1
Chen, ML; Li, K; Zhang, J; Zhu, ZL1
Beer, B; Giesinger, J; Holzner, B; Hubalek, M; Kemmler, G; Meraner, V; Oberacher, H; Oberguggenberger, A; Schubert, B; Seeber, B; Sperner-Unterweger, B; Sztankay, M; Wildt, L1
Hampton, T1
Dowsett, M; Haynes, BP; Lønning, PE1
Angelucci, D; Ausili Cefaro, G; Cianchetti, E; Cioffi, P; De Tursi, M; Di Nicola, M; Grassadonia, A; Grossi, S; Iacobelli, S; Iezzi, L; Marinelli, C; Natoli, C; Noccioli, P; Politi, R; Tavoletta, S; Tinari, N; Zilli, M1
A'Hern, R; Afentakis, M; Arnedos, M; Dowsett, M; Drury, S; Hills, M; Reis-Filho, JS; Salter, J; Smith, IE1
Brown, P1
Farquhar, C; Franik, S; Kremer, JA; Nelen, WL1
Bock, VL; Friedlander, M; Kossard, S; Waring, D; Wood, GK1
Bari, SB; Chaudhari, NS; Deshmukh, PK; Pandey, AP; Patil, PO; Tekade, AR1
Brufsky, A; Mathew, A1
Badovinac-Crnjevic, T; Chalchal, H; Chapman, JA; Cheung, AM; Elliott, CR; Goss, PE; Hershman, DL; Ingle, JN; Khosla, S; Linden, HM; Muss, HB; Pritchard, KI; Rowland, K; Scher, J; Shepherd, LE; St Louis, J; Stearns, V1
Andrews, C; Clark, K; Edge, SB; Fetterly, G; Hicks, DG; Kulkarni, S; McCann, SE; Morrison, CD; Thompson, LU; Wilton, J1
Glueck, CJ; Pandit, RS1
Atkins, L; Barni, S; Deschamp, V; Franquet, A; Gnant, M; Kreienberg, R; Markopoulos, C; Marty, M; Neciosup, S; Neven, P; Tanner, M; Tesarova, P2
Fan, Y; Gong, DD; Man, CF; Xu, J1
Kawano, K; Tashima, Y1
Goto, N; Hatori, S; Inafuku, K; Inari, H; Kawamoto, M; Masuda, M; Tanabe, H1
Aranoff, GS; Cameo, T; Fennoy, I; Hassoun, AA; Lerner, SE; McMahon, DJ; Oberfield, SE; Shams, K; Sopher, AB; Yang, C1
Balaez, A; Beck, DT; Beggs, LA; Borst, SE; Combs, SM; Conover, CF; Lachacz, SA; Leeper, AM; Miller, JR; Otzel, DM; Williams, AA; Wronski, TJ; Yarrow, JF; Ye, F; Zheng, N1
Chandarlapaty, S; Crews, JR; Davidson, NE; Esteva, FJ; Giordano, SH; Gonzalez-Angulo, AM; Kirshner, JJ; Krop, I; Levinson, J; Lin, NU; Modi, S; Patt, DA; Perez, EA; Perlmutter, J; Ramakrishna, N; Temin, S; Winer, EP1
Kang, XM; Ma, WJ; Song, Y; Wang, L; Zhang, QY; Zhao, H1
Arsav, V; Benderli Cihan, Y1
Brufsky, AM1
Agrawal, A; Cheung, KL; Gutteridge, E; Marenah, C; Mathew, J; Prinsloo, P; Robertson, JF1
Albert, US; Hadji, P; Hars, O; Kalder, M; Kyvernitakis, I; Winarno, AS1
Atkins, JT; Falchook, GS; Fu, S; Hong, DS; Janku, F; Kurzrock, R; Moulder, SL; Naing, A; Piha-Paul, SA; Stephens, PJ; Tsimberidou, AM; Wheler, JJ; Yelensky, R; Zinner, R1
Esfahani, K; Ferrario, C; Le, P; Panasci, L1
Dryden, R; Harrow, A; McCowan, C; Parsons, M; Radley, A; Thompson, AM; Wells, M1
Krug, L; Lountzis, N; Shockman, S1
Duggan, N; Fullerton, J; Hussey, MJ; Loughlin, L; MacLean, MR; Mair, KM; Nilsen, M; Roberts, S; Rowlands, DJ; Thomas, M; Wright, AF1
Chen, D; Deng, Y; Feng, G; He, P; Hu, R; Huang, T; Li, E; Li, L; Li, Y; Liang, Z; Lin, Y; Liu, J; Lu, Y; Ma, R; Su, F; Sun, S; Tong, Z; Wang, S; Wang, X; Wu, Y; Xu, Z; Zhang, H; Zhang, X; Zhang, Y; Zhao, Y1
Dowsett, M; Gao, Q; Garcia-Murillas, I; López-Knowles, E; Martin, LA; Segal, CV; Smith, I; Turner, NC1
Coonahan, E; Giangregorio, R; Kaplan, DL; Lovett, ML; Yucel, T1
Dattani, M; Freeman, A; Hakeem, V; Senniappan, S; Stoneham, S; Wood, D1
Bowman, M; Bruner, D; DeMichele, A; Farrar, JT; Mao, JJ; Seluzicki, C; Xie, SX; Zee, J1
Liu, M; Liu, P; Xie, F; Yang, DQ; Zhou, B1
Andou, A; Higashi, R; Okutani, D; Yamadori, I1
Kumar, RB; Neely, EK; Payne, SL; Ranadive, SA; Suchet, DI1
Batzler, A; Carlson, EE; Chapman, JA; Ellis, MJ; Furukawa, Y; Goss, PE; Ingle, JN; Jenkins, GD; Khosla, S; Kubo, M; Liu, M; Nakamura, Y; Schaid, DJ; Shepherd, LE; Wang, L; Weinshilboum, RM1
Olin, JL; St Pierre, M1
Klein, KO1
Acosta, JI; Alderete, TJ; Bimonte-Nelson, HA; Camp, BW; Demers, LM; Koebele, SV; Mennenga, SE; Mousa, AA; Tsang, CW1
Barman, P; Buzdar, AU; Desta, Z; Dudenkov, TT; Flockhart, DA; Goetz, MP; Ingle, JN; Kalari, KR; Northfelt, DW; Perez, EA; Robson, ME; Wang, L; Weinshilboum, RM; Williard, CV1
Andò, S; Barone, I; Brown, PH; Fuqua, SA; Iacopetta, D; O'Malley, BW; Rechoum, Y; Rovito, D; Weigel, NL1
Abubakar, MB; Gan, SH; Wei, K1
Crocker, MK; Gourgari, E; Lodish, M; Stratakis, CA1
Campos-Gómez, S; Chapa-Ibargüengoitia, M; de la Peña-Lopez, R; Dorantes-Heredia, R; Flores-Arredondo, JH1
Billen, J; Christiaens, MR; Jans, I; Laenen, A; Lintermans, A; Neven, P; Paridaens, R; Pauwels, S; Van Asten, K; Van Herck, E; Vanderschueren, D; Verhaeghe, J; Vermeersch, P; Wildiers, H1
Armengol-Alonso, A; Dalmau, E; Muñoz, M; Seguí-Palmer, MÁ1
Aihara, T; Andoh, M; Aogi, K; Fukuuchi, A; Hozumi, Y; Iwata, H; Kim, R; Makino, H; Mukai, H; Ohashi, Y; Ohno, S; Takatsuka, Y; Tamura, M; Tsugawa, K; Watanabe, T; Yamaguchi, T; Yokota, I1
Cowens, JW; Cuzick, J; Dowsett, M; Dubsky, P; Ferree, S; Fesl, C; Filipits, M; Gnant, M; Lopez-Knowles, E; Schaper, C; Sestak, I1
Albertini, S; Kelly, E; Lu, CY; Vitry, A1
Abehsera, D; de Santiago, J; Panal, M; Revello, R; Sánchez-Mendez, JI; Zapardiel, I1
Balic, M; Bartsch, R; Bjelic-Radisic, V; Dubsky, P; Eidtmann, H; Eiermann, W; Fesl, C; Fitzal, F; Gnant, M; Greil, R; Hochreiner, G; Jakesz, R; Knauer, M; Kwasny, W; Luschin-Ebengreuth, G; Mlineritsch, B; Moik, M; Ploner, F; Seifert, M; Selim, U; Sevelda, P; Steger, G; Stoeger, H; Taucher, S; Wette, V1
Han, S; Li, P; Zheng, W; Zhou, F; Zhou, N1
Kaldygul Kabakovna, S; Kuanysh Shadybayevich, N; Lewis, L; Ramil Zufarovich, A; Suriya Ertugyrovna, Y; Taylor, M1
Fuhrmann, U; Korolainen, H; Prelle, K; Rotgeri, A; Sacher, F; Schmitz, H; Sundholm, O1
Blake, GM; Coleman, R; Cuzick, J; Dowsett, M; Eastell, R; Forbes, JF; Gossiel, F; Howell, A; Patel, R; Sestak, I; Singh, S1
Benemei, S; Coppi, E; De Logu, F; Di Tommaso, MR; Fusi, C; Geppetti, P; Marone, IM; Materazzi, S; Minocci, D; Moneti, G; Nassini, R; Pieraccini, G; Susini, T; Trevisan, G; Tuccinardi, T1
Budd, GT; Chapman, JA; Ellis, MJ; Goss, PE; Ingle, JN; Kundapur, J; Le Maitre, A; Liedke, PE; Ma, CX; Pritchard, KI; Rabaglio, M; Shepherd, LE; Sledge, GW; Stearns, V1
Evans, A; Lacey, R1
Lanuti, M; Lerwill, MF; Moy, B; Rafferty, EA; Specht, MC1
Bachelot, T; Barrios, C; de Boer, R; Di Leo, A; Janni, W; Jerusalem, G; Neven, P1
Osborne, CK; Rimawi, MF; Schiff, R1
Chatziralli, IP; Chrysikos, D; Ladas, I; Moschos, MM; Sergentanis, T; Zagouri, F; Zografos, G1
Addison, CL; Arnaout, A; Clemons, M; Kuchuk, I; Namazi, M; Pond, GR; Robertson, S; Simos, D1
Egawa, C; Goto, T; Hashimoto, T; Ishida, T; Kagawa, Y; Kato, T; Katsura, Y; Kimura, K; Kusama, H; Matsushita, K; Morimoto, Y; Nagano, T; Nakahira, S; Nakatsuka, S; Nitta, K; Okishiro, M; Oku, K; Sakisaka, H; Sato, Y; Takatsuka, Y; Takeda, Y; Takeno, A; Tamura, S; Taniguchi, K1
Chen, R; Cui, J; Hu, H; Li, P; Liu, X; Wang, Q; Wei, W1
Barbie, TU; Ma, C; Margenthaler, JA1
Badawy, SZ; Brown, S; Kaufman, L; Wojtowycz, MA1
Behl, G; Dave, V; Deshpande, PB; Kumar, AR; Kushwaha, K; Nayak, UY; Raghavendra, R; Shavi, GV; Sreenivasa Reddy, M; Udupa, N1
Bayer, J; Katzler, O; Mebes, I; Rune, G; Schultz, H; Sommer, T; Tobia, MJ1
Bevers, TB1
Akagi, K; Hayasaka, A; Igeta, S; Ishigaki, N; Iwahashi, H; Kudo, T; Makino, H; Matsuura, R; Sakurada, J; Shima, T; Suzuki, H; Toyoshima, M; Yoshinaga, K1
Ahrendt, GM; Bender, CM; Berga, SL; Brufsky, AM; Casillo, FE; Dailey, MM; Erickson, KI; Gentry, AL; Kratofil, FM; McAuliffe, PF; Merriman, JD; Rosenzweig, MQ; Ryan, CM; Sereika, SM1
Balic, M; Cowens, JW; Cuzick, J; Dowsett, M; Dubsky, P; Ferree, S; Fesl, C; Filipits, M; Gnant, M; Greil, R; Jakesz, R; Lopez-Knowles, E; Nielsen, T; Rudas, M; Schaper, C; Sestak, I; Stoeger, H1
Biggers, A; Charlson, JA; Kamaraju, S; Laud, PW; Neuner, JM; Pezzin, LE; Smallwood, AJ; Smith, EC; Wozniak, EM1
Hosie, MJ; Mwakikunga, A1
Chang, CH; Chen, SJ; Liu, CY1
Brodie, A; Guha, R; Jaiswal, AK; Khatri, R; Rassool, FV; Shah, P; Tomkinson, AE1
Atkins, JT; Janku, F; Kurzrock, R; Moulder, SL; Stephens, PJ; Wheler, JJ; Yelensky, R1
Lin, JB; Mast, N; Pikuleva, IA1
Audisio, R; Cheung, KL; Collins, K; Morgan, JL; Reed, MW; Robinson, TG; Wyld, L1
Iwase, T; Komoike, Y; Nakamura, T; Ohashi, Y; Ohtsu, H; Saji, S; Shimozuma, K; Takei, H; Yagata, H1
Bonneterre, J; Delbeuck, X; Kramar, A; Le Rhun, E; Lefeuvre-Plesse, C; Pasquier, F; Skrobala, E1
Dimitrakakis, C; Glaser, R1
Bachelot, T; Bonnefoi, H; Breton-Callu, C; Dalenc, F; Daly, C; de Lara, CT; Debled, M; Fournier, M; Gros, A; Iggo, R; Lortal, B; MacGrogan, G; Madranges, N; Mauriac, L; Nikolski, M; Pulido, M; Quenel-Tueux, N; Rabbitts, P; Rudewicz, J; Soueidan, H; Wood, H1
Ditkoff, E; Ellen, J; Feustel, P; Grossman, M; Helo, S; McCullough, A; Mechlin, C1
Islam, MS; Lucas, R; Tanner, P; Wright, G1
Buist, MR; Kenter, GG; van der Velden, J; van Driel, WJ; van Lonkhuijzen, LR; van Meurs, HS1
Bozhok, AA; Dashyan, GA; Komyakhov, AV; Lalak, IA; Manikhas, AG; Paltuev, RM; Petrenko, OL; Semiglazov, VF; Semiglazov, VV; Semiglazova, TY1
Colleoni, M; Munzone, E1
Dowsett, M; Yeo, B1
Chen, JL; Jiang, B; Lou, HG; Ruan, ZR; Shao, R; Yu, LY1
Harbeck, N1
Dewar, JA; Ellis, MJ; Feltl, D; Hewson, N; Jasiówka, M; Llombart-Cussac, A; Robertson, JF; Rukazenkov, Y1
Kuerer, H; Mitchell, KB1
Baba, M; Egawa, C; Hashimoto, T; Hidaka, T; Hirokaga, K; Ichii, S; Kikawa, Y; Kitatsuji, K; Kokufu, I; Konishi, M; Konishi, Y; Kono, S; Matsumoto, T; Minohata, J; Mitsunobu, M; Miya, A; Miyashita, M; Miyauchi, K; Miyoshi, Y; Nishikawa, H; Nishino, M; Oh, K; Okuno, T; Sakita, I; Sakoda, Y; Suwa, H; Takao, S; Wakita, K; Yamagami, K1
Deshpande, PB; Kumar, AR; Maliyakkal, N; Nayak, UY; Raghavendra, R; Reddya, MS; Shavi, GV; Shrawan, B; Udupa, N1
Jeyaraj, PA; Julka, PK; Kamal, VK; Mahajan, MK; Malik, A; Patil, J; Rath, GK; Roy, S; Shankar, A1
Martin-Kleisch, A; Zulfiqar, AA1
Horio, M; Ichihara, S; Inoue, T; Ishihara, Y; Ito, M; Kondo, I; Maeda, O; Matsumura, Y; Moritani, S; Sugiyama, K; Yamamoto, S1
Dermitzaki, E; Papadimitriou, A; Papadimitriou, DT; Papaevangelou, V; Papagianni, M; Papaioannou, G1
Akyol, M; Alacacioglu, A; Bayoglu, V; Demir, L; Dirican, A; Ellidokuz, H; Gumus, Z; Kucukzeybek, B; Kucukzeybek, Y; Salman, T; Sutcu, R; Tarhan, MO; Varol, U; Yildiz, I; Yildiz, Y1
Basaria, S; Carlson, O; Chia, CW; Dias, JP; Egan, JM; Ferrucci, L; Melvin, D; Shardell, MD; Simonsick, EM1
Cuzick, J; Forbes, JF; Howell, A; Sestak, I; Spagnolo, F1
Agrogiannis, G; Boutas, I; Creatsas, G; Gregoriou, O; Kalampokas, T; Konstantopoulos, P; Korou, LM; Pergialiotis, V; Perrea, D; Salakos, N1
Bratta, M; Candeloro, G; D'Orazi, V; Fumagalli, LA; Pasta, V; Rea, S; Recchia, F; Rosselli, M1
Babilonti, L; Bogliolo, S; Cassani, C; De Silvestri, A; Dominoni, M; Gaggero, CR; Gardella, B; Musacchi, V; Spinillo, A; Zanellini, F1
Bonanni, B; Bundred, N; Coleman, RE; Cuzick, J; Eiermann, W; Ellis, I; Forbes, JF; Holcombe, C; Howell, A; Jones, L; Levy, C; Neven, P; Sestak, I; Stierer, M; von Minckwitz, G1
Albain, KS; Brufsky, AM; Cecchini, RS; Cianfrocca, ME; Costantino, JP; Fehrenbacher, L; Ganz, PA; Gross, HM; Hopkins, JO; Julian, TB; Mamounas, EP; Margolese, RG; Seay, TE; Soori, GS; Sturtz, K; Vallow, LA; Whitworth, PW; Wolmark, N; Wozniak, TF2
Cui, S; Lü, H; Niu, L; Yan, M; Zeng, H; Zhang, M1
Ahn, HY; Chung, KH; Kim, HR; Oh, SM; Park, YJ1
Basaran, G; Bogaerts, J; Cameron, D; Cufer, T; Debled, M; Dirix, L; Piccart, M; Thery, JC; Tjan-Heijnen, VC; Tryfonidis, K; Van den Weyngaert, D1
Akkar, OB; Cetin, A; Kacan, SB; Kacan, T; Karakus, S; Ozer, H; Seker, M; Yildiz, C1
Creekmore, A; Crowder, R; Doyle, A; Ellis, MJ; Erlichman, C; Gao, F; Guo, Z; Hoog, J; Lockhart, AC; Ma, CX; Naughton, M; Pluard, T; Sanchez, C1
Bacci, M; Chiarugi, P; Dowsett, M; Fearns, A; Gao, Q; Giannoni, E; Isacke, CM; Martin, LA; Morandi, A; Pintus, G; Ribas, R; Taddei, ML1
Aomatsu, N; Fujii, N; Haraoka, G; Hiramatsu, S; Hosoi, K; Iwauchi, T; Kosaka, K; Morimoto, J; Nishii, T; Takeuchi, K; Tei, S; Tsujio, G; Uchima, Y; Wang, E1
Avenel-Audran, M; Cellier, P; Georgin-Mège, M; Le Corre, Y; Marchand, A; Martin, L1
Büyükünal, C; Ceylaner, S; Ercan, O; Evliyaoğlu, O; Özcabı, B; Özcan, R; Tahmiscioğlu Bucak, F; Tüysüz, B1
Beauchemin, C; Lachaine, J; Letarte, N; Mathurin, K; Yelle, L1
Callet, N; Fourme, E; Noguès, C; Reyal, F; Sénéchal, C; Stoppa-Lyonnet, D; This, P1
Berishaj, M; Bonafé, M; Bowman, RL; Bromberg, J; Ceccarelli, C; Chang, Q; Chen, J; Colameco, C; Cricca, M; Daly, L; DeMichele, A; Fabbri, N; Feldman, M; Gasparre, G; Healey, JH; Lyden, D; Mao, JJ; Nnoli, J; Perna, F; Rajasekhar, VK; Sansone, P; Santini, D; Shih, NN; Taffurelli, M; Vidone, M1
Albain, KS; Barlow, WE; Dakhil, SR; Gralow, J; Hayes, DF; Hertz, DL; Hortobagyi, GN; Kidwell, KM; Livingston, RB; Mehta, RS; Rae, JM; Tirumali, NR; Vandenberg, TA1
Adlis, SA; Kirstein, MN; Lerner, RE; Liang, S; Richter, SA; Robien, K; Shapiro, AC1
Amico, AL; Olopade, OI; Saha, P1
Basaria, S; Chia, CW; Dias, JP; Egan, JM; Ferrucci, L; Gharib, M; Melvin, D; Shardell, M1
Andrew, R; Faqehi, AM; Gibb, FW; Homer, NZ; Livingstone, DE; McInnes, KJ; Upreti, R; Walker, BR1
Batson, S; Jones, N; Livings, C; Telford, C1
Bundred, N; Butler, H; Derynck, M; Earl, G; Gazinska, P; Gendreau, S; Hadad, S; Hu, J; Korbie, D; Lackner, MR; Lim, L; Macaskill, J; Mainwaring, P; Parker, P; Pinder, SE; Price, R; Purushotham, A; Sarker, SJ; Schmid, P; Shia, A; Thompson, A; Trau, M; Wheatley, D; Wilson, TR; Woodman, N; Zammit, C1
Bender, CM; McCue, M; Merriman, JD; Nugent, BD; Rosenzweig, M; Sereika, SM1
Amaral, C; Correia-da-Silva, G; Sobral, AF; Teixeira, N1
Chapman, JA; Elliott, C; Gelmon, KA; Goss, PE; Ingle, JN; Muss, HB; Pritchard, KI; Shepherd, LE; Whelan, TJ1
Asaithambi, K; Jayaram, P; Medhamurthy, R; Tripathy, S1
Gibbs, RB; Li, J; Oberly, PJ; Poloyac, SM1
Cuzick, J; Dowsett, M; Schnabel, CA; Schroeder, BE; Sestak, I; Sgroi, D; Zhang, Y1
Andre, F; Bartlett, CH; Beaney, M; Bliss, JM; Cristofanilli, M; Dowsett, M; Fribbens, C; Garcia-Murillas, I; Hrebien, S; Jiang, J; Johnston, SR; Kilburn, L; Koehler, M; Loi, S; Loibl, S; O'Leary, B; Turner, NC1
Alran, S; Balleyguier, C; Becette, V; Bourgier, C; Boussion, V; Cherel, P; Kerbrat, P; Lavau-Denes, S; Lemonnier, J; Lerebours, F; Martin, AL; Mathieu, MC; Mouret-Fourme, E; Mouret-Reynier, MA; Nabholz, JM; Rivera, S; Salmon, R; Sigal, B; Thibault, F; Trassard, M; Venat-Bouvet, L1
Gilarranz, YJ; Lopez-Tarruella, S; Martin, M1
Altinok, AY; Altug, T; Azria, D; Bese, NS; Ober, A; Ozsahin, EM; Sut, N; Yildirim, S1
Bjørkøy, G; Dixon, JM; Flågeng, MH; Geisler, J; Knappskog, S; Larionov, A; Lilleng, PK; Lønning, PE; Mellgren, G; Miller, WR; Prestvik, WS1
Yu, R1
Klein, S; Kraetzschmar, J; Nave, R; Rautenberg, T; Rohde, B; Schmitz, H; Schultze-Mosgau, MH; Waellnitz, K1
Buus, R; Cuzick, J; Denkert, C; Dowsett, M; Dubsky, P; Krappmann, K; Kronenwett, R; Petry, C; Scheer, M; Sestak, I1
Bowers, C; Erickson, D; Takahashi, P; Veldhuis, JD; Yang, R1
Brufsky, AM; Davidson, NE1
Archer-Chicko, CL; DeMichele, A; Fritz, JS; Kawut, SM; Klinger, JR; Ky, B; Palevsky, HI; Palmisciano, AJ; Patel, M; Pinder, D; Propert, KJ; Smith, KA; Stanczyk, F; Tracy, R; Vaidya, A; Ventetuolo, CE; Whittenhall, ME1
Burris, K; Fisher, J; Miller, M; Patel, M1
Arpino, G; De Placido, G; De Placido, S; De Rosa, P; Locci, M; Nazzaro, G; Pagano, T; Schettini, F; Vallone, R1
Basik, M; Clemons, M; Cristofanilli, M; Dreosti, L; Grzeda, L; Hegg, R; Johnston, S; Lausoontornsiri, W; Mann, H; Stuart, M1
Niraula, S; Ocana, A1
Damaso, L; Gaete, X; Gagliardi, P; Hossain, J; Mauras, N; Mericq, V; Merinbaum, D; Permuy, J; Ross, JL; Singh, RJ; Yu, YM1
Carrillo, JA; Gervasini, G; Jara, C; Martínez, R; Olier, C; Romero, N1
Baron, P; Beatty, J; Beitsch, P; de Snoo, FA; Dul, CL; Lee, LA; Mislowsky, A; Murray, M; Nash, C; Pellicane, JV; Rotkis, M; Stork-Sloots, L; Whitworth, P1
Chia, SK; McLeod, D; Paterson, A; Pritchard, KI; Provencher, L; Rayson, D; Simmons, C1
Berberoğlu, M; Burgu, B; Çamtosun, E; İsakoca, M; Kansu, A; Koç Yekedüz, M; Kocaay, P; Kuloğlu, Z; Şıklar, Z; Soygür, T1
Bondarenko, IM; Cardona-Huerta, S; Cheung, KL; Dvorkin, M; Ellis, MJ; Fazal, M; Grinsted, LM; Manikhas, A; Noguchi, S; Panasci, L; Philco-Salas, MJ; Robertson, JFR; Rowbottom, J; Ruiz-Borrego, M; Shao, Z; Shparyk, Y; Stuart, M; Trishkina, E1
Nave, R; Ploeger, BA; Reinecke, I; Schmitz, H; Schultze-Mosgau, MH1
Guo, W; Huang, XH; Liang, RH; Su, L; Wang, CJ1
Goodwin, A; Lee, CI; Wilcken, N1
Allred, DC; Babiera, G; Barnes, M; Brink, A; Budd, GT; Carey, L; Creighton, CJ; Crouch, E; Dayao, Z; DeSchryver, K; Dowsett, M; Ellis, MJ; Esserman, L; Goncalves, R; Guenther, JM; Hoog, J; Hunt, K; Leitch, M; Luo, J; Ma, CX; Olson, JA; Ota, D; Pluard, T; Sanati, S; Silverman, P; Suman, VJ; Tao, Y; Unzeitig, G; Watson, M; Whitworth, P; Winer, E1
Bender, CM; Brufsky, AM; Clark, BZ; Conley, YP; Ghotkar, P; Jankowitz, RC; Koleck, TA; McAuliffe, PF; Ryan, CM; Sereika, SM1
Amadori, D; Burris, H; Comarella, L; De Boer, R; Dowsett, M; Ejlertsen, B; Gnant, M; Hart, L; Jonat, W; McIntyre, K; O'Shaughnessy, J; Poggio, S; Pritchard, KI; Salomon, H; Smith, I; Wamil, B; Yardley, D1
Dattani, M; Hawton, K; Raine, J; Rumsby, G; Walton-Betancourth, S1
Brower, V1
Bergamaschi, CC; Coscia, EB; Gerenutti, M; Groppo, FC; Sabha, M1
Bodurka, DC; Coleman, RL; Gershenson, DM; Lu, KH; Malpica, A; Sun, CC1
Corrigan, MA; Jinih, M; O'Reilly, S; Redmond, HP; Relihan, N1
Giorgadze, E; Khachidze, N; Tsagareli, M1
Alencar, AP; Andrade, DB; Barros-Oliveira, MDC; Borges, RS; Borges, US; Costa-Silva, DR; da Silva, BB; Lopes-Costa, PV; Silva, VC1
Alvarez, CA; Balasubramian, BA; Jean, GW; Murphy, CC; Tiro, JA1
Beer, B; Czech, T; Daniaux, M; Holzner, B; Hubalek, M; Kemmler, G; Meraner, V; Oberacher, H; Oberguggenberger, A; Sperner-Unterweger, B; Sztankay, M; Weigel, G; Wildt, L1
Cohen, PR1
Carpenter, NA; Crook, EK1
Abd-Allateef, M; El-Hiti, GA; Hassan, F; Yousif, E1
Averineni, RK; Danilenkoff, C; Deshpande, PB; Ginjupalli, K; Nayak, UY; Raghavendra, R; Reddy, MS; Sadhu, SS; Shavi, GV; Udupa, N1
Pan, W; Sun, X; Tang, X; Wu, S; Yang, Y1
Ali, SM; Budd, GT; Chapman, JW; Elliott, CR; Ellis, MJ; Garg, A; Goss, PE; Han, L; Ingle, JN; Leitzel, K; Lipton, A; Pritchard, KI; Rabaglio, M; Shepherd, LE; Sledge, GW1
Ahmed, I; Bartlett, JMS; Brookes, CL; Cuzick, J; Dell'Orto, P; Dowsett, M; Forbes, JF; Mallon, EA; Putter, H; Rea, DW; Regan, MM; Sestak, I; Seynaeve, C; Thürlimann, B; Van de Velde, CJH; Viale, G1
Beale, PJ; Bonaventura, A; DeFazio, A; Friedlander, ML; Goh, JCH; Grant, PT; Hadley, AM; Mapagu, C; Martyn, J; McNally, OM; Mileshkin, LR; OʼConnell, RL; Scurry, J; Sjoquist, KM1
Hambly, R; Lally, A1
Baj, F; Baravalle, R; Ciaramella, A; Di Nardo, G; Gilardi, G1
Andrade, DB; Barros-Oliveira, MDC; Borges, RS; Borges, US; Costa-Silva, DR; Silva, BBD; Silva, JM; Tavares, CB1
Hong, N; Kim, SI; Park, S; Rhee, Y; Seo, DH; Sohn, JH; Yoon, HG1
Ding, H; Fang, L; Huang, P; Tong, Y; Xin, W; Zhou, Q1
Chen, T; Chu, F; Gong, Y; Lei, H; Liu, X; Lu, F; Xing, Y; Xu, B; Yan, M1
Eswaran, S; Ghoulam, E; Jakate, S; Klapko, O; Usha, L1
Armstrong, DK; Bergstrom, J; DeBernardo, R; Fader, AN; Gaillard, S; Jernigan, A; Levinson, KL; Michener, C; Ricci, S; Roche, KL; Rose, PG; Shih, IM; Stone, RL; Tanner, EJ; Wang, TL; Wethingon, S; Yang, B; Zhang, G1
Austin, ED; Brittain, EL; Chen, X; Farber-Eger, EH; Fessel, JP; Hemnes, AR; Loyd, JE; Talati, M; West, J1
Chang, X; Höchel, J; Klein, S; Müller, A; Nave, R1
He, Y; Huang, Y; Wang, C; Wu, K; Zhang, J; Zheng, S1
Cuzick, J; Dowsett, M; Heindl, A; Naidoo, K; Sestak, I; Yuan, Y1
Chen, X; Gu, L; Guo, P; Lv, M; Sun, X; Wang, B; Wang, S; Zhao, S1
Baravalle, R; Catucci, G; Ciaramella, A; Cimicata, G; Dell'Angelo, V; Di Nardo, G; Gilardi, G; Ugliengo, P1
Barriga, S; Bourayou, N; Campone, M; Chen, SC; Di Leo, A; Forrester, T; Freedman, OC; Frenzel, M; Garnica Jaliffe, G; Goetz, MP; Huober, J; Manso, L; Paluch-Shimon, S; Park, IH; Smith, IC; Sohn, J; Toi, M; Trédan, O1
Brasil, OFM; Correa de Mello, P1
de Boer, M; De Graaf, H; de Roos, WK; Erdkamp, FLG; Honkoop, AH; Imholz, ALT; Kroep, JR; Linn, SC; Peer, PGM; Seynaeve, CM; Smorenburg, CH; Swinkels, ACP; Tjan-Heijnen, VCG; van den Berkmortel, FWPJ; van der Sangen, MJC; van Hellemond, IEG1
Vohora, D; Zameer, S1
Fujii, H; Hojo, T; Hosoya, T; Inano, A; Ishii, A; Kataoka, M; Kusuhara, H; Sugiyama, Y; Takahashi, K; Takashima, T; Tanaka, M; Tazawa, S; Tokai, H; Watanabe, Y; Yamashita, S; Yano, T; Yoshida, S1
Barnes, KM; Bryant, JC; Cutler, GB; Flor, AC; Jones, JV; Leschek, EW1
Chen, BE; Goss, PE; Liedke, PER; O'Shaughnessy, J; Parulekar, WR; Ramjeesingh, R; Shepherd, LE; Strasser-Weippl, K; Sudan, G1
Alaamery, M; Alghamdi, B; Almutairi, MS; Alomran, N; Alyafee, YA; Bawazeer, S; Daghestani, M; Massadeh, S; Sheereen, A1
Asano, Y; Goto, W; Hatano, T; Hirakawa, K; Kashiwagi, S; Motomura, H; Noda, S; Ohira, M; Onoda, N; Takada, K; Takashima, T; Tsujio, G1
Akami, T; Hatakeyama, T; Matsumura, A; Mugitani, T; Ogino, S; Okano, S; Sakai, T1
Ellis, MJ; Fazal, M; Noguchi, S; Robertson, JFR; Shao, Z; Thirlwell, J1
Abubakar, MB; Gan, SH1
Galal, AAA; Khater, SI; Metwally, MMM; Mohamed, AA1
Telford, C1
Evans, DG; Howell, A; Howell, SJ1
Iwatsuki, K; Katayama, N; Morizane, S; Motoki, T; Omori, M; Sugimoto, S1
Eltrop, SM; Farquhar, C; Franik, S; Kiesel, L; Kremer, JA1
Chen, XY; Cheng, DX; Dai, XJ; Li, J; Ma, XF; Shi, CT; Wu, YQ; Zhang, YF; Zhong, DF1
Akiyoshi, T; Kuwamura, T; Murakami, S; Ogasa, Y; Suematsu, F; Tanaka, H; Umeda, S1
Bogliolo, S; Carletti, GV; Cassani, C; De Silvestri, A; Dominoni, M; Gardella, B; Spinillo, A1
Chen, Y; Ding, S; Liu, S; Peng, Y; Zheng, J1
Abadie-Lacourtoisie, S; Bazan, F; Chabaud, S; Colombe-Vermorel, A; Coquan, E; Dalban, C; Diaz, JJ; Fabbro, M; Frenel, JS; Garin, G; Heudel, PE; Marcel, V; Martinez, S; Mourksi, NE; Odeyer, L; Pérol, D; Ray-Coquard, I; Simioni, V; Tabone-Eglinger, S; Treilleux, I1
Egawa, C; Hasegawa, Y; Higaki, K; Hozumi, Y; Iijima, K; Iwase, T; Komoike, Y; Masuoka, H; Mukai, H; Nakamura, T; Ohtani, S; Ohtsu, H; Saji, S; Sato, Y; Takei, H; Tanabe, M; Tanaka, M; Yanagita, Y1
Albain, KS; Barlow, WE; Dakhil, SR; Gersch, CL; Gralow, JR; Hayes, DF; Henderson, NC; Henry, NL; Hertz, DL; Hortobagyi, GN; Kidwell, KM; Medley, S; Mehta, RS; Pusztai, L; Rae, JM; Rutherford, DV; Tirumali, NR; Vandenberg, TA1
Arnachellen, D; Augustine, TN; Pillay, K; Xulu, KR1

Reviews

269 review(s) available for anastrozole and triazoles

ArticleYear
ARIMIDEX: a new oral, once-a-day aromatase inhibitor.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 53, Issue:1-6

    Topics: Administration, Oral; Aldosterone; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Estradiol; Female; Humans; Hydrocortisone; Nitriles; Triazoles

1995
New aromatase inhibitors for breast cancer.
    Drug and therapeutics bulletin, 1997, Volume: 35, Issue:7

    Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Randomized Controlled Trials as Topic; Triazoles

1997
Vorozole.
    Drugs & aging, 1997, Volume: 11, Issue:3

    Topics: Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles

1997
ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancer.
    The Journal of steroid biochemistry and molecular biology, 1997, Volume: 61, Issue:3-6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Nitriles; Triazoles

1997
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
    Journal of surgical oncology, 1997, Volume: 66, Issue:3

    Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles

1997
Anastrozole: a new selective nonsteroidal aromatase inhibitor.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:11

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Nitriles; Postmenopause; Safety; Survival Rate; Treatment Outcome; Triazoles; United States

1997
The relevance of preclinical models to the treatment of postmenopausal breast cancer.
    Oncology, 1997, Volume: 54 Suppl 2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Mammary Neoplasms, Experimental; Nitriles; Postmenopause; Rats; Triazoles

1997
Anastrozole--a new generation in aromatase inhibition: clinical pharmacology.
    Oncology, 1997, Volume: 54 Suppl 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Nitriles; Triazoles

1997
Clinical overview of anastrozole--a new selective oral aromatase inhibitor.
    Oncology, 1997, Volume: 54 Suppl 2

    Topics: Administration, Oral; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Nitriles; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles

1997
Anastrozole: a selective aromatase inhibitor for the treatment of breast cancer.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Mar-01, Volume: 55, Issue:5

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Nitriles; Triazoles

1998
Anastrozole: a new addition to the armamentarium against advanced breast cancer.
    American journal of clinical oncology, 1998, Volume: 21, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Nitriles; Tamoxifen; Triazoles

1998
Emerging role of aromatase inhibitors in the treatment of breast cancer.
    Oncology (Williston Park, N.Y.), 1998, Volume: 12, Issue:3 Suppl 5

    Topics: Aged; Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Triazoles

1998
Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management.
    Cancer investigation, 1998, Volume: 16, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Nitriles; Triazoles

1998
Theoretical considerations for the ideal aromatase inhibitor.
    Breast cancer research and treatment, 1998, Volume: 49 Suppl 1

    Topics: Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles

1998
Pharmacological and clinical profile of anastrozole.
    Breast cancer research and treatment, 1998, Volume: 49 Suppl 1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Humans; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Triazoles

1998
Anastrozole. A review of its use in the management of postmenopausal women with advanced breast cancer.
    Drugs & aging, 1998, Volume: 13, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Neoplasm Staging; Nitriles; Postmenopause; Treatment Outcome; Triazoles

1998
The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:4

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Belgium; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Female; Humans; Letrozole; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Severity of Illness Index; Survival Rate; Tamoxifen; Treatment Outcome; Triazoles

1999
New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women.
    The Netherlands journal of medicine, 1999, Volume: 55, Issue:2

    Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Triazoles

1999
[Aromatase inhibitors].
    Bulletin du cancer, 1999, Volume: 86, Issue:10

    Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estrogen Antagonists; Estrone; Female; Humans; Letrozole; Nitriles; Triazoles

1999
Lessons from the use of aromatase inhibitors in the neoadjuvant setting.
    Endocrine-related cancer, 1999, Volume: 6, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles

1999
Aromatase inhibitors: a dose-response effect?
    Endocrine-related cancer, 1999, Volume: 6, Issue:2

    Topics: Aminoglutethimide; Anastrozole; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrogens; Fadrozole; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles

1999
Use of aromatase inhibitors in breast carcinoma.
    Endocrine-related cancer, 1999, Volume: 6, Issue:1

    Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Tamoxifen; Triazoles

1999
Steroidal aromatase inhibitors in elderly patients.
    Critical reviews in oncology/hematology, 2000, Volume: 33, Issue:2

    Topics: Aged; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles

2000
Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance.
    Journal of molecular endocrinology, 2000, Volume: 25, Issue:1

    Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Dinoprostone; Endometriosis; Enzyme Inhibitors; Estrogens; Estrone; Female; Humans; Middle Aged; Mullerian Ducts; Nitriles; Pregnancy; Triazoles

2000
[Chemo/endocrine therapy for breast cancer patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:8

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Female; Gonadotropin-Releasing Hormone; Humans; Nitriles; Tamoxifen; Triazoles

2000
[Aromatase inhibitors for treatment of advanced breast cancers].
    Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58 Suppl

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Fadrozole; Female; Humans; Letrozole; Nitriles; Treatment Outcome; Triazoles

2000
New aromatase inhibitors in the treatment of advanced breast cancer.
    International journal of oncology, 2000, Volume: 17, Issue:5

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Multicenter Studies as Topic; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Triazoles

2000
Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrol.
    Anti-cancer drugs, 2000, Volume: 11, Issue:9

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol; Neoplasm Metastasis; Nitriles; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles

2000
[Endometriosis and aromatase inhibitor].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 1

    Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Dinoprostone; Endometriosis; Enzyme Inhibitors; Estrogen Antagonists; Estrogens; Fadrozole; Female; Humans; Middle Aged; Nitriles; Triazoles

2001
[Preclinical evaluation of aromatase inhibitors antitumor activity].
    Bulletin du cancer, 2000, Volume: 87 Spec No

    Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Models, Animal; Nitriles; Rats; Structure-Activity Relationship; Triazoles

2000
[Aromatase inhibitors: pharmacological aspects].
    Bulletin du cancer, 2000, Volume: 87 Spec No

    Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles

2000
[Aromatase inhibitors: a review of clinical trials].
    Bulletin du cancer, 2000, Volume: 87 Spec No

    Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Randomized Controlled Trials as Topic; Triazoles

2000
[Development of a novel aromatase inhibitor, anastrozole (Arimidex)--its basic and clinical studies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:4

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase I as Topic; Dogs; Enzyme Inhibitors; Female; Humans; Mice; Middle Aged; Nitriles; Postmenopause; Rats; Triazoles

2001
[Developments of hormonal agents for breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:7

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Middle Aged; Nitriles; Tamoxifen; Triazoles

2001
Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
    Oncology (Williston Park, N.Y.), 2001, Volume: 15, Issue:8

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles

2001
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:9

    Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting

2001
New combinations with Herceptin in metastatic breast cancer.
    Oncology, 2001, Volume: 61 Suppl 2

    Topics: Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Interactions; Drug Synergism; Epirubicin; Female; Fluorouracil; Gemcitabine; Heart Diseases; Hematologic Diseases; Humans; Methotrexate; Neoplasm Metastasis; Nitriles; Organoplatinum Compounds; Paclitaxel; Tamoxifen; Thiotepa; Trastuzumab; Treatment Outcome; Triazoles; Vinblastine; Vinorelbine

2001
Role of anti-aromatase agents in postmenopausal advanced breast cancer.
    Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:4

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Phytogenic; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles

2001
Third-generation aromatase inhibitors in the treatment of advanced breast cancer.
    Breast cancer (Tokyo, Japan), 2001, Volume: 8, Issue:4

    Topics: Adult; Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Letrozole; Mastectomy; Middle Aged; Neoplasm Staging; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome; Triazoles

2001
Aromatase and aromatase inhibitors.
    Breast cancer (Tokyo, Japan), 2001, Volume: 8, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Letrozole; Nitriles; Survival Analysis; Treatment Outcome; Triazoles

2001
A summary of second-line randomized studies of aromatase inhibitors.
    The Journal of steroid biochemistry and molecular biology, 2001, Volume: 79, Issue:1-5

    Topics: Aminoglutethimide; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Drug Tolerance; Enzyme Inhibitors; Estrogen Receptor Modulators; Fadrozole; Female; Humans; Letrozole; Megestrol Acetate; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2001
A vision for the future?
    British journal of cancer, 2001, Volume: 85 Suppl 2

    Topics: Anastrozole; Breast Neoplasms; Estradiol; Female; Fulvestrant; Goserelin; Humans; Menopause; Nitriles; Tamoxifen; Triazoles

2001
Anastrozole (Arimidex)--an aromatase inhibitor for the adjuvant setting?
    British journal of cancer, 2001, Volume: 85 Suppl 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Nitriles; Triazoles

2001
Are differences in the available aromatase inhibitors and inactivators significant?
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:12 Suppl

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles

2001
Preliminary data from ongoing adjuvant aromatase inhibitor trials.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:12 Suppl

    Topics: Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles

2001
Aromatase inhibitors continue their ATAC on tamoxifen.
    Trends in molecular medicine, 2002, Volume: 8, Issue:4 Suppl

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Nitriles; Tamoxifen; Triazoles

2002
Antiaromatase agents: evolving role in adjuvant therapy.
    Clinical breast cancer, 2002, Volume: 3, Issue:1

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Tamoxifen; Triazoles

2002
Aromatase inhibition for ovarian stimulation: future avenues for infertility management.
    Current opinion in obstetrics & gynecology, 2002, Volume: 14, Issue:3

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Drug Administration Schedule; Enzyme Inhibitors; Female; Follicular Phase; Humans; Infertility, Female; Mice; Nitriles; Ovulation Induction; Pregnancy; Triazoles

2002
[The role of aromatase inhibitors in the treatment of breast neoplasms. An evaluation of clinical efficacy and the tolerability profile].
    Minerva ginecologica, 2002, Volume: 54, Issue:2

    Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Enzyme Inhibitors; Female; Follow-Up Studies; Forecasting; Humans; Letrozole; Middle Aged; Nitriles; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Triazoles

2002
[Antiestrogen therapy in the treatment of breast neoplasms].
    Minerva ginecologica, 2002, Volume: 54, Issue:3

    Topics: Adult; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Forecasting; Humans; Indoles; Letrozole; Middle Aged; Neoplasm Metastasis; Nitriles; Osteoporosis; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Toremifene; Triazoles

2002
Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer.
    Expert review of anticancer therapy, 2001, Volume: 1, Issue:2

    Topics: Adjuvants, Pharmaceutic; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Neoadjuvant Therapy; Nitriles; Postmenopause; Tamoxifen; Triazoles

2001
Letrozole for the management of breast cancer.
    Expert review of anticancer therapy, 2002, Volume: 2, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Tolerance; Estrogen Receptor Modulators; Estrogens; Female; Humans; Letrozole; Neoadjuvant Therapy; Nitriles; Postmenopause; Progestins; Receptors, Estrogen; Treatment Outcome; Triazoles

2002
Evolving uses of hormonal agents for breast cancer therapy.
    Clinical therapeutics, 2002, Volume: 24 Suppl C

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Nitriles; Tamoxifen; Toremifene; Triazoles

2002
Recent advances in aromatase inhibitor therapy for breast cancer.
    Seminars in oncology, 2002, Volume: 29, Issue:3 Suppl 11

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Premenopause; Triazoles

2002
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Aug-01, Volume: 20, Issue:15

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Enzyme Inhibitors; Evidence-Based Medicine; Expert Testimony; Female; Humans; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Triazoles

2002
Anastrozole in the management of breast cancer.
    Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:9

    Topics: Anastrozole; Animals; Breast Neoplasms; Disease Management; Drug Evaluation; Female; Humans; Nitriles; Survival Analysis; Triazoles

2002
New generation aromatase inhibitors--from the advanced to the adjuvant setting.
    Breast cancer research and treatment, 2002, Volume: 75 Suppl 1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles

2002
The evolving role of aromatase inhibitors in breast cancer.
    International journal of clinical oncology, 2002, Volume: 7, Issue:5

    Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Humans; Letrozole; Nitriles; Triazoles

2002
An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.
    Cancer, 2002, Nov-01, Volume: 95, Issue:9

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles

2002
Anastrozole: in early breast cancer.
    Drugs, 2002, Volume: 62, Issue:17

    Topics: Administration, Oral; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Therapy, Combination; Enzyme Inhibitors; Female; Half-Life; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome; Triazoles

2002
Breast cancer chemoprevention--an update.
    Current medical research and opinion, 2002, Volume: 18, Issue:6

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Forecasting; Genes, BRCA2; Humans; Incidence; Middle Aged; Nitriles; Odds Ratio; Receptors, Estrogen; Tamoxifen; Triazoles

2002
Anastrozole (Arimidex) in clinical practice versus the old 'gold standard', tamoxifen.
    Expert review of anticancer therapy, 2002, Volume: 2, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Approval; Female; Humans; Nitriles; Tamoxifen; Triazoles; United States

2002
Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:1 Pt 2

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Female; Humans; Letrozole; Lipids; Nitriles; Postmenopause; Triazoles

2003
Adjuvant endocrine therapy in postmenopausal breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:1 Pt 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Nitriles; Postmenopause; Tamoxifen; Triazoles

2003
Current and future status of adjuvant therapy for breast cancer.
    Cancer, 2003, Feb-01, Volume: 97, Issue:3 Suppl

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Female; Forecasting; Humans; Nitriles; Osteoporosis; Receptors, Estrogen; Tamoxifen; Triazoles

2003
Is tamoxifen the Rosetta stone for breast cancer?
    Journal of the National Cancer Institute, 2003, Mar-05, Volume: 95, Issue:5

    Topics: Acetyltransferases; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Controlled Clinical Trials as Topic; Disease-Free Survival; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Histone Acetyltransferases; Humans; Metaphor; Nitriles; Nuclear Receptor Coactivator 1; Nuclear Receptor Coactivator 3; Oncogene Proteins; Phosphorylation; Prospective Studies; Receptor, ErbB-2; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Signal Transduction; Tamoxifen; Trans-Activators; Transcription Factors; Treatment Failure; Treatment Outcome; Triazoles

2003
Aromatase inhibitors as adjuvant therapy in breast cancer.
    Oncology (Williston Park, N.Y.), 2003, Volume: 17, Issue:3

    Topics: Aminoglutethimide; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Nitriles; Triazoles

2003
[Present and future of adjuvant hormone therapy in breast cancer: clinical evidence and clinical trials].
    Revista clinica espanola, 2003, Volume: 203, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Letrozole; Nitriles; Tamoxifen; Triazoles

2003
Current status of endocrine therapy for breast cancer.
    Breast cancer (Tokyo, Japan), 2003, Volume: 10, Issue:2

    Topics: Algorithms; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemoprevention; Chemotherapy, Adjuvant; Climacteric; Female; Goserelin; Humans; Neoplasm Metastasis; Nitriles; Tamoxifen; Triazoles

2003
Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.
    Clinical breast cancer, 2003, Volume: 4 Suppl 1

    Topics: Age Factors; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Female; Humans; Multicenter Studies as Topic; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Time Factors; Treatment Outcome; Triazoles; United States

2003
Hormonal therapy in postmenopausal women with breast cancer.
    Oncology, 2003, Volume: 64, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Neoadjuvant Therapy; Nitriles; Postmenopause; Progestins; Triazoles

2003
Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
    Journal of the National Cancer Institute, 2003, Jun-04, Volume: 95, Issue:11

    Topics: Anastrozole; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Drug Administration Schedule; Enzyme Inhibitors; Estrogen Receptor Modulators; Estrogens; Female; Humans; Ki-67 Antigen; Nitriles; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2003
The current status of aromatase inhibitors in the management of breast cancer.
    The Surgical clinics of North America, 2003, Volume: 83, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles

2003
A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.
    American journal of clinical oncology, 2003, Volume: 26, Issue:4

    Topics: Aminoglutethimide; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles

2003
Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy.
    American journal of clinical oncology, 2003, Volume: 26, Issue:4

    Topics: Anastrozole; Androstadienes; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Humans; Letrozole; Neoplasm Metastasis; Nitriles; Tamoxifen; Triazoles; Xenograft Model Antitumor Assays

2003
Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study).
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2003, Volume: 163

    Topics: Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Prognosis; Tamoxifen; Triazoles

2003
Safety issues surrounding the use of aromatase inhibitors in breast cancer.
    Expert opinion on drug safety, 2003, Volume: 2, Issue:1

    Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Metabolism; Nitriles; Patient Satisfaction; Quality of Life; Safety; Tamoxifen; Triazoles

2003
Should aromatase inhibitors replace tamoxifen?
    Drug and therapeutics bulletin, 2003, Volume: 41, Issue:8

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2003
[Perspectives for the hormonal therapy of breast cancer].
    Magyar onkologia, 2003, Volume: 47, Issue:2

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Letrozole; Nitriles; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Toremifene; Triazoles

2003
Pharmacokinetics of third-generation aromatase inhibitors.
    Seminars in oncology, 2003, Volume: 30, Issue:4 Suppl 14

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles

2003
The role of aromatase inhibitors in the treatment of metastatic breast cancer.
    Seminars in oncology, 2003, Volume: 30, Issue:4 Suppl 14

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Triazoles

2003
Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate.
    Breast cancer research and treatment, 2003, Volume: 80 Suppl 1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Evidence-Based Medicine; Female; Follow-Up Studies; Humans; Middle Aged; Nitriles; Postmenopause; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Tamoxifen; Time Factors; Triazoles

2003
Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
    Breast cancer research and treatment, 2003, Volume: 80 Suppl 1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Endocrine System; Female; Humans; Menopause; Neoplasm Metastasis; Nitriles; Patient Selection; Receptors, Estrogen; Tamoxifen; Triazoles

2003
Fulvestrant in postmenopausal women with advanced breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-01, Volume: 9, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Drug Approval; Estradiol; Female; Fulvestrant; Humans; Nitriles; Postmenopause; Survival Rate; Treatment Outcome; Triazoles; United States; United States Food and Drug Administration

2003
Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cross-Over Studies; Double-Blind Method; Female; Humans; Middle Aged; Multicenter Studies as Topic; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Retrospective Studies; Tamoxifen; Treatment Outcome; Triazoles

2003
[Adjuvant endocrine treatment of breast cancer beyond St. Gallen 2003].
    Zentralblatt fur Gynakologie, 2003, Volume: 125, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Nitriles; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2003
Role of anastrozole in adjuvant therapy for postmenopausal patients.
    Seminars in oncology, 2003, Volume: 30, Issue:5 Suppl 16

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Nitriles; Postmenopause; Tamoxifen; Triazoles

2003
Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 86, Issue:3-5

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrogens; Estrone; Humans; Nitriles; Postmenopause; Radioimmunoassay; Triazoles

2003
Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 86, Issue:3-5

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Ki-67 Antigen; Letrozole; Neoadjuvant Therapy; Nitriles; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles

2003
New findings about endocrine therapy for breast cancer.
    Breast (Edinburgh, Scotland), 2003, Volume: 12, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2003
The best use of adjuvant endocrine treatments.
    Breast (Edinburgh, Scotland), 2003, Volume: 12, Issue:6

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Female; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Nitriles; Ovary; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Triazoles

2003
Challenges in the endocrine management of breast cancer.
    Breast (Edinburgh, Scotland), 2003, Volume: 12 Suppl 2

    Topics: Adult; Aged; Anastrozole; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Letrozole; Mastectomy, Segmental; Mice; Middle Aged; Nitriles; Prognosis; Randomized Controlled Trials as Topic; Receptors, Estrogen; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles; United Kingdom

2003
Aromatase inhibitors in breast cancer therapy.
    Clinical breast cancer, 2003, Volume: 4 Suppl 2

    Topics: Anastrozole; Androstadienes; Breast Neoplasms; Clinical Trials as Topic; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Letrozole; Neoplasm Recurrence, Local; Nitriles; Triazoles

2003
Focus on anastrozole and breast cancer.
    Current medical research and opinion, 2003, Volume: 19, Issue:8

    Topics: Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Therapy, Combination; Enzyme Inhibitors; Estrogens; Female; Goserelin; Humans; Nitriles; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen; Triazoles

2003
A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases.
    Breast cancer research and treatment, 2003, Volume: 82, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase III as Topic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles

2003
[Neoadjuvant endocrine therapy for breast cancer: an overview].
    Bulletin du cancer, 2004, Volume: 91, Issue:1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Female; Humans; Letrozole; Neoadjuvant Therapy; Nitriles; Tamoxifen; Triazoles

2004
Anastrozole (Arimidex).
    Clinical journal of oncology nursing, 2004, Volume: 8, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Half-Life; Humans; Metabolic Clearance Rate; Nitriles; Nurse's Role; Oncology Nursing; Patient Education as Topic; Triazoles

2004
[Controversies in endocrine therapy for breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:2

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Estrogen Replacement Therapy; Female; Humans; Letrozole; Mastectomy, Segmental; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Tamoxifen; Triazoles

2004
Fulvestrant: a review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
    Drugs, 2004, Volume: 64, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles

2004
Aromatase inhibitors for breast cancer in postmenopausal women.
    The oncologist, 2004, Volume: 9, Issue:2

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles

2004
Aromatase inhibitors: current indications and future prospects for treatment of postmenopausal breast cancer.
    Journal of the American Geriatrics Society, 2004, Volume: 52, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Approval; Drug Interactions; Economics, Pharmaceutical; Female; Forecasting; Geriatrics; Humans; Letrozole; Neoadjuvant Therapy; Nitriles; Patient Selection; Postmenopause; Practice Patterns, Physicians'; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles; United States; United States Food and Drug Administration

2004
Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?
    Cancer treatment reviews, 2004, Volume: 30, Issue:4

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2004
Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?
    British journal of cancer, 2004, May-04, Volume: 90, Issue:9

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2004
Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:7

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Brachial Plexus Neuropathies; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Neoplasms; Nitriles; Radiography, Thoracic; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triazoles; Uterine Neoplasms

2004
[Aromatase inhibitors in the adjuvant therapy of breast carcinomas].
    Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:6

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Letrozole; Neoplasm Recurrence, Local; Nitriles; Patient Care Management; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tamoxifen; Treatment Outcome; Triazoles

2004
Endocrine approaches for the treatment of early and advanced breast cancer in postmenopausal women.
    The international journal of biochemistry & cell biology, 2004, Volume: 36, Issue:11

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Nitriles; Postmenopause; Tamoxifen; Triazoles

2004
Current developments in hormonal therapy of breast cancer.
    Clinical breast cancer, 2004, Volume: 5 Suppl 1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Tamoxifen; Triazoles

2004
The ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial: an update.
    Clinical breast cancer, 2004, Volume: 5 Suppl 1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Middle Aged; Multicenter Studies as Topic; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2004
Switching trial of adjuvant tamoxifen with an aromatase inhibitor in postmenopausal patients with breast cancer.
    Clinical breast cancer, 2004, Volume: 5 Suppl 1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2004
The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.
    Cancer, 2004, Oct-01, Volume: 101, Issue:7

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Enzyme Inhibitors; Evidence-Based Medicine; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Prospective Studies; Tamoxifen; Triazoles

2004
Role of aromatase inhibitors in the treatment of breast cancer.
    Clinical therapeutics, 2004, Volume: 26, Issue:8

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles

2004
[Postoperative hormone (endocrine) therapy in endometrial carcinoma].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Chemotherapy, Adjuvant; Drug Therapy, Combination; Endometrial Neoplasms; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Nitriles; Postoperative Care; Tamoxifen; Treatment Outcome; Triazoles

2004
Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:12

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemoprevention; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles

2004
Breast cancer (metastatic).
    Clinical evidence, 2003, Issue:10

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Nitriles; Tamoxifen; Triazoles

2003
[Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
    Bulletin du cancer, 2004, Volume: 91, Issue:12

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Letrozole; Menopause; Neoplasms, Hormone-Dependent; Nitriles; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2004
Advances in endocrine therapy for breast cancer: considering efficacy, safety, and quality of life.
    Clinical journal of oncology nursing, 2004, Volume: 8, Issue:6

    Topics: Algorithms; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Decision Trees; Drug Administration Schedule; Drug Monitoring; Estradiol; Female; Fulvestrant; Humans; Letrozole; Neoplasm Recurrence, Local; Nitriles; Nurse's Role; Oncology Nursing; Patient Education as Topic; Patient Selection; Postmenopause; Quality of Life; Safety; Selective Estrogen Receptor Modulators; Social Support; Tamoxifen; Treatment Outcome; Triazoles

2004
Aromatase inhibitors and breast cancer: time for a change?
    International journal of clinical practice, 2004, Volume: 58, Issue:12

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Humans; Letrozole; Multicenter Studies as Topic; Nitriles; Randomized Controlled Trials as Topic; Risk Factors; Tamoxifen; Treatment Outcome; Triazoles

2004
Endometriosis: new genetic approaches and therapy.
    Annual review of medicine, 2005, Volume: 56

    Topics: Anastrozole; Aromatase Inhibitors; Drug Therapy, Combination; Endometriosis; Endometrium; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Techniques; Gonadotropin-Releasing Hormone; Humans; Long-Term Care; Nitriles; Oligonucleotide Array Sequence Analysis; Triazoles

2005
Endocrine treatment options for advanced breast cancer--the role of fulvestrant.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gefitinib; Humans; Nitriles; Postmenopause; Quinazolines; Tamoxifen; Treatment Outcome; Triazoles

2005
Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
    Cancer treatment reviews, 2005, Volume: 31, Issue:1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Evidence-Based Medicine; Female; Humans; Letrozole; Mastectomy, Segmental; Neoadjuvant Therapy; Nitriles; Randomized Controlled Trials as Topic; Receptors, Estrogen; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2005
Clinical applications of hormonal therapy in ovarian cancer.
    Current treatment options in oncology, 2005, Volume: 6, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leuprolide; Medroxyprogesterone; Neoplasm Invasiveness; Neoplasm Staging; Nitriles; Ovarian Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2005
Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Feb-01, Volume: 62, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2005
Aromatase inhibitors in advanced breast cancer.
    Seminars in oncology, 2004, Volume: 31, Issue:6 Suppl 12

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Neoplasm Metastasis; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Triazoles

2004
Innovations in antineoplastic therapy.
    The Nursing clinics of North America, 2005, Volume: 40, Issue:1

    Topics: Adjuvants, Immunologic; Alemtuzumab; Aminoglycosides; Anastrozole; Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzamides; Bile; Boronic Acids; Bortezomib; Capecitabine; Cetuximab; Decanoic Acids; Deoxycytidine; Docetaxel; Drug Approval; Estradiol; Fluorouracil; Fulvestrant; Gefitinib; Gemtuzumab; Humans; Imatinib Mesylate; Letrozole; Leuprolide; Nitriles; Oligopeptides; Organoplatinum Compounds; Oxaliplatin; Oxides; Piperazines; Polyesters; Pyrazines; Pyrimidines; Quinazolines; Taxoids; Thionucleotides; Tissue Extracts; Triazoles; United States; United States Food and Drug Administration; Vidarabine Phosphate

2005
Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone receptor-positive advanced breast cancer.
    Cancer investigation, 2005, Volume: 23, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Estradiol; Female; Fulvestrant; Humans; Immunohistochemistry; Injections, Intramuscular; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Triazoles

2005
Aromatase inhibition: translation into a successful therapeutic approach.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Apr-15, Volume: 11, Issue:8

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Letrozole; Molecular Structure; Nitriles; Triazoles

2005
Aromatase inhibitors in the treatment of early and advanced breast cancer.
    Acta oncologica (Stockholm, Sweden), 2005, Volume: 44, Issue:1

    Topics: Adult; Aged; Anastrozole; Aromatase Inhibitors; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Immunohistochemistry; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nitriles; Postmenopause; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Triazoles

2005
Effectiveness and tolerability of fulvestrant in postmenopausal women with hormone receptor-positive breast cancer.
    Clinical breast cancer, 2005, Volume: 6 Suppl 1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estradiol; Female; Fulvestrant; Humans; Injections, Intramuscular; Neoplasm Staging; Nitriles; Postmenopause; Quality of Life; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2005
Aromatase inhibitors for the treatment and prevention of breast cancer.
    Clinical breast cancer, 2005, Volume: 6, Issue:1

    Topics: Adult; Aged; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Nitriles; Randomized Controlled Trials as Topic; Risk Assessment; Survival Rate; Tamoxifen; Treatment Outcome; Triazoles

2005
[Aromatase inhibitors in adjuvant setting in breast cancer].
    Bulletin du cancer, 2004, Dec-01, Volume: 91 Suppl 4

    Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Menopause; Nitriles; Triazoles

2004
A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer.
    Cancer treatment reviews, 2005, Volume: 31, Issue:4

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2005
Aromatase inhibitors for therapy of advanced breast cancer.
    The Journal of steroid biochemistry and molecular biology, 2005, Volume: 95, Issue:1-5

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Drug Evaluation; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2005
The aromatase inhibitors in early breast cancer: who, when, and why?
    The Medical journal of Australia, 2005, Jul-04, Volume: 183, Issue:1

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Letrozole; Nitriles; Patient Selection; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2005
Anastrozole.
    Drugs of today (Barcelona, Spain : 1998), 2005, Volume: 41, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Recurrence; Survival Rate; Tamoxifen; Triazoles

2005
Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now?
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2005
Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.
    Oncology, 2005, Volume: 69, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Controlled Clinical Trials as Topic; Estrogen Receptor Modulators; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2005
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
    Cancer, 2005, Oct-01, Volume: 104, Issue:7

    Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles

2005
Breast adenocarcinoma metastatic to epidural cervical spine meningioma: case report and review of the literature.
    Journal of neuro-oncology, 2005, Volume: 75, Issue:2

    Topics: Adenocarcinoma; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carrier Proteins; Cervical Vertebrae; Female; Fractures, Compression; Glycoproteins; Humans; Immunohistochemistry; Lumbar Vertebrae; Magnetic Resonance Imaging; Membrane Transport Proteins; Meningioma; Middle Aged; Nitriles; Radiography; Spinal Cord Neoplasms; Treatment Outcome; Triazoles

2005
Breast cancer (metastatic).
    Clinical evidence, 2005, Issue:13

    Topics: Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Bridged-Ring Compounds; Female; Humans; Nitriles; Progestins; Tamoxifen; Taxoids; Trastuzumab; Triazoles

2005
Recent advances in the use of aromatase inhibitors for women with postmenopausal breast cancer.
    The journal of the British Menopause Society, 2005, Volume: 11, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Letrozole; Nitriles; Postmenopause; Triazoles

2005
Adjuvant endocrine therapy in postmenopausal breast cancer patients.
    Breast (Edinburgh, Scotland), 2005, Volume: 14, Issue:6

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2005
The biology of steroid hormones and endocrine treatment of breast cancer.
    Breast (Edinburgh, Scotland), 2005, Volume: 14, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Goserelin; Humans; Nitriles; Postmenopause; Triazoles

2005
New developments in the treatment of postmenopausal breast cancer.
    Trends in endocrinology and metabolism: TEM, 2005, Volume: 16, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2005
Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
    Breast (Edinburgh, Scotland), 2006, Volume: 15, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Female; Fulvestrant; Hormone Replacement Therapy; Humans; Lipids; Middle Aged; Nitriles; Osteoporosis, Postmenopausal; Risk Factors; Tamoxifen; Triazoles; Triglycerides

2006
Life following aromatase inhibitors--where now for endocrine sequencing?
    Breast cancer research and treatment, 2005, Volume: 93 Suppl 1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Nitriles; Triazoles

2005
Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:2

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Endometrial Neoplasms; Estradiol; Female; Fulvestrant; Humans; Joint Diseases; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2006
Defining the roles of aromatase inhibitors in the adjuvant treatment of early-stage breast cancer.
    Clinical breast cancer, 2005, Volume: 6, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Neoplasm Staging; Nitriles; Research Design; Tamoxifen; Triazoles

2005
Testotoxicosis: current viewpoint.
    Pediatric endocrinology reviews : PER, 2005, Volume: 3, Issue:2

    Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Body Height; Child; Clinical Trials, Phase II as Topic; Humans; Male; Nitriles; Point Mutation; Puberty, Precocious; Receptors, LH; Tosyl Compounds; Triazoles

2005
Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer.
    MedGenMed : Medscape general medicine, 2005, Aug-24, Volume: 7, Issue:3

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Letrozole; Nitriles; Postmenopause; Triazoles

2005
Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention.
    Oncology, 2006, Volume: 70, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Estrogen Receptor Modulators; Female; Humans; Neoadjuvant Therapy; Nitriles; Postmenopause; Survival Analysis; Tamoxifen; Triazoles

2006
Adjuvant endocrine therapy for postmenopausal women with early breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-01, Volume: 12, Issue:3 Pt 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2006
[Precocious puberty].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 4

    Topics: Anastrozole; Aromatase Inhibitors; Female; Fibrous Dysplasia, Polyostotic; Gonadotropins, Pituitary; Humans; Leuprolide; Male; Nitriles; Prognosis; Puberty, Precocious; Surgical Procedures, Operative; Triazoles

2006
[Clinical application of the gonadotropin--ovulation induction].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 4

    Topics: Anastrozole; Anovulation; Aromatase Inhibitors; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Nitriles; Ovulation Induction; Pregnancy; Pregnancy Outcome; Pulse Therapy, Drug; Triazoles

2006
Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.
    Journal of surgical oncology, 2006, Jun-01, Volume: 93, Issue:7

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Letrozole; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2006
Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.
    Breast cancer research and treatment, 2006, Volume: 99, Issue:3

    Topics: Acute Disease; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Incidence; Nitriles; Pulmonary Embolism; Triazoles; Venous Thrombosis

2006
Pre-menopausal breast cancer and aromatase inhibitors: Treating a new generation of women.
    Breast cancer research and treatment, 2006, Volume: 99, Issue:3

    Topics: Adult; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Therapy; Estrogens; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Premenopause; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles

2006
Anastrozole for breast cancer: recent advances and ongoing challenges.
    Expert review of anticancer therapy, 2006, Volume: 6, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Nitriles; Tamoxifen; Triazoles

2006
The adjuvant endocrine treatment revolution: focus on anastrozole.
    Expert opinion on drug metabolism & toxicology, 2006, Volume: 2, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Molecular Structure; Nitriles; Treatment Outcome; Triazoles

2006
Time to response: comparison of fulvestrant and oral endocrine agents.
    Clinical breast cancer, 2006, Volume: 7, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Injections, Intramuscular; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2006
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
    Journal of the National Cancer Institute, 2006, Sep-20, Volume: 98, Issue:18

    Topics: Adult; Aged; Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles

2006
Bone safety of aromatase inhibitors versus tamoxifen.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2006, Volume: 16 Suppl 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Female; Fractures, Bone; Humans; Letrozole; Nitriles; Postmenopause; Tamoxifen; Triazoles

2006
Update on the use of aromatase inhibitors in breast cancer.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:14

    Topics: Anastrozole; Androstadienes; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Triazoles

2006
Refining the postmenopausal breast cancer treatment paradigm: the FACE trial.
    Expert review of anticancer therapy, 2006, Volume: 6, Issue:10

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Multicenter Studies as Topic; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Triazoles

2006
Aromatase inhibitors and bone health in women with breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Nov-20, Volume: 24, Issue:33

    Topics: Absorptiometry, Photon; Algorithms; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Remodeling; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Life Style; Neoplasms, Hormone-Dependent; Nitriles; Osteoporosis, Postmenopausal; Population Surveillance; Risk Factors; Triazoles

2006
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis.
    The Lancet. Oncology, 2006, Volume: 7, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Disease-Free Survival; Female; Humans; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen; Triazoles

2006
Adjuvant therapy for patients who have node-positive breast cancer.
    Advances in surgery, 2006, Volume: 40

    Topics: Adult; Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Lymphatic Metastasis; Middle Aged; Nitriles; Postmenopause; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome; Triazoles

2006
Do endocrine treatments for breast cancer have a negative impact on lipid profiles and cardiovascular risk in postmenopausal women?
    American heart journal, 2007, Volume: 153, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Estrogens; Female; Humans; Nitriles; Postmenopause; Risk Factors; Tamoxifen; Thromboembolism; Triazoles; Triglycerides

2007
Economic evaluation of the prevention and treatment of breast cancer--present status and open issues.
    Breast cancer (Tokyo, Japan), 2007, Volume: 14, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Female; Humans; Letrozole; Neoplasm Recurrence, Local; Nitriles; Quality-Adjusted Life Years; Tamoxifen; Triazoles

2007
Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current data.
    Current medical research and opinion, 2006, Volume: 22, Issue:12

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Nitriles; Quality of Life; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2006
Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer.
    Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:1

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Ovariectomy; Ovary; Postmenopause; Premenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen; Triazoles

2007
[Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].
    Nederlands tijdschrift voor geneeskunde, 2006, Dec-30, Volume: 150, Issue:52

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Letrozole; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2006
[Advancement in endocrine therapy for breast cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2007
New advances in ovulation induction.
    Current opinion in obstetrics & gynecology, 2007, Volume: 19, Issue:3

    Topics: Anastrozole; Aromatase Inhibitors; Clomiphene; Estrogen Antagonists; Female; Fertility Agents, Female; Gonadotropins; Humans; Infertility, Female; Letrozole; Nitriles; Ovary; Ovulation Induction; Pregnancy; Pregnancy Rate; Tamoxifen; Treatment Outcome; Triazoles

2007
Hormonal therapies for early breast cancer: systematic review and economic evaluation.
    Health technology assessment (Winchester, England), 2007, Volume: 11, Issue:26

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Drug Administration Schedule; Female; Humans; Letrozole; Neoplasm Recurrence, Local; Nitriles; Quality-Adjusted Life Years; Survival Analysis; Tamoxifen; Time Factors; Triazoles

2007
Aromatase inhibitors and musculoskeletal pain in patients with breast cancer.
    Clinical journal of oncology nursing, 2007, Volume: 11, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Drug Monitoring; Female; Humans; Musculoskeletal Diseases; Nitriles; Nurse's Role; Nursing Assessment; Nursing Research; Oncology Nursing; Pain; Pain Management; Pain Measurement; Patient Care Planning; Patient Education as Topic; Patient Selection; Postmenopause; Quality of Life; Receptors, Estrogen; Treatment Outcome; Triazoles

2007
[Antiestrogen treatment in postmenopausal patients with metastatic breast cancer].
    Ugeskrift for laeger, 2007, Sep-10, Volume: 169, Issue:37

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Nitriles; Postmenopause; Prognosis; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2007
Reducing the risk of late recurrence in hormone-responsive breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18 Suppl 8

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Female; Humans; Letrozole; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Tamoxifen; Triazoles

2007
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer.
    International journal of clinical practice, 2007, Volume: 61, Issue:12

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Chemotherapy, Adjuvant; Drug Resistance; Female; Humans; Letrozole; Musculoskeletal Diseases; Nitriles; Postmenopause; Premenopause; Tamoxifen; Thromboembolism; Triazoles

2007
Safety of aromatase inhibitors in the adjuvant setting.
    Breast cancer research and treatment, 2007, Volume: 105 Suppl 1

    Topics: Anastrozole; Androstadienes; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Causality; Chemotherapy, Adjuvant; Comorbidity; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Incidence; Letrozole; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Nitriles; Osteoporosis; Rats; Survival Analysis; Tamoxifen; Triazoles

2007
Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer.
    Clinical breast cancer, 2007, Volume: 7, Issue:9

    Topics: Adenocarcinoma; Adult; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptives, Oral; Female; Ferritins; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Membrane Proteins; Mutation; Nitriles; Phlebotomy; Porphyria Cutanea Tarda; Triazoles

2007
Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Clinical therapeutics, 2007, Volume: 29, Issue:8

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Letrozole; Nitriles; Postmenopause; Practice Guidelines as Topic; Quality of Life; Risk Assessment; Secondary Prevention; Tamoxifen; Treatment Outcome; Triazoles

2007
Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature.
    Minerva ginecologica, 2007, Volume: 59, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cognition; Female; Gonadotropin-Releasing Hormone; Humans; Neuropsychological Tests; Nitriles; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2007
Anastrozole for malignant and benign conditions: present applications and future therapeutic integrations.
    Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:14

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Nitriles; Triazoles

2007
Effectively nursing patients receiving aromatase inhibitor therapy.
    Breast (Edinburgh, Scotland), 2008, Volume: 17, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Arthralgia; Atrophy; Breast Neoplasms; Cardiovascular Diseases; Comorbidity; Female; Hot Flashes; Humans; Lubricants; Neoplasm Recurrence, Local; Nitriles; Patient Education as Topic; Quality of Life; Tamoxifen; Triazoles; Vagina; Weight Gain

2008
Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.
    Cancer treatment reviews, 2008, Volume: 34, Issue:2

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2008
The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer.
    Breast (Edinburgh, Scotland), 2008, Volume: 17 Suppl 1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Disease-Free Survival; Evidence-Based Medicine; Letrozole; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Quality of Life; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome; Triazoles

2008
Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2008, Volume: 34, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles

2008
Aromatase inhibitors in early breast-cancer treatment: The story so far.
    Breast (Edinburgh, Scotland), 2008, Volume: 17 Suppl 3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Letrozole; Nitriles; Triazoles

2008
The role of endocrine therapies in reducing risk of recurrence in postmenopausal women with hormone receptor-positive breast cancer.
    European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2008, Volume: 12, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Letrozole; Neoplasm Recurrence, Local; Nitriles; Nurse Clinicians; Nurse Practitioners; Nurse's Role; Oncology Nursing; Patient Education as Topic; Patient Selection; Postmenopause; Receptors, Estrogen; Risk Factors; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2008
Neoadjuvant endocrine therapy for breast cancer: past, present and future.
    Anti-cancer drugs, 2008, Volume: 19, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Forecasting; Humans; Letrozole; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Patient Selection; Postmenopause; Tamoxifen; Triazoles

2008
Targeting breast cancer with hormonal treatment options.
    The Nurse practitioner, 2008, Volume: 33, Issue:5

    Topics: Aftercare; Ambulatory Care; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estrogen Receptor Modulators; Humans; Information Services; Internet; Letrozole; Nitriles; Nurse Practitioners; Patient Selection; Postmenopause; Practice Guidelines as Topic; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Triazoles

2008
The emerging role of aromatase inhibitors in the adjuvant management of breast cancer.
    Reviews on recent clinical trials, 2006, Volume: 1, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Therapy, Combination; Humans; Letrozole; Neoplasm Recurrence, Local; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome; Triazoles

2006
Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease.
    Clinical breast cancer, 2008, Volume: 8, Issue:1

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Tamoxifen; Treatment Outcome; Triazoles

2008
Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer.
    Drugs, 2008, Volume: 68, Issue:9

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Triazoles

2008
[Adjuvant endocrine therapy in postmenopausal hormone-sensitive breast cancer: to start, to switch or to extend?].
    Magyar onkologia, 2008, Volume: 52, Issue:2

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Resistance, Neoplasm; Estrogen Receptor Modulators; Female; Humans; Letrozole; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2008
Skeletal effects of drugs to treat cancer.
    Current drug safety, 2008, Volume: 3, Issue:3

    Topics: Anastrozole; Animals; Antineoplastic Agents; Aromatase Inhibitors; Bone Density; Bone Diseases, Metabolic; Fractures, Bone; Humans; Neoplasms; Nitriles; Triazoles

2008
Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.
    Expert review of anticancer therapy, 2008, Volume: 8, Issue:12

    Topics: Anastrozole; Antineoplastic Agents; Breast Neoplasms; Early Diagnosis; Humans; Nitriles; Tamoxifen; Triazoles

2008
Aromatase inhibitors and breast cancer.
    Annals of the New York Academy of Sciences, 2009, Volume: 1155

    Topics: Anastrozole; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Humans; Letrozole; Nitriles; Receptor Cross-Talk; Transplantation, Heterologous; Trastuzumab; Triazoles

2009
Future targets in endometriosis treatment: targeting the endometriotic implant.
    Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:3

    Topics: Anastrozole; Angiogenesis Inhibitors; Animals; Aromatase Inhibitors; Clinical Trials as Topic; Endometriosis; Female; Humans; Letrozole; Molecular Structure; Nitriles; Triazoles

2009
[Adjuvant breast cancer treatment with hormono-radiotherapy].
    Bulletin du cancer, 2009, Volume: 96, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2009
Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer.
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:9

    Topics: Anastrozole; Androstadienes; Animals; Breast Neoplasms; Disease Management; Early Detection of Cancer; Female; Humans; Letrozole; Nitriles; Randomized Controlled Trials as Topic; Triazoles

2009
Medical treatment for rectovaginal endometriosis: what is the evidence?
    Human reproduction (Oxford, England), 2009, Volume: 24, Issue:10

    Topics: Anastrozole; Aromatase Inhibitors; Cohort Studies; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices; Levonorgestrel; Nitriles; Pain; Patient Preference; Randomized Controlled Trials as Topic; Rectal Diseases; Treatment Outcome; Triazoles; Vaginal Diseases

2009
Breast cancer chemoprevention - a vision not yet realized.
    European journal of cancer care, 2009, Volume: 18, Issue:5

    Topics: Anastrozole; Anticarcinogenic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Quality of Life; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Triazoles

2009
Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer.
    Breast (Edinburgh, Scotland), 2009, Volume: 18 Suppl 2

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Secondary Prevention; Survival Analysis; Tamoxifen; Triazoles; Women's Health

2009
Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer.
    American journal of clinical oncology, 2010, Volume: 33, Issue:3

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Celecoxib; Estrogens; Female; Humans; Letrozole; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Pyrazoles; Randomized Controlled Trials as Topic; Recurrence; Salvage Therapy; Sulfonamides; Tamoxifen; Triazoles

2010
A case of ectopic breast cancer with a literature review.
    Surgical oncology, 2011, Volume: 20, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Choristoma; Female; Humans; Japan; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Nitriles; Survival Analysis; Treatment Outcome; Triazoles

2011
Aromatase inhibitors for female infertility: a systematic review of the literature.
    Reproductive biomedicine online, 2009, Volume: 19, Issue:4

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Clomiphene; Female; Fertilization in Vitro; Gonadotropins; Humans; Infant, Newborn; Infertility, Female; Letrozole; Nitriles; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Triazoles

2009
Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
    Minerva ginecologica, 2009, Volume: 61, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Cytochrome P-450 CYP2D6; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Genotype; Humans; Neoadjuvant Therapy; Nitriles; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2009
[A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].
    Journal des maladies vasculaires, 2010, Volume: 35, Issue:1

    Topics: Adenocarcinoma, Mucinous; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Estrogens; Female; Galantamine; Humans; Mammography; Mastectomy; Neoplasms, Hormone-Dependent; Nitriles; Paraneoplastic Syndromes; Pravastatin; Progesterone; Radiotherapy, Adjuvant; Raynaud Disease; Seasons; Triazoles; Verapamil

2010
[Management of metastatic HER2-positive breast cancer: present and future].
    Bulletin du cancer, 2010, Volume: 97, Issue:3

    Topics: Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Bevacizumab; Brain Neoplasms; Breast Neoplasms; Disease Progression; Female; Heart; Humans; Lactams, Macrocyclic; Lapatinib; Letrozole; Neoplasm Proteins; Nitriles; Quinazolines; Quinolines; Receptor, ErbB-2; Trastuzumab; Triazoles

2010
Endometriosis: in search of optimal treatment.
    Minerva ginecologica, 2010, Volume: 62, Issue:1

    Topics: Adalimumab; Anastrozole; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aromatase Inhibitors; Endometriosis; Estrogen Receptor Modulators; Etanercept; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Letrozole; Nitriles; Pentoxifylline; Progesterone; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Triazoles; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha

2010
Adjuvant endocrine therapy for early breast cancer: the story so far.
    Cancer investigation, 2010, Volume: 28, Issue:4

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Receptors, Estrogen; Tamoxifen; Triazoles

2010
Question 2. Which medications effectively reduce pubertal gynaecomastia?
    Archives of disease in childhood, 2010, Volume: 95, Issue:3

    Topics: Anastrozole; Aromatase Inhibitors; Child; Estrogen Antagonists; Evidence-Based Medicine; Gynecomastia; Humans; Male; Nitriles; Puberty; Tamoxifen; Treatment Outcome; Triazoles

2010
Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer.
    Breast cancer research and treatment, 2010, Volume: 123, Issue:1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Triazoles

2010
Anastrozole.
    Expert opinion on drug safety, 2010, Volume: 9, Issue:6

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Estrogen Antagonists; Female; Humans; Nitriles; Polymorphism, Single Nucleotide; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Time Factors; Triazoles

2010
Women and bone health: maximizing the benefits of aromatase inhibitor therapy.
    Oncology, 2010, Volume: 79, Issue:1-2

    Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Colorectal Neoplasms; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Letrozole; Nitriles; Osteoporosis; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; RANK Ligand; Secondary Prevention; Tamoxifen; Triazoles; Zoledronic Acid

2010
The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:6

    Topics: Anastrozole; Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Female; Fluorouracil; Humans; Lapatinib; Letrozole; Neoplasm Metastasis; Nitriles; Quinazolines; Receptor, ErbB-2; Taxoids; Trastuzumab; Treatment Outcome; Triazoles

2011
When to start an aromatase inhibitor: now or later?
    Journal of surgical oncology, 2011, Jun-01, Volume: 103, Issue:7

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Cost-Benefit Analysis; Drug Administration Schedule; Female; Humans; Letrozole; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitriles; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2011
Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole--of clinical importance?
    British journal of cancer, 2011, Mar-29, Volume: 104, Issue:7

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Cytochrome P-450 CYP2D6; Female; Letrozole; Mice; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2011
Overview of adjuvant trials of aromatase inhibitors in early breast cancer.
    Steroids, 2011, Volume: 76, Issue:8

    Topics: Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen; Triazoles

2011
Preventive therapy for breast cancer: a consensus statement.
    The Lancet. Oncology, 2011, Volume: 12, Issue:5

    Topics: Anastrozole; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Consensus Development Conferences as Topic; Diphosphonates; Estrogen Receptor Modulators; Expert Testimony; Female; Fenretinide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Nitriles; Norpregnenes; Piperidines; Premenopause; Pyrrolidines; Raloxifene Hydrochloride; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Triazoles

2011
[Neoadjuvant endocrine therapy for postmenopausal estrogen receptor-positive patients with breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:4

    Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Postmenopause; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Triazoles

2011
[Aromatase inhibitors and arthralgia].
    Magyar onkologia, 2011, Volume: 55, Issue:1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Letrozole; Medication Adherence; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Quality of Life; Risk Factors; Triazoles

2011
The emerging use of aromatase inhibitors for endometriosis treatment.
    Reproductive biology and endocrinology : RB&E, 2011, Jun-21, Volume: 9

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Disease Models, Animal; Endometriosis; Endometrium; Estrogens; Female; Fertility; Humans; Letrozole; Mice; Nitriles; Ovary; Pelvic Pain; Rats; Triazoles

2011
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review.
    Reproductive biology and endocrinology : RB&E, 2011, Jun-21, Volume: 9

    Topics: Anastrozole; Aromatase Inhibitors; Clinical Trials as Topic; Endometriosis; Female; Humans; Letrozole; Nitriles; Pain, Postoperative; Pelvic Pain; Triazoles

2011
Clinical and economic benefits of aromatase inhibitor therapy in early-stage breast cancer.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Sep-15, Volume: 68, Issue:18

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cost-Benefit Analysis; Female; Humans; Letrozole; Nitriles; Postmenopause; Survival Analysis; Triazoles

2011
Update on adjuvant hormonal treatment of early breast cancer.
    Advances in therapy, 2011, Volume: 28 Suppl 6

    Topics: Administration, Oral; Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Neoplasm Staging; Nitriles; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2011
Management of patients with metastatic breast cancer.
    Advances in therapy, 2011, Volume: 28 Suppl 6

    Topics: Adult; Age Factors; Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Disease Management; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Estradiol; Female; Fulvestrant; Humans; Letrozole; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Nitriles; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Treatment Outcome; Triazoles

2011
Initialization of adjuvant hormonal treatment for breast cancer.
    Advances in therapy, 2011, Volume: 28 Suppl 6

    Topics: Adult; Age Factors; Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Early Detection of Cancer; Female; Humans; Mastectomy; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Premenopause; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2011
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis.
    Health technology assessment (Winchester, England), 2011, Volume: 15, Issue:42

    Topics: Anastrozole; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cost-Benefit Analysis; Disease-Free Survival; Female; Humans; Lapatinib; Letrozole; Nitriles; Quinazolines; Receptor, ErbB-2; Trastuzumab; Triazoles

2011
Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomes.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2012, Volume: 15, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cost-Benefit Analysis; Female; Humans; Models, Economic; Neoplasm Recurrence, Local; Nitriles; Quality-Adjusted Life Years; Tamoxifen; Time Factors; Triazoles

2012
Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:6

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Female; Humans; Hysterectomy; Leiomyosarcoma; Middle Aged; Nitriles; Retrospective Studies; Sarcoma, Endometrial Stromal; Triazoles; Uterine Neoplasms

2012
Aromatase inhibitors--a viable option for recurrent granulosa cell tumour of ovary: overview and case report.
    JPMA. The Journal of the Pakistan Medical Association, 2012, Volume: 62, Issue:5

    Topics: Anastrozole; Aromatase Inhibitors; Female; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Ovarian Neoplasms; Tomography, X-Ray Computed; Triazoles

2012
Soy products in the management of breast cancer.
    Current opinion in clinical nutrition and metabolic care, 2012, Volume: 15, Issue:6

    Topics: Anastrozole; Animals; Aryl Hydrocarbon Hydroxylases; Asian People; Breast Neoplasms; Cytochrome P-450 CYP1B1; Diet; Drug Interactions; Female; Humans; Incidence; Isoflavones; Meta-Analysis as Topic; Nitriles; Polymorphism, Genetic; Prognosis; Proto-Oncogene Proteins c-mdm2; Receptor, ErbB-2; Recurrence; Risk Factors; Soy Foods; Tamoxifen; Triazoles

2012
Aromatase inhibitors in the treatment of elderly women with metastatic breast cancer.
    Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:2

    Topics: Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Comorbidity; Disease Management; Disease Progression; Drug Therapy, Combination; Female; Geriatric Assessment; Health Status; Humans; Letrozole; Life Expectancy; Nitriles; Prognosis; Quality of Life; Treatment Outcome; Triazoles

2013
A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer.
    Breast cancer research and treatment, 2013, Volume: 138, Issue:3

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Estradiol; Female; Fulvestrant; Humans; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Treatment Outcome; Triazoles

2013
Pharmacogenomics of endocrine therapy in breast cancer.
    Journal of human genetics, 2013, Volume: 58, Issue:6

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Genome-Wide Association Study; Humans; Japan; Letrozole; Musculoskeletal Physiological Phenomena; Nitriles; Pharmacogenetics; Phenotype; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2013
Targeting receptor tyrosine kinases in HER2-negative breast cancer.
    Current opinion in oncology, 2013, Volume: 25, Issue:6

    Topics: Anastrozole; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Clinical Trials, Phase II as Topic; Disease-Free Survival; Drug Administration Schedule; ErbB Receptors; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Molecular Targeted Therapy; Nitriles; Prospective Studies; Protein Kinase Inhibitors; Quinazolines; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Receptor, ErbB-3; Signal Transduction; Treatment Outcome; Triazoles; Up-Regulation

2013
Co-targeting estrogen receptor and HER2 pathways in breast cancer.
    Breast (Edinburgh, Scotland), 2014, Volume: 23, Issue:1

    Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Everolimus; Female; Fulvestrant; Gefitinib; Humans; Lapatinib; Letrozole; Molecular Targeted Therapy; Nitriles; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Signal Transduction; Sirolimus; Tamoxifen; Trastuzumab; Triazoles

2014
Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    The Cochrane database of systematic reviews, 2014, Feb-24, Issue:2

    Topics: Anastrozole; Aromatase Inhibitors; Birth Rate; Clomiphene; Coitus; Female; Fertility Agents, Female; Humans; Infertility, Female; Letrozole; Nitriles; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Randomized Controlled Trials as Topic; Triazoles

2014
Cutaneous adverse effects of hormonal adjuvant therapy for breast cancer: a case of localised urticarial vasculitis following anastrozole therapy and a review of the literature.
    The Australasian journal of dermatology, 2014, Volume: 55, Issue:4

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Lobular; Chemotherapy, Adjuvant; Drug Eruptions; Female; Humans; Nitriles; Triazoles; Urticaria; Vasculitis

2014
Current concepts in breast cancer chemoprevention.
    Polskie Archiwum Medycyny Wewnetrznej, 2014, Volume: 124, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemoprevention; Estrogen Antagonists; Estrogens; Female; Humans; Incidence; Nitriles; Postmenopause; Premenopause; Prospective Studies; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2014
Fulvestrant 250 mg versus anastrozole 1 mg in the treatment of advanced breast cancer: a meta-analysis of randomized controlled trials.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Triazoles; Women

2014
[A case of local recurrence developing thirty-nine years after mastectomy for breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:3

    Topics: Adenocarcinoma; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Biopsy, Needle; Breast Neoplasms; Female; Humans; Mastectomy; Neoplasm Recurrence, Local; Nitriles; Time Factors; Triazoles

2014
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jul-01, Volume: 32, Issue:19

    Topics: Ado-Trastuzumab Emtansine; Anastrozole; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Clinical Trials as Topic; Comorbidity; Docetaxel; Drug Administration Schedule; Evidence-Based Medicine; Female; Health Status Disparities; Healthcare Disparities; Humans; Lapatinib; Letrozole; Maytansine; Molecular Targeted Therapy; Nitriles; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Societies, Medical; Taxoids; Trastuzumab; Treatment Outcome; Triazoles; United States

2014
Predictive and prognostic value of the 21-gene recurrence score in hormone receptor-positive, node-positive breast cancer.
    American journal of clinical oncology, 2014, Volume: 37, Issue:4

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase III as Topic; Disease-Free Survival; Female; Genetic Markers; Humans; Nitriles; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Reproducibility of Results; Tamoxifen; Treatment Outcome; Triazoles; Validation Studies as Topic

2014
Aromatase inhibitors in breast cancer prevention.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:12

    Topics: Anastrozole; Androstadienes; Anticarcinogenic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Neoplasm Invasiveness; Nitriles; Postmenopause; Risk; Triazoles

2014
Is there a role for estrogen activity assays? Recombinant cell bioassay for estrogen: Development and applications.
    Steroids, 2015, Volume: 99, Issue:Pt A

    Topics: Anastrozole; Aromatase Inhibitors; Biological Assay; Breast Neoplasms; Child; Estradiol; Female; Humans; Leuprolide; Male; Nitriles; Puberty, Precocious; Radioimmunoassay; Recombinant Proteins; Reference Values; Saccharomyces cerevisiae; Sensitivity and Specificity; Triazoles; Turner Syndrome

2015
The influence of genetic polymorphisms on the efficacy and side effects of anastrozole in postmenopausal breast cancer patients.
    Pharmacogenetics and genomics, 2014, Volume: 24, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase; Breast Neoplasms; Cytochrome P-450 CYP3A; Female; Glucuronosyltransferase; Humans; Nitriles; Polymorphism, Single Nucleotide; Postmenopause; Precision Medicine; Triazoles

2014
Current status of hormone therapy in patients with hormone receptor positive (HR+) advanced breast cancer.
    Breast (Edinburgh, Scotland), 2014, Volume: 23, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Neoplasm Metastasis; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2014
A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancer.
    Cancer treatment reviews, 2015, Volume: 41, Issue:2

    Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bevacizumab; Biomarkers, Tumor; Breast Neoplasms; Clinical Trials as Topic; Disease-Free Survival; Estradiol; Everolimus; Female; Fulvestrant; Humans; Molecular Targeted Therapy; Nitriles; Patient Selection; Postmenopause; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sirolimus; Treatment Failure; Treatment Outcome; Triazoles

2015
Targeting HER2 for the treatment of breast cancer.
    Annual review of medicine, 2015, Volume: 66

    Topics: Anastrozole; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Female; Humans; Lapatinib; Nitriles; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Trastuzumab; Triazoles

2015
Testosterone and breast cancer prevention.
    Maturitas, 2015, Volume: 82, Issue:3

    Topics: Anastrozole; Androgens; Aromatase; Aromatase Inhibitors; Breast; Breast Neoplasms; Drug Implants; Estrogens; Female; Humans; Nitriles; Testosterone; Triazoles

2015
Ductal Carcinoma In Situ: Treatment Update and Current Trends.
    Current oncology reports, 2015, Volume: 17, Issue:11

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Mammography; Mastectomy, Segmental; Neoplasm Recurrence, Local; Nitriles; Practice Guidelines as Topic; Precision Medicine; Prognosis; Radiotherapy, Adjuvant; Tamoxifen; Triazoles

2015
Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma.
    Archives of gynecology and obstetrics, 2016, Volume: 293, Issue:4

    Topics: Adenocarcinoma; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitriles; Treatment Outcome; Triazoles

2016
[Hormonotherapy for breast cancer prevention: What about women with genetic predisposition to breast cancer?].
    Bulletin du cancer, 2016, Volume: 103, Issue:3

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Endometrial Neoplasms; Female; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Humans; Mastectomy; Mutation; Nitriles; Prophylactic Surgical Procedures; Raloxifene Hydrochloride; Tamoxifen; Triazoles

2016
Network Meta-Analysis Comparing Overall Survival for Fulvestrant 500 mg Versus Alternative Therapies for Treatment of Postmenopausal, Estrogen Receptor-Positive Advanced Breast Cancer Following Failure on Prior Endocrine Therapy.
    Clinical breast cancer, 2016, Volume: 16, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Estradiol; Everolimus; Female; Fulvestrant; Humans; Letrozole; Megestrol Acetate; Network Meta-Analysis; Nitriles; Postmenopause; Receptors, Estrogen; Treatment Outcome; Triazoles

2016
Unravelling exemestane: From biology to clinical prospects.
    The Journal of steroid biochemistry and molecular biology, 2016, Volume: 163

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Apoptosis; Aromatase Inhibitors; Autophagy; Biotransformation; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Clinical Trials as Topic; Drug Resistance, Neoplasm; Female; Humans; Nitriles; Tamoxifen; Triazoles

2016
Endocrine therapy for hormone treatment-naïve advanced breast cancer.
    Breast (Edinburgh, Scotland), 2016, Volume: 28

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Estradiol; Female; Fulvestrant; Humans; Letrozole; Nitriles; Piperazines; Pyridines; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2016
Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategy.
    Cancer treatment reviews, 2016, Volume: 50

    Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Disease-Free Survival; Drug Resistance, Neoplasm; Estradiol; Everolimus; Female; Fulvestrant; Humans; Letrozole; Nitriles; Piperazines; Pyridines; Randomized Controlled Trials as Topic; Trastuzumab; Triazoles

2016
Fulvestrant for hormone-sensitive metastatic breast cancer.
    The Cochrane database of systematic reviews, 2017, 01-03, Volume: 1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Estradiol; Female; Fulvestrant; Humans; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Triazoles

2017
Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.
    The breast journal, 2017, Volume: 23, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Tamoxifen; Triazoles

2017
ADJUVANT (HORMONAL) THERAPY AS A CAUSE OF BONE LOSS IN PATIENTS WITH BREAST CANCER (REVIEW OF LITERATURE).
    Georgian medical news, 2017, Issue:262

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Estrogen Antagonists; Female; Humans; Letrozole; Nitriles; Osteoporosis; Postmenopause; Premenopause; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2017
A meta-analysis of randomized controlled trials comparing the efficacy and safety of anastrozole versus tamoxifen for breast cancer.
    Oncotarget, 2017, Jul-18, Volume: 8, Issue:29

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Nitriles; Randomized Controlled Trials as Topic; Recurrence; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2017
HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2.
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 79

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Drug Substitution; Female; Humans; Mastectomy; Middle Aged; Multicenter Studies as Topic; Nitriles; Prospective Studies; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Triazoles

2017
Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review.
    Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemoprevention; Chemotherapy, Adjuvant; Female; Humans; Nitriles; Postmenopause; Reproducibility of Results; Tamoxifen; Treatment Outcome; Triazoles

2017
Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis.
    Medicine, 2017, Volume: 96, Issue:33

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Disease-Free Survival; Estradiol; Female; Fulvestrant; Humans; Letrozole; Neoplasms, Hormone-Dependent; Network Meta-Analysis; Nitriles; Receptor, ErbB-2; Tamoxifen; Triazoles

2017
Personalized prevention in high risk individuals: Managing hormones and beyond.
    Breast (Edinburgh, Scotland), 2018, Volume: 39

    Topics: Adult; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemoprevention; Early Detection of Cancer; Female; Genes, BRCA1; Genes, BRCA2; Humans; Mammography; Middle Aged; Nitriles; Precision Medicine; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Tamoxifen; Triazoles

2018
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
    The Cochrane database of systematic reviews, 2018, 05-24, Volume: 5

    Topics: Abortion, Spontaneous; Anastrozole; Aromatase Inhibitors; Birth Rate; Clomiphene; Coitus; Female; Fertility Agents, Female; Humans; Infertility, Female; Letrozole; Live Birth; Nitriles; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy, Multiple; Randomized Controlled Trials as Topic; Triazoles

2018

Trials

302 trial(s) available for anastrozole and triazoles

ArticleYear
ARIMIDEX: a new oral, once-a-day aromatase inhibitor.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 53, Issue:1-6

    Topics: Administration, Oral; Aldosterone; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Estradiol; Female; Humans; Hydrocortisone; Nitriles; Triazoles

1995
Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers.
    British journal of cancer, 1996, Volume: 73, Issue:4

    Topics: Adrenocorticotropic Hormone; Anastrozole; Aromatase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hormones; Humans; Hydrocortisone; Luteinizing Hormone; Nitriles; Postmenopause; Steroids; Triazoles

1996
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Prognosis; Survival Rate; Tamoxifen; Triazoles

1996
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol; Middle Aged; Nitriles; Postmenopause; Prospective Studies; Quality of Life; Remission Induction; Survival Rate; Triazoles

1996
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.
    British journal of cancer, 1996, Volume: 74, Issue:8

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Estrogen Antagonists; Estrogens; Female; Humans; Middle Aged; Nitriles; Postmenopause; Triazoles

1996
A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.
    Cancer, 1997, Feb-15, Volume: 79, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Pregnanes; Triazoles

1997
Validated assay for the quantification of anastrozole in human plasma by capillary gas chromatography-63Ni electron capture detection.
    Journal of chromatography. B, Biomedical sciences and applications, 1997, Oct-24, Volume: 700, Issue:1-2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Chromatography, Gas; Drug Stability; Female; Humans; Nitriles; Reproducibility of Results; Sensitivity and Specificity; Triazoles

1997
A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancer.
    Oncology, 1997, Volume: 54 Suppl 2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Female; Humans; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles

1997
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
    Cancer, 1998, Sep-15, Volume: 83, Issue:6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Megestrol; Nitriles; Postmenopause; Proportional Hazards Models; Survival Rate; Triazoles

1998
The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer.
    British journal of cancer, 1999, Volume: 79, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Estrogens; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

1999
Anastrozole shows evidence of activity in postmenopausal patients who have responded or stabilised on formestane therapy.
    European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:5

    Topics: Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Female; Humans; Nitriles; Postmenopause; Prospective Studies; Receptors, Estrogen; Treatment Outcome; Triazoles

1999
A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex) with intramuscular formestane in postmenopausal women with advanced breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:10

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Estrogens; Female; Humans; Injections, Intramuscular; Middle Aged; Nitriles; Triazoles

1999
Critique of survival update analysis from two phase III anastrozole clinical trials.
    Annals of surgical oncology, 1999, Volume: 6, Issue:8 Suppl

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Nitriles; Survival Rate; Triazoles

1999
Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer.
    Breast cancer research and treatment, 1999, Volume: 58, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Europe; Female; Humans; Megestrol Acetate; Nitriles; Postmenopause; Prospective Studies; Survival Analysis; Triazoles; United States

1999
The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoadjuvant Therapy; Nitriles; Postmenopause; Receptors, Estrogen; Treatment Outcome; Triazoles; Ultrasonography

2000
Estrogen suppression in males: metabolic effects.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:7

    Topics: Adolescent; Adult; Anastrozole; Antineoplastic Agents, Hormonal; Body Composition; Bone and Bones; Calcium; Estradiol; Estrogen Antagonists; Growth Substances; Hormones; Human Growth Hormone; Humans; Keto Acids; Kinetics; Leuprolide; Male; Muscle, Skeletal; Nitriles; Proteins; Triazoles

2000
A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
    Gynecologic oncology, 2000, Volume: 78, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Carcinoma; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Triazoles

2000
Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:9

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Dipeptides; Enzyme Inhibitors; Estradiol; Estrogens; Feedback; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Luteinizing Hormone; Male; Middle Aged; Nitriles; Testosterone; Triazoles

2000
Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women.
    European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Female; Humans; Nitriles; Postmenopause; Tamoxifen; Triazoles

2000
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Nov-15, Volume: 18, Issue:22

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Double-Blind Method; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2000
Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Nov-15, Volume: 18, Issue:22

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Double-Blind Method; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2000
Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:5

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Estrogens; Female; Hormones; Humans; Ki-67 Antigen; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Proteins; Receptors, Growth Factor; Trefoil Factor-1; Triazoles; Tumor Suppressor Proteins

2001
Aromatization mediates testosterone's short-term feedback restraint of 24-hour endogenously driven and acute exogenous gonadotropin-releasing hormone-stimulated luteinizing hormone and follicle-stimulating hormone secretion in young men.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:6

    Topics: Administration, Cutaneous; Adult; Anastrozole; Aromatase Inhibitors; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Estradiol; Feedback; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Ketoconazole; Luteinizing Hormone; Male; Nitriles; Prospective Studies; Testosterone; Triazoles

2001
[Aromatase inhibitors: anastrozole versus tamoxifen as first-ine therapy for advanced postmenopausal breast cancer].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Nitriles; Postmenopause; Tamoxifen; Triazoles

2001
The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers.
    British journal of clinical pharmacology, 2001, Volume: 51, Issue:5

    Topics: Adult; Anastrozole; Anticoagulants; Cross-Over Studies; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Humans; Male; Middle Aged; Nitriles; Triazoles; Warfarin

2001
Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial.
    British journal of cancer, 2001, Aug-03, Volume: 85, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Middle Aged; Nitriles; Postmenopause; Safety; Tamoxifen; Treatment Outcome; Triazoles

2001
Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.
    Cancer, 2001, Oct-15, Volume: 92, Issue:8

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Humans; Male; Middle Aged; Nitriles; Pain Measurement; Prostate-Specific Antigen; Prostatic Neoplasms; Triazoles

2001
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.
    Cancer, 2001, Nov-01, Volume: 92, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Female; Hemorrhage; Humans; Middle Aged; Nitriles; Postmenopause; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen; Thromboembolism; Treatment Outcome; Triazoles

2001
Pharmacokinetics of anastrozole in Chinese male volunteers.
    Acta pharmacologica Sinica, 2001, Volume: 22, Issue:6

    Topics: Adult; Anastrozole; Area Under Curve; Biological Availability; Cross-Over Studies; Humans; Male; Nitriles; Tissue Distribution; Triazoles

2001
Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-01, Volume: 20, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Chromatography, High Pressure Liquid; Cross-Over Studies; Enzyme Inhibitors; Estradiol; Estrogens; Estrone; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Radioimmunoassay; Triazoles

2002
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.
    Lancet (London, England), 2002, Jun-22, Volume: 359, Issue:9324

    Topics: Aged; Anastrozole; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Endpoint Determination; Enzyme Inhibitors; Female; Humans; Middle Aged; Nitriles; Postmenopause; Prognosis; Tamoxifen; Triazoles

2002
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Aug-15, Volume: 20, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; North America; Postmenopause; Quality of Life; Survival Rate; Triazoles

2002
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Aug-15, Volume: 20, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Logistic Models; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Quality of Life; Survival Rate; Triazoles

2002
Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer.
    British journal of cancer, 2002, Jul-29, Volume: 87, Issue:3

    Topics: Aged; Anastrozole; Antigens, Nuclear; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Female; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Middle Aged; Neoadjuvant Therapy; Nitriles; Nuclear Proteins; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2002
The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment.
    European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:15

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Humans; Nitriles; Patient Selection; Postmenopause; Surveys and Questionnaires; Tamoxifen; Triazoles

2002
Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal women.
    European journal of cancer (Oxford, England : 1990), 2002, Volume: 38 Suppl 6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Nitriles; Postmenopause; Retrospective Studies; Treatment Outcome; Triazoles

2002
Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    British journal of cancer, 2002, Oct-21, Volume: 87, Issue:9

    Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Radioimmunoassay; Receptors, Estrogen; Triazoles

2002
Differential effects of androgens and estrogens on bone turnover in normal men.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:1

    Topics: Administration, Cutaneous; Adult; Anastrozole; Androgens; Aromatase Inhibitors; Biomarkers; Bone Remodeling; Bone Resorption; Drug Synergism; Enzyme Inhibitors; Estrogens; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; Injections, Subcutaneous; Male; Nitriles; Osteogenesis; Testosterone; Triazoles

2003
Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.
    Clinical breast cancer, 2003, Volume: 4 Suppl 1

    Topics: Age Factors; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Female; Humans; Multicenter Studies as Topic; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Time Factors; Treatment Outcome; Triazoles; United States

2003
Fulvestrant (Faslodex) versus anastrozole for the second-line treatment of advanced breast cancer in subgroups of postmenopausal women with visceral and non-visceral metastases: combined results from two multicentre trials.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Estradiol; Female; Fulvestrant; Humans; Liver Neoplasms; Lung Neoplasms; Nitriles; Postmenopause; Retrospective Studies; Treatment Outcome; Triazoles

2003
Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study.
    American journal of clinical oncology, 2003, Volume: 26, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Prospective Studies; Remission Induction; Survival Analysis; Tamoxifen; Triazoles

2003
Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy.
    Breast cancer research and treatment, 2003, Volume: 79, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Female; Follow-Up Studies; Fulvestrant; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles

2003
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.
    Cancer, 2003, Jul-15, Volume: 98, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Double-Blind Method; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Middle Aged; Nitriles; Postmenopause; Prospective Studies; Treatment Outcome; Triazoles

2003
Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Double-Blind Method; Female; Follow-Up Studies; Humans; Nitriles; Postmenopause; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2003
Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation.
    Southern medical journal, 2003, Volume: 96, Issue:6

    Topics: Adult; Anastrozole; Aromatase; Aromatase Inhibitors; Body Mass Index; Ejaculation; Enzyme Inhibitors; Estradiol; Follow-Up Studies; Gonadal Steroid Hormones; Gonadotropins; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Nitriles; Outcome Assessment, Health Care; Testosterone; Time Factors; Triazoles

2003
Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 86, Issue:1

    Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles

2003
Anastrozole and quinapril can be safely coadministered to elderly women with breast cancer and hypertension: a pharmacokinetic study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:10

    Topics: Age Factors; Aged; Aged, 80 and over; Anastrozole; Antihypertensive Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Interactions; Female; Humans; Hypertension; Nitriles; Quinapril; Tetrahydroisoquinolines; Triazoles

2003
An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Middle Aged; Nitriles; Triazoles

2003
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update ana
    Cancer, 2003, Nov-01, Volume: 98, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2003
Endogenous estrogens influence endothelial function in young men.
    Circulation research, 2003, Nov-28, Volume: 93, Issue:11

    Topics: Adolescent; Adult; Anastrozole; Aorta; Aromatase Inhibitors; Blood Flow Velocity; Blood Pressure; Brachial Artery; C-Reactive Protein; Carotid Arteries; Compliance; Double-Blind Method; Enzyme Inhibitors; Estrogens; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Homocysteine; Humans; Lipoproteins; Male; Nitriles; Nitroglycerin; Prospective Studies; Reference Values; Risk Factors; Triazoles; Ultrasonography; Vasodilation

2003
Advanced breast cancer updates on anastrozole versus tamoxifen.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 86, Issue:3-5

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Treatment Outcome; Triazoles

2003
'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 86, Issue:3-5

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2003
The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
    BJOG : an international journal of obstetrics and gynaecology, 2003, Volume: 110, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Protocols; Double-Blind Method; Female; Humans; Hysteroscopy; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2003
Phase II trial of anastrozole in women with asymptomatic müllerian cancer.
    Gynecologic oncology, 2003, Volume: 91, Issue:3

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Nitriles; Ovarian Neoplasms; Peritoneal Neoplasms; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2003
The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial.
    Human reproduction (Oxford, England), 2004, Volume: 19, Issue:1

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Bone Density; Drug Administration Schedule; Drug Therapy, Combination; Endometriosis; Enzyme Inhibitors; Estradiol; Female; Goserelin; Humans; Menopause; Nitriles; Palliative Care; Patient Selection; Postoperative Care; Quality of Life; Secondary Prevention; Severity of Illness Index; Survival Analysis; Treatment Outcome; Triazoles

2004
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
    Psycho-oncology, 2004, Volume: 13, Issue:1

    Topics: Affect; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Cognition Disorders; Depression; England; Estrogens; Female; Humans; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nitriles; Personality Inventory; Pilot Projects; Reaction Time; Self-Assessment; Tamoxifen; Triazoles; Verbal Learning

2004
Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.
    British journal of cancer, 2004, Feb-09, Volume: 90, Issue:3

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Disease-Free Survival; Estradiol; Female; Goserelin; Humans; Injections, Subcutaneous; Middle Aged; Nitriles; Premenopause; Tamoxifen; Treatment Outcome; Triazoles

2004
Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:3

    Topics: Aged; Aging; Anastrozole; Aromatase Inhibitors; Enzyme Inhibitors; Estrogens; Humans; Hypogonadism; Male; Middle Aged; Nitriles; Quality of Life; Testosterone; Treatment Outcome; Triazoles

2004
Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and
    Breast cancer research and treatment, 2004, Volume: 85, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Disease-Free Survival; Double-Blind Method; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Survival Rate; Switzerland; Tamoxifen; Triazoles

2004
Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole.
    Hormone research, 2004, Volume: 62, Issue:3

    Topics: Adolescent; Anastrozole; Aromatase Inhibitors; Dehydroepiandrosterone Sulfate; Estrogens; Gynecomastia; Humans; Male; Nitriles; Pilot Projects; Puberty; Treatment Outcome; Triazoles

2004
Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy.
    Cancer, 2004, Aug-15, Volume: 101, Issue:4

    Topics: Age Factors; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Chemotherapy, Adjuvant; Decision Making; Female; Humans; Mastectomy; Middle Aged; Neoplasm Staging; Nitriles; Odds Ratio; Postmenopause; Risk Factors; Tamoxifen; Triazoles; United Kingdom; United States

2004
Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:9

    Topics: Adolescent; Anastrozole; Child; Double-Blind Method; Enzyme Inhibitors; Estradiol; Gynecomastia; Humans; Male; Nitriles; Testosterone; Triazoles

2004
The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.
    Cancer, 2004, Oct-01, Volume: 101, Issue:7

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Enzyme Inhibitors; Evidence-Based Medicine; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Prospective Studies; Tamoxifen; Triazoles

2004
Giving patients a choice improves quality of life: a multi-centre, investigator-blind, randomised, crossover study comparing letrozole with anastrozole.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2004, Volume: 16, Issue:7

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Cross-Over Studies; Decision Making; Female; Humans; Letrozole; Middle Aged; Nitriles; Patient Participation; Postmenopause; Quality of Life; Single-Blind Method; Treatment Outcome; Triazoles

2004
Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
    Anti-cancer drugs, 2004, Volume: 15, Issue:8

    Topics: Anastrozole; Aromatase Inhibitors; Belgium; Body Mass Index; Breast Neoplasms; Data Interpretation, Statistical; Demography; Dyspareunia; Female; Hot Flashes; Humans; Letrozole; Logistic Models; Memory Disorders; Menopause; Middle Aged; Musculoskeletal Diseases; Nitriles; Pain; Patient Selection; Prospective Studies; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Tamoxifen; Time Factors; Triazoles; Urination Disorders; Vaginal Diseases; Withholding Treatment

2004
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
    Human reproduction (Oxford, England), 2005, Volume: 20, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Protocols; Double-Blind Method; Endometrium; Female; Humans; Hysteroscopy; Nitriles; Sensitivity and Specificity; Tamoxifen; Triazoles; Ultrasonography

2005
Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status.
    European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:18

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Proliferation; Double-Blind Method; Female; Genes, erbB-2; Humans; Lymphatic Metastasis; Nitriles; Postmenopause; Receptor, ErbB-2; Receptors, Progesterone; Triazoles

2004
A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers.
    Fertility and sterility, 2004, Volume: 82, Issue:6

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Antagonists; Female; Follicle Stimulating Hormone; Gastrointestinal Diseases; Headache; Humans; Menstruation Disturbances; Nitriles; Ovarian Follicle; Premenopause; Reference Values; Time Factors; Triazoles; Ultrasonography

2004
Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
    American journal of obstetrics and gynecology, 2004, Volume: 191, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Breast Neoplasms; Combined Modality Therapy; Endometrium; Female; Humans; Immunohistochemistry; Mastectomy; Middle Aged; Nitriles; Postmenopause; Prognosis; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Receptors, Progesterone; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2004
Biomarker investigations from the ATAC trial: the role of TA01.
    Breast cancer research and treatment, 2004, Volume: 87 Suppl 1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Neoplasm Recurrence, Local; Nitriles; Oligonucleotide Array Sequence Analysis; Patient Care Planning; Prognosis; Tamoxifen; Triazoles

2004
Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Feb-01, Volume: 118, Issue:2

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Body Mass Index; Endometrial Hyperplasia; Endometrium; Female; Humans; Middle Aged; Nitriles; Obesity; Postmenopause; Triazoles; Ultrasonography

2005
The role of aromatization in testosterone supplementation: effects on cognition in older men.
    Neurology, 2005, Jan-25, Volume: 64, Issue:2

    Topics: Aged; Aged, 80 and over; Aging; Anastrozole; Aromatase; Aromatase Inhibitors; Double-Blind Method; Estradiol; Humans; Male; Memory; Memory Disorders; Middle Aged; Neuropsychological Tests; Nitriles; Prostate-Specific Antigen; Spatial Behavior; Testosterone; Triazoles; Verbal Learning

2005
Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
    Clinical endocrinology, 2005, Volume: 62, Issue:2

    Topics: Aged; Analysis of Variance; Anastrozole; Aromatase Inhibitors; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Homeostasis; Humans; Hypogonadism; Intercellular Adhesion Molecule-1; Interleukin-6; Lipids; Male; Middle Aged; Nitriles; Risk Factors; Testosterone; Triazoles; Vascular Cell Adhesion Molecule-1

2005
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-01, Volume: 23, Issue:4

    Topics: Aged; Aged, 80 and over; Anastrozole; Anilides; Breast Diseases; Double-Blind Method; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Tamoxifen; Testosterone; Tosyl Compounds; Triazoles

2005
Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole.
    Prostate cancer and prostatic diseases, 2005, Volume: 8, Issue:1

    Topics: Aged; Aged, 80 and over; Anastrozole; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Diseases; Double-Blind Method; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Placebos; Prostatic Neoplasms; Tamoxifen; Testosterone; Tosyl Compounds; Treatment Outcome; Triazoles

2005
Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jan-15, Volume: 11, Issue:2 Pt 2

    Topics: Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Proliferation; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Female; Follow-Up Studies; Humans; Ki-67 Antigen; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Survival Rate; Tamoxifen; Treatment Outcome; Triazoles

2005
Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-10, Volume: 23, Issue:11

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Double-Blind Method; Female; Humans; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Nitriles; Postmenopause; Predictive Value of Tests; Receptor, ErbB-2; Tamoxifen; Treatment Outcome; Triazoles

2005
Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer.
    Acta oncologica (Stockholm, Sweden), 2005, Volume: 44, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Estradiol; Female; Humans; Japan; Lipids; Lipoprotein Lipase; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2005
[Survival of breast cancer patients treated with inhibitors of the aromatase vs tamoxifen].
    Ginecologia y obstetricia de Mexico, 2004, Volume: 72

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Nitriles; Prospective Studies; Survival Rate; Tamoxifen; Triazoles

2004
Zoledronic acid prevents cancer treatment-induced bone loss.
    Oncology (Williston Park, N.Y.), 2005, Volume: 19, Issue:3

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Resorption; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Female; Goserelin; Humans; Imidazoles; Nitriles; Premenopause; Tamoxifen; Triazoles; Zoledronic Acid

2005
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
    Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:4

    Topics: Aged; Aged, 80 and over; Anastrozole; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Interactions; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds; Triazoles

2005
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
    British journal of cancer, 2005, May-09, Volume: 92, Issue:9

    Topics: Administration, Oral; Adult; Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Triazoles

2005
Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2005, Volume: 16, Issue:12

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Biomarkers; Bone and Bones; Bone Resorption; Estradiol; Glycoproteins; Humans; Hypogonadism; Male; Nitriles; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Testosterone; Triazoles

2005
Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial.
    The Lancet. Oncology, 2005, Volume: 6, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; England; ErbB Receptors; Female; Gefitinib; Humans; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Protein Kinase Inhibitors; Quinazolines; Receptors, Estrogen; Treatment Outcome; Triazoles; Ultrasonography

2005
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trials.
    Cancer, 2005, Jul-15, Volume: 104, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Nitriles; Postmenopause; Survival Analysis; Survival Rate; Triazoles

2005
Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-01, Volume: 23, Issue:22

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Female; Humans; Middle Aged; Neoadjuvant Therapy; Nitriles; Odds Ratio; Placebos; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2005
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-01, Volume: 23, Issue:22

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Female; Humans; Middle Aged; Nitriles; Postmenopause; Prospective Studies; Survival Analysis; Tamoxifen; Triazoles

2005
Comparative effects of anastrozole, tamoxifen alone and in combination on plasma lipids and bone-derived resorption during neoadjuvant therapy in the impact trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:10

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers; Bone Resorption; Breast Neoplasms; Double-Blind Method; Estradiol; Female; Humans; Lipids; Middle Aged; Neoadjuvant Therapy; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2005
Anastrazole and oral contraceptives: a novel treatment for endometriosis.
    Fertility and sterility, 2005, Volume: 84, Issue:2

    Topics: Adult; Anastrozole; Contraceptives, Oral; Drug Therapy, Combination; Endometriosis; Female; Humans; Middle Aged; Nitriles; Pain Measurement; Pelvic Pain; Prospective Studies; Triazoles

2005
Do biomarker changes during neoadjuvant endocrine therapy reflect breast tumor receptor status?
    Nature clinical practice. Oncology, 2005, Volume: 2, Issue:10

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Ki-67 Antigen; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Receptor, ErbB-2; Reference Values; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2005
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.
    Human reproduction (Oxford, England), 2006, Volume: 21, Issue:2

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Endometrial Neoplasms; Endometrium; Female; Humans; Middle Aged; Nitriles; Polyps; Risk Factors; Tamoxifen; Triazoles

2006
Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Oct-20, Volume: 23, Issue:30

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2005
Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-01, Volume: 12, Issue:3 Pt 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Female; Humans; In Situ Nick-End Labeling; Ki-67 Antigen; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Prognosis; Tamoxifen; Triazoles

2006
Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-01, Volume: 12, Issue:3 Pt 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2006
Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-15, Volume: 12, Issue:4

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Dilatation and Curettage; Endometrium; Female; Humans; Hysteroscopy; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles; Ultrasonography; Uterine Hemorrhage

2006
The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals.
    European journal of endocrinology, 2006, Volume: 154, Issue:4

    Topics: Anastrozole; Androgens; Aromatase Inhibitors; Bone and Bones; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Estradiol; Follicle Stimulating Hormone; Humans; Lipids; Luteinizing Hormone; Nitriles; Ovariectomy; Placebos; Risk Factors; Transsexualism; Triazoles

2006
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
    Cancer, 2006, May-15, Volume: 106, Issue:10

    Topics: Aged; Anastrozole; Breast Neoplasms; Confidence Intervals; Cross-Sectional Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Logistic Models; Mastectomy; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Postmenopause; Preoperative Care; Receptors, Estrogen; Reference Values; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2006
A double-blind randomised trial to evaluate the effect of anastrozole for the treatment of non-toxic multinodular goitre.
    International journal of clinical practice, 2006, Volume: 60, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Double-Blind Method; Female; Goiter, Nodular; Humans; Middle Aged; Nitriles; Triazoles

2006
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17 Suppl 7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Humans; Nitriles; Postmenopause; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2006
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230).
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2006, Volume: 21, Issue:8

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers; Bone Density; Bone Remodeling; Breast Neoplasms; Female; Fractures, Bone; Hip; Humans; Lumbar Vertebrae; Middle Aged; Nitriles; Postmenopause; Radiography; Risk; Tamoxifen; Triazoles

2006
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.
    The Lancet. Oncology, 2006, Volume: 7, Issue:8

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Therapy, Combination; Drug Tolerance; Female; Follow-Up Studies; Humans; Middle Aged; Nitriles; Postmenopause; Risk Assessment; Tamoxifen; Triazoles

2006
Estrogen receptors evolution in neoadjuvant aromatase inhibitor (AI) therapy for breast cancer in elderly women: stability of hormonal receptor expression during treatment.
    American journal of clinical oncology, 2006, Volume: 29, Issue:4

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoadjuvant Therapy; Nitriles; Receptors, Estrogen; Triazoles

2006
Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer.
    Breast cancer research and treatment, 2006, Volume: 100, Issue:3

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Follow-Up Studies; Health Status; Humans; Nitriles; Odds Ratio; Patient Dropouts; Postmenopause; Quality of Life; Risk Assessment; Surveys and Questionnaires; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2006
A prospective randomized trial comparing anastrozole and clomiphene citrate in an ovulation induction protocol using gonadotropins.
    Fertility and sterility, 2006, Volume: 86, Issue:6

    Topics: Administration, Oral; Adult; Anastrozole; Clomiphene; Drug Combinations; Female; Fertility Agents, Female; Gonadotropins; Humans; Infertility, Female; Nitriles; Ovulation Induction; Pregnancy; Pregnancy Outcome; Prospective Studies; Triazoles

2006
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Mar-01, Volume: 25, Issue:7

    Topics: Adult; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Diphosphonates; Female; Goserelin; Humans; Imidazoles; Middle Aged; Nitriles; Osteoporosis, Postmenopausal; Tamoxifen; Triazoles; Zoledronic Acid

2007
Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:6

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cryopreservation; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Letrozole; Luteinizing Hormone; Nitriles; Oocytes; Ovulation Induction; Prospective Studies; Triazoles

2007
Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
    International journal of radiation oncology, biology, physics, 2007, Jun-01, Volume: 68, Issue:2

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prospective Studies; Radiotherapy Dosage; Survival Rate; Tamoxifen; Triazoles

2007
The FACE trial: letrozole or anastrozole as initial adjuvant therapy?
    Cancer investigation, 2007, Volume: 25, Issue:1

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Lymphatic Metastasis; Nitriles; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Research Design; Triazoles

2007
Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy.
    Breast (Edinburgh, Scotland), 2007, Volume: 16, Issue:5

    Topics: Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Japan; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Prospective Studies; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2007
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, May-20, Volume: 25, Issue:15

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Canada; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Female; Humans; Letrozole; Middle Aged; Nitriles; Placebos; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Tamoxifen; Treatment Outcome; Triazoles

2007
A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2007, Volume: 23, Issue:2

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Clomiphene; Endometrium; Estradiol; Female; Fertility Agents, Female; Humans; Infertility, Female; Nitriles; Ovulation Induction; Pregnancy; Pregnancy Rate; Triazoles

2007
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer.
    Cancer, 2007, Jul-15, Volume: 110, Issue:2

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Humans; Middle Aged; Nitriles; Paclitaxel; Postmenopause; Receptors, Estrogen; Triazoles

2007
Molecular response to aromatase inhibitor treatment in primary breast cancer.
    Breast cancer research : BCR, 2007, Volume: 9, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Female; Gene Expression Regulation, Neoplastic; Humans; Letrozole; Nitriles; Polymerase Chain Reaction; Postmenopause; Receptors, Estrogen; Triazoles; Up-Regulation

2007
Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jul-01, Volume: 25, Issue:19

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Middle Aged; Nitriles; Postmenopause; Prospective Studies; Secondary Prevention; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2007
Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Bone, 2007, Volume: 41, Issue:3

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Collagen Type I; Diphosphonates; Estradiol; Female; Fractures, Bone; Humans; Middle Aged; Nitriles; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause; Triazoles

2007
Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial.
    British journal of cancer, 2007, Jul-16, Volume: 97, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles; United Kingdom

2007
A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Sep-01, Volume: 25, Issue:25

    Topics: Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; ErbB Receptors; Estradiol; Female; Gefitinib; Humans; Ki-67 Antigen; Mastectomy; Nitriles; Quinazolines; Receptor, ErbB-2; Receptors, Progesterone; Triazoles

2007
RETRACTED: Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial.
    Fertility and sterility, 2008, Volume: 89, Issue:5

    Topics: Abortion, Spontaneous; Adult; Anastrozole; Aromatase Inhibitors; Clomiphene; Drug Resistance; Endometrium; Estradiol; Female; Fertility Agents, Female; Humans; Infertility, Female; Letrozole; Nitriles; Ovarian Follicle; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Progesterone; Prospective Studies; Triazoles

2008
Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women.
    Breast cancer research : BCR, 2007, Volume: 9, Issue:4

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Bone Density; Bone Remodeling; Bone Resorption; Breast Neoplasms; Estrogens; Female; Humans; Letrozole; Lipids; Menopause; Middle Aged; Nitriles; Peptide Fragments; Placebos; Procollagen; Single-Blind Method; Tamoxifen; Triazoles

2007
The effect of anastrazole on symptomatic uterine leiomyomata.
    Obstetrics and gynecology, 2007, Volume: 110, Issue:3

    Topics: Adult; Age Factors; Anastrozole; Antineoplastic Agents, Hormonal; Endometrium; Estradiol; Female; Gonadotropins; Hematocrit; Humans; Leiomyomatosis; Middle Aged; Nitriles; Organ Size; Prospective Studies; Severity of Illness Index; Treatment Outcome; Triazoles; Uterine Neoplasms

2007
A decade of letrozole: FACE.
    Breast cancer research and treatment, 2007, Volume: 105 Suppl 1

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Disease-Free Survival; Estrogen Receptor Modulators; Female; Humans; Letrozole; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen; Triazoles

2007
[Phase II clinical trial of neoadjuvant hormone therapy in comparison with chemotherapy of patients with breast cancer].
    Voprosy onkologii, 2007, Volume: 53, Issue:4

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Doxorubicin; Female; Humans; Mammography; Middle Aged; Neoadjuvant Therapy; Nitriles; Paclitaxel; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome; Triazoles

2007
Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer.
    Nature clinical practice. Oncology, 2008, Volume: 5, Issue:2

    Topics: Aged; Anastrozole; Breast Neoplasms; Female; Humans; Nitriles; Postmenopause; Prospective Studies; Survivors; Tamoxifen; Treatment Outcome; Triazoles

2008
The ATAC trial: the vanguard trial for use of aromatase inhibitors in early breast cancer.
    Expert review of anticancer therapy, 2007, Volume: 7, Issue:8

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2007
Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women.
    European journal of cancer (Oxford, England : 1990), 2007, Volume: 43, Issue:17

    Topics: Adrenal Glands; Alkaline Phosphatase; Anastrozole; Androstadienes; Aromatase Inhibitors; Biomarkers; Body Mass Index; Bone and Bones; Bone Remodeling; Bone Resorption; Female; Humans; Letrozole; Lipids; Middle Aged; Nitriles; Postmenopause; Triazoles

2007
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
    Journal of the National Cancer Institute, 2007, Dec-19, Volume: 99, Issue:24

    Topics: Aged; Aged, 80 and over; Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Austria; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Lymphatic Metastasis; Male; Middle Aged; Nitriles; Odds Ratio; Postmenopause; Proportional Hazards Models; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Research Design; Tamoxifen; Treatment Outcome; Triazoles

2007
Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial.
    Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Female; Humans; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles

2008
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
    The Lancet. Oncology, 2008, Volume: 9, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Alkylating; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Fractures, Bone; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Tamoxifen; Time Factors; Triazoles

2008
Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:3

    Topics: Adolescent; Adult; Age Determination by Skeleton; Anastrozole; Aromatase Inhibitors; Blood Glucose; Body Composition; Body Height; Bone Density; Follow-Up Studies; Growth Disorders; Growth Hormone; Humans; Lipids; Male; Nitriles; Puberty; Testosterone; Triazoles

2008
Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial.
    Fertility and sterility, 2009, Volume: 92, Issue:3

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Clomiphene; Dose-Response Relationship, Drug; Endometrium; Female; Fertility Agents, Female; Humans; Nitriles; Ovarian Follicle; Ovulation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Outcome; Triazoles

2009
ERBB2 status and outcome of endocrine treatment.
    The Lancet. Oncology, 2008, Volume: 9, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; ErbB Receptors; Female; Humans; Nitriles; Postmenopause; Prognosis; Tamoxifen; Triazoles

2008
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Mar-01, Volume: 26, Issue:7

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Tamoxifen; Time Factors; Tissue Array Analysis; Treatment Outcome; Triazoles

2008
Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
    Fertility and sterility, 2009, Volume: 91, Issue:1

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Menstruation; Middle Aged; Nitriles; Perimenopause; Triazoles; Uterine Neoplasms

2009
Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Mar-01, Volume: 26, Issue:7

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Female; Humans; Neoplasm Invasiveness; Nitriles; Postmenopause; Prospective Studies; Tamoxifen; Treatment Outcome; Triazoles

2008
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Apr-01, Volume: 26, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Over Studies; Estradiol; Estrone; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Radioimmunoassay; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2008
Follicular and endocrine response to anastrozole versus clomiphene citrate administered in follicular phase to normoovulatory women: a randomized comparison.
    Fertility and sterility, 2009, Volume: 91, Issue:5

    Topics: Adolescent; Adult; Anastrozole; Aromatase Inhibitors; Clomiphene; Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Luteinizing Hormone; Nitriles; Ovarian Follicle; Ovulation Induction; Sex Hormone-Binding Globulin; Triazoles

2009
A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women.
    Breast cancer research and treatment, 2009, Volume: 114, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Progesterone; Treatment Outcome; Triazoles

2009
The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, May-01, Volume: 14, Issue:9

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Estrogen Antagonists; Female; Humans; Middle Aged; Neoadjuvant Therapy; Nitriles; Tamoxifen; Triazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2008
Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial.
    Human reproduction (Oxford, England), 2008, Volume: 23, Issue:8

    Topics: Adult; Anastrozole; Androgens; Aromatase Inhibitors; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Follicle Stimulating Hormone, Human; Follicular Fluid; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Nitriles; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Recombinant Proteins; Sperm Injections, Intracytoplasmic; Testosterone; Triazoles

2008
Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole.
    Breast (Edinburgh, Scotland), 2008, Volume: 17, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrium; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles; Ultrasonography

2008
Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.
    Clinical endocrinology, 2009, Volume: 70, Issue:1

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Biological Availability; Body Composition; Dinoprostone; Double-Blind Method; Humans; Hypogonadism; Male; Middle Aged; Nitriles; Outcome Assessment, Health Care; Testosterone; Triazoles

2009
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
    The Lancet. Oncology, 2008, Volume: 9, Issue:9

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Female; Goserelin; Humans; Imidazoles; Linear Models; Nitriles; Osteoporosis; Premenopause; Prospective Studies; Tamoxifen; Triazoles; Zoledronic Acid

2008
Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II).
    The Lancet. Oncology, 2008, Volume: 9, Issue:10

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Attention; Breast Neoplasms; Cognition; Double-Blind Method; Female; Humans; Memory; Middle Aged; Neuropsychological Tests; Nitriles; Postmenopause; Triazoles

2008
Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS).
    Health expectations : an international journal of public participation in health care and health policy, 2008, Volume: 11, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Australia; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Decision Support Techniques; Feedback; Female; Health Knowledge, Attitudes, Practice; Humans; Informed Consent; Middle Aged; Nitriles; Patient Education as Topic; Patient Selection; Pilot Projects; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Teaching Materials; Triazoles

2008
Estrogen, testosterone, and sequential movement in men.
    Behavioral neuroscience, 2008, Volume: 122, Issue:5

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Anastrozole; Androgens; Aromatase Inhibitors; Estrogens; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Movement; Nitriles; Radioimmunoassay; Reaction Time; Regression Analysis; Testosterone; Time Factors; Triazoles

2008
Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Oct-01, Volume: 14, Issue:19

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Breast Neoplasms; Chromatography, High Pressure Liquid; Estradiol; Estrogens; Estrone; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Radioimmunoassay; Triazoles

2008
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Oct-01, Volume: 14, Issue:19

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Diseases; Breast Neoplasms; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Ibandronic Acid; Lumbar Vertebrae; Middle Aged; Nitriles; Placebos; Triazoles

2008
Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole.
    Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:6

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Asian People; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fractures, Bone; Humans; Incidence; Japan; Joint Diseases; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles; White People

2009
Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility.
    Acta obstetricia et gynecologica Scandinavica, 2009, Volume: 88, Issue:2

    Topics: Abortion, Spontaneous; Adult; Anastrozole; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Female; Humans; Infant, Newborn; Infertility, Female; Letrozole; Nitriles; Ovulation Induction; Pregnancy; Pregnancy Outcome; Triazoles

2009
Comparing the cost of adjuvant anastrozole with the benefits of managing less patients with relapsed breast cancer.
    Breast cancer research and treatment, 2009, Volume: 117, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Tamoxifen; Triazoles; United Kingdom

2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    The New England journal of medicine, 2009, Feb-12, Volume: 360, Issue:7

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Disease-Free Survival; Drug Therapy, Combination; Estrogen Antagonists; Female; Follow-Up Studies; Goserelin; Humans; Imidazoles; Middle Aged; Nitriles; Premenopause; Receptors, Estrogen; Tamoxifen; Triazoles; Zoledronic Acid

2009
Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study.
    European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 144, Issue:1

    Topics: Adult; Anastrozole; Aromatase Inhibitors; CA-125 Antigen; Down-Regulation; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Goserelin; Humans; Nitriles; Pilot Projects; Pregnancy; Pregnancy Outcome; Prospective Studies; Triazoles; Uterine Diseases

2009
A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases.
    Clinical breast cancer, 2009, Volume: 9, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Brain Neoplasms; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Nitriles; Pilot Projects; Postmenopause; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Triazoles

2009
21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.
    Breast (Edinburgh, Scotland), 2009, Volume: 18, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biopsy, Needle; Breast Neoplasms; Disease-Free Survival; Female; Gene Expression Profiling; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Predictive Value of Tests; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2009
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-20, Volume: 27, Issue:27

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Nitriles; Postmenopause; Triazoles

2009
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer.
    Breast cancer research and treatment, 2010, Volume: 119, Issue:1

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Cell Proliferation; Chemotherapy, Adjuvant; Drug Administration Schedule; Estradiol; Female; Humans; Ki-67 Antigen; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles

2010
Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Oct-20, Volume: 27, Issue:30

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carpal Tunnel Syndrome; Chemotherapy, Adjuvant; Double-Blind Method; Female; Humans; Middle Aged; Nitriles; Postmenopause; Risk Factors; Tamoxifen; Triazoles

2009
Comparison of the effect of the aromatase inhibitor, anastrazole, to the antioestrogen, tamoxifen citrate, on canine prostate and semen.
    Reproduction in domestic animals = Zuchthygiene, 2009, Volume: 44 Suppl 2

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Dog Diseases; Dogs; Estrogen Antagonists; Male; Nitriles; Prostate; Prostatic Hyperplasia; Semen; Tamoxifen; Triazoles

2009
[Safety and compliance with UFT (tegafur and uracil) alone and in combination with hormone therapy in patients with breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Patient Compliance; Postmenopause; Tamoxifen; Tegafur; Triazoles; Uracil

2009
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Nov-20, Volume: 27, Issue:33

    Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Confidence Intervals; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Prognosis; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Statistics, Nonparametric; Survival Analysis; Trastuzumab; Treatment Outcome; Triazoles

2009
Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:12

    Topics: Aged; Aging; Anastrozole; Aromatase Inhibitors; Biomarkers; Bone and Bones; Bone Density; Double-Blind Method; Endpoint Determination; Enzyme-Linked Immunosorbent Assay; Hormones; Humans; Male; Middle Aged; Nitriles; Patient Compliance; Steroids; Testis; Testosterone; Triazoles

2009
Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Nov-15, Volume: 15, Issue:22

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast; Breast Neoplasms; Cytochrome P-450 CYP2D6; Disease-Free Survival; Female; Genotype; Humans; Nitriles; Pharmacogenetics; Precancerous Conditions; Risk; Tamoxifen; Treatment Outcome; Triazoles

2009
A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.
    Breast cancer research and treatment, 2010, Volume: 119, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Bone and Bones; Bone Resorption; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2010
Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study.
    Breast cancer research and treatment, 2010, Volume: 120, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Musculoskeletal Diseases; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Triazoles

2010
Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-20, Volume: 28, Issue:6

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Double-Blind Method; Etidronic Acid; Female; Fractures, Bone; Hormone Replacement Therapy; Humans; Middle Aged; Neoplasm Staging; Nitriles; Osteoporosis, Postmenopausal; Postmenopause; Prognosis; Risedronic Acid; Survival Rate; Treatment Outcome; Triazoles

2010
A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
    Epilepsy & behavior : E&B, 2010, Volume: 17, Issue:2

    Topics: Adolescent; Adult; Anastrozole; Aromatase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Nitriles; Prospective Studies; Sexual Dysfunction, Physiological; Testosterone; Triazoles; Young Adult

2010
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Apr-10, Volume: 28, Issue:11

    Topics: Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Genetic Testing; Humans; Lymph Nodes; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Risk Factors; Survival Rate; Tamoxifen; Treatment Outcome; Triazoles

2010
Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Mar-15, Volume: 16, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Double-Blind Method; ErbB Receptors; Female; Gefitinib; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Prospective Studies; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Tissue Distribution; Treatment Outcome; Triazoles

2010
Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.
    European journal of endocrinology, 2010, Volume: 162, Issue:6

    Topics: Abdominal Fat; Age Factors; Analysis of Variance; Anastrozole; Arginine; Dihydrotestosterone; Double-Blind Method; Estradiol; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Male; Nitriles; Oligopeptides; Prospective Studies; Somatostatin; Testosterone; Triazoles

2010
Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system.
    Onkologie, 2010, Volume: 33, Issue:4

    Topics: Anastrozole; Antineoplastic Agents; Breast Neoplasms; Computer Simulation; Cost-Benefit Analysis; Female; Germany; Health Care Costs; Humans; Incidence; Middle Aged; Models, Economic; Nitriles; Tamoxifen; Triazoles

2010
Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study.
    Breast cancer research and treatment, 2010, Volume: 121, Issue:2

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Japan; Kaplan-Meier Estimate; Neoplasm Staging; Nitriles; Postmenopause; Tamoxifen; Triazoles

2010
Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.
    Breast cancer research : BCR, 2010, Volume: 12, Issue:2

    Topics: Administration, Oral; Aged; Anastrozole; Aromatase Inhibitors; Arthralgia; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Drug Therapy, Combination; Dyspepsia; Etidronic Acid; Female; Humans; Middle Aged; Nausea; Nitriles; Osteoporosis, Postmenopausal; Patient Dropouts; Prospective Studies; Risedronic Acid; Risk Factors; Time Factors; Treatment Outcome; Triazoles

2010
Adding zoledronic acid to endocrine therapy in the adjuvant treatment of hormone-sensitive breast cancer in premenopausal women: a new care standard or a provocative idea?
    Current oncology reports, 2010, Volume: 12, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Drug Therapy, Combination; Female; Humans; Imidazoles; Neoplasms, Hormone-Dependent; Nitriles; Premenopause; Prognosis; Survival Rate; Tamoxifen; Triazoles; Zoledronic Acid

2010
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jul-20, Volume: 28, Issue:21

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Double-Blind Method; Estrogen Antagonists; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Tamoxifen; Triazoles

2010
Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Sep-01, Volume: 28, Issue:25

    Topics: Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Goserelin; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Premenopause; Triazoles

2010
The ATAC adjuvant breast-cancer trial: six-year results of the endometrial subprotocol.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2010, Volume: 30, Issue:6

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Endometrium; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2010
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability.
    Breast cancer research and treatment, 2011, Volume: 125, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Endocrine System; Humans; Letrozole; Middle Aged; Nitriles; Quality of Life; Tamoxifen; Treatment Outcome; Triazoles

2011
Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.
    Menopause (New York, N.Y.), 2011, Volume: 18, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Female; Humans; Middle Aged; Nitriles; Postmenopause; Quality of Life; Sexual Dysfunction, Physiological; Tamoxifen; Treatment Outcome; Triazoles; Uterus

2011
Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial.
    Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Nitriles; Prospective Studies; Receptors, Progesterone; Tamoxifen; Triazoles

2011
Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Density; Bone Resorption; Breast Neoplasms; Female; Hip; Humans; Lumbar Vertebrae; Nitriles; Tamoxifen; Time; Triazoles

2011
Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.
    Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:1

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; China; Disease Progression; Double-Blind Method; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Nitriles; Time Factors; Treatment Outcome; Triazoles

2011
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer.
    Breast cancer research and treatment, 2011, Volume: 125, Issue:1

    Topics: Adult; Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzenesulfonates; Breast Neoplasms; Disease-Free Survival; Drug Resistance, Neoplasm; Endothelial Cells; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Niacinamide; Nitriles; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Receptors, Estrogen; Receptors, Progesterone; Sorafenib; Stem Cells; Time Factors; Treatment Outcome; Triazoles; United States

2011
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.
    The Lancet. Oncology, 2010, Volume: 11, Issue:12

    Topics: Administration, Oral; Anastrozole; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Neoplasm Staging; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2010
Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT).
    Journal of pediatric endocrinology & metabolism : JPEM, 2010, Volume: 23, Issue:10

    Topics: Anastrozole; Anilides; Bone Development; Child; Child, Preschool; Drug Therapy, Combination; Gonadotropins; Growth; Humans; Male; Nitriles; Pilot Projects; Puberty, Precocious; Tosyl Compounds; Triazoles

2010
Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associations.
    Breast cancer research : BCR, 2010, Dec-20, Volume: 12 Suppl 4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Case-Control Studies; Female; Gene Expression; Genome-Wide Association Study; Humans; Interleukin-17; Linkage Disequilibrium; Musculoskeletal Diseases; Nitriles; Pharmacogenetics; Polymorphism, Single Nucleotide; Triazoles

2010
The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:8

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Japan; Lipids; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles; Triglycerides

2011
Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study.
    Fertility and sterility, 2011, Volume: 95, Issue:5

    Topics: Adolescent; Adult; Anastrozole; Clomiphene; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fertility Agents, Female; Humans; Infertility, Female; Nitriles; Ovarian Hyperstimulation Syndrome; Ovulation; Ovulation Induction; Pregnancy; Pregnancy Rate; Triazoles; Young Adult

2011
Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose-response study.
    Fertility and sterility, 2011, Volume: 95, Issue:5

    Topics: Adolescent; Adult; Anastrozole; Anovulation; Clomiphene; Dose-Response Relationship, Drug; Female; Fertility Agents, Female; Humans; Infertility, Female; Nitriles; Ovulation Induction; Pregnancy; Pregnancy Rate; Single-Blind Method; Triazoles; Young Adult

2011
Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC 03.
    Breast cancer research and treatment, 2011, Volume: 127, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Quality of Life; Tamoxifen; Treatment Outcome; Triazoles

2011
Effects of exemestane, anastrozole and tamoxifen on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients: results of N-SAS BC 04, the TEAM Japan substudy.
    Oncology, 2010, Volume: 79, Issue:5-6

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Resorption; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2010
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jul-01, Volume: 29, Issue:19

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Female; Goserelin; Humans; Middle Aged; Nitriles; Premenopause; Prospective Studies; Recurrence; Retrospective Studies; Risk; Tamoxifen; Treatment Outcome; Triazoles

2011
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based int
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-10, Volume: 29, Issue:17

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Ki-67 Antigen; Letrozole; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Postmenopause; Prognosis; Receptors, Estrogen; Triazoles

2011
Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.
    Breast cancer research and treatment, 2011, Volume: 128, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Bone and Bones; Breast Neoplasms; Female; Humans; Lipid Metabolism; Lipids; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Toremifene; Triazoles

2011
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
    The Lancet. Oncology, 2011, Volume: 12, Issue:7

    Topics: Adult; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Disease-Free Survival; Female; Follow-Up Studies; Humans; Imidazoles; Middle Aged; Neoplasm Staging; Nitriles; Premenopause; Tamoxifen; Treatment Outcome; Triazoles; Zoledronic Acid

2011
Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy.
    Breast cancer research and treatment, 2011, Volume: 130, Issue:2

    Topics: Aged; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Female; Humans; Letrozole; Middle Aged; Musculoskeletal Pain; Nitriles; Testosterone; Triazoles

2011
Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology Research Consortium.
    Clinical breast cancer, 2011, Volume: 11, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Disease-Free Survival; Estradiol; Female; Fulvestrant; Hormone Replacement Therapy; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Receptors, Estrogen; Triazoles

2011
Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial.
    Breast cancer research and treatment, 2011, Volume: 129, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Calcium; Ergocalciferols; Female; Humans; Middle Aged; Musculoskeletal Diseases; Nitriles; Pain; Parathyroid Hormone; Triazoles; Vitamin D

2011
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
    Cancer, 2012, Jan-01, Volume: 118, Issue:1

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cross-Over Studies; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Treatment Outcome; Triazoles

2012
Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole.
    The Journal of surgical research, 2012, Volume: 176, Issue:1

    Topics: Aged; Aged, 80 and over; Anastrozole; Antigens, CD34; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Middle Aged; Nitriles; Oligonucleotide Array Sequence Analysis; Paraffin Embedding; Pilot Projects; Preoperative Period; Triazoles; Wound Healing

2012
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.
    Breast cancer research and treatment, 2011, Volume: 129, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Cell Cycle; Cyclin D1; Estradiol; Female; Fulvestrant; Gefitinib; Humans; Ki-67 Antigen; Male; Mitogen-Activated Protein Kinases; Neoadjuvant Therapy; Nitriles; Oncogene Protein v-akt; Proto-Oncogene Proteins; Quinazolines; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2011
Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-10, Volume: 29, Issue:32

    Topics: Adult; Age Factors; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Comorbidity; Double-Blind Method; Female; Humans; Middle Aged; Nitriles; Retrospective Studies; Risk; Tamoxifen; Triazoles

2011
Outcomes of Japanese breast cancer patients treated with pre-operative and post-operative anastrozole or tamoxifen.
    Cancer science, 2012, Volume: 103, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Asian People; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Nitriles; Postoperative Period; Tamoxifen; Triazoles

2012
Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies.
    Genetic epidemiology, 2012, Volume: 36, Issue:1

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Case-Control Studies; Data Mining; Female; Genome-Wide Association Study; Genome, Human; Humans; Linkage Disequilibrium; Models, Genetic; Nitriles; Polymorphism, Single Nucleotide; Raloxifene Hydrochloride; Software; Tamoxifen; Triazoles

2012
Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole.
    Breast cancer research and treatment, 2012, Volume: 132, Issue:2

    Topics: Adult; Aged; Anastrozole; Anticarcinogenic Agents; Aromatase Inhibitors; Arthralgia; Biomarkers; Breast Neoplasms; Double-Blind Method; Female; Humans; Logistic Models; Middle Aged; Nitriles; Odds Ratio; Placebos; Postmenopause; Risk Assessment; Risk Factors; Treatment Outcome; Triazoles; United Kingdom; Vitamin D; Vitamin D Deficiency

2012
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-
    Breast cancer research and treatment, 2012, Volume: 133, Issue:1

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Depression; Female; Humans; Maintenance Chemotherapy; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Quality of Life; Stress, Psychological; Surveys and Questionnaires; Tamoxifen; Treatment Outcome; Triazoles

2012
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.
    The Lancet. Oncology, 2012, Volume: 13, Issue:4

    Topics: Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Goserelin; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Premenopause; Receptor, ErbB-2; Tamoxifen; Triazoles

2012
Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men.
    Steroids, 2012, Volume: 77, Issue:5

    Topics: Adolescent; Adult; Anastrozole; Androgens; Apolipoproteins B; Aromatase Inhibitors; Cholesterol; Cholesterol, HDL; Clusterin; Drug Administration Schedule; Fasting; Gonadotropin-Releasing Hormone; Humans; Lipids; Lipoproteins, HDL; Male; Middle Aged; Nitriles; Oligopeptides; Testosterone; Time Factors; Triazoles; Young Adult

2012
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Mar-01, Volume: 30, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Austria; Breast Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prospective Studies; Survival Rate; Tamoxifen; Triazoles

2012
Pharmacokinetic comparison of 2 formulations of anastrozole (1 mg) in healthy Korean male volunteers: a randomized, single-dose, 2-period, 2-sequence, crossover study.
    Clinical therapeutics, 2012, Volume: 34, Issue:2

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Chemistry, Pharmaceutical; Cross-Over Studies; Double-Blind Method; Humans; Male; Middle Aged; Nitriles; Triazoles

2012
Aromatase inhibitors and calcium absorption in early stage breast cancer.
    Breast cancer research and treatment, 2012, Volume: 134, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Calcium; Diet; Female; Humans; Intestinal Absorption; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Triazoles; Vitamin D

2012
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Jun-01, Volume: 30, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Recurrence; Triazoles

2012
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer.
    Breast cancer research and treatment, 2012, Volume: 133, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Fulvestrant; Gefitinib; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Quinazolines; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Treatment Outcome; Triazoles

2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.
    Breast cancer research : BCR, 2012, Apr-04, Volume: 14, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclin D1; Female; Follow-Up Studies; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Triazoles

2012
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients' persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer.
    Breast cancer research and treatment, 2012, Volume: 134, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Patient Compliance; Physician-Patient Relations; Postmenopause; Practice Patterns, Physicians'; Prospective Studies; Surveys and Questionnaires; Triazoles

2012
Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios.
    Fertility and sterility, 2012, Volume: 98, Issue:1

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Estradiol; Hormones; Humans; Infertility, Male; Letrozole; Male; Nitriles; Organ Size; Semen Analysis; Testis; Testosterone; Triazoles

2012
Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer.
    Anticancer research, 2012, Volume: 32, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Anti-Inflammatory Agents; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Nitriles; Prednisolone; Triazoles

2012
Lipid profiles within the SABRE trial of anastrozole with and without risedronate.
    Breast cancer research and treatment, 2012, Volume: 134, Issue:3

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Cholesterol, HDL; Cholesterol, LDL; Etidronic Acid; Female; Humans; Lipids; Middle Aged; Nitriles; Risedronic Acid; Treatment Outcome; Triazoles; Triglycerides

2012
Combination anastrozole and fulvestrant in metastatic breast cancer.
    The New England journal of medicine, 2012, Aug-02, Volume: 367, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cross-Over Studies; Disease-Free Survival; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Triazoles

2012
Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.
    Cancer, 2013, Feb-15, Volume: 119, Issue:4

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Double-Blind Method; Female; Goserelin; Humans; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Nitriles; Predictive Value of Tests; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Triazoles

2013
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' study.
    Breast cancer research and treatment, 2012, Volume: 136, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Neoplasm Staging; Nitriles; Treatment Outcome; Triazoles

2012
Phase II study of neoadjuvant anastrozole and concurrent radiotherapy for postmenopausal breast cancer patients.
    Breast cancer (Tokyo, Japan), 2014, Volume: 21, Issue:5

    Topics: Aged; Aged, 80 and over; Anastrozole; Breast Neoplasms; Chemoradiotherapy; Female; Humans; Middle Aged; Neoadjuvant Therapy; Nitriles; Postmenopause; Prospective Studies; Receptors, Estrogen; Treatment Outcome; Triazoles

2014
Use of a urine anastrozole assay to determine treatment discontinuation among women with hormone-sensitive breast cancer: a pilot study.
    Journal of oncology practice, 2012, Volume: 8, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Medication Adherence; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Pilot Projects; Postmenopause; Surveys and Questionnaires; Treatment Outcome; Triazoles

2012
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-10, Volume: 31, Issue:11

    Topics: Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; History, 18th Century; Hot Flashes; Humans; Hypercholesterolemia; Kaplan-Meier Estimate; Middle Aged; Nitriles; Osteoporosis; Postmenopause; Time Factors; Treatment Outcome; Triazoles

2013
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cance
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Early Detection of Cancer; Female; Follow-Up Studies; Humans; Medication Adherence; Middle Aged; Nitriles; Patient Compliance; Postmenopause; Prospective Studies; Triazoles

2013
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: long term results of the Italian Tamoxifen Anastrozole trial.
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:7

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Endometrial Neoplasms; Female; Follow-Up Studies; Fractures, Bone; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Risk Factors; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2013
Influence of compliance on bone mineral density changes in postmenopausal women with early breast cancer on Anastrozole.
    Journal of cancer research and clinical oncology, 2013, Volume: 139, Issue:6

    Topics: Absorptiometry, Photon; Aged; Anastrozole; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Nitriles; Osteoporosis, Postmenopausal; Patient Compliance; Postmenopause; Receptors, Steroid; Time Factors; Treatment Outcome; Triazoles

2013
Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: results of the JMTO BC08-01 phase II trial.
    Oncology reports, 2013, Volume: 29, Issue:5

    Topics: Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; ErbB Receptors; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles

2013
A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer.
    Breast cancer research : BCR, 2013, Mar-05, Volume: 15, Issue:2

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Double-Blind Method; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Middle Aged; Neoplasm Grading; Nitriles; Postmenopause; Preoperative Care; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2013
Predictors of recovery of ovarian function during aromatase inhibitor therapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:8

    Topics: Adult; Amenorrhea; Anastrozole; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Estradiol; Female; Humans; Middle Aged; Nitriles; Ovary; Primary Ovarian Insufficiency; Prospective Studies; Receptors, Estrogen; Tamoxifen; Triazoles; Uterine Hemorrhage

2013
A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer.
    Breast cancer research and treatment, 2013, Volume: 139, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Bone and Bones; Breast Neoplasms; Female; Humans; Japan; Lipids; Middle Aged; Neoplasm Grading; Nitriles; Postmenopause; Treatment Outcome; Triazoles

2013
Prevalence of menopausal symptoms and their influence on adherence in women with breast cancer.
    Climacteric : the journal of the International Menopause Society, 2014, Volume: 17, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Anxiety; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Hot Flashes; Humans; Letrozole; Medication Adherence; Middle Aged; Musculoskeletal Pain; Nitriles; Sleep Wake Disorders; Time Factors; Triazoles; Urinary Bladder Diseases; Vaginal Diseases

2014
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
    British journal of cancer, 2013, Aug-06, Volume: 109, Issue:3

    Topics: Adolescent; Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Obesity; Overweight; Postmenopause; Retrospective Studies; Triazoles; Young Adult

2013
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentr
    The Lancet. Oncology, 2013, Volume: 14, Issue:10

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Disease-Free Survival; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Neoplasm Metastasis; Nitriles; Postmenopause; Receptors, Estrogen; Triazoles

2013
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
    The Lancet. Oncology, 2013, Volume: 14, Issue:11

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Follow-Up Studies; Gene Expression Profiling; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Prognosis; Prospective Studies; Receptors, Estrogen; Tamoxifen; Triazoles

2013
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer.
    BMC cancer, 2013, Sep-18, Volume: 13

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Postmenopause; Prognosis; Tamoxifen; Treatment Outcome; Triazoles

2013
Neoadjuvant treatment of endometrial cancer using anastrozole: a randomised pilot study.
    Gynecologic oncology, 2013, Volume: 131, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Cell Growth Processes; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Nitriles; Pilot Projects; Placebos; Proto-Oncogene Proteins c-bcl-2; Receptors, Progesterone; Triazoles

2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
    Lancet (London, England), 2014, Mar-22, Volume: 383, Issue:9922

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Double-Blind Method; Female; Humans; Longitudinal Studies; Middle Aged; Nitriles; Postmenopause; Proportional Hazards Models; Risk Factors; Treatment Outcome; Triazoles

2014
Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
    The journal of sexual medicine, 2014, Volume: 11, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Absorptiometry, Photon; Adult; Anastrozole; Azasteroids; Body Composition; Body Mass Index; Dihydrotestosterone; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Estradiol; Humans; Insulin Resistance; Male; Middle Aged; Nitriles; Obesity; Testosterone; Triazoles; Young Adult

2014
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Arthralgia; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Substitution; Female; Humans; Incidence; Medication Adherence; Middle Aged; Nitriles; Prospective Studies; Treatment Outcome; Triazoles

2014
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.
    The Lancet. Oncology, 2014, Volume: 15, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bones of Lower Extremity; Breast Neoplasms; Calcium; Canada; Chemotherapy, Adjuvant; Dietary Supplements; Diphosphonates; Female; Fractures, Bone; Humans; Lumbar Vertebrae; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Radiography; Time Factors; Treatment Outcome; Triazoles; United States; Vitamin D

2014
A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers.
    Nutrition and cancer, 2014, Volume: 66, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Estrogen Receptor beta; Female; Flax; Gonadal Steroid Hormones; Humans; Lignans; Linear Models; Middle Aged; Nitriles; Pilot Projects; Treatment Outcome; Triazoles; Young Adult

2014
The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study
    Breast (Edinburgh, Scotland), 2014, Volume: 23, Issue:4

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Lymph Node Excision; Mastectomy; Medication Adherence; Middle Aged; Nitriles; Patient Education as Topic; Postmenopause; Triazoles

2014
Pilot randomised study of early intervention based on tumour markers in the follow-up of patients with primary breast cancer.
    Breast (Edinburgh, Scotland), 2014, Volume: 23, Issue:5

    Topics: Adult; Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Early Detection of Cancer; Female; Follow-Up Studies; Goserelin; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mucin-1; Nitriles; Pilot Projects; Single-Blind Method; Tamoxifen; Treatment Outcome; Triazoles

2014
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway.
    Oncotarget, 2014, May-30, Volume: 5, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Everolimus; Female; Genital Neoplasms, Female; Humans; Kaplan-Meier Estimate; Middle Aged; Nitriles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome; Triazoles; Young Adult

2014
A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer.
    Cancer science, 2014, Volume: 105, Issue:9

    Topics: Aged; Anastrozole; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Fatty Liver; Female; Humans; Liver; Middle Aged; Nitriles; Prospective Studies; Tamoxifen; Treatment Failure; Triazoles

2014
Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition.
    Breast cancer research : BCR, 2014, Jun-30, Volume: 16, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; ErbB Receptors; Female; Gefitinib; Humans; Ki-67 Antigen; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Nitriles; Phosphatidylinositol 3-Kinases; Prognosis; Protein Kinase Inhibitors; Quinazolines; Receptors, Estrogen; Receptors, Progesterone; TOR Serine-Threonine Kinases; Triazoles

2014
Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial.
    Cancer, 2014, Dec-01, Volume: 120, Issue:23

    Topics: Aged; Anastrozole; Androstadienes; Anxiety; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Depression; Electroacupuncture; Fatigue; Female; Humans; Letrozole; Middle Aged; Nitriles; Quality of Life; Sleep Wake Disorders; Stress, Psychological; Treatment Outcome; Triazoles

2014
Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer.
    Genetics and molecular research : GMR, 2014, Jul-24, Volume: 13, Issue:3

    Topics: Absorptiometry, Photon; Aged; Alkaline Phosphatase; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Calcitonin; Calcium; Female; Femur; Humans; Middle Aged; Nitriles; Osteocalcin; Osteoporosis; Pain; Phosphorus; Spine; Triazoles

2014
Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:11

    Topics: Adolescent; Anastrozole; Aromatase Inhibitors; Body Height; Child; Estradiol; Growth Disorders; Humans; Letrozole; Luteinizing Hormone; Male; Nitriles; Puberty; Testosterone; Treatment Outcome; Triazoles

2014
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.
    Molecular endocrinology (Baltimore, Md.), 2014, Volume: 28, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Bone Density; Female; Gene-Environment Interaction; Genome-Wide Association Study; Genotype; Humans; Middle Aged; Nitriles; Osteoporosis; Osteoporotic Fractures; Polymorphism, Single Nucleotide; Triazoles

2014
Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole.
    Steroids, 2015, Volume: 99, Issue:Pt A

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Middle Aged; Nitriles; Postmenopause; Testosterone; Triazoles

2015
Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial.
    Breast cancer research and treatment, 2014, Volume: 148, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Tamoxifen; Triazoles

2014
Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Mar-10, Volume: 33, Issue:8

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Austria; Breast Neoplasms; Data Interpretation, Statistical; Female; Follow-Up Studies; Hormones; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Prognosis; Proportional Hazards Models; Regression Analysis; Risk; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2015
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:2

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Disease-Free Survival; Female; Follow-Up Studies; Goserelin; Humans; Imidazoles; Kaplan-Meier Estimate; Middle Aged; Nitriles; Premenopause; Tamoxifen; Triazoles; Zoledronic Acid

2015
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial.
    The Lancet. Oncology, 2014, Volume: 15, Issue:13

    Topics: Adult; Aged; Anastrozole; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Etidronic Acid; Female; Follow-Up Studies; Humans; International Agencies; Middle Aged; Nitriles; Osteoporosis; Postmenopause; Prognosis; Risedronic Acid; Triazoles

2014
Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Jan-20, Volume: 33, Issue:3

    Topics: Adult; Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Hot Flashes; Humans; Kaplan-Meier Estimate; Middle Aged; Musculoskeletal System; Nitriles; Triazoles; Vasomotor System

2015
Does patient education work in breast cancer? Final results from the global CARIATIDE study.
    Future oncology (London, England), 2015, Volume: 11, Issue:2

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Nitriles; Patient Compliance; Patient Education as Topic; Tamoxifen; Triazoles

2015
Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors.
    Cutaneous and ocular toxicology, 2016, Volume: 35, Issue:1

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Electroretinography; Evoked Potentials, Visual; Female; Humans; Letrozole; Middle Aged; Nerve Fibers; Nitriles; Optic Nerve; Retina; Tomography, Optical Coherence; Triazoles; Visual Acuity

2016
Evaluating the feasibility of performing window of opportunity trials in breast cancer.
    International journal of surgical oncology, 2015, Volume: 2015

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Administration Schedule; Feasibility Studies; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Nitriles; Pilot Projects; Prospective Studies; Triazoles

2015
Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:2

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Joint Diseases; Middle Aged; Nitriles; Postmenopause; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Triazoles

2016
A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.
    Breast cancer research and treatment, 2015, Volume: 152, Issue:3

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Female; Humans; Letrozole; Memory; Middle Aged; Nitriles; Postmenopause; Psychomotor Performance; Quality of Life; Tamoxifen; Triazoles

2015
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.
    British journal of cancer, 2015, Aug-11, Volume: 113, Issue:4

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Nitriles; Postmenopause; Triazoles

2015
A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men.
    The journal of sexual medicine, 2015, Volume: 12, Issue:8

    Topics: Anastrozole; Clomiphene; Double-Blind Method; Fertility Agents, Male; Follicle Stimulating Hormone; Hormones; Humans; Hypogonadism; Infertility, Male; Luteinizing Hormone; Male; Nitriles; Prospective Studies; Testosterone; Treatment Outcome; Triazoles

2015
[BREAST-CONSERVING SURGERY AFTER NEOADJUVANT THERAPY FOR BREAST CANCER].
    Voprosy onkologii, 2015, Volume: 61, Issue:3

    Topics: Adult; Aged; Anastrozole; Androstadienes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Doxorubicin; Everolimus; Female; Humans; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Nitriles; Paclitaxel; Postmenopause; Receptor, ErbB-2; Receptors, Estrogen; Sirolimus; TOR Serine-Threonine Kinases; Trastuzumab; Treatment Outcome; Triazoles

2015
Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Nov-10, Volume: 33, Issue:32

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Drug Administration Schedule; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Kaplan-Meier Estimate; Middle Aged; Nitriles; Treatment Outcome; Triazoles

2015
Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.
    Journal of endocrinological investigation, 2016, Volume: 39, Issue:4

    Topics: Anastrozole; Aromatase Inhibitors; Body Height; Bone Density; Case-Control Studies; Child; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Greece; Growth Disorders; Humans; Leuprolide; Nitriles; Prognosis; Prospective Studies; Puberty, Precocious; Sexual Maturation; Triazoles

2016
Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial.
    Andrology, 2016, Volume: 4, Issue:1

    Topics: Aged; Aged, 80 and over; Aging; Anastrozole; Aromatase; Aromatase Inhibitors; Body Composition; Bone and Bones; Bone Density; Double-Blind Method; Estradiol; Humans; Male; Nitriles; Placebos; Testosterone; Triazoles

2016
Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Jan-10, Volume: 34, Issue:2

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carpal Tunnel Syndrome; Double-Blind Method; Female; Humans; Incidence; International Cooperation; Middle Aged; Nitriles; Odds Ratio; Risk Factors; Severity of Illness Index; Triazoles

2016
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
    Lancet (London, England), 2016, Feb-27, Volume: 387, Issue:10021

    Topics: Administration, Oral; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Tamoxifen; Triazoles

2016
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Lancet (London, England), 2016, Feb-27, Volume: 387, Issue:10021

    Topics: Administration, Oral; Age Factors; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Double-Blind Method; Embolism; Female; Humans; Mastectomy, Segmental; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Thrombosis; Triazoles

2016
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Lancet (London, England), 2016, Feb-27, Volume: 387, Issue:10021

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Double-Blind Method; Female; Follow-Up Studies; Humans; Mastectomy, Segmental; Middle Aged; Nitriles; Postmenopause; Quality of Life; Tamoxifen; Triazoles

2016
A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 53

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Double-Blind Method; Early Termination of Clinical Trials; Female; Gefitinib; Humans; Middle Aged; Nitriles; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome; Triazoles

2016
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, 06-01, Volume: 22, Issue:11

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Estradiol; Female; Fulvestrant; Heterocyclic Compounds, 3-Ring; Humans; Hyperglycemia; Hypoglycemic Agents; Maximum Tolerated Dose; Middle Aged; Nitriles; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Treatment Outcome; Triazoles

2016
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.
    British journal of clinical pharmacology, 2016, Volume: 81, Issue:6

    Topics: Anastrozole; Breast Neoplasms; Drug Interactions; Estradiol; Female; Fulvestrant; Humans; Nitriles; Triazoles

2016
Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS).
    Breast cancer research and treatment, 2016, Volume: 155, Issue:3

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia; Bone Density; Breast Neoplasms; Cholecalciferol; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Letrozole; Middle Aged; Musculoskeletal Diseases; Nitriles; Triazoles; Vitamin D

2016
Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:4

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Double-Blind Method; Humans; Male; Nitriles; Organ Size; Prostate; Testosterone; Treatment Outcome; Triazoles; Ultrasonography

2016
Aromatase Inhibition Reduces Insulin Sensitivity in Healthy Men.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:5

    Topics: Adolescent; Adult; Anastrozole; Aromatase Inhibitors; Cross-Over Studies; Double-Blind Method; Estradiol; Glucose; Glucose Clamp Technique; Healthy Volunteers; Humans; Insulin Resistance; Lipolysis; Liver; Male; Middle Aged; Muscle, Skeletal; Nitriles; Testosterone; Triazoles; Young Adult

2016
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 06-10, Volume: 34, Issue:17

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Combined Modality Therapy; Drug Synergism; Female; Humans; Indazoles; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Postmenopause; Preoperative Care; Protein Kinase Inhibitors; Receptor, ErbB-2; Receptors, Estrogen; Sulfonamides; Triazoles

2016
Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27.
    Breast cancer research and treatment, 2016, Volume: 156, Issue:2

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Cause of Death; Chemotherapy, Adjuvant; Comorbidity; Female; Humans; Middle Aged; Nitriles; Postmenopause; Survival Analysis; Treatment Outcome; Triazoles

2016
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 09-01, Volume: 34, Issue:25

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; DNA, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Middle Aged; Nitriles; Piperazines; Prospective Studies; Pyridines; Retrospective Studies; Triazoles

2016
Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial
    Cancer, 2016, Volume: 122, Issue:19

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Estradiol; Female; Follow-Up Studies; France; Fulvestrant; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Postmenopause; Prognosis; Receptor, ErbB-2; Survival Rate; Triazoles

2016
Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial.
    Human reproduction (Oxford, England), 2016, Volume: 31, Issue:8

    Topics: Administration, Intravaginal; Adult; Anastrozole; Aromatase Inhibitors; Endometriosis; Estradiol; Female; Healthy Volunteers; Humans; Levonorgestrel; Nitriles; Ovarian Follicle; Premenopause; Triazoles; Women's Health; Young Adult

2016
Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:11

    Topics: Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Double-Blind Method; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Human Growth Hormone; Humans; Middle Aged; Nitriles; Postmenopause; Somatostatin; Triazoles

2016
Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.
    American journal of respiratory and critical care medicine, 2017, 02-01, Volume: 195, Issue:3

    Topics: Anastrozole; Aromatase Inhibitors; Biomarkers; Double-Blind Method; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nitriles; Progesterone; Steroids; Triazoles

2017
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer.
    Breast cancer research and treatment, 2016, Volume: 160, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; ErbB Receptors; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Retreatment; Signal Transduction; Treatment Outcome; Triazoles

2016
Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:12

    Topics: Adolescent; Anastrozole; Aromatase Inhibitors; Body Composition; Body Height; Drug Therapy, Combination; Dwarfism; Growth Hormone; Humans; Letrozole; Male; Nitriles; Outcome Assessment, Health Care; Puberty; Triazoles

2016
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping.
    Annals of surgical oncology, 2017, Volume: 24, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Clinical Decision-Making; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Gene Expression Profiling; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Letrozole; Mastectomy, Segmental; Middle Aged; Molecular Typing; Neoadjuvant Therapy; Nitriles; Prospective Studies; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Registries; Tamoxifen; Taxoids; Treatment Outcome; Triazoles; Young Adult

2017
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
    Lancet (London, England), 2016, 12-17, Volume: 388, Issue:10063

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast; Breast Neoplasms; Disease-Free Survival; Double-Blind Method; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Triazoles

2016
Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms.
    Journal of clinical pharmacology, 2017, Volume: 57, Issue:5

    Topics: Administration, Intravaginal; Adult; Anastrozole; Computer Simulation; Contraceptive Agents, Female; Drug Combinations; Drug Interactions; Endometriosis; Estradiol; Female; Humans; Levonorgestrel; Models, Biological; Nitriles; Ovarian Follicle; Sex Hormone-Binding Globulin; Triazoles; Young Adult

2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Apr-01, Volume: 35, Issue:10

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Clinical Decision-Making; Female; Follow-Up Studies; Humans; Ki-67 Antigen; Letrozole; Middle Aged; Mitotic Index; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Transcriptome; Triazoles

2017
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Apr-01, Volume: 35, Issue:10

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Arthralgia; Breast Neoplasms; Chemotherapy, Adjuvant; Depression; Disease-Free Survival; Dyspnea; Female; Hot Flashes; Humans; Hypertension; Letrozole; Lymphatic Metastasis; Mastectomy; Middle Aged; Myalgia; Neoplasm Staging; Nitriles; Postmenopause; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Triazoles

2017
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.
    Cancer, 2017, Jul-01, Volume: 123, Issue:13

    Topics: Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Disease-Free Survival; Female; Humans; Male; Mastectomy; Middle Aged; Multivariate Analysis; Nitriles; Osteoporosis, Postmenopausal; Proportional Hazards Models; Radiotherapy, Adjuvant; Receptors, Estrogen; Treatment Outcome; Triazoles

2017
Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Carcinoma, Ovarian Epithelial; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Nitriles; Organoplatinum Compounds; Ovarian Neoplasms; Prospective Studies; Quality of Life; Receptors, Estrogen; Receptors, Progesterone; Tissue Array Analysis; Triazoles

2017
Impact of nonsteroidal aromatase inhibitors on steroid profile in a Chinese population.
    Medicine, 2017, Volume: 96, Issue:28

    Topics: Aminoglutethimide; Anastrozole; Aromatase Inhibitors; Biomarkers, Pharmacological; Doping in Sports; Female; Hormones; Humans; Letrozole; Male; Models, Biological; Nitriles; Single-Blind Method; Steroids; Substance-Related Disorders; Triazoles; Young Adult

2017
Absence of Effect of Intravaginal Miconazole, Clindamycin, Nonoxynol-9, and Tampons on the Pharmacokinetics of an Anastrozole/Levonorgestrel Intravaginal Ring.
    Journal of clinical pharmacology, 2018, Volume: 58, Issue:1

    Topics: Administration, Intravaginal; Adult; Anastrozole; Anti-Bacterial Agents; Antifungal Agents; Clindamycin; Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Levonorgestrel; Menstrual Hygiene Products; Miconazole; Nitriles; Nonoxynol; Triazoles

2018
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Nov-10, Volume: 35, Issue:32

    Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzimidazoles; Biomarkers, Tumor; Breast Neoplasms; Double-Blind Method; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptor, ErbB-2; Survival Rate; Treatment Outcome; Triazoles

2017
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.
    The Lancet. Oncology, 2017, Volume: 18, Issue:11

    Topics: Administration, Oral; Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Mastectomy; Maximum Tolerated Dose; Middle Aged; Netherlands; Nitriles; Postmenopause; Prognosis; Prospective Studies; Receptor, ErbB-2; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2017
Comparison of pharmacokinetics of newly discovered aromatase inhibitors by a cassette microdosing approach in healthy Japanese subjects.
    Drug metabolism and pharmacokinetics, 2017, Volume: 32, Issue:6

    Topics: Administration, Intravenous; Administration, Oral; Aged; Anastrozole; Aniline Compounds; Animals; Aromatase; Aromatase Inhibitors; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Discovery; Healthy Volunteers; Humans; Japan; Male; Molecular Structure; Nitriles; Rats; Structure-Activity Relationship; Triazoles

2017
Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
    The Journal of pediatrics, 2017, Volume: 190

    Topics: Adult; Anastrozole; Androgen Antagonists; Aromatase Inhibitors; Body Height; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Nitriles; Puberty, Precocious; Spironolactone; Testolactone; Treatment Outcome; Triazoles; Triptorelin Pamoate

2017
Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27.
    European journal of cancer (Oxford, England : 1990), 2018, Volume: 90

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease-Free Survival; Female; Humans; Middle Aged; Nitriles; Treatment Outcome; Triazoles

2018
Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON).
    Breast cancer (Tokyo, Japan), 2018, Volume: 25, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; China; Disease-Free Survival; Estradiol; Female; Fulvestrant; Humans; Japan; Middle Aged; Nitriles; Postmenopause; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Response Evaluation Criteria in Solid Tumors; Taiwan; Triazoles

2018
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 06-20, Volume: 41, Issue:18

    Topics: Adjuvants, Immunologic; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Nitriles; Prospective Studies; Tamoxifen; Triazoles

2023

Other Studies

678 other study(ies) available for anastrozole and triazoles

ArticleYear
Arimidex: a potent and selective fourth-generation aromatase inhibitor.
    Breast cancer research and treatment, 1994, Volume: 30, Issue:1

    Topics: Administration, Oral; Anastrozole; Animals; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Dogs; Estrogens; Female; Hormones; In Vitro Techniques; Macaca nemestrina; Male; Nitriles; Postmenopause; Rats; Triazoles

1994
Anastrozole for metastatic breast cancer.
    The Medical letter on drugs and therapeutics, 1996, Jul-05, Volume: 38, Issue:978

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Neoplasm Metastasis; Nitriles; Triazoles

1996
New aromatase inhibitors: more selectivity, less toxicity, unfortunately, the same activity.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Nitriles; Triazoles

1996
Aromatase inhibitors in metastatic breast cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:4 Suppl 9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles

1996
The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033)--a potent, selective aromatase inhibitor.
    The Journal of steroid biochemistry and molecular biology, 1996, Volume: 58, Issue:4

    Topics: Adrenal Glands; Aminoglutethimide; Anastrozole; Androstenedione; Animals; Aromatase Inhibitors; Cortodoxone; Enzyme Inhibitors; Fadrozole; Female; Hormones; Humans; Macaca nemestrina; Male; Metyrapone; Nitriles; Organ Size; Potassium; Prostate; Rats; Rats, Wistar; Seminal Vesicles; Sodium; Triazoles; Uterus

1996
Role of new selective aromatase inhibitor in therapy for metastatic breast cancer in postmenopausal women.
    The Nurse practitioner, 1997, Volume: 22, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Nitriles; Postmenopause; Tamoxifen; Triazoles

1997
Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
    Drug metabolism and disposition: the biological fate of chemicals, 1997, Volume: 25, Issue:5

    Topics: Anastrozole; Aromatase Inhibitors; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; In Vitro Techniques; Microsomes, Liver; Mixed Function Oxygenases; Nifedipine; Nitriles; Oxidoreductases, N-Demethylating; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Substrate Specificity; Triazoles

1997
Fetal death in mice lacking 5alpha-reductase type 1 caused by estrogen excess.
    Molecular endocrinology (Baltimore, Md.), 1997, Volume: 11, Issue:7

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Anastrozole; Androstenedione; Animals; Biological Assay; Decidua; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Estrogen Antagonists; Estrogens; Female; Fetal Death; Gene Expression Regulation, Enzymologic; In Situ Hybridization; Litter Size; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitriles; Placenta; RNA, Messenger; Steroids; Tamoxifen; Triazoles; Uterus

1997
Aromatase inhibitors come of age.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:7

    Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Nitriles; Triazoles

1997
A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
    Cancer letters, 1997, Sep-16, Volume: 118, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Analysis of Variance; Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fadrozole; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Ovariectomy; Postmenopause; Triazoles; Tumor Cells, Cultured

1997
Predictors of response to second-line endocrine therapy for breast cancer.
    Breast cancer research and treatment, 1997, Volume: 45, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Gonanes; Goserelin; Humans; Megestrol Acetate; Middle Aged; Nitriles; Ovariectomy; Predictive Value of Tests; Remission Induction; Tamoxifen; Triazoles

1997
The weanling male rat as an assay for endocrine disruption: preliminary observations.
    Regulatory toxicology and pharmacology : RTP, 1997, Volume: 26, Issue:3

    Topics: Anastrozole; Androgen Antagonists; Animals; Body Weight; Cyproterone Acetate; Drug Evaluation, Preclinical; Endocrine System Diseases; Female; Lactose; Male; Methylcellulose; Nitriles; Organ Size; Oxazines; Oxazoles; Rats; Rats, Inbred Strains; Toxicology; Triazoles; Uterus; Weaning

1997
Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat.
    The American journal of physiology, 1998, Volume: 274, Issue:2

    Topics: Aging; Anastrozole; Androgen Antagonists; Androstenedione; Anilides; Animals; Body Weight; Bone Resorption; Enzyme Inhibitors; Estradiol; Female; Nitriles; Ovariectomy; Rats; Rats, Sprague-Dawley; Testosterone; Tosyl Compounds; Triazoles

1998
[Two new therapeutic principles in the management of breast cancer and colorectal cancer: selective oral aromatase inhibition and thymidilate synthase inhibition].
    Der Internist, 1997, Volume: 38, Issue:3 Suppl Se

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Colorectal Neoplasms; Enzyme Inhibitors; Female; Humans; Male; Nitriles; Palliative Care; Triazoles

1997
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor.
    Fertility and sterility, 1998, Volume: 69, Issue:4

    Topics: Administration, Oral; Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Biopsy; Endometriosis; Enzyme Inhibitors; Female; Humans; Middle Aged; Nitriles; Polymerase Chain Reaction; Postmenopause; Rats; Recurrence; RNA, Messenger; Time Factors; Triazoles

1998
Preclinical studies using the intratumoral aromatase model for postmenopausal breast cancer.
    Oncology (Williston Park, N.Y.), 1998, Volume: 12, Issue:3 Suppl 5

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Nitriles; Organ Size; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles; Tumor Cells, Cultured; Uterus

1998
Aromatase inhibitors and their future role in post-menopausal women with early breast cancer.
    British journal of cancer, 1998, Volume: 78 Suppl 4

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Middle Aged; Nitriles; Postmenopause; Triazoles

1998
Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy.
    The Prostate, 1998, Oct-01, Volume: 37, Issue:2

    Topics: Anastrozole; Animals; Aromatase; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dogs; Enzyme Inhibitors; Finasteride; Male; Nitriles; Oxidoreductases; Prostate; Prostatic Hyperplasia; Testosterone; Triazoles

1998
The effects of aromatase inhibitors and antiestrogens in the nude mouse model.
    Breast cancer research and treatment, 1998, Volume: 50, Issue:1

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Nitriles; Tamoxifen; Triazoles; Tumor Cells, Cultured

1998
The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity.
    The Journal of steroid biochemistry and molecular biology, 1998, Volume: 67, Issue:4

    Topics: Anastrozole; Androstenedione; Aromatase; Aromatase Inhibitors; Base Sequence; Breast Neoplasms; Cell Division; Cells, Cultured; Choriocarcinoma; DNA Primers; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fibroblasts; Fulvestrant; Humans; Letrozole; Microsomes; Nitriles; Placenta; RNA, Messenger; Triazoles; Tumor Cells, Cultured

1998
Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones.
    Endocrinology, 1999, Volume: 140, Issue:1

    Topics: Anastrozole; Androgen Antagonists; Androstenedione; Anilides; Animals; Bone Marrow; Enzyme Inhibitors; Estradiol; Estrogens; Female; Gene Expression Regulation; Macrophage Colony-Stimulating Factor; Molecular Weight; Nitriles; Ovariectomy; Polymerase Chain Reaction; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sex Characteristics; Tosyl Compounds; Transcription, Genetic; Triazoles

1999
Mitogenic and antioxidant mechanisms of estradiol action in preovulatory ovine follicles: relevance to luteal function.
    Biology of reproduction, 1999, Volume: 61, Issue:2

    Topics: Anastrozole; Animals; Antioxidants; Apoptosis; Aromatase Inhibitors; Corpus Luteum; DNA Fragmentation; Enzyme Inhibitors; Estradiol; Female; Mitosis; Nitriles; Ovarian Follicle; Oxidative Stress; Progesterone; Proliferating Cell Nuclear Antigen; Sheep; Triazoles

1999
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.
    Breast cancer research and treatment, 1999, Volume: 55, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Evaluation Studies as Topic; Female; Hormone Replacement Therapy; Humans; Megestrol Acetate; Menopause; Middle Aged; Nitriles; Pilot Projects; Quality of Life; Surveys and Questionnaires; Tamoxifen; Time Factors; Triazoles

1999
5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
    The Prostate, 1999, Dec-01, Volume: 41, Issue:4

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Anastrozole; Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Blotting, Southern; Dihydrotestosterone; Enzyme Inhibitors; Etiocholanolone; Humans; Hydrogen-Ion Concentration; Isoenzymes; Male; Microsomes; Nitriles; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone; Triazoles; Tumor Cells, Cultured

1999
The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer.
    Breast cancer research and treatment, 1999, Volume: 57, Issue:2

    Topics: Analysis of Variance; Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Disease Models, Animal; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Tamoxifen; Time Factors; Triazoles; Tumor Cells, Cultured

1999
Safety and tolerability of endocrine therapies used in the treatment of advanced breast cancer.
    Annals of surgical oncology, 1999, Volume: 6, Issue:8 Suppl

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Tolerance; Female; Humans; Megestrol Acetate; Nitriles; Safety; Tamoxifen; Triazoles

1999
Future directions in endocrine treatment of advanced breast cancer.
    Annals of surgical oncology, 1999, Volume: 6, Issue:8 Suppl

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Megestrol Acetate; Nitriles; Tamoxifen; Triazoles

1999
Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility.
    The Journal of endocrinology, 2000, Volume: 164, Issue:2

    Topics: Anastrozole; Animals; Copulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fertility; Follicle Stimulating Hormone; Male; Nitriles; Organ Size; Rats; Rats, Wistar; Spermatogenesis; Testis; Testosterone; Triazoles

2000
A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue.
    The Journal of steroid biochemistry and molecular biology, 2000, Volume: 72, Issue:5

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chromatography, High Pressure Liquid; Estradiol; Estrone; Female; Humans; Nitriles; Postmenopause; Radioimmunoassay; Reproducibility of Results; Sensitivity and Specificity; Triazoles

2000
Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women.
    Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Asian People; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrogens; Estrone; Female; Humans; Japan; Middle Aged; Nitriles; Triazoles; White People

2000
[Aromatase inhibitors in the treatment of breast cancer].
    Revue medicale de la Suisse romande, 2000, Volume: 120, Issue:6

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles

2000
Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate.
    Anti-cancer drugs, 2000, Volume: 11, Issue:7

    Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Canada; Costs and Cost Analysis; Decision Support Techniques; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Quality of Life; Randomized Controlled Trials as Topic; Triazoles

2000
An overview of the use of non-steroidal aromatase inhibitors in the treatment of breast cancer.
    European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 4

    Topics: Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles

2000
Gonadotropins stimulate growth of MCF-7 human breast cancer cells by promoting intracellular conversion of adrenal androgens to estrogens.
    Oncology, 2000, Volume: 59 Suppl 1

    Topics: Anastrozole; Androgens; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Chorionic Gonadotropin, beta Subunit, Human; Dehydroepiandrosterone; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Humans; Nitriles; Triazoles; Tumor Cells, Cultured

2000
Endocrine options for breast cancer treatment: looking beyond tamoxifen.
    Breast cancer (Tokyo, Japan), 2000, Volume: 7, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Goserelin; Humans; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles

2000
Clarification of anastrozole/megestrol acetate trial program design.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Dec-15, Volume: 18, Issue:24

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Nitriles; Prospective Studies; Research Design; Triazoles

2000
The uterotrophic activity of nonylphenol in the rat is not mediated by aromatase enzyme induction.
    Toxicology letters, 2001, Jan-03, Volume: 118, Issue:3

    Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Enzyme Induction; Enzyme Inhibitors; Female; Nitriles; Organ Size; Phenols; Rats; Rats, Wistar; Receptors, Estrogen; Tetrahydronaphthalenes; Triazoles; Uterus

2001
Clinical trials in cancer: what makes for a successful study?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:11

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Drug Industry; Female; Humans; Interinstitutional Relations; Mastectomy; Medical Audit; Motivation; Multicenter Studies as Topic; Nitriles; Patient Selection; Patients; Physician-Patient Relations; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Tamoxifen; Triazoles

2000
Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene.
    The oncologist, 2001, Volume: 6, Issue:1

    Topics: Anastrozole; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Bexarotene; Breast Neoplasms; Drug Approval; Female; Humans; Leukemia, Promyelocytic, Acute; Lymphoma, T-Cell, Cutaneous; Nitriles; Oxides; Paclitaxel; Tamoxifen; Tetrahydronaphthalenes; Triazoles; United States; United States Food and Drug Administration

2001
Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up?
    Journal of endocrinological investigation, 2000, Volume: 23, Issue:11

    Topics: Anastrozole; Aromatase Inhibitors; Body Height; Bone Development; Child, Preschool; Enzyme Inhibitors; Growth Disorders; Growth Plate; Human Growth Hormone; Humans; Male; Nitriles; Puberty, Precocious; Triazoles

2000
Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:1

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Dexamethasone; Enzyme Inhibitors; Estrogen Antagonists; Feedback; Follicle Stimulating Hormone; Glucocorticoids; Gonadal Steroid Hormones; Gonadotropins; Humans; Ketoconazole; Luteinizing Hormone; Male; Nitriles; Testosterone; Triazoles

2001
Estrogenic upregulation of DNA polymerase beta in oocytes of preovulatory ovine follicles.
    Molecular reproduction and development, 2001, Volume: 58, Issue:4

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Blastocyst; Corpus Luteum; Dactinomycin; Dinoprost; DNA Polymerase beta; DNA Repair; Drug Administration Schedule; Enzyme Induction; Enzyme Inhibitors; Estradiol; Estrus; Female; Follicular Phase; Gonadotropins; Meiosis; Nitriles; Nucleic Acid Synthesis Inhibitors; Oocytes; Ovarian Follicle; Ovulation Induction; Sheep; Triazoles

2001
The Twenty-third Annual San Antonio Breast Cancer Symposium.
    Current medical research and opinion, 2001, Volume: 16, Issue:4

    Topics: Anastrozole; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Combined Modality Therapy; Deoxycytidine; Estradiol; Estrogen Antagonists; Female; Fluorouracil; Fulvestrant; Humans; Letrozole; Male; Mastectomy; Nitriles; Prognosis; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2001
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, May-01, Volume: 19, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2001
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, May-01, Volume: 19, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2001
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, May-01, Volume: 19, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2001
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, May-01, Volume: 19, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2001
Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, May-01, Volume: 19, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2001
Aromatase inhibitors and arthralgia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, May-15, Volume: 19, Issue:10

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Arthralgia; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Middle Aged; Nitriles; Postmenopause; Triazoles

2001
The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:6

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Biomarkers; Bone Density; Bone Remodeling; Enzyme Inhibitors; Gonadal Steroid Hormones; Gonadotropins; Humans; Lipids; Male; Nitriles; Triazoles

2001
Aromatase inhibitors and inactivators in breast cancer.
    BMJ (Clinical research ed.), 2001, Oct-20, Volume: 323, Issue:7318

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Estrogens; Female; Humans; Letrozole; Nitriles; Tamoxifen; Triazoles

2001
HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.
    Cancer research, 2001, Dec-01, Volume: 61, Issue:23

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Female; Gene Amplification; Humans; Immunohistochemistry; Ki-67 Antigen; Multicenter Studies as Topic; Nitriles; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Triazoles

2001
[Clinical study of anastrozole in the treatment of postmenopausal women with advanced breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1999, Volume: 21, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Postmenopause; Triazoles

1999
Aromatase inhibitors for male infertility.
    The Journal of urology, 2002, Volume: 167, Issue:2 Pt 1

    Topics: Anastrozole; Aromatase Inhibitors; Enzyme Inhibitors; Estradiol; Humans; Infertility, Male; Klinefelter Syndrome; Liver Function Tests; Male; Nitriles; Sperm Motility; Testolactone; Testosterone; Triazoles

2002
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:11

    Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Enzyme Inhibitors; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Retrospective Studies; Treatment Failure; Triazoles

2001
World's largest breast cancer treatment trial supports anastrozole use.
    Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Humans; Multicenter Studies as Topic; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2002
Local endocrine effects of aromatase inhibitors within the breast.
    The Journal of steroid biochemistry and molecular biology, 2001, Volume: 79, Issue:1-5

    Topics: Anastrozole; Androstadienes; Aromatase; Aromatase Inhibitors; Breast; Breast Neoplasms; Cells, Cultured; Chemotherapy, Adjuvant; Enzyme Inhibitors; Estrogens; Estrone; Female; Fibroblasts; Humans; In Vitro Techniques; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles

2001
Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy.
    The Journal of steroid biochemistry and molecular biology, 2001, Volume: 79, Issue:1-5

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Letrozole; Menopause; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles

2001
[Aromatase inhibitors of the 3rd generation. What can the "pill against breast cancer" really do?].
    MMW Fortschritte der Medizin, 2002, Jan-31, Volume: 144, Issue:5

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Humans; Letrozole; Nitriles; Triazoles

2002
Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture.
    Molecular reproduction and development, 2002, Volume: 61, Issue:4

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Cells, Cultured; Enzyme Inhibitors; Estradiol; Female; Meiosis; Metaphase; Mice; Mice, Inbred C57BL; Nitriles; Oocytes; Ovarian Follicle; Progesterone; Spindle Apparatus; Testosterone; Triazoles

2002
Hormones 'R' us.
    Clinical breast cancer, 2002, Volume: 2, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Estrogen Antagonists; Female; Humans; Nitriles; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2002
Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Mar-19, Volume: 99, Issue:6

    Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Arteriosclerosis; Cell Adhesion; Dihydrotestosterone; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Gene Expression Regulation; Humans; Male; Mice; Nitriles; Receptors, Estrogen; RNA, Messenger; Testosterone; Triazoles; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1

2002
Experience of hormonal therapy with anastrozole for previously treated metastatic breast cancer.
    The Israel Medical Association journal : IMAJ, 2002, Volume: 4, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Retrospective Studies; Survival Analysis; Triazoles

2002
New breast cancer drugs expand treatment options.
    Harvard women's health watch, 2002, Volume: 9, Issue:8

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Tamoxifen; Triazoles

2002
Comparison of in vitro exemestane activity versus other antiaromatase agents.
    Clinical breast cancer, 2000, Volume: 1 Suppl 1

    Topics: Aminoglutethimide; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Choriocarcinoma; Female; Humans; Nitriles; Triazoles; Tumor Cells, Cultured

2000
Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients.
    The Journal of steroid biochemistry and molecular biology, 2002, Volume: 80, Issue:4-5

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Letrozole; Middle Aged; Nitriles; Postmenopause; Time Factors; Triazoles

2002
A better medication for treating breast cancer?
    The Johns Hopkins medical letter health after 50, 2002, Volume: 14, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Nitriles; Tamoxifen; Triazoles

2002
Efficacy of anastrozole in male breast cancer.
    American journal of clinical oncology, 2002, Volume: 25, Issue:3

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms, Male; Combined Modality Therapy; Enzyme Inhibitors; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nitriles; Treatment Failure; Triazoles

2002
The oncology nurse's role in educating patients on endocrine therapy for metastatic breast cancer--focus on fulvestrant.
    Cancer nursing, 2002, Volume: 25 Suppl 2

    Topics: Administration, Oral; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Receptor Modulators; Female; Humans; Injections, Intramuscular; Nitriles; Nurse's Role; Oncology Nursing; Patient Education as Topic; Triazoles

2002
Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-01, Volume: 20, Issue:13

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cross-Over Studies; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Nitriles; Postmenopause; Research Design; Triazoles

2002
Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.
    Lancet (London, England), 2002, Jun-22, Volume: 359, Issue:9324

    Topics: Anastrozole; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Tamoxifen; Triazoles

2002
Estrogen as therapy for breast cancer.
    Breast cancer research : BCR, 2002, Volume: 4, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase II as Topic; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estrogens; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Salvage Therapy; Tamoxifen; Treatment Outcome; Triazoles

2002
Promising results for Arimidex and Femara.
    Expert review of anticancer therapy, 2001, Volume: 1, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase III as Topic; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2001
Stick with tried-and-true breast cancer treatment.
    Health news (Waltham, Mass.), 2002, Volume: 8, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Nitriles; Tamoxifen; Triazoles

2002
New alternative to tamoxifen.
    Harvard women's health watch, 2002, Volume: 9, Issue:11

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Nitriles; Triazoles

2002
Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androgens; Biological Availability; Biomarkers; Biopsy, Needle; Breast Neoplasms; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Female; Humans; Middle Aged; Neoplasm Staging; Nitriles; Osteocalcin; Postmenopause; Prognosis; Prospective Studies; Sensitivity and Specificity; Sex Hormone-Binding Globulin; Treatment Outcome; Triazoles

2002
Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
    Journal of pediatric endocrinology & metabolism : JPEM, 2002, Volume: 15 Suppl 3

    Topics: Anastrozole; Aromatase Inhibitors; Child; Enzyme Inhibitors; Estrogen Antagonists; Female; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menarche; Nitriles; Puberty, Precocious; Tamoxifen; Triazoles

2002
Concept evaluation: an assay for receptor-mediated and biochemical antiestrogens using pubertal rats.
    Regulatory toxicology and pharmacology : RTP, 2002, Volume: 35, Issue:3

    Topics: Administration, Oral; Anastrozole; Animals; Biological Assay; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Injections, Subcutaneous; Nitriles; Oligopeptides; Organ Size; Rats; Rats, Wistar; Sexual Maturation; Tetrahydronaphthalenes; Triazoles; Uterus; Vagina

2002
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Sep-01, Volume: 20, Issue:17

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Nitriles; Randomized Controlled Trials as Topic; Research Design; Tamoxifen; Triazoles

2002
Rapid determination of anastrozole in plasma by gas chromatography with electron capture detection and its application to an oral pharmacokinetic study in healthy volunteers.
    Biomedical chromatography : BMC, 2002, Volume: 16, Issue:6

    Topics: Administration, Oral; Adult; Anastrozole; Area Under Curve; Aromatase Inhibitors; Chromatography, Gas; Cross-Over Studies; Enzyme Inhibitors; Half-Life; Humans; Male; Nitriles; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Triazoles

2002
[Advanced breast cancer with lung and pleural metastases responsive to anastrozole--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Lung Neoplasms; Middle Aged; Nitriles; Pleural Effusion, Malignant; Pleural Neoplasms; Postmenopause; Receptors, Estrogen; Triazoles

2002
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:10

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Bromocriptine; Cabergoline; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Male; Nitriles; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome; Triazoles

2002
[Campaign against breast cancer. Are aromatase inhibitors the better choice? (interview by Dr. Dorothea Dlugosch)].
    MMW Fortschritte der Medizin, 2002, Sep-19, Volume: 144, Issue:38

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Female; Humans; Nitriles; Tamoxifen; Treatment Outcome; Triazoles

2002
Anastrozole versus progestins/tamoxifen.
    European journal of cancer (Oxford, England : 1990), 2002, Volume: 38 Suppl 6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Forecasting; Humans; Multicenter Studies as Topic; Nitriles; Progestins; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; Tamoxifen; Triazoles

2002
Selective oestrogen receptor downregulator.
    European journal of cancer (Oxford, England : 1990), 2002, Volume: 38 Suppl 6

    Topics: Anastrozole; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Down-Regulation; Estradiol; Female; Fulvestrant; Humans; Nitriles; Receptors, Estrogen; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2002
From the Food and Drug Administration.
    JAMA, 2002, Nov-06, Volume: 288, Issue:17

    Topics: Adenine; Anastrozole; Antineoplastic Agents, Hormonal; Antiviral Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Hepatitis B, Chronic; Humans; Nitriles; Organophosphonates; Triazoles; United States; United States Food and Drug Administration

2002
Invasive lobular carcinoma of the breast presenting successively with colonic and gastric metastases.
    International journal of clinical practice, 2002, Volume: 56, Issue:8

    Topics: Aged; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Endoscopy; Female; Humans; Nitriles; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Triazoles

2002
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma.
    Cancer, 2002, Dec-01, Volume: 95, Issue:11

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Female; Humans; Multicenter Studies as Topic; Nitriles; Reproducibility of Results; Research Design; Retrospective Studies; Survival; Tamoxifen; Triazoles

2002
Effects of anastrozole on lipid metabolism compared with tamoxifen in rats.
    Breast cancer research and treatment, 2002, Volume: 76, Issue:2

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Cholesterol; Drug Combinations; Enzyme Inhibitors; Female; Lipoprotein Lipase; Nitriles; Rats; Tamoxifen; Triazoles; Triglycerides

2002
Current role of endocrine therapy in the management of breast cancer.
    Breast cancer (Tokyo, Japan), 2002, Volume: 9, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogen Receptor Modulators; Female; Humans; Letrozole; Nitriles; Tamoxifen; Triazoles

2002
Has tamoxifen had its day?
    Breast cancer research : BCR, 2002, Volume: 4, Issue:6

    Topics: Anastrozole; Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Female; Humans; Nitriles; Postmenopause; Tamoxifen; Triazoles

2002
A new day dawns: women without oestrogen or is a balance best?
    Breast cancer research : BCR, 2002, Volume: 4, Issue:6

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogen Antagonists; Female; Humans; Nitriles; Tamoxifen; Triazoles

2002
Questions about anastrozole for early breast cancer.
    Lancet (London, England), 2002, Dec-07, Volume: 360, Issue:9348

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Female; Humans; Nitriles; Triazoles

2002
Questions about anastrozole for early breast cancer.
    Lancet (London, England), 2002, Dec-07, Volume: 360, Issue:9348

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Female; Humans; Nitriles; Triazoles

2002
Advances in breast oncology: the 2002 ASCO meeting.
    Current medical research and opinion, 2002, Volume: 18, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclooxygenase Inhibitors; Docetaxel; Evidence-Based Medicine; Female; Humans; Nitriles; Paclitaxel; Sentinel Lymph Node Biopsy; Tamoxifen; Taxoids; Technology Assessment, Biomedical; Triazoles

2002
New treatment option for postmenopausal women with early breast cancer.
    Expert review of anticancer therapy, 2002, Volume: 2, Issue:6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Approval; Enzyme Inhibitors; Female; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2002
[A case of recurrent breast cancer with carcinomatous pleurisy successfully treated with combined chemoendocrine-therapy of CTF (CPA, THP and 5-FU) and anastrozole following instillation therapy 12 years after radical mastectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:13

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Medullary; Cyclophosphamide; Doxorubicin; Drainage; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy, Radical; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Pleural Effusion, Malignant; Pleurisy; Triazoles

2002
[Summit meeting of breast cancer experts--many new ideas and practical progress. When the breast becomes malignant].
    MMW Fortschritte der Medizin, 2003, Jan-23, Volume: 145, Issue:3-4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Mammography; Mass Screening; Nitriles; Quality Assurance, Health Care; Tamoxifen; Triazoles

2003
Update on ATAC.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:3

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Nitriles; Tamoxifen; Triazoles

2003
Anastrozole (Arimidex) vs. tamoxifen for treatment of early breast cancer.
    The Medical letter on drugs and therapeutics, 2003, Mar-17, Volume: 45, Issue:1152

    Topics: Anastrozole; Asthenia; Breast Neoplasms; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Estrogen Antagonists; Fees, Pharmaceutical; Female; Headache; Humans; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2003
Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.
    The New England journal of medicine, 2003, May-08, Volume: 348, Issue:19

    Topics: Adipose Tissue; Adolescent; Adult; Anastrozole; Androstenedione; Aromatase; Aromatase Inhibitors; Base Sequence; Child; Chromosome Mapping; Chromosomes, Human, Pair 15; Dexamethasone; Enzyme Inhibitors; Estradiol; Estrone; Fibroblasts; Glucocorticoids; Gynecomastia; Humans; Male; Molecular Sequence Data; Mutation; Nitriles; Promoter Regions, Genetic; RNA, Messenger; Transcription, Genetic; Triazoles

2003
Anastrozole-induced remission of diaphragmatic paralysis from metastatic breast cancer treated with multiple prior therapies.
    Breast cancer (Tokyo, Japan), 2003, Volume: 10, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Humans; Mediastinal Neoplasms; Middle Aged; Nitriles; Remission Induction; Respiratory Paralysis; Triazoles

2003
Anastrozole as a preventive agent in breast cancer.
    Lancet (London, England), 2003, May-31, Volume: 361, Issue:9372

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Humans; Informed Consent; Nitriles; Postmenopause; Triazoles

2003
Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen.
    American journal of clinical oncology, 2003, Volume: 26, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Canada; Cost-Benefit Analysis; Decision Support Techniques; Enzyme Inhibitors; Humans; Letrozole; Meta-Analysis as Topic; Nitriles; Quality of Life; Tamoxifen; Triazoles

2003
ATAC trial: reporting interim results is not helpful.
    BMJ (Clinical research ed.), 2003, Jun-14, Volume: 326, Issue:7402

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Nitriles; Tamoxifen; Triazoles

2003
Breast cancer prevention.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 2003, Volume: 53, Issue:487

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Utilization; Female; Humans; Nitriles; Tamoxifen; Triazoles

2003
[Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient].
    MMW Fortschritte der Medizin, 2003, Jun-12, Volume: 145, Issue:24

    Topics: Adult; Age Factors; Aged; Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Immunotherapy; Letrozole; Meta-Analysis as Topic; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Premenopause; Prognosis; Quality of Health Care; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Toremifene; Trastuzumab; Triazoles

2003
Economic evaluation of antiaromatase agents in the second-line treatment of metastatic breast cancer.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:11

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Canada; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Enzyme Inhibitors; Female; Humans; Letrozole; Megestrol; Middle Aged; Nitriles; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles

2003
Examining quality of life issues in relation to endocrine therapy for breast cancer.
    American journal of clinical oncology, 2003, Volume: 26, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Decision Making; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Nitriles; Quality of Life; Tamoxifen; Triazoles

2003
A new notocotylid trematode, Uniserialis gippyensis gen. et sp. nov., from the mallard, Anas platyrhyncha platyrhyncha L.
    The Journal of parasitology, 1958, Volume: 44, Issue:4, Section

    Topics: Anastrozole; Animals; Birds; Nitriles; Poultry; Trematoda; Triazoles

1958
Imprinting and associative learning: the stability of the following response in Peking ducks (Anas platyrhynchus).
    Journal of comparative and physiological psychology, 1958, Volume: 51, Issue:5

    Topics: Anastrozole; Animals; Conditioning, Classical; Ducks; Humans; Learning; Nitriles; Triazoles

1958
Anastrozole for ductal carcinoma in situ.
    Lancet (London, England), 2003, Sep-06, Volume: 362, Issue:9386

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Attitude to Health; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Humans; Mass Screening; Nitriles; Triazoles

2003
The comparative anatomy of the respiratory pathways in the domestic fowl (Gallus domesticus), pigeon (Columbia livia) and domestic duck (Anas platyrhyncha).
    Journal of anatomy, 1960, Volume: 94

    Topics: Anastrozole; Anatomy, Comparative; Animals; Chickens; Columbidae; Ducks; Nitriles; Poultry; Respiratory System; Triazoles

1960
[On the female hybrid issuing from the crossbreeding of Cairina moschata L. (male) and Anas platvrhvnchos L. (female)].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1960, Volume: 154

    Topics: Anastrozole; Animals; Ducks; Female; Hybridization, Genetic; Male; Nitriles; Triazoles

1960
The effect of total and subtotal adrenalectomy on the renal and extra-renal response of the domestic duct (Anas platyrhynchus) to saline loading.
    Endocrinology, 1961, Volume: 69

    Topics: Adrenalectomy; Anastrozole; Kidney; Nitriles; Sodium Chloride; Triazoles

1961
Doctors test drug to prevent cancer in high risk women.
    BMJ (Clinical research ed.), 2003, Oct-04, Volume: 327, Issue:7418

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Risk Factors; Triazoles

2003
Future directions in the endocrine therapy of breast cancer.
    Breast cancer research and treatment, 2003, Volume: 80 Suppl 1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Endocrine System; Estradiol; Female; Fulvestrant; Humans; Nitriles; Receptors, Estrogen; Tamoxifen; Triazoles

2003
Adjuvant aromatase inhibitors: are we there yet?
    Cancer, 2003, Nov-01, Volume: 98, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles

2003
ATAC trial did not report interim results.
    BMJ (Clinical research ed.), 2003, Nov-01, Volume: 327, Issue:7422

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Nitriles; Postmenopause; Tamoxifen; Triazoles

2003
The effects of hormone therapy on cognition in breast cancer.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 86, Issue:3-5

    Topics: Affect; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cognition; Cognition Disorders; Enzyme Inhibitors; Female; Humans; Memory; Middle Aged; Nitriles; Pilot Projects; Psychometrics; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2003
Hormonal therapy: introduction.
    Breast (Edinburgh, Scotland), 2003, Volume: 12 Suppl 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Letrozole; Nitriles; Prognosis; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles; United Kingdom

2003
Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer.
    Clinical therapeutics, 2003, Volume: 25, Issue:11

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Health Care Costs; Health Services; Humans; Nitriles; Postmenopause; Quality-Adjusted Life Years; Tamoxifen; Triazoles

2003
Spreading the word, but not too thinly.
    Lancet (London, England), 2004, Jan-10, Volume: 363, Issue:9403

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Editorial Policies; Estradiol; Female; Fulvestrant; Humans; Nitriles; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Treatment Outcome; Triazoles

2004
Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-01, Volume: 10, Issue:1 Pt 2

    Topics: Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Time Factors; Triazoles

2004
Prevention strategies with aromatase inhibitors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-01, Volume: 10, Issue:1 Pt 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Female; Humans; Isoenzymes; Membrane Proteins; Models, Biological; Neoplasms; Nitriles; Placebos; Postmenopause; Prostaglandin-Endoperoxide Synthases; Receptors, Estrogen; Tamoxifen; Time Factors; Triazoles

2004
Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study.
    Journal of surgical oncology, 2004, Volume: 85, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Anthracyclines; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Bridged-Ring Compounds; Feasibility Studies; Female; Goserelin; Humans; Lymph Nodes; Middle Aged; Neoadjuvant Therapy; Nitriles; Pilot Projects; Sentinel Lymph Node Biopsy; Tamoxifen; Taxoids; Triazoles

2004
Anas domestica as a definitive host and Ophicephalus argus as a second intermediate host of Clonorchis sinensis.
    Japanese journal of medicine, 1951, Volume: 4, Issue:3

    Topics: Anastrozole; Animals; Clonorchis sinensis; Ducks; Nitriles; Trematoda; Triazoles

1951
Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.
    International journal of impotence research, 2004, Volume: 16, Issue:1

    Topics: Adult; Anastrozole; Androgens; Aromatase Inhibitors; Enzyme Inhibitors; Gynecomastia; Humans; Hypogonadism; Male; Middle Aged; Nitriles; Testosterone; Triazoles

2004
[New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].
    MMW Fortschritte der Medizin, 2003, Dec-11, Volume: 145, Issue:50

    Topics: Adolescent; Adult; Age Factors; Anastrozole; Anticarcinogenic Agents; Breast Neoplasms; Celecoxib; Child; Double-Blind Method; Estrogen Antagonists; Female; Germany; Hormone Replacement Therapy; Humans; Hysterectomy; Life Style; Mammography; Menarche; Menopause; Middle Aged; Nitriles; Ovariectomy; Pregnancy; Pyrazoles; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Smoking; Sulfonamides; Tamoxifen; Triazoles; Uterine Cervical Neoplasms

2003
[Interview with Prof. Dr. Wolfgang Eiermann. Which women need a medicamentous breast cancer prophylaxis?].
    MMW Fortschritte der Medizin, 2003, Dec-11, Volume: 145, Issue:50

    Topics: Age Factors; Anastrozole; Anticarcinogenic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Life Style; Mammography; Middle Aged; Nitriles; Quality of Life; Risk Assessment; Risk Factors; Tamoxifen; Triazoles

2003
[The uterine sarcoma, a new risk identified for tamoxifen].
    Presse medicale (Paris, France : 1983), 2004, Mar-13, Volume: 33, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinosarcoma; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Humans; Metrorrhagia; Middle Aged; Neoplasms, Second Primary; Nitriles; Risk; Tamoxifen; Triazoles; Uterine Neoplasms

2004
Adjuvant use of anastrozole in breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Apr-15, Volume: 22, Issue:8

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Nitriles; Triazoles

2004
Comment on "Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results" by J.-M. Nabholtz et al.
    European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:7

    Topics: Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Letrozole; Nitriles; Postmenopause; Survival Analysis; Tamoxifen; Triazoles

2004
Effect of estrogen deprivation on follicle/oocyte maturation and embryo development in mice.
    Chinese medical journal, 2004, Volume: 117, Issue:4

    Topics: Anastrozole; Animals; Chorionic Gonadotropin; Embryonic and Fetal Development; Estrogens; Female; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitriles; Oocytes; Ovarian Follicle; Pregnancy; Triazoles

2004
Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor.
    Fertility and sterility, 2004, Volume: 81, Issue:5

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Drug Therapy, Combination; Endometriosis; Enzyme Inhibitors; Female; Humans; Nitriles; Progesterone; Triazoles

2004
Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2004, Volume: 85, Issue:3

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Clomiphene; Estrogen Antagonists; Female; Humans; Letrozole; Nitriles; Ovulation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Triazoles

2004
Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy.
    Acta radiologica (Stockholm, Sweden : 1987), 2004, Volume: 45, Issue:1

    Topics: Adult; Aged; Anastrozole; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Goserelin; Humans; Imidazoles; Letrozole; Magnetic Resonance Imaging; Middle Aged; Nitriles; Pamidronate; Pilot Projects; Prospective Studies; Tamoxifen; Triazoles; Zoledronic Acid

2004
An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole.
    European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Randomized Controlled Trials as Topic; Triazoles

2004
Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
    Gynecologic oncology, 2004, Volume: 94, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Endometrial Neoplasms; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Progestins; Prolactin; Sarcoma, Endometrial Stromal; Triazoles

2004
Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy.
    Gynecologic oncology, 2004, Volume: 94, Issue:3

    Topics: Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Nitriles; Obesity; Triazoles

2004
[Ulcus terebrans. Therapy options and their limits].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:10

    Topics: Aged; Anastrozole; Breast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Ductal, Breast; Combined Modality Therapy; Debridement; Female; Humans; Incidental Findings; Neoplasm Staging; Neoplasms, Multiple Primary; Nitriles; Palliative Care; Radioisotope Teletherapy; Scalp; Skin Neoplasms; Skin Ulcer; Triazoles

2004
Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Cancer, 2004, Sep-15, Volume: 101, Issue:6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cost-Benefit Analysis; Disease-Free Survival; Female; Humans; Middle Aged; Models, Theoretical; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Triazoles

2004
[Therapeutic effects of Anastrozole in patients with advanced and recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cholesterol; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Salvage Therapy; Survival Rate; Triazoles

2004
[Combination therapy with Anastrozole and 5'-DFUR as a treatment for metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:10

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Receptors, Estrogen; Survival Rate; Triazoles

2004
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Nov-01, Volume: 22, Issue:21

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Nitriles; Odds Ratio; Postmenopause; Quality of Life; Surveys and Questionnaires; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2004
Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
    Clinical therapeutics, 2004, Volume: 26, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Budgets; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Female; Humans; Italy; Letrozole; Markov Chains; Megestrol; Models, Economic; National Health Programs; Nitriles; Postmenopause; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2004
[Anastrozole-resistant breast cancer responsive to exemestane--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:12

    Topics: Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Resistance, Neoplasm; Female; Humans; Nitriles; Postmenopause; Triazoles

2004
The responsiveness of a tumour to any kind of therapy is reflected by the objective response rate.
    European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:18

    Topics: Anastrozole; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Triazoles

2004
Arimidex inhibition on proliferation of human breast solid tumors measured by ATP bioluminescence.
    Life sciences, 2004, Dec-31, Volume: 76, Issue:7

    Topics: Adenosine Triphosphatases; Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Proliferation; Female; Humans; Luminescent Measurements; Luminescent Proteins; Middle Aged; Nitriles; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Triazoles; Tumor Cells, Cultured

2004
Oestrogen-selective modulation of FSH and LH secretion by pituitary gland.
    British journal of cancer, 2005, Jan-31, Volume: 92, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogens; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Nitriles; Pituitary Gland; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2005
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.
    Endocrine-related cancer, 2004, Volume: 11, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Glycoproteins; Humans; Middle Aged; Nitriles; Osteopontin; Osteoprotegerin; Postmenopause; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Sialoglycoproteins; Survival Analysis; Triazoles

2004
How rapidly do oncologists respond to clinical trial data?
    The oncologist, 2005, Volume: 10, Issue:1

    Topics: Adult; Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Evidence-Based Medicine; Female; Health Care Surveys; Humans; Medical Oncology; Middle Aged; Nitriles; Postmenopause; Practice Patterns, Physicians'; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles

2005
An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys.
    Journal of pediatric endocrinology & metabolism : JPEM, 2004, Volume: 17, Issue:12

    Topics: Absorptiometry, Photon; Adolescent; Anastrozole; Aromatase Inhibitors; Blood Glucose; Body Composition; Bone Density; Growth Hormone; Humans; Insulin; Male; Nitriles; Pilot Projects; Triazoles

2004
Anastrozole data show continued delay in relapse, but no clear survival advantage.
    Journal of the National Cancer Institute, 2005, Jan-19, Volume: 97, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cost-Benefit Analysis; Disease-Free Survival; Drug Costs; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles; United Kingdom

2005
Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy.
    Bulletin of experimental biology and medicine, 2004, Volume: 138, Issue:5

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Gene Expression Regulation, Neoplastic; Humans; Nitriles; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Triazoles

2004
[Weekly paclitaxel administration and intraabdominal CBDCA injection possibly beneficial treatment for recurrent breast cancer associated with metastatic ovarian cancer and peritoneal dissemination after operation--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:3

    Topics: Adenocarcinoma, Scirrhous; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Administration Schedule; Female; Floxuridine; Humans; Hysterotomy; Infusions, Intravenous; Injections, Intraperitoneal; Middle Aged; Nitriles; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Triazoles

2005
[Breast carcinoma: new, much promising trends. The cancer anxiety of women -- will be taken better care soon?].
    MMW Fortschritte der Medizin, 2005, Mar-10, Volume: 147, Issue:10

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Austria; Breast Neoplasms; Clinical Trials as Topic; Female; Fractures, Bone; Germany; Humans; Mammography; Middle Aged; Multicenter Studies as Topic; Nitriles; Osteoporosis; Randomized Controlled Trials as Topic; Risk; Risk Factors; Tamoxifen; Time Factors; Triazoles

2005
[New strategies against breast carcinoma. To outwit the resistance tendency of tumor cells].
    MMW Fortschritte der Medizin, 2005, Mar-10, Volume: 147, Issue:10

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Nitriles; Tamoxifen; Time Factors; Triazoles

2005
Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach.
    Molecular cancer research : MCR, 2005, Volume: 3, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Letrozole; Nitriles; Oligonucleotide Array Sequence Analysis; Tamoxifen; Triazoles; Up-Regulation

2005
Remission of macroglobulinemia during anastrozole treatment for breast cancer.
    The New England journal of medicine, 2005, Apr-21, Volume: 352, Issue:16

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Nitriles; Remission Induction; Triazoles; Waldenstrom Macroglobulinemia

2005
[Three cases of advanced breast cancer successfully treated with a weekly dose of paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Mastectomy, Modified Radical; Middle Aged; Neoplasm Invasiveness; Nitriles; Paclitaxel; Skin Neoplasms; Sternum; Triazoles

2005
Novel males' capacity to disrupt early pregnancy in mice (Mus musculus) is attenuated via a chronic reduction of males' urinary 17beta-estradiol.
    Psychoneuroendocrinology, 2005, Volume: 30, Issue:7

    Topics: Anastrozole; Animals; Aromatase; Diet; Embryo Implantation; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fertility; Insemination; Male; Mice; Nitriles; Phytoestrogens; Pregnancy; Pregnancy, Animal; Social Isolation; Testosterone; Triazoles

2005
Current and future perspectives on fulvestrant.
    Clinical breast cancer, 2005, Volume: 6 Suppl 1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Estradiol; Female; Fulvestrant; Humans; Nitriles; Receptors, Estrogen; Triazoles

2005
Alternative to tamoxifen effective for preventing breast cancer recurrence.
    Mayo Clinic women's healthsource, 2005, Volume: 9, Issue:5

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Triazoles

2005
Regression of choroidal metastases from breast carcinoma using aromatase inhibitors.
    The British journal of ophthalmology, 2005, Volume: 89, Issue:6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Choroid Neoplasms; Female; Humans; Nitriles; Triazoles

2005
The aromatase inhibitor anastrozole is associated with favorable embryo development and implantation markers in mice ovarian stimulation cycles.
    Fertility and sterility, 2005, Volume: 83, Issue:6

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Biomarkers; Embryonic Development; Estrous Cycle; Female; Male; Mice; Nitriles; Ovulation Induction; Triazoles

2005
Selected highlights from the 27th San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8-11 December 2004.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7

    Topics: Anastrozole; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Delivery Systems; Drug Therapy, Combination; Estradiol; Female; Fulvestrant; Gonadal Steroid Hormones; Humans; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Tamoxifen; Taxoids; Trastuzumab; Triazoles

2005
Aromatase inhibitors: cellular and molecular effects.
    The Journal of steroid biochemistry and molecular biology, 2005, Volume: 95, Issue:1-5

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; Female; Gene Expression; Humans; Ki-67 Antigen; Letrozole; Neoadjuvant Therapy; Nitriles; Oligonucleotide Array Sequence Analysis; Receptors, Progesterone; Tamoxifen; Triazoles

2005
Sperm analysis in growth hormone-deficient adolescents previously treated with an aromatase inhibitor: comparison with normal controls.
    Fertility and sterility, 2005, Volume: 84, Issue:1

    Topics: Adolescent; Adult; Anastrozole; Aromatase Inhibitors; Cohort Studies; Human Growth Hormone; Humans; Male; Nitriles; Reference Standards; Reference Values; Sperm Count; Spermatozoa; Triazoles

2005
Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer.
    The Journal of steroid biochemistry and molecular biology, 2005, Volume: 95, Issue:1-5

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Female; Gene Expression; Humans; Nitriles; Oligonucleotide Array Sequence Analysis; Triazoles

2005
Case records of the Massachusetts General Hospital. Case 24-2005. A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer.
    The New England journal of medicine, 2005, Aug-11, Volume: 353, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Diagnosis, Differential; Female; Humans; Mammography; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Nitriles; Radiotherapy, Adjuvant; Receptors, Estrogen; Sentinel Lymph Node Biopsy; Tamoxifen; Triazoles

2005
Radiotherapeutic prophylaxis of gynecomastia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-20, Volume: 23, Issue:24

    Topics: Anastrozole; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Gynecomastia; Humans; Male; Nitriles; Pain; Prostatic Neoplasms; Quality of Life; Tamoxifen; Tosyl Compounds; Triazoles

2005
Promising switch to anastrozole for breast-cancer treatment.
    The Lancet. Oncology, 2005, Volume: 6, Issue:9

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Nitriles; Triazoles

2005
[Neoadjuvant endocrine therapy with anastrozole significantly downstaged an elderly breast cancer woman with locally-advanced breast cancer which became operable].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:9

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Neoadjuvant Therapy; Nitriles; Postmenopause; Preoperative Care; Sternum; Triazoles

2005
[Aromatase inhibitors in the treatment of breast cancer: current status and some problems].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:8

    Topics: Adult; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Nitriles; Triazoles

2005
A step too far?
    The Lancet. Oncology, 2005, Volume: 6, Issue:10

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Approval; Female; Humans; Nitriles; Scotland; Triazoles; United Kingdom

2005
Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study.
    Fertility and sterility, 2005, Volume: 84, Issue:4

    Topics: Administration, Intravaginal; Adult; Anastrozole; Aromatase Inhibitors; Chi-Square Distribution; Endometriosis; Female; Humans; Nitriles; Pilot Projects; Rectal Diseases; Triazoles; Vaginal Diseases

2005
Regression of tamoxifen-stimulated massive uterine fibroid after conversion to anastrozole.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2005, Volume: 25, Issue:6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Female; Humans; Leiomyoma; Nitriles; Remission Induction; Retreatment; Tamoxifen; Triazoles; Ultrasonography; Uterine Neoplasms

2005
Durable response of metastatic endometrial carcinoma to treatment with fulvestrant (Faslodex) after prior progestin and anastrozole therapy.
    Gynecologic oncology, 2006, Volume: 100, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; Female; Fulvestrant; Humans; Lung Neoplasms; Nitriles; Progestins; Triazoles

2006
Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    The Journal of steroid biochemistry and molecular biology, 2005, Volume: 97, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Estrogen Antagonists; Humans; Inhibitory Concentration 50; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Tamoxifen; Time Factors; Triazoles

2005
Case 24-2005: a woman with estrogen-receptor-positive breast cancer.
    The New England journal of medicine, 2005, Nov-24, Volume: 353, Issue:21

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Diseases, Metabolic; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fractures, Bone; Humans; Nitriles; Receptors, Estrogen; Tamoxifen; Triazoles

2005
Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy.
    Breast (Edinburgh, Scotland), 2006, Volume: 15, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Endometrial Neoplasms; Female; Humans; Hysterectomy; Immunohistochemistry; Keratins; Mastectomy, Modified Radical; Middle Aged; Mucin-1; Nitriles; Ovariectomy; Triazoles; Ultrasonography; Vagina

2006
Anal localization as first manifestation of metastatic ductal breast carcinoma.
    Techniques in coloproctology, 2005, Volume: 9, Issue:3

    Topics: Aged; Anastrozole; Anus Neoplasms; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Colectomy; Female; Follow-Up Studies; Humans; Immunohistochemistry; Neoplasm Staging; Nitriles; Rare Diseases; Risk Assessment; Treatment Outcome; Triazoles

2005
Aromatase inhibitors in human lung cancer therapy.
    Cancer research, 2005, Dec-15, Volume: 65, Issue:24

    Topics: Anastrozole; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Carcinoma, Non-Small-Cell Lung; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoblotting; Immunoenzyme Techniques; Lung Neoplasms; Male; Mice; Mice, Nude; Nitriles; Ovariectomy; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous; Triazoles

2005
Treatment guidelines for adjuvant breast cancer are moving toward double standards: one for the rich and one for the poor.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Decision Making; Developing Countries; Disease-Free Survival; Drug Costs; Female; Humans; Nitriles; Tamoxifen; Triazoles

2005
Regulation of sexual behaviour in male macaques by sex steroid modulation of the serotonergic system.
    Experimental physiology, 2006, Volume: 91, Issue:2

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Autonomic Nervous System; Estradiol; Female; Gonadal Steroid Hormones; Macaca; Male; Nitriles; Oligopeptides; Reaction Time; Serotonin; Sexual Behavior, Animal; Triazoles; Tryptophan

2006
Influence of adjuvant anastrozole on bone mineral density in Japanese postmenopausal breast cancer patients: is there a racial difference?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:7

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Asian People; Biomarkers; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Estrogens; Female; Humans; Japan; Middle Aged; Nitriles; Postmenopause; Triazoles; White People

2006
Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer.
    Oncology, 2005, Volume: 69, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Confidence Intervals; Disease Progression; Drug Administration Schedule; Female; Humans; Letrozole; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Treatment Outcome; Triazoles

2005
Improvement in dermatomyositis rash associated with the use of antiestrogen medication.
    Archives of dermatology, 2006, Volume: 142, Issue:1

    Topics: Adult; Anastrozole; Biopsy; Breast Neoplasms; Dermatomyositis; Diagnosis, Differential; Estrogen Antagonists; Exanthema; Female; Follow-Up Studies; Glucocorticoids; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Skin; Tamoxifen; Triazoles

2006
Anastrozole called breast cancer "lifesaver". Recipients showed a 40 percent decrease in relapse risk when switched to anastrazole after tamoxifen.
    Health news (Waltham, Mass.), 2005, Volume: 11, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Tamoxifen; Triazoles

2005
Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.
    Journal of the National Cancer Institute, 2006, Jan-18, Volume: 98, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Europe; Female; Humans; Letrozole; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Survival Analysis; Survival Rate; Treatment Outcome; Triazoles

2006
Effects of decreased estradiol-17beta on the serum and anterior pituitary IGF-I system in pigs.
    The Journal of endocrinology, 2005, Volume: 187, Issue:3

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Blotting, Western; Estradiol; Female; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor I; Male; Nitriles; Pituitary Gland, Anterior; Pituitary Hormones, Anterior; Swine; Testosterone; Triazoles

2005
Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor.
    European journal of endocrinology, 2006, Volume: 154, Issue:2

    Topics: Anastrozole; Anti-Mullerian Hormone; Aromatase Inhibitors; Child; DNA; Female; Glycoproteins; Gynecomastia; Humans; Inhibins; Longitudinal Studies; Male; Nitriles; Pedigree; Penetrance; Peutz-Jeghers Syndrome; Sequence Analysis, DNA; Sertoli Cell Tumor; Testicular Hormones; Triazoles

2006
Photodynamic therapy for solitary retinal metastasis from breast carcinoma.
    Eye (London, England), 2006, Volume: 20, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Middle Aged; Nitriles; Photochemotherapy; Retinal Neoplasms; Triazoles

2006
[Advance and current status of exemestane and androstadienes in the treatment of breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:12

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Nitriles; Postmenopause; Triazoles

2005
Changing the gold standard in adjuvant therapy for breast cancer:from tamoxifen to aromatase inhibition.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2005, Volume: 59 Suppl 2

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Tamoxifen; Triazoles

2005
Does survival increase in metastatic breast cancer with recently available anticancer drugs?
    Oncology research, 2006, Volume: 15, Issue:9

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Neoplasm Metastasis; Nitriles; Retrospective Studies; Survival Analysis; Tamoxifen; Triazoles

2006
Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2006, Volume: 14, Issue:9

    Topics: Analysis of Variance; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Canada; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Disease-Free Survival; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Sensitivity and Specificity; Survival Rate; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2006
[Advances in the treatment of breast carcinoma. New therapy schedules with astonishing success quotas].
    MMW Fortschritte der Medizin, 2006, Mar-23, Volume: 148, Issue:12

    Topics: Age Factors; Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Aromatase Inhibitors; Breast Neoplasms; Docetaxel; Female; Humans; Mammography; Meta-Analysis as Topic; Middle Aged; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Risk; Tamoxifen; Taxoids; Time Factors; Trastuzumab; Triazoles

2006
Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis.
    Breast cancer research and treatment, 2006, Volume: 100, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Renal Dialysis; Tamoxifen; Triazoles

2006
Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry.
    Rapid communications in mass spectrometry : RCM, 2006, Volume: 20, Issue:12

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Humans; Male; Nitriles; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tandem Mass Spectrometry; Triazoles

2006
Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jun-01, Volume: 24, Issue:16

    Topics: Adult; Amenorrhea; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Estrogen Receptor Modulators; Female; Follicle Stimulating Hormone; Humans; Letrozole; Luteinizing Hormone; Middle Aged; Neoplasm Staging; Nitriles; Ovariectomy; Practice Guidelines as Topic; Tamoxifen; Triazoles

2006
Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:5

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Computer Simulation; Cost-Benefit Analysis; Estrogen Antagonists; Estrogens; Fees, Pharmaceutical; Female; Follow-Up Studies; Humans; Letrozole; Markov Chains; Middle Aged; Models, Theoretical; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Receptors, Estrogen; Tamoxifen; Triazoles

2006
Primary hormone treatment in postmenopausal women with breast cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:5

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Contraindications; Estrogens; Female; Humans; Letrozole; Mastectomy; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Radiography; Receptors, Estrogen; Triazoles

2006
Estrogen receptors: role in breast cancer.
    Critical reviews in clinical laboratory sciences, 2006, Volume: 43, Issue:4

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Gene Expression Regulation, Neoplastic; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Letrozole; Models, Biological; Nitriles; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2006
Management of choroidal metastases from breast carcinomas using aromatase inhibitors.
    Current opinion in ophthalmology, 2006, Volume: 17, Issue:3

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Choroid Neoplasms; Combined Modality Therapy; Female; Humans; Letrozole; Mastectomy, Radical; Mastectomy, Segmental; Mastectomy, Simple; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2006
Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial.
    Cancer, 2006, Aug-01, Volume: 107, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Nitriles; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Tamoxifen; Treatment Outcome; Triazoles

2006
Leuprolide acetate plus aromatase inhibition for male breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jul-20, Volume: 24, Issue:21

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Humans; Letrozole; Leuprolide; Lung Neoplasms; Lymphatic Metastasis; Male; Mastectomy, Modified Radical; Middle Aged; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome; Triazoles

2006
Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases.
    Gynecologic oncology, 2006, Volume: 103, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Female; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Ovarian Neoplasms; Triazoles

2006
Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole.
    Breast cancer research and treatment, 2007, Volume: 101, Issue:3

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Disease-Free Survival; Drug Administration Schedule; Drug Costs; Female; Humans; Markov Chains; Middle Aged; Models, Economic; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Quality-Adjusted Life Years; Tamoxifen; Treatment Outcome; Triazoles; United States

2007
Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: a Slovenian perspective.
    Anti-cancer drugs, 2006, Volume: 17, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cost-Benefit Analysis; Decision Trees; Disease-Free Survival; Economics, Pharmaceutical; Humans; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Slovenia; Tamoxifen; Treatment Outcome; Triazoles

2006
Joint symptoms: a practical problem of anastrozole.
    Breast cancer (Tokyo, Japan), 2006, Volume: 13, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Interviews as Topic; Joint Diseases; Middle Aged; Nitriles; Postmenopause; Triazoles

2006
[Unclear about anastrozole and cancer treatment].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006, Aug-24, Volume: 126, Issue:16

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Drug Prescriptions; Humans; Nitriles; Norway; Reimbursement Mechanisms; Triazoles

2006
Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole.
    The Journal of pediatrics, 2006, Volume: 149, Issue:3

    Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Child; Child, Preschool; Humans; Male; Mutation; Nitriles; Puberty, Precocious; Receptors, LH; Tosyl Compounds; Triazoles

2006
Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    Anti-cancer drugs, 2006, Volume: 17, Issue:8

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Ovariectomy; Ovary; Premenopause; Receptors, Steroid; Triazoles

2006
Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor-positive early breast cancer. Analysis based on the ATAC trial.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2006, Volume: 16 Suppl 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Canada; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Disease-Free Survival; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Quality-Adjusted Life Years; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Survival Rate; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2006
Anastrozole improved testosterone-induced impairment acquisition of spatial learning and memory in the hippocampal CA1 region in adult male rats.
    Behavioural brain research, 2006, Dec-15, Volume: 175, Issue:2

    Topics: Analysis of Variance; Anastrozole; Animals; Aromatase Inhibitors; Discrimination Learning; Escape Reaction; Estradiol; Hippocampus; Male; Maze Learning; Memory Disorders; Microinjections; Nitriles; Rats; Rats, Wistar; Reaction Time; Spatial Behavior; Statistics, Nonparametric; Testosterone; Triazoles

2006
Formulation of anastrozole microparticles as biodegradable anticancer drug carriers.
    AAPS PharmSciTech, 2006, Jul-21, Volume: 7, Issue:3

    Topics: Anastrozole; Antineoplastic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Lactic Acid; Nitriles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Triazoles

2006
Anastrozole-induced hepatotoxicity.
    European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:11

    Topics: Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Lobular; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Diseases; Liver Function Tests; Nausea; Nitriles; Triazoles

2006
Aromatase inhibitors and bipolar mood disorder: a case report.
    Bipolar disorders, 2006, Volume: 8, Issue:5 Pt 1

    Topics: Aggression; Anastrozole; Aromatase Inhibitors; Bipolar Disorder; Breast Neoplasms; Carcinoma, Lobular; Chemotherapy, Adjuvant; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Irritable Mood; Letrozole; Middle Aged; Nitriles; Substance Withdrawal Syndrome; Triazoles

2006
Henoch-Schönlein purpura (HSP) during treatment with anastrozole.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; IgA Vasculitis; Nitriles; Triazoles

2007
Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Humans; Markov Chains; Middle Aged; Models, Economic; Nitriles; Postmenopause; Quality of Life; Quality-Adjusted Life Years; Tamoxifen; Treatment Outcome; Triazoles

2007
Clinically occult cutaneous metastases.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing

2006
Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
    Journal of neurochemistry, 2007, Volume: 100, Issue:3

    Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Cell Survival; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Resistance; Estrogens; Female; Male; Nerve Degeneration; Neural Pathways; Neuronal Plasticity; Neurotoxins; Nitriles; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Sex Characteristics; Substantia Nigra; Triazoles

2007
Liver toxicity after treatment with gefitinib and anastrozole: drug-drug interactions through cytochrome p450?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Dec-10, Volume: 24, Issue:35

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Gefitinib; Humans; Isoenzymes; Lymphatic Metastasis; Middle Aged; Nitriles; Quinazolines; Triazoles

2006
Impact of aromatase inhibitors on adhesion formation in a rat model.
    Fertility and sterility, 2007, Volume: 87, Issue:4

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Cytokines; Disease Models, Animal; Female; Medroxyprogesterone Acetate; Nitriles; Postoperative Complications; Rats; Rats, Wistar; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tissue Adhesions; Triazoles; Uterine Diseases; Uterus

2007
Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole.
    Breast (Edinburgh, Scotland), 2007, Volume: 16, Issue:3

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Belgium; Breast Neoplasms; Canada; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Drug Costs; Female; Humans; Letrozole; Markov Chains; Middle Aged; Nitriles; Postmenopause; Proportional Hazards Models; Quality-Adjusted Life Years; Tamoxifen; Triazoles

2007
Severe acute hepatitis in a patient treated with anastrozole.
    Lancet (London, England), 2007, Jan-06, Volume: 369, Issue:9555

    Topics: Anastrozole; Aromatase Inhibitors; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Humans; Middle Aged; Nitriles; Triazoles

2007
[Two patients having recurrent breast cancer with brain metastases well controlled with a gamma knife radio-surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:12

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Female; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy; Middle Aged; Nitriles; Paclitaxel; Pleurisy; Pleurodesis; Radiosurgery; Triazoles

2006
[Locally advanced breast cancer with a good response to sequential endocrine monotherapy--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1

    Topics: Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Humans; Nitriles; Remission Induction; Tamoxifen; Triazoles

2007
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
    Journal of the National Cancer Institute, 2007, Jan-17, Volume: 99, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Humans; Ki-67 Antigen; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Receptors, Estrogen; Sample Size; Tamoxifen; Triazoles

2007
Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photospray tandem mass spectrometry applied to pharmacokinetic studies.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, May-01, Volume: 850, Issue:1-2

    Topics: Anastrozole; Aromatase Inhibitors; Calibration; Chromatography, High Pressure Liquid; Humans; Nitriles; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Triazoles

2007
Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone
    Breast cancer research and treatment, 2007, Volume: 106, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Drug Costs; Female; Health Services Research; Humans; Markov Chains; Middle Aged; Nitriles; Postmenopause; Quality-Adjusted Life Years; Tamoxifen; Triazoles; United Kingdom; United States

2007
Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors.
    Breast cancer research and treatment, 2007, Volume: 106, Issue:2

    Topics: Adult; Aged; Amenorrhea; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Female; Humans; Lasers; Middle Aged; Nitriles; Ophthalmoscopy; Optic Disk; Selective Estrogen Receptor Modulators; Survival Rate; Survivors; Tamoxifen; Triazoles; Visual Acuity

2007
Potential benefit of maintenance trastuzumab and anastrozole therapy in male advanced breast cancer.
    Breast (Edinburgh, Scotland), 2007, Volume: 16, Issue:3

    Topics: Adult; Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms, Male; Humans; Male; Nitriles; Receptor, ErbB-2; Receptors, Estrogen; Trastuzumab; Triazoles

2007
t(8;16) AML developed subsequent to breast cancer therapy.
    Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Estrogens; Fatal Outcome; Female; Fluorouracil; Humans; Idarubicin; Leukemia, Myelomonocytic, Acute; Mastectomy, Modified Radical; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nitriles; Radiotherapy, Adjuvant; Translocation, Genetic; Triazoles

2006
Unusual macular degeneration following breast cancer.
    Acta ophthalmologica Scandinavica, 2007, Volume: 85, Issue:6

    Topics: Adenocarcinoma; Anastrozole; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Choroid Neoplasms; Female; Humans; Lymphatic Metastasis; Macular Degeneration; Mastectomy, Radical; Middle Aged; Nitriles; Technetium; Tomography, X-Ray Computed; Triazoles

2007
[A case of advanced breast cancer with multiple liver metastases resistant to chemotherapy responding to high-dose toremifene].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Middle Aged; Nitriles; Quality of Life; Remission Induction; Toremifene; Triazoles

2007
A case of porphyria cutanea tarda resulting in digital amputation and improved by anastrazole.
    Clinical and experimental dermatology, 2007, Volume: 32, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Fingers; Hand Dermatoses; Humans; Lymphoma, B-Cell; Middle Aged; Nitriles; Porphyria Cutanea Tarda; Treatment Outcome; Triazoles

2007
[Clinical study of aromatase inhibitors in advanced breast cancer].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2007, Apr-18, Volume: 39, Issue:2

    Topics: Adult; Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles

2007
Patients' knowledge and experience of adjuvant endocrine therapy for early breast cancer: a European study.
    Breast (Edinburgh, Scotland), 2007, Volume: 16, Issue:5

    Topics: Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Communication Barriers; Decision Making; Europe; Female; Health Knowledge, Attitudes, Practice; Humans; Letrozole; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Selective Estrogen Receptor Modulators; Surveys and Questionnaires; Tamoxifen; Triazoles

2007
Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients.
    Cancer investigation, 2007, Volume: 25, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles

2007
Parotid gland metastasis of a breast cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007, Volume: 9, Issue:4

    Topics: Anastrozole; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Humans; Immunohistochemistry; Mastectomy, Radical; Middle Aged; Nitriles; Parotid Gland; Parotid Neoplasms; Receptors, Estrogen; Time Factors; Treatment Outcome; Triazoles

2007
Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.
    Current medical research and opinion, 2007, Volume: 23, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colles' Fracture; Female; Fractures, Bone; Humans; Middle Aged; Nitriles; Postmenopause; Risk Assessment; Tamoxifen; Triazoles; Wrist Injuries

2007
Optimal use of aromatase inhibitors: to lead or to follow?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jul-01, Volume: 25, Issue:19

    Topics: Aged; Alleles; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Humans; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Recurrence; Tamoxifen; Treatment Outcome; Triazoles

2007
Bone density in breast cancer: when to intervene?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-01, Volume: 25, Issue:22

    Topics: Absorptiometry, Photon; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Goserelin; Humans; Imidazoles; Nitriles; Osteoporosis; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles; Zoledronic Acid

2007
Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2008, Volume: 9, Issue:2

    Topics: Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cost-Benefit Analysis; Female; Humans; Letrozole; Markov Chains; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Quality of Life; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles; United Kingdom

2008
Nanomolar concentrations of anabolic-androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures.
    Brain research, 2007, Aug-24, Volume: 1165

    Topics: Anastrozole; Androgen Antagonists; Androgens; Animals; Aromatase Inhibitors; Cell Death; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Female; Flutamide; L-Lactate Dehydrogenase; Mice; N-Methylaspartate; Neuroglia; Neurons; Nitriles; Pregnancy; Testosterone; Triazoles

2007
Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor.
    Obstetrics and gynecology, 2007, Volume: 110, Issue:2 Pt 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Combined Modality Therapy; Female; Humans; Hysterectomy; Immunohistochemistry; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Nitriles; Remission Induction; Treatment Outcome; Triazoles; Uterine Neoplasms

2007
Enhancement of the antitumor activity of tamoxifen and anastrozole by the farnesyltransferase inhibitor lonafarnib (SCH66336).
    Anti-cancer drugs, 2007, Volume: 18, Issue:8

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Apoptosis; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Synergism; Enzyme Inhibitors; Farnesyltranstransferase; Female; G1 Phase; Humans; In Situ Nick-End Labeling; Mice; Mice, Nude; Neoplasm Transplantation; Nitriles; Ovariectomy; Piperidines; Pyridines; S Phase; Tamoxifen; Triazoles

2007
Severe disabling tendinopathy caused by anastrazole.
    Rheumatology (Oxford, England), 2007, Volume: 46, Issue:10

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Female; Humans; Middle Aged; Nitriles; Tendinopathy; Triazoles; Wrist Joint

2007
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
    Organic & biomolecular chemistry, 2007, Sep-21, Volume: 5, Issue:18

    Topics: Anastrozole; Aromatase Inhibitors; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Models, Molecular; Nitriles; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Sulfatases; Triazoles

2007
Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients.
    The journal of obstetrics and gynaecology research, 2007, Volume: 33, Issue:5

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Drug Interactions; Etidronic Acid; Female; Humans; Middle Aged; Nitriles; Osteoporosis; Postmenopause; Risedronic Acid; Triazoles

2007
Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management.
    Joint bone spine, 2007, Volume: 74, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Nitriles; Postmenopause; Triazoles

2007
Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome.
    The Journal of rheumatology, 2007, Volume: 34, Issue:11

    Topics: Aged; Anastrozole; Antibodies, Antinuclear; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Chemotherapy, Adjuvant; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Nitriles; Sjogren's Syndrome; Tamoxifen; Triazoles

2007
Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2007, Volume: 23, Issue:10

    Topics: Amino Acids; Anastrozole; Animals; Aromatase Inhibitors; Bone Density; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Female; Letrozole; Nitriles; Osteocalcin; Rats; Testosterone; Triazoles

2007
Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2007, Volume: 85, Issue:3

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Estrogen Antagonists; Female; Humans; Middle Aged; Nitriles; Postmenopause; Radiotherapy Dosage; Retrospective Studies; Tamoxifen; Treatment Outcome; Triazoles

2007
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
    Organic & biomolecular chemistry, 2007, Oct-21, Volume: 5, Issue:20

    Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Molecular Conformation; Nitriles; Rats; Rats, Wistar; Structure-Activity Relationship; Sulfatases; Triazoles

2007
Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
    The Journal of reproductive medicine, 2007, Volume: 52, Issue:10

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Endometrial Hyperplasia; Female; Humans; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles; Uterine Hemorrhage

2007
Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer.
    International journal of radiation oncology, biology, physics, 2007, Dec-01, Volume: 69, Issue:5

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Mastectomy, Segmental; Neoplasm Recurrence, Local; Nitriles; Tamoxifen; Triazoles

2007
New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
    Bioorganic & medicinal chemistry, 2008, Feb-01, Volume: 16, Issue:3

    Topics: Anastrozole; Aromatase Inhibitors; Benzene; Cyclization; Flavanones; Humans; Hydrogen Bonding; Letrozole; Microsomes; Molecular Structure; Nitriles; Structure-Activity Relationship; Triazoles

2008
[Solitary oesophageal metastasis of breast cancer after 17 years latency].
    Magyar sebeszet, 2007, Volume: 60, Issue:6

    Topics: Adenocarcinoma; Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Chemotherapy, Adjuvant; Deglutition; Esophageal Neoplasms; Esophagus; Fatal Outcome; Female; Humans; Intubation; Middle Aged; Minimally Invasive Surgical Procedures; Nitriles; Palliative Care; Radiotherapy, Adjuvant; Thoracotomy; Tomography, X-Ray Computed; Treatment Outcome; Triazoles

2007
Anastrozole-induced subacute cutaneous lupus erythematosus.
    The British journal of dermatology, 2008, Volume: 158, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Female; Humans; Lupus Erythematosus, Cutaneous; Nitriles; Treatment Outcome; Triazoles

2008
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
    Cancer, 2008, Feb-01, Volume: 112, Issue:3 Suppl

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles

2008
Extended adjuvant therapy for breast cancer--how much is enough?
    Journal of the National Cancer Institute, 2007, Dec-19, Volume: 99, Issue:24

    Topics: Aminoglutethimide; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Austria; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome; Triazoles

2007
Long-term outcomes of aromatase inhibition for breast cancer.
    The Lancet. Oncology, 2008, Volume: 9, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Female; Follow-Up Studies; Fractures, Bone; Humans; Nitriles; Postmenopause; Survival Analysis; Tamoxifen; Time Factors; Triazoles

2008
The effects of anastrozole on neonatal rat skin.
    European journal of gynaecological oncology, 2007, Volume: 28, Issue:6

    Topics: Anastrozole; Animals; Animals, Newborn; Aromatase Inhibitors; Female; Nitriles; Rats; Rats, Sprague-Dawley; Skin; Triazoles

2007
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Feb-01, Volume: 26, Issue:4

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Prescriptions; Female; Humans; Longitudinal Studies; Middle Aged; Neoplasm Staging; Nitriles; Patient Compliance; Triazoles

2008
Erythema multiforme after radiotherapy with aromatase inhibitor administration in breast-conservation treatment for breast cancer.
    Breast cancer (Tokyo, Japan), 2008, Volume: 15, Issue:4

    Topics: Administration, Oral; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Erythema Multiforme; Female; Humans; Middle Aged; Nitriles; Radiotherapy; Triazoles

2008
[Efficacy of sequential treatment with anastrozole following exemestane compared with exemestane following anastrozole in patients with metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Retrospective Studies; Survival Rate; Triazoles

2008
Anticancer therapy in patients with porphyrias: evidence today.
    Expert opinion on drug safety, 2008, Volume: 7, Issue:2

    Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Docetaxel; Epoetin Alfa; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Hematinics; Humans; Letrozole; Middle Aged; Nitriles; Porphyria, Acute Intermittent; Porphyria, Variegate; Recombinant Proteins; Risk Assessment; Taxoids; Triazoles; Uterine Neoplasms

2008
Controversies in endocrine treatment: effective utilization of steroidal and nonsteroidal aromatase inhibitors: now and in the future. Forward.
    Anti-cancer drugs, 2008, Volume: 19 Suppl 2

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles

2008
Inappropriate ATAC on tamoxifen.
    The Lancet. Oncology, 2008, Volume: 9, Issue:4

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Risk Assessment; Survival Analysis; Tamoxifen; Time Factors; Triazoles

2008
Inappropriate ATAC on tamoxifen.
    The Lancet. Oncology, 2008, Volume: 9, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiovascular Diseases; Female; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Prognosis; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2008
Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report.
    Archives of gynecology and obstetrics, 2009, Volume: 279, Issue:1

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Disease-Free Survival; Endometrial Neoplasms; Female; Goserelin; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Nitriles; Sarcoma, Endometrial Stromal; Triazoles

2009
Process analytical technology: non-destructive assessment of anastrozole entrapment within PLGA microparticles by near infrared spectroscopy and chemical imaging.
    Journal of microencapsulation, 2008, Volume: 25, Issue:3

    Topics: Algorithms; Anastrozole; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Models, Chemical; Models, Statistical; Multivariate Analysis; Nitriles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectroscopy, Near-Infrared; Technology, Pharmaceutical; Triazoles

2008
The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:7

    Topics: Anastrozole; Aromatase Inhibitors; Child; Child, Preschool; Female; Fibrous Dysplasia, Polyostotic; Humans; Nitriles; Prospective Studies; Puberty, Precocious; Triazoles; Uterine Hemorrhage

2008
[A case of elderly breast cancer achieving partial response by letrozole with stable disease to anastrozole as neoadjuvant endocrine therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:4

    Topics: Aged, 80 and over; Anastrozole; Breast Neoplasms; Endocrine System; Female; Humans; Letrozole; Neoadjuvant Therapy; Nitriles; Postmenopause; Tomography, X-Ray Computed; Triazoles; Ultrasonography

2008
Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model.
    Cancer research, 2008, May-01, Volume: 68, Issue:9

    Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Proliferation; Estradiol; Female; Fulvestrant; Humans; Mice; Mice, Nude; Nitriles; Organ Size; Ovariectomy; Receptors, Growth Factor; Signal Transduction; Triazoles; Tumor Burden; Tumor Cells, Cultured; Uterus; Xenograft Model Antitumor Assays

2008
Retinal hemorrhages in anastrozole users.
    Optometry and vision science : official publication of the American Academy of Optometry, 2008, Volume: 85, Issue:5

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Female; Fluorescein Angiography; Humans; Middle Aged; Nitriles; Patient Selection; Retinal Hemorrhage; Retrospective Studies; Tamoxifen; Tomography, Optical Coherence; Triazoles

2008
Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.
    Oncology, 2007, Volume: 73, Issue:5-6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Atrophy; Breast Neoplasms; Fatal Outcome; Female; Glomerulosclerosis, Focal Segmental; Humans; Inflammation; Nitriles; Triazoles

2007
Is long-term adjuvant treatment of breast cancer with anastrozole indicated?
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Female; Humans; Nitriles; Time Factors; Triazoles

2008
Treatment of male infertility secondary to morbid obesity.
    Nature clinical practice. Endocrinology & metabolism, 2008, Volume: 4, Issue:7

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Follicle Stimulating Hormone; Humans; Hypogonadism; Infertility, Male; Luteinizing Hormone; Male; Nitriles; Obesity, Morbid; Spermatogenesis; Testosterone; Triazoles

2008
A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole.
    Archives of gynecology and obstetrics, 2009, Volume: 279, Issue:2

    Topics: Anastrozole; Aromatase Inhibitors; Fallopian Tubes; Female; Humans; Hysterectomy; Leiomyoma; Lung Neoplasms; Middle Aged; Nitriles; Ovariectomy; Triazoles; Uterine Neoplasms

2009
[Intensification of a diffuse chronic pain syndrome by the introduction of an aromatase inhibitor].
    Praxis, 2008, Feb-06, Volume: 97, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Fibromyalgia; Humans; Mastectomy; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2008
Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole.
    American journal of obstetrics and gynecology, 2008, Volume: 199, Issue:3

    Topics: Adenocarcinoma; Anastrozole; Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Receptors, Estrogen; Tomography, X-Ray Computed; Triazoles

2008
MCF-7aro/ERE, a novel cell line for rapid screening of aromatase inhibitors, ERalpha ligands and ERRalpha ligands.
    Biochemical pharmacology, 2008, Jul-15, Volume: 76, Issue:2

    Topics: Anastrozole; Aromatase Inhibitors; Biological Assay; Cell Line, Tumor; Coumarins; ERRalpha Estrogen-Related Receptor; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Fulvestrant; Genes, Reporter; Genistein; Humans; Letrozole; Ligands; Luciferases; Nitriles; Receptors, Estrogen; Response Elements; Tamoxifen; Thiazoles; Transfection; Triazoles

2008
Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor.
    Fertility and sterility, 2008, Volume: 90, Issue:5

    Topics: Anastrozole; Aromatase Inhibitors; Disease Progression; Endometriosis; Female; Humans; Kidney Function Tests; Middle Aged; Nitriles; Severity of Illness Index; Stents; Treatment Failure; Triazoles; Ureteral Diseases; Ureteral Obstruction; Urologic Surgical Procedures

2008
Cutaneous vasculitis in breast cancer treated with chemotherapy.
    Clinical immunology (Orlando, Fla.), 2008, Volume: 129, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Female; Humans; Middle Aged; Nitriles; Paraneoplastic Syndromes; Skin Diseases, Vascular; Tamoxifen; Triazoles; Vasculitis

2008
[Extended adjuvant hormone therapy (in breast cancer): Why? To whom? What? How long?].
    Magyar onkologia, 2008, Volume: 52, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Estrogen Receptor Modulators; Female; Humans; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Time Factors; Triazoles

2008
Development and validation of an improved high-throughput method for the determination of anastrozole in human plasma by LC-MS/MS and atmospheric pressure chemical ionization.
    Journal of pharmaceutical and biomedical analysis, 2008, Nov-04, Volume: 48, Issue:3

    Topics: Acetonitriles; Anastrozole; Area Under Curve; Aromatase Inhibitors; Atmospheric Pressure; Chromatography, Liquid; Half-Life; Humans; Male; Methyl Ethers; Nitriles; Omeprazole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solvents; Spectrometry, Mass, Electrospray Ionization; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Time Factors; Triazoles

2008
Successful management of a leiomyomatosis peritonealis disseminata with an aromatase inhibitor.
    Obstetrics and gynecology, 2008, Volume: 112, Issue:2 Pt 2

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Female; Humans; Leiomyomatosis; Nitriles; Peritoneal Cavity; Postmenopause; Triazoles

2008
Characterization of the weak estrogen receptor alpha agonistic activity of exemestane.
    Breast cancer research and treatment, 2009, Volume: 116, Issue:3

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Profiling; Humans; Microarray Analysis; Nitriles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles; Tumor Cells, Cultured

2009
Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.
    The Lancet. Oncology, 2008, Volume: 9, Issue:9

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthritis; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Drug Interactions; Female; Humans; Joint Diseases; Likelihood Functions; Logistic Models; Middle Aged; Multivariate Analysis; Nitriles; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tamoxifen; Triazoles

2008
Vitreo-retinal traction and anastrozole use.
    Breast cancer research and treatment, 2009, Volume: 117, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fovea Centralis; Humans; Middle Aged; Nitriles; Tamoxifen; Tomography, Optical Coherence; Triazoles

2009
Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2008, Volume: 14, Issue:3

    Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Nitriles; Osteoporosis; Retrospective Studies; Triazoles

2008
Clinical trial presentations, agency guidelines, and oncology practice: findings from the arimidex, tamoxifen, alone or in combination trial.
    Clinical breast cancer, 2008, Volume: 8, Issue:4

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Nitriles; Practice Guidelines as Topic; Tamoxifen; Triazoles

2008
IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole.
    Expert review of anticancer therapy, 2008, Volume: 8, Issue:9

    Topics: Adult; Aged; Anastrozole; Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Double-Blind Method; Etidronic Acid; Female; Humans; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Nitriles; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Risedronic Acid; Triazoles

2008
Encapsulation and extended release of anti-cancer anastrozole by stealth nanoparticles.
    Drug delivery, 2008, Volume: 15, Issue:5

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Delayed-Action Preparations; Dendrimers; Drug Carriers; Nanoparticles; Nitriles; Particle Size; Polyamines; Polyethylene Glycols; Solubility; Surface Properties; Triazoles

2008
Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
    Journal of the National Cancer Institute, 2008, Sep-17, Volume: 100, Issue:18

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cytochrome P-450 CYP2D6; Estrogen Receptor Modulators; Female; Humans; Markov Chains; Middle Aged; Nitriles; Postmenopause; Tamoxifen; Triazoles

2008
Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
    Journal of the National Cancer Institute, 2008, Sep-17, Volume: 100, Issue:18

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Asian People; Breast Neoplasms; Chemotherapy, Adjuvant; Cytochrome P-450 CYP2D6; Decision Making; Disease-Free Survival; Estrogen Receptor Modulators; Female; Genotype; Humans; Markov Chains; Middle Aged; Nitriles; Patient Participation; Postmenopause; Tamoxifen; Triazoles

2008
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Journal of the National Cancer Institute, 2008, Oct-01, Volume: 100, Issue:19

    Topics: Aged; Analysis of Variance; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Letrozole; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Postmenopause; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Receptors, Estrogen; Reproducibility of Results; Risk Assessment; Risk Factors; Tamoxifen; Treatment Outcome; Triazoles

2008
Primary uterine rhabdomyosarcoma in a patient with a history of breast cancer and gastrointestinal stromal tumor.
    The journal of obstetrics and gynaecology research, 2008, Volume: 34, Issue:4 Pt 2

    Topics: Aged; Anastrozole; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Gastrointestinal Stromal Tumors; Humans; Neoplasms, Second Primary; Nitriles; Rhabdomyosarcoma, Embryonal; Stomach; Triazoles; Uterine Neoplasms; Uterus

2008
[A case of recurrent breast cancer with multiple lung metastases responding to anastrozole monotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:10

    Topics: Anastrozole; Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Radiography; Triazoles

2008
Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial.
    The Lancet. Oncology, 2008, Volume: 9, Issue:12

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Arthralgia; Biomarkers, Tumor; Breast Neoplasms; Female; Hot Flashes; Humans; Joints; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Postmenopause; Predictive Value of Tests; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen; Treatment Outcome; Triazoles; Vasomotor System

2008
A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial.
    American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Genital Diseases, Female; Humans; Neoplasms, Hormone-Dependent; Nitriles; Retrospective Studies; Tamoxifen; Triazoles

2009
Effects of 17beta-estradiol on rat urinary bladder: gender differences in anoxia-glucopenia and reperfusion damage.
    Neurourology and urodynamics, 2009, Volume: 28, Issue:6

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Glucose; Hypoxia; In Vitro Techniques; Injections, Subcutaneous; Male; Muscle Contraction; Neuroprotective Agents; Nitriles; Rats; Rats, Wistar; Reperfusion Injury; Sex Factors; Testosterone; Time Factors; Triazoles; Urinary Bladder; Urinary Bladder Diseases

2009
Anastrozole: brain draining or sparing?
    The Lancet. Oncology, 2008, Volume: 9, Issue:10

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Attention; Breast Neoplasms; Cognition; Humans; Memory; Nitriles; Postmenopause; Triazoles

2008
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
    Psycho-oncology, 2009, Volume: 18, Issue:8

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Disorders; Female; Follow-Up Studies; Humans; Mental Recall; Middle Aged; Neoplasms, Hormone-Dependent; Neuropsychological Tests; Nitriles; Prospective Studies; Psychometrics; Reaction Time; Receptors, Estrogen; Tamoxifen; Triazoles

2009
A paraneoplastic manifestation of metastatic breast cancer responding to endocrine therapy: a case report.
    World journal of surgical oncology, 2008, Dec-16, Volume: 6

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Creatine Kinase; Female; Humans; Immunoglobulin G; Middle Aged; Neoplasm Metastasis; Nitriles; Paraneoplastic Syndromes; Triazoles

2008
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Nitriles; Patient Compliance; Postmenopause; Tamoxifen; Triazoles

2009
Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
    Journal of pediatric endocrinology & metabolism : JPEM, 2008, Volume: 21, Issue:10

    Topics: Anastrozole; Androgen Antagonists; Aromatase Inhibitors; Body Height; Child, Preschool; Cyproterone Acetate; Humans; Infant; Male; Mutation; Nitriles; Puberty, Precocious; Receptors, LH; Treatment Outcome; Triazoles

2008
Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.
    European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 143, Issue:2

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Chronic Disease; Dose-Response Relationship, Drug; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Letrozole; Luteinizing Hormone; Nitriles; Pelvic Pain; Premenopause; Treatment Outcome; Triazoles; Uterine Diseases

2009
Side effects of anastrozole in the experimental pre-menopausal mammary carcinogenesis.
    Neoplasma, 2009, Volume: 56, Issue:2

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitriles; Rats; Rats, Sprague-Dawley; Triazoles; Uterus; Vagina

2009
Mean platelet volume increase after tamoxifen, but not after anastrazole in adjuvant therapy of breast cancer.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:2

    Topics: Adult; Aged; Anastrozole; Blood Platelets; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Nitriles; Platelet Count; Retrospective Studies; Tamoxifen; Triazoles

2010
Collaborative work on evaluation of ovarian toxicity. 8) Two- or four-week repeated-dose studies and fertility study of Anastrozole in female rats.
    The Journal of toxicological sciences, 2009, Volume: 34 Suppl 1

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Corpus Luteum; Drug Administration Schedule; Estrous Cycle; Female; Fertility; Japan; Male; Nitriles; Organ Size; Ovarian Follicle; Ovary; Pregnancy; Public-Private Sector Partnerships; Rats; Rats, Inbred F344; Societies, Scientific; Specific Pathogen-Free Organisms; Toxicity Tests; Triazoles; Uterus

2009
Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma.
    Current medical research and opinion, 2009, Volume: 25, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Carcinoma; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Letrozole; Middle Aged; Neoplasm Metastasis; Nitriles; Organ Size; Retrospective Studies; Time Factors; Triazoles

2009
Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
    Breast (Edinburgh, Scotland), 2009, Volume: 18, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Staging; Nitriles; Retrospective Studies; Tamoxifen; Treatment Outcome; Triazoles

2009
[A case of metastatic breast cancer resistant to anastrozole treatment responding to high-dose toremifene].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:4

    Topics: Anastrozole; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Middle Aged; Nitriles; Tomography, X-Ray Computed; Toremifene; Triazoles

2009
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10

    Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzodioxoles; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; CSK Tyrosine-Protein Kinase; Cyclin-Dependent Kinase Inhibitor p27; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Nitriles; Phosphatidylinositol 3-Kinases; Protein-Tyrosine Kinases; Quinazolines; Signal Transduction; src-Family Kinases; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays

2009
[Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:5

    Topics: Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Hormone Replacement Therapy; Humans; Lymphatic Metastasis; Nitriles; Pleural Neoplasms; Radiography; Recurrence; Skin Neoplasms; Tamoxifen; Tegafur; Time Factors; Triazoles; Uracil

2009
Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:8

    Topics: Adolescent; Anastrozole; Aromatase Inhibitors; Breast; Child; Gynecomastia; Humans; Male; Nitriles; Puberty; Triazoles

2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    The New England journal of medicine, 2009, May-28, Volume: 360, Issue:22

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Data Interpretation, Statistical; Diphosphonates; Disease-Free Survival; Drug Therapy, Combination; Female; Goserelin; Humans; Imidazoles; Nitriles; Premenopause; Tamoxifen; Triazoles; Zoledronic Acid

2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    The New England journal of medicine, 2009, May-28, Volume: 360, Issue:22

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Disease-Free Survival; Drug Therapy, Combination; Female; Goserelin; Humans; Imidazoles; Nitriles; Premenopause; Tamoxifen; Triazoles; Zoledronic Acid

2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    The New England journal of medicine, 2009, May-28, Volume: 360, Issue:22

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Therapy, Combination; Female; Goserelin; Humans; Nitriles; Premenopause; Tamoxifen; Triazoles

2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    The New England journal of medicine, 2009, May-28, Volume: 360, Issue:22

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Confidence Intervals; Diphosphonates; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Imidazoles; Nitriles; Premenopause; Tamoxifen; Triazoles; Zoledronic Acid

2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    The New England journal of medicine, 2009, May-28, Volume: 360, Issue:22

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Nitriles; Premenopause; Triazoles; Vitamin D; Vitamins; Zoledronic Acid

2009
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    The New England journal of medicine, 2009, May-28, Volume: 360, Issue:22

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Diphosphonates; Disease-Free Survival; Drug Therapy, Combination; Female; Goserelin; Humans; Imidazoles; Nitriles; Premenopause; Receptor, ErbB-2; Tamoxifen; Triazoles; Zoledronic Acid

2009
Effects of morphine on testosterone levels in rat C6 glioma cells: modulation by anastrozole.
    Journal of cellular physiology, 2009, Volume: 221, Issue:1

    Topics: Anastrozole; Animals; Cell Line, Tumor; Glioma; Morphine; Nitriles; Rats; Testosterone; Triazoles

2009
Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.
    Critical reviews in oncology/hematology, 2009, Volume: 72, Issue:1

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Nitriles; Receptors, Estrogen; Tamoxifen; Triazoles

2009
Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients.
    Breast cancer (Tokyo, Japan), 2010, Volume: 17, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Arthralgia; Bone Density; Breast Neoplasms; Cerebral Infarction; Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Japan; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Survival Rate; Treatment Outcome; Triazoles

2010
Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
    Anticancer research, 2009, Volume: 29, Issue:6

    Topics: Anastrozole; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Humans; Letrozole; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tamoxifen; Triazoles; Tumor Cells, Cultured

2009
LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
    Journal of pharmaceutical and biomedical analysis, 2009, Oct-15, Volume: 50, Issue:3

    Topics: Anastrozole; Aromatase Inhibitors; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Stability; Humidity; Hydrolysis; Nitriles; Oxidation-Reduction; Photolysis; Quality Control; Tandem Mass Spectrometry; Temperature; Triazoles

2009
Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
    Onkologie, 2009, Volume: 32, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Retinal Artery Occlusion; Triazoles

2009
Metastasis of lobular breast carcinoma to the uterus in a patient under anastrozole therapy.
    Onkologie, 2009, Volume: 32, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Lobular; Diagnosis, Differential; Female; Humans; Middle Aged; Nitriles; Triazoles; Uterine Neoplasms

2009
Promising effect of aromatase inhibitors on recurrent granulosa cell tumors.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:5

    Topics: Adult; Aged; Anastrozole; Aromatase Inhibitors; Female; Granulosa Cell Tumor; Humans; Letrozole; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Ovarian Neoplasms; Ovariectomy; Prognosis; Treatment Outcome; Triazoles

2009
[Criteria for evaluating the effectiveness of aromatase inhibitors in the neoadjuvant treatment of patients with endometrial carcinoma].
    Voprosy onkologii, 2009, Volume: 55, Issue:3

    Topics: Adult; Aged; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Biomarkers, Tumor; Chemotherapy, Adjuvant; Endometrial Neoplasms; Estradiol; Female; Humans; Ki-67 Antigen; Letrozole; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Receptors, Progesterone; Time Factors; Treatment Outcome; Triazoles

2009
Concurrent administration of chemo-endocrine therapy for postmenopausal breast cancer patients.
    Breast cancer (Tokyo, Japan), 2010, Volume: 17, Issue:4

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Nitriles; Paclitaxel; Postmenopause; Treatment Outcome; Triazoles; Tumor Burden

2010
A case of uterine tumour resembling ovarian sex cord tumour responding to second-line, single agent anastrazole.
    Internal medicine journal, 2009, Volume: 39, Issue:9

    Topics: Anastrozole; Diagnosis, Differential; Female; Humans; Middle Aged; Nitriles; Ovarian Neoplasms; Triazoles; Uterine Neoplasms

2009
How to treat hormone receptor-positive, human epidermal growth factor receptor 2-amplified breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Nov-20, Volume: 27, Issue:33

    Topics: Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lapatinib; Nitriles; Prognosis; Quinazolines; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptors, Estrogen; Risk Assessment; Survival Analysis; Time Factors; Trastuzumab; Triazoles

2009
NCCN Guideline update: Breast Cancer Version 1.2004.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2004, Volume: 2, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Female; Humans; Letrozole; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Estrogen; Tamoxifen; Triazoles

2004
Evaluation of plasma and tissue estrogen suppression with third-generation aromatase inhibitors: of relevance to clinical understanding?
    The Journal of steroid biochemistry and molecular biology, 2010, Feb-28, Volume: 118, Issue:4-5

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Letrozole; Nitriles; Postmenopause; Triazoles

2010
Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.
    Fertility and sterility, 2010, May-15, Volume: 93, Issue:8

    Topics: Anastrozole; Animals; Apoptosis; Aromatase; Aromatase Inhibitors; Ascitic Fluid; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Letrozole; Mice; Nitriles; Prostaglandins E; Triazoles; Vascular Endothelial Growth Factor A

2010
Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors.
    Drug metabolism reviews, 2010, Volume: 42, Issue:1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Letrozole; Nitriles; Pharmacogenetics; Receptors, Estrogen; Tamoxifen; Triazoles

2010
Impact of aromatase inhibitors on bone health in breast cancer patients.
    The Journal of steroid biochemistry and molecular biology, 2010, Feb-28, Volume: 118, Issue:4-5

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Breast Neoplasms; Calcium; Diphosphonates; Female; Humans; Letrozole; Nitriles; Triazoles; Vitamin D

2010
Aromatase inhibition in male breast cancer patients: biological and clinical implications.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma; Estradiol; Humans; Letrozole; Male; Middle Aged; Neoplasm Metastasis; Nitriles; Retrospective Studies; Survival Analysis; Testosterone; Treatment Outcome; Triazoles

2010
Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines.
    The Journal of steroid biochemistry and molecular biology, 2010, Feb-28, Volume: 118, Issue:4-5

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Letrozole; Nitriles; Tamoxifen; Triazoles

2010
Musculoskeletal manifestations in patients with malignant disease.
    Clinical rheumatology, 2010, Volume: 29, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Joint Diseases; Letrozole; Male; Middle Aged; Muscular Diseases; Neoplasms; Nitriles; Osteoporosis; Statistics, Nonparametric; Triazoles

2010
A remarkable case of cutaneous metastatic breast carcinoma.
    Dermatology online journal, 2009, Jul-15, Volume: 15, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Epirubicin; Female; Humans; Mammaplasty; Mastectomy, Modified Radical; Middle Aged; Neoadjuvant Therapy; Nitriles; Radiography; Skin Neoplasms; Taxoids; Triazoles

2009
Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor.
    Dermatology online journal, 2009, Jul-15, Volume: 15, Issue:7

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Diagnostic Errors; Drug Eruptions; Female; Humans; Mastectomy, Segmental; Nitriles; Postoperative Complications; Pruritus; Radiotherapy, Adjuvant; Scabies; Triazoles

2009
Treatment of autonomous ovarian follicular cyst with long-term anastrozole therapy.
    Indian journal of pediatrics, 2009, Volume: 76, Issue:9

    Topics: Anastrozole; Aromatase Inhibitors; Child; Female; Humans; Nitriles; Ovarian Cysts; Puberty, Precocious; Recurrence; Triazoles

2009
A simple, selective and rapid validated method for estimation of anastrazole in human plasma by liquid chromatography-tandem mass spectrometry and its application to bioequivalence study.
    Biomedical chromatography : BMC, 2010, Volume: 24, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Chromatography, Liquid; Humans; Nitriles; Tandem Mass Spectrometry; Therapeutic Equivalency; Triazoles

2010
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration.
    World journal of surgical oncology, 2009, Nov-12, Volume: 7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Nitriles; Perimenopause; Postmenopause; Triazoles

2009
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
    Breast cancer research and treatment, 2010, Volume: 123, Issue:2

    Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin-1; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Nitriles; Pyrrolidines; Receptor, Endothelin A; Tamoxifen; Time Factors; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays

2010
Testosterone: more is not always better.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:12

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Bone and Bones; Bone Density; Estrogens; Humans; Male; Middle Aged; Nitriles; Randomized Controlled Trials as Topic; Receptors, Androgen; Testosterone; Triazoles

2009
Role of testosterone/estradiol ratio in predicting the efficacy of tamoxifen citrate treatment in idiopathic oligoasthenoteratozoospermic men.
    Urologia internationalis, 2009, Volume: 83, Issue:4

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Estradiol; Humans; Male; Nitriles; Oligospermia; Predictive Value of Tests; Sperm Motility; Spermatozoa; Tamoxifen; Testosterone; Triazoles

2009
Retrospective analysis of concurrent vs. sequential administration of radiotherapy and hormone therapy using aromatase inhibitor for hormone receptor-positive postmenopausal breast cancer.
    Anticancer research, 2009, Volume: 29, Issue:11

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Radiotherapy, Adjuvant; Retrospective Studies; Triazoles

2009
[A case of inflammatory breast cancer responding to anastrozole].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Adenocarcinoma, Scirrhous; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Inflammation; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2009
[A successful case of advanced breast cancer of the elderly treated with the only breast-hormone therapy as PST].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aortic Aneurysm, Thoracic; Aortic Dissection; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Hypertension; Nitriles; Receptors, Estrogen; Triazoles

2009
Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo.
    Fertility and sterility, 2010, Volume: 94, Issue:5

    Topics: Adult; Anastrozole; Animals; Antineoplastic Agents; Biopsy; Case-Control Studies; Cell Proliferation; Cell Survival; Cells, Cultured; Endometriosis; Endometrium; Female; Fluorouracil; Humans; Methotrexate; Mice; Mice, Nude; Nitriles; Progesterone; Transplantation, Heterologous; Triazoles; Uterine Diseases

2010
Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Mar-01, Volume: 28, Issue:7

    Topics: Aged; Anastrozole; Breast Neoplasms; Estradiol; Estrogens; Female; Gene Expression Profiling; Humans; Ki-67 Antigen; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Triazoles

2010
Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation.
    International journal of pharmaceutics, 2010, May-31, Volume: 391, Issue:1-2

    Topics: Adhesives; Administration, Cutaneous; Administration, Oral; Anastrozole; Animals; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Female; Mice; Mice, Inbred Strains; Nitriles; Permeability; Rats; Rats, Wistar; Skin; Skin Absorption; Tissue Distribution; Triazoles

2010
Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptors.
    Applied immunohistochemistry & molecular morphology : AIMM, 2010, Volume: 18, Issue:3

    Topics: Anastrozole; Anesthetics, Combined; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Early Detection of Cancer; Female; Gonadal Steroid Hormones; Humans; Immunohistochemistry; Neoplasm Recurrence, Local; Nitriles; Practice Guidelines as Topic; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen; Triazoles

2010
Comparison of the effects of raloxifene and anastrozole on experimental endometriosis.
    European journal of obstetrics, gynecology, and reproductive biology, 2010, Volume: 150, Issue:1

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Disease Models, Animal; Endometriosis; Female; Nitriles; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Wistar; Single-Blind Method; Triazoles

2010
Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
    Breast cancer research and treatment, 2010, Volume: 121, Issue:1

    Topics: Age Factors; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemoprevention; Double-Blind Method; Female; Health Knowledge, Attitudes, Practice; Humans; Mammography; Mass Screening; Middle Aged; Nitriles; Patient Selection; Randomized Controlled Trials as Topic; Risk Factors; Socioeconomic Factors; Surveys and Questionnaires; Triazoles

2010
Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor.
    Journal of pediatric endocrinology & metabolism : JPEM, 2009, Volume: 22, Issue:12

    Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Body Height; Body Weight; Child Development; Child, Preschool; Drug Therapy, Combination; Humans; Male; Nitriles; Point Mutation; Puberty, Precocious; Receptors, LH; Tosyl Compounds; Triazoles

2009
Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.
    Journal of clinical and experimental neuropsychology, 2010, Volume: 32, Issue:8

    Topics: Aged; Anastrozole; Breast Neoplasms; Case-Control Studies; Cognition Disorders; Estrogen Antagonists; Fatigue; Female; Humans; Memory Disorders; Middle Aged; Mood Disorders; Neuropsychological Tests; Nitriles; Postmenopause; Statistics, Nonparametric; Surveys and Questionnaires; Tamoxifen; Triazoles

2010
Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer.
    Cancer research, 2010, Apr-15, Volume: 70, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Breast Neoplasms; Cohort Studies; Dose-Response Relationship, Drug; Estrogens; Estrone; Female; Humans; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Testosterone; Triazoles

2010
Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.
    Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:3

    Topics: Adult; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Endometrial Neoplasms; Endometrial Stromal Tumors; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Nitriles; Triazoles

2011
[Endometrial stromal sarcoma: complete response to therapy with aromatase-inhibitor, anastrozole].
    Voprosy onkologii, 2010, Volume: 56, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Nitriles; Remission Induction; Sarcoma, Endometrial Stromal; Tomography, X-Ray Computed; Treatment Outcome; Triazoles

2010
[Goserelin plus anastrozole in the treatment of premenopausal patients with metastatic breast cancer].
    Zhonghua yi xue za zhi, 2010, Mar-02, Volume: 90, Issue:8

    Topics: Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Goserelin; Humans; Middle Aged; Nitriles; Premenopause; Prognosis; Survival Rate; Treatment Outcome; Triazoles

2010
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer.
    Breast cancer research and treatment, 2010, Volume: 121, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Expression Profiling; Humans; Neoadjuvant Therapy; Nitriles; Reverse Transcriptase Polymerase Chain Reaction; Triazoles

2010
Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer.
    Breast cancer research and treatment, 2011, Volume: 125, Issue:1

    Topics: Adult; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Databases as Topic; Delivery of Health Care; Drug Costs; Female; Health Knowledge, Attitudes, Practice; Humans; Insurance, Health; Letrozole; Logistic Models; Medication Adherence; Middle Aged; Nitriles; Odds Ratio; Postmenopause; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Triazoles; United States

2011
Obesity and hormone therapy in breast cancer: an unfinished puzzle.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jul-20, Volume: 28, Issue:21

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Menopause; Nitriles; Obesity; Tamoxifen; Triazoles

2010
Impact of the estrus cycle and reduction in estrogen levels with aromatase inhibition, on renal function and nitric oxide activity in female rats.
    Steroids, 2010, Volume: 75, Issue:12

    Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Estradiol; Estrogens; Estrous Cycle; Female; Hemodynamics; Kidney; Nitric Oxide; Nitric Oxide Synthase; Nitriles; Rats; Rats, Sprague-Dawley; Sexual Abstinence; Triazoles

2010
Rheumatoid arthritis and aromatase inhibitors.
    Joint bone spine, 2011, Volume: 78, Issue:1

    Topics: Adenocarcinoma; Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Arthritis, Rheumatoid; Breast Neoplasms; Carcinoma, Ductal; Combined Modality Therapy; Female; Humans; Letrozole; Middle Aged; Nitriles; Triazoles

2011
Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapy.
    American journal of clinical oncology, 2011, Volume: 34, Issue:3

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Pennsylvania; Radiation Injuries; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Triazoles

2011
An ultraperformance liquid chromatography-tandem mass spectrometry method for determination of anastrozole in human plasma and its application to a pharmacokinetic study.
    Biomedical chromatography : BMC, 2011, Volume: 25, Issue:4

    Topics: Administration, Oral; Anastrozole; Chromatography, High Pressure Liquid; Humans; Least-Squares Analysis; Male; Nitriles; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Triazoles

2011
Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study.
    Onkologie, 2010, Volume: 33, Issue:7

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Cost-Benefit Analysis; Diphosphonates; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Costs; Female; Germany; Goserelin; Humans; Imidazoles; Markov Chains; Monte Carlo Method; Multicenter Studies as Topic; National Health Programs; Neoplasms, Multiple Primary; Nitriles; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles; Zoledronic Acid

2010
A rare case of breast cancer metastasis.
    Breast disease, 2010, Volume: 31, Issue:1

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Female; Humans; Kidney Neoplasms; Mastectomy, Modified Radical; Middle Aged; Nephrectomy; Nitriles; Triazoles

2010
The differences in outcome between ATAC and BIG 1-98 suggest efficacy differences between these two nonsteroidal AIs.
    Cancer investigation, 2010, Volume: 28 Suppl 1

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Letrozole; Nitriles; Research Design; Tamoxifen; Treatment Outcome; Triazoles

2010
[Clinical significance and pathological evaluation of neoadjuvant chemotherapy in breast cancer].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2010, Volume: 39, Issue:4

    Topics: Anastrozole; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Female; Humans; Neoadjuvant Therapy; Nitriles; Taxoids; Trastuzumab; Treatment Outcome; Triazoles

2010
Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy.
    Psycho-oncology, 2011, Volume: 20, Issue:9

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Checklist; Chemotherapy, Adjuvant; Cognition; Dyspareunia; Female; Hot Flashes; Humans; Middle Aged; Nausea; Nitriles; Pain; Psychometrics; Reproducibility of Results; Self Report; Triazoles; Urinary Incontinence; Weight Loss

2011
[Inhibitory effect of Jiawei Sanleng pill medicated serum on estrogen production and its influence on apoptosis of human endometrial cells of endometriosis].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2010, Volume: 33, Issue:3

    Topics: Anastrozole; Animals; Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Endometriosis; Endometrium; Estradiol; Estrogens; Female; Flow Cytometry; Humans; Nitriles; Plants, Medicinal; Rats; Rats, Wistar; Serum; Time Factors; Triazoles

2010
Cognitive changes associated with endocrine therapy for breast cancer.
    Maturitas, 2010, Volume: 67, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Female; Humans; Letrozole; Memory; Neoplasms, Hormone-Dependent; Nitriles; Prospective Studies; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles; United States; Women's Health

2010
Rectal metastasis from lobular carcinoma of the breast: a case report.
    Collegium antropologicum, 2010, Volume: 34, Issue:2

    Topics: Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Lobular; Female; Humans; Nitriles; Rectal Neoplasms; Treatment Outcome; Triazoles

2010
Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
    Pediatrics, 2010, Volume: 126, Issue:3

    Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Child, Preschool; Humans; Letrozole; Male; Nitriles; Puberty, Precocious; Testosterone; Tosyl Compounds; Triazoles

2010
[An elderly advanced breast cancer with a good response to anastrozole].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:8

    Topics: Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Neoplasm Staging; Nitriles; Tomography, X-Ray Computed; Triazoles; Ultrasonography

2010
Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important.
    Breast cancer research : BCR, 2010, Volume: 12, Issue:4

    Topics: Anastrozole; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Drug Therapy, Combination; Female; Humans; Nitriles; Osteoporosis; Triazoles

2010
Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.
    Analytical and bioanalytical chemistry, 2010, Volume: 398, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Breast Neoplasms; Chromatography, Liquid; Female; Humans; Letrozole; Middle Aged; Nitriles; Selective Estrogen Receptor Modulators; Tamoxifen; Tandem Mass Spectrometry; Triazoles

2010
Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer.
    Current medical research and opinion, 2010, Volume: 26, Issue:10

    Topics: Aged; Anastrozole; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cost-Benefit Analysis; Drug Substitution; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Receptors, Estrogen; Triazoles; United Kingdom; United States

2010
Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.
    Breast cancer research and treatment, 2011, Volume: 128, Issue:2

    Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Combinations; Estrogen Receptor alpha; Estrogens; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Oxonic Acid; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tegafur; Transplantation, Heterologous; Triazoles; Tumor Cells, Cultured; Uracil

2011
In vivo treatments with fulvestrant and anastrozole differentially affect gene expression in the rat efferent ductules.
    Biology of reproduction, 2011, Volume: 84, Issue:1

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Ejaculatory Ducts; Estradiol; Fulvestrant; Gene Expression Regulation; Male; Nitriles; Rats; Rats, Wistar; Sp1 Transcription Factor; Testosterone; Transcription Factor AP-1; Triazoles

2011
Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women.
    European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:16

    Topics: Adult; Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; Middle Aged; Nitriles; Ovary; Premenopause; Tamoxifen; Triazoles

2010
Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: a Peripheral Quantitative Computed Tomography (pQCT) study.
    Bone, 2011, Volume: 48, Issue:2

    Topics: Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Postmenopause; Radiography; Radius; Tibia; Triazoles

2011
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Nov-01, Volume: 28, Issue:31

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Case-Control Studies; Chromosome Mapping; Chromosomes, Human, Pair 14; Clinical Trials, Phase III as Topic; Estrogens; Female; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Genotype; Humans; Logistic Models; Middle Aged; Musculoskeletal System; Neoplasm Staging; Nitriles; Polymorphism, Single Nucleotide; Postmenopause; Proto-Oncogene Proteins; Randomized Controlled Trials as Topic; Receptors, Interleukin-17; Retrospective Studies; Severity of Illness Index; Triazoles

2010
What is the value of the 21 gene recurrence score in HER2-negative patients?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Nov-01, Volume: 28, Issue:31

    Topics: Anastrozole; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Kaplan-Meier Estimate; Nitriles; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; RNA, Neoplasm; Tamoxifen; Triazoles

2010
Combining luteinising hormone releasing hormone agonists and aromatase inhibitors in breast cancer.
    European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:16

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Goserelin; Humans; Luteinizing Hormone; Nitriles; Triazoles

2010
Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.
    Oncology, 2010, Volume: 79, Issue:1-2

    Topics: Adult; Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Estrogen Receptor alpha; Estrogen Receptor beta; Fadrozole; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Nitriles; Phosphorylation; Predictive Value of Tests; Prognosis; Retrospective Studies; Serine; Tamoxifen; Triazoles

2010
10 years of ATAC: one question answered, many others unresolved.
    The Lancet. Oncology, 2010, Volume: 11, Issue:12

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Nitriles; Tamoxifen; Triazoles

2010
[Advanced breast cancer in a patient achieving long-term SD after letrozole administration for liver metastasis developing during anastrozole therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:13

    Topics: Aged; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Letrozole; Liver Neoplasms; Nitriles; Triazoles

2010
A novel approach for long-term oral drug administration in animal research.
    Journal of neuroscience methods, 2011, Feb-15, Volume: 195, Issue:2

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Protein Precursor; Anastrozole; Animal Experimentation; Animals; Antipsychotic Agents; Body Weight; Chromatography, Liquid; Disease Models, Animal; Female; Gels; Humans; Mass Spectrometry; Mice; Mice, Transgenic; Nitriles; Presenilin-1; Reproducibility of Results; tau Proteins; Triazoles

2011
Does anastrozole affect bone resorption similarly in early and late postmenopausal women?
    Calcified tissue international, 2011, Volume: 88, Issue:3

    Topics: Age Factors; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Bone Density; Bone Resorption; Breast Neoplasms; Carcinoma; Case-Control Studies; Collagen Type I; Cross-Sectional Studies; Female; Humans; Middle Aged; Nitriles; Osteoporosis, Postmenopausal; Peptides; Postmenopause; Risk Factors; Triazoles

2011
In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole.
    British journal of clinical pharmacology, 2010, Volume: 70, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chromatography, Liquid; Cytochrome P-450 CYP3A; Female; Glucuronides; Glucuronosyltransferase; Humans; In Vitro Techniques; Metabolic Networks and Pathways; Microsomes, Liver; Nitriles; Oxidation-Reduction; Tandem Mass Spectrometry; Triazoles

2010
[A case of stage IV breast cancer with bone metastases that responded well for long-term to hormonal therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diphosphonates; Female; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles

2010
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:8

    Topics: Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Arthralgia; Body Mass Index; Breast Neoplasms; Cohort Studies; Female; Hand Strength; Humans; Letrozole; Middle Aged; Musculoskeletal Diseases; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Syndrome; Tamoxifen; Triazoles

2011
Risk of Ipsilateral breast tumor recurrence in patients treated with Tamoxifen or Anastrozole following breast-conserving surgery with or without radiotherapy.
    Anticancer research, 2011, Volume: 31, Issue:1

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tamoxifen; Treatment Outcome; Triazoles

2011
Anastrozole can cause severe hypercalcaemia mimicking primary hyperparathyroidism.
    Breast cancer (Tokyo, Japan), 2014, Volume: 21, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Calcium; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Nitriles; Parathyroid Hormone; Triazoles

2014
Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, May-01, Volume: 17, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Nitriles; Predictive Value of Tests; Receptors, Estrogen; Sensitivity and Specificity; Triazoles

2011
Prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: two years' treatment with anastrozole and genetic study.
    Hormone research in paediatrics, 2011, Volume: 75, Issue:5

    Topics: Anastrozole; Aromatase Inhibitors; Child; Diseases in Twins; Genetics; Gynecomastia; Humans; Male; Nitriles; Peutz-Jeghers Syndrome; Puberty; Sequence Analysis, DNA; Time Factors; Triazoles; Twins, Monozygotic

2011
A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Apr-01, Volume: 17, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Resistance, Neoplasm; Estrogen Receptor Modulators; Female; Gene Expression Profiling; Genetic Association Studies; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Letrozole; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Oligonucleotide Array Sequence Analysis; Proportional Hazards Models; Proto-Oncogene Proteins c-myc; RNA Interference; Tamoxifen; Treatment Outcome; Triazoles

2011
Anastrozole versus clomiphene citrate: which is better for ovulation induction?
    Fertility and sterility, 2011, Volume: 95, Issue:5

    Topics: Anastrozole; Aromatase Inhibitors; Clinical Trials, Phase II as Topic; Clomiphene; Female; Fertility Agents, Female; Humans; Infertility, Female; Nitriles; Ovulation Induction; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles

2011
10-year analysis of the ATAC trial: wrong conclusion?
    The Lancet. Oncology, 2011, Volume: 12, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2011
Premenopausal hormone-responsive breast cancer with extensive axillary nodes involvement: total estrogen blockade and chemotherapy.
    Anticancer research, 2011, Volume: 31, Issue:2

    Topics: Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Docetaxel; Epirubicin; Estriol; Estrogen Antagonists; Female; Humans; Ifosfamide; Leuprolide; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Triazoles; Tumor Necrosis Factor Ligand Superfamily Member 15

2011
Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation.
    Journal of materials science. Materials in medicine, 2011, Volume: 22, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Area Under Curve; Breast Neoplasms; Chitosan; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Diffusion; Glutaral; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Microspheres; Nitriles; Particle Size; Polymers; Spectroscopy, Fourier Transform Infrared; Triazoles

2011
Association between breast cancer subtypes and response to neoadjuvant anastrozole.
    Steroids, 2011, Volume: 76, Issue:8

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Oligonucleotide Array Sequence Analysis; Postmenopause; Receptor, ErbB-2; Receptors, Estrogen; Recurrence; Treatment Outcome; Triazoles

2011
Anastrozole-related acute hepatitis with autoimmune features: a case report.
    BMC gastroenterology, 2011, Mar-31, Volume: 11

    Topics: Acute Disease; Aged; Anastrozole; Antibodies, Antinuclear; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Female; Hepatitis, Autoimmune; Humans; Nitriles; Treatment Outcome; Triazoles

2011
Predictive algorithms for adjuvant therapy: TransATAC.
    Steroids, 2011, Volume: 76, Issue:8

    Topics: Algorithms; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Ki-67 Antigen; Neoplasm Recurrence, Local; Nitriles; Prognosis; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Triazoles

2011
Synthesis of α-aryl nitriles through palladium-catalyzed decarboxylative coupling of cyanoacetate salts with aryl halides and triflates.
    Angewandte Chemie (International ed. in English), 2011, May-02, Volume: 50, Issue:19

    Topics: Acetates; Anastrozole; Catalysis; Flurbiprofen; Halogens; Mesylates; Nitriles; Palladium; Salts; Triazoles

2011
An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibition.
    Steroids, 2011, Volume: 76, Issue:8

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Estradiol; Estrogens; Female; Fulvestrant; Gene Expression Profiling; Humans; Insulin-Like Growth Factor I; Models, Biological; Nitriles; Postmenopause; Receptors, Estrogen; Recurrence; Triazoles

2011
Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer.
    Fertility and sterility, 2011, Volume: 95, Issue:7

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Substitution; Female; Humans; Middle Aged; Nitriles; Ovarian Hyperstimulation Syndrome; Ovariectomy; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome; Triazoles

2011
Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer.
    Anticancer research, 2011, Volume: 31, Issue:4

    Topics: Anastrozole; Androgens; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Gas Chromatography-Mass Spectrometry; Humans; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Steryl-Sulfatase; Tamoxifen; Triazoles

2011
Development and validation of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of exemestane in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Jul-01, Volume: 879, Issue:21

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Chromatography, Liquid; Humans; Linear Models; Nitriles; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles

2011
Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats.
    American journal of physiology. Renal physiology, 2011, Volume: 301, Issue:3

    Topics: Acute Kidney Injury; Albuminuria; Anastrozole; Animals; Aromatase Inhibitors; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Estradiol; Interleukin-6; Male; Nitriles; Rats; Rats, Sprague-Dawley; Streptozocin; Testosterone; Transforming Growth Factor beta; Triazoles

2011
Hydrophilic interaction chromatography-electrospray ionization tandem mass spectrometric analysis of anastrozole in human plasma and its application to a pharmacokinetic study.
    Biomedical chromatography : BMC, 2012, Volume: 26, Issue:2

    Topics: Anastrozole; Chromatography, Liquid; Humans; Hydrophobic and Hydrophilic Interactions; Linear Models; Male; Nitriles; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles

2012
Five-day anastrozole group in infertility needs supplemental human chorionic gonadotropin.
    Fertility and sterility, 2011, Volume: 96, Issue:2

    Topics: Anastrozole; Aromatase Inhibitors; Chorionic Gonadotropin; Clomiphene; Drug Administration Schedule; Drug Therapy, Combination; Female; Fertility Agents, Female; Humans; Infertility, Female; Nitriles; Ovulation; Ovulation Induction; Time Factors; Treatment Outcome; Triazoles

2011
Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.
    Hormones & cancer, 2011, Volume: 2, Issue:3

    Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Calcitriol; Cell Line, Tumor; Cell Proliferation; Estrogens; Female; Humans; Immunohistochemistry; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Nitriles; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Triazoles; Vitamins; Xenograft Model Antitumor Assays

2011
Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:4

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors; Surgical Procedures, Operative; Tamoxifen; Triazoles; Wounds and Injuries

2012
Direct spectroscopic evidence for binding of anastrozole to the iron heme of human aromatase. Peering into the mechanism of aromatase inhibition.
    Chemical communications (Cambridge, England), 2011, Oct-14, Volume: 47, Issue:38

    Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Binding Sites; Computer Simulation; Electron Spin Resonance Spectroscopy; Heme; Humans; Iron; Nitriles; Quantum Theory; Triazoles

2011
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.
    Cancer prevention research (Philadelphia, Pa.), 2011, Volume: 4, Issue:12

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Estrogens; Female; Humans; Mammography; Middle Aged; Nitriles; Postmenopause; Prognosis; Prospective Studies; Triazoles

2011
Determination and characterization of degradation products of anastrozole by LC-MS/MS and NMR spectroscopy.
    Journal of pharmaceutical and biomedical analysis, 2011, Dec-15, Volume: 56, Issue:5

    Topics: Anastrozole; Aromatase Inhibitors; Chromatography, Liquid; Magnetic Resonance Spectroscopy; Nitriles; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles

2011
Is primary endocrine therapy effective in treating the elderly, unfit patient with breast cancer?
    Annals of the Royal College of Surgeons of England, 2011, Volume: 93, Issue:4

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Female; Humans; Letrozole; Middle Aged; Nitriles; Receptors, Estrogen; Retrospective Studies; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2011
Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice.
    Neurobiology of disease, 2012, Volume: 45, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Anastrozole; Animals; Aromatase Inhibitors; Disease Models, Animal; Female; Hippocampus; Male; Mice; Mice, Transgenic; Neurons; Nitriles; Orchiectomy; Ovariectomy; Plaque, Amyloid; Triazoles

2012
[The effect of diet induced obesity on testicular tissue and serum oxidative stress parameters].
    Actas urologicas espanolas, 2012, Volume: 36, Issue:3

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Biomarkers; Body Weight; Catalase; Diet, High-Fat; Glutathione; Gonadal Steroid Hormones; Infertility, Male; Lipid Peroxidation; Lipids; Male; Nitric Oxide; Nitriles; Obesity; Oxidative Stress; Pituitary Hormones, Anterior; Random Allocation; Rats; Rats, Wistar; Spermatogenesis; Superoxide Dismutase; Superoxide Dismutase-1; Testis; Triazoles

2012
The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia.
    BMC cancer, 2011, Oct-10, Volume: 11

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia; Female; Humans; Incidence; Menopause; Middle Aged; Nitriles; Prospective Studies; Time Factors; Triazoles

2011
Embracing the complexity of comorbidity.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-10, Volume: 29, Issue:32

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Nitriles; Tamoxifen; Triazoles

2011
Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-15, Volume: 17, Issue:24

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Proliferation; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Nitriles; Outcome Assessment, Health Care; Postmenopause; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2011
The breast cancer chemoprevention debate.
    Journal of the National Cancer Institute, 2011, Nov-16, Volume: 103, Issue:22

    Topics: Anastrozole; Androstadienes; Anticarcinogenic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemoprevention; Clinical Trials as Topic; Female; Humans; Models, Statistical; Nitriles; Raloxifene Hydrochloride; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2011
Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer.
    Annals of surgical oncology, 2012, Volume: 19, Issue:4

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease Progression; Female; Follow-Up Studies; Humans; Letrozole; Nitriles; Receptor, ErbB-2; Survival Rate; Tamoxifen; Treatment Outcome; Triazoles

2012
Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer.
    Journal of the National Cancer Institute. Monographs, 2011, Volume: 2011, Issue:43

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Ki-67 Antigen; Lapatinib; Molecular Targeted Therapy; Multicenter Studies as Topic; Neoadjuvant Therapy; Nitriles; Predictive Value of Tests; Preoperative Period; Quinazolines; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Triazoles

2011
Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome.
    Endocrine journal, 2012, Volume: 59, Issue:2

    Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Child Development; Child, Preschool; Drug Therapy, Combination; Fibrous Dysplasia, Polyostotic; Humans; Male; Nitriles; Puberty, Precocious; Tosyl Compounds; Treatment Outcome; Triazoles

2012
A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines.
    Journal of alternative and complementary medicine (New York, N.Y.), 2011, Volume: 17, Issue:11

    Topics: Aconitine; Aconitum; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Chemotherapy, Adjuvant; Drugs, Chinese Herbal; Female; Hemorrhage; Humans; Medicine, Kampo; Middle Aged; Mucous Membrane; Nitriles; Phytotherapy; Qi; Triazoles; Vagina

2011
Effect of simvastatin on the pharmacokinetics of anastrozole.
    Breast cancer research and treatment, 2012, Volume: 131, Issue:2

    Topics: Aged; Anastrozole; Anticholesteremic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Estradiol; Estrone; Female; Humans; Middle Aged; Nitriles; Pilot Projects; Simvastatin; Triazoles

2012
[Effects of anastrozole on lipid metabolism in Chinese postmenopausal women with breast cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:7

    Topics: Age Factors; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Follow-Up Studies; Humans; Hyperlipidemias; Lipid Metabolism; Lipids; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Triazoles; Triglycerides

2011
Effect of the aromatase inhibitor anastrozole on uterine and leiomyoma Doppler blood flow in patients scheduled for hysterectomy: a pilot study.
    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2012, Volume: 40, Issue:1

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Female; Humans; Hysterectomy; Leiomyoma; Menorrhagia; Middle Aged; Nitriles; Pilot Projects; Regional Blood Flow; Treatment Outcome; Triazoles; Ultrasonography, Doppler; Uterine Neoplasms

2012
Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.
    Cancer prevention research (Philadelphia, Pa.), 2012, Volume: 5, Issue:2

    Topics: Aged; Anastrozole; Aromatase; Aromatase Inhibitors; Biomarkers, Tumor; Biopsy, Fine-Needle; Breast Neoplasms; DNA; Female; Genotype; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Middle Aged; Neoplasms, Second Primary; Nitriles; Polymerase Chain Reaction; Prognosis; Triazoles

2012
Grover disease (transient acantholytic dermatosis) induced by anastrozole.
    Cutis, 2011, Volume: 88, Issue:4

    Topics: Acantholysis; Aged; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Ichthyosis; Nitriles; Triazoles

2011
Effects of aromatase inhibitor on menopausal hyperplasia in a case of obesity.
    Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:1

    Topics: Administration, Oral; Aged; Anastrozole; Aromatase Inhibitors; Atrophy; Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Menopause; Nitriles; Obesity; Time; Treatment Outcome; Triazoles; Ultrasonography; Uterine Hemorrhage

2012
Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2011, Volume: 14, Issue:8

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Computer Simulation; Cost-Benefit Analysis; Cytochrome P-450 CYP2D6; Decision Support Techniques; Economics, Pharmaceutical; Female; Genotype; Humans; Markov Chains; Nitriles; Pharmacogenetics; Randomized Controlled Trials as Topic; Research Design; Tamoxifen; Triazoles; United Kingdom

2011
Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer.
    Journal of bone and mineral metabolism, 2012, Volume: 30, Issue:4

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Resorption; Breast Neoplasms; Calcium Carbonate; Cohort Studies; Combined Modality Therapy; Dietary Supplements; Etidronic Acid; Female; Follow-Up Studies; Humans; Neoplasm Staging; Nitriles; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Risedronic Acid; Severity of Illness Index; Triazoles; Vitamin D

2012
Aromatase inhibitors in premenopausal breast cancer.
    The Lancet. Oncology, 2012, Volume: 13, Issue:4

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Goserelin; Humans; Neoadjuvant Therapy; Nitriles; Tamoxifen; Triazoles

2012
Deep time: the long and the short of adjuvant endocrine therapy for breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Mar-01, Volume: 30, Issue:7

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Tamoxifen; Triazoles

2012
Incidence and management of arthralgias in breast cancer patients treated with aromatase inhibitors in an outpatient oncology clinic.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:4

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Female; Humans; Incidence; Neoplasms, Hormone-Dependent; Nitriles; Outpatients; Retrospective Studies; Triazoles

2012
Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats.
    American journal of physiology. Renal physiology, 2012, May-01, Volume: 302, Issue:9

    Topics: Albuminuria; Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Supplements; Dihydrotestosterone; Disease Models, Animal; Estrogen Receptor alpha; Incidence; Male; Nitriles; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Streptozocin; Triazoles; Tumor Necrosis Factor-alpha

2012
Genesis and outcome of a breast cancer trial to develop the aromatase inhibitor anastrozole.
    Clinical chemistry, 2012, Volume: 58, Issue:4

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Nitriles; Randomized Controlled Trials as Topic; Triazoles

2012
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.
    Journal of the National Cancer Institute, 2012, Mar-21, Volume: 104, Issue:6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cytochrome P-450 CYP2D6; Female; Genotype; Germ-Line Mutation; Glucuronosyltransferase; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Odds Ratio; Postmenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Risk Assessment; Risk Factors; Tamoxifen; Triazoles; United Kingdom

2012
Spectral characterization of the binding and conformational changes of serum albumins upon interaction with an anticancer drug, anastrozole.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2012, Jun-15, Volume: 92

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Cattle; Circular Dichroism; Fluorescence Resonance Energy Transfer; Humans; Nitriles; Protein Binding; Protein Conformation; Serum Albumin; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Thermodynamics; Triazoles

2012
[Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer].
    Voprosy onkologii, 2011, Volume: 57, Issue:6

    Topics: Adult; Aged; Anastrozole; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Endometrial Neoplasms; Female; Glucose; Humans; Hypoglycemic Agents; Ki-67 Antigen; Letrozole; Metformin; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Nitriles; Treatment Outcome; Triazoles

2011
[A case of recurrent breast cancer with brain metastases successfully treated with vinorelbine and anastrozole after multiple chemo-endocrine therapies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:3

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Receptors, Estrogen; Recurrence; Triazoles; Vinblastine; Vinorelbine

2012
Combined treatment with GH and anastrozole in a pubertal boy with Cushing's disease and postsurgical GH deficiency.
    European journal of endocrinology, 2012, Volume: 166, Issue:6

    Topics: Adolescent; Anastrozole; Aromatase Inhibitors; Body Height; Drug Therapy, Combination; Growth Disorders; Hormone Replacement Therapy; Human Growth Hormone; Humans; Male; Nitriles; Pituitary ACTH Hypersecretion; Triazoles

2012
A priming role of local estrogen on exogenous estrogen-mediated synaptic plasticity and neuroprotection.
    Experimental & molecular medicine, 2012, Jun-30, Volume: 44, Issue:6

    Topics: Anastrozole; Androstadienes; Animals; Aromatase Inhibitors; Cell Line; Cell Survival; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Hippocampus; Hydrogen Peroxide; Nervous System; Neuronal Plasticity; Neuroprotective Agents; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Rats; Triazoles; Wortmannin

2012
Polyendocrine treatment in estrogen receptor-positive breast cancer: a "FACT" yet to be proven.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Jun-01, Volume: 30, Issue:16

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Nitriles; Triazoles

2012
Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial.
    Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:9

    Topics: Absorptiometry, Photon; Age Factors; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Middle Aged; Nitriles; Osteoporosis; Osteoporosis, Postmenopausal; Outcome and Process Assessment, Health Care; Prospective Studies; Randomized Controlled Trials as Topic; Risedronic Acid; Risk Assessment; Risk Factors; Time Factors; Triazoles

2012
Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer.
    Breast cancer research and treatment, 2012, Volume: 134, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tamoxifen; Triazoles; Weight Gain

2012
Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
    Breast cancer research : BCR, 2012, May-18, Volume: 14, Issue:3

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Neoadjuvant Therapy; Neoplasm Proteins; Nitriles; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Receptors, Estrogen; RNA Interference; RNA, Small Interfering; Signal Transduction; Triazoles

2012
Impact of Aromatase protein variants and drug interactions in breast cancer: a molecular docking approach.
    Journal of receptor and signal transduction research, 2012, Volume: 32, Issue:4

    Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Catalytic Domain; Drug Interactions; Female; Humans; Ligands; Models, Molecular; Mutant Proteins; Nitriles; Triazoles

2012
Whole-genome analysis informs breast cancer response to aromatase inhibition.
    Nature, 2012, Jun-10, Volume: 486, Issue:7403

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; DNA Repair; Exome; Exons; Female; Genetic Variation; Genome, Human; Humans; Letrozole; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 1; Mutation; Nitriles; Receptors, Estrogen; Treatment Outcome; Triazoles

2012
Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol.
    Steroids, 2012, Volume: 77, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Anastrozole; Androgen Antagonists; Animals; Aorta; Aromatase Inhibitors; Cell Adhesion; Cell Proliferation; Dose-Response Relationship, Drug; Endothelial Cells; Estradiol; Estrogen Antagonists; Female; Finasteride; Flutamide; Fulvestrant; Monocytes; Myocytes, Smooth Muscle; Nitric Oxide; Nitriles; Rats; Rats, Wistar; Testosterone; Triazoles

2012
Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
    Radiology, 2012, Volume: 264, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Letrozole; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Retrospective Studies; Subtraction Technique; Triazoles

2012
Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
    Journal of pediatric endocrinology & metabolism : JPEM, 2012, Volume: 25, Issue:3-4

    Topics: Age Determination by Skeleton; Anastrozole; Aromatase Inhibitors; Cafe-au-Lait Spots; Child, Preschool; Female; Fibrous Dysplasia, Polyostotic; Humans; Nitriles; Prognosis; Puberty, Precocious; Triazoles; Uterine Hemorrhage

2012
Inflammatory osteoarthritis which was precipitated by Arimidex and resolved with tamoxifen.
    BMJ case reports, 2010, Nov-02, Volume: 2010

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Female; Humans; Middle Aged; Nitriles; Osteoarthritis; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2010
Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Aug-20, Volume: 30, Issue:24

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Estrogens; Estrone; Female; Humans; Letrozole; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Triazoles

2012
Aromatase inhibition in obese women: how much is enough?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Aug-20, Volume: 30, Issue:24

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Estrogens; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles

2012
Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.
    Carcinogenesis, 2012, Volume: 33, Issue:11

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Carcinogens; Cell Proliferation; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nicotiana; Nitriles; Nitrosamines; Receptors, Estrogen; Triazoles

2012
Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: results of an experimental study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:3

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Combined Modality Therapy; Female; Letrozole; Nitriles; Pulmonary Fibrosis; Radiation Injuries, Experimental; Rats; Rats, Wistar; Statistics, Nonparametric; Tamoxifen; Triazoles

2013
Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacy.
    Nature reviews. Clinical oncology, 2012, Volume: 9, Issue:10

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Nitriles; Prognosis; Triazoles

2012
Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.
    Journal of general internal medicine, 2013, Volume: 28, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clobetasol; Drug Eruptions; Female; Glucocorticoids; Humans; Middle Aged; Nitriles; Triazoles; Vulvar Lichen Sclerosus

2013
Dry eye syndrome in aromatase inhibitor users.
    Clinical & experimental ophthalmology, 2013, Volume: 41, Issue:3

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Blepharitis; Breast Neoplasms; Conjunctival Diseases; Dry Eye Syndromes; Female; Humans; Keratitis; Letrozole; Middle Aged; Nitriles; Ovarian Neoplasms; Retrospective Studies; Triazoles; Vision Disorders

2013
The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 78, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; ErbB Receptors; Estrogen Receptor alpha; Estrogen Receptor beta; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Gene Expression; Humans; Inhibitory Concentration 50; Lung Neoplasms; MAP Kinase Signaling System; Nitriles; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Quinazolines; Triazoles

2012
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Nitriles; Practice Guidelines as Topic; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Risk Assessment; Tamoxifen; Treatment Outcome; Triazoles

2013
Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.
    BMC cancer, 2012, Oct-15, Volume: 12

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Data Collection; Female; Humans; Medication Adherence; Middle Aged; Nitriles; Reproducibility of Results; Surveys and Questionnaires; Time Factors; Triazoles

2012
Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index.
    British journal of cancer, 2012, Nov-20, Volume: 107, Issue:11

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Disease-Free Survival; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Triazoles

2012
Influence of ovarian and non-ovarian estrogens on weight gain in response to disruption of sweet taste--calorie relations in female rats.
    Hormones and behavior, 2013, Volume: 63, Issue:1

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Body Weight; Energy Intake; Energy Metabolism; Female; Nitriles; Ovariectomy; Rats; Rats, Sprague-Dawley; Saccharin; Sweetening Agents; Taste; Triazoles; Weight Gain

2013
Anastrozole and celecoxib for endometriosis treatment, good to keep them apart?
    Reproduction (Cambridge, England), 2013, Volume: 145, Issue:2

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Combinations; Drug Evaluation, Preclinical; Drug Incompatibility; Endometriosis; Female; Mesentery; Mice; Mice, Inbred BALB C; Nitriles; Peritoneal Diseases; Pyrazoles; Sulfonamides; Triazoles; Uterine Diseases

2013
Aromatase inhibitors associated with knee subchondral bone expansion without cartilage loss.
    Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:6

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Case-Control Studies; Female; Humans; Letrozole; Magnetic Resonance Imaging; Menisci, Tibial; Middle Aged; Nitriles; Postmenopause; Prospective Studies; Tibia; Triazoles

2013
Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in the United States.
    Journal of medical economics, 2013, Volume: 16, Issue:2

    Topics: Anastrozole; Antineoplastic Agents; Breast Neoplasms; Budgets; Cost-Benefit Analysis; Drug Costs; ErbB Receptors; Everolimus; Female; Health Care Costs; Humans; Letrozole; Middle Aged; Nitriles; Receptor, ErbB-2; Severity of Illness Index; Sirolimus; Treatment Failure; Triazoles; United States

2013
Development and validation of a simple and sensitive high performance liquid chromatographic method for the simultaneous determination of anastrozole, bicalutamide, tamoxifen, and their synthetic impurities.
    Talanta, 2012, Nov-15, Volume: 101

    Topics: Analysis of Variance; Anastrozole; Anilides; Calibration; Chromatography, High Pressure Liquid; Limit of Detection; Nitriles; Reproducibility of Results; Tamoxifen; Tosyl Compounds; Triazoles

2012
In vivo response of melatonin, gonadal activity and biochemical changes during CYP19 inhibited sex reversal in common carp Cyprinus carpio (L).
    Animal reproduction science, 2013, Jan-30, Volume: 136, Issue:4

    Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Carps; Fadrozole; Female; Gonads; Male; Melatonin; Nitriles; Sex Differentiation; Testosterone; Triazoles

2013
[Quality of life analysis of postmenopausal, early breast cancer patients treated with anastrozole (RADAR-II)].
    Magyar onkologia, 2012, Volume: 56, Issue:4

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Health Status; Humans; Hungary; Middle Aged; Neoplasm Staging; Nitriles; Patient Satisfaction; Postmenopause; Prospective Studies; Quality of Life; Surveys and Questionnaires; Triazoles

2012
Fast disintegrating films containing anastrozole as a dosage form for dysphagia patients.
    Archives of pharmacal research, 2012, Volume: 35, Issue:12

    Topics: Anastrozole; Animals; Deglutition Disorders; Dosage Forms; Drug Carriers; Male; Nitriles; Rats; Rats, Wistar; Solubility; Time Factors; Triazoles; X-Ray Diffraction

2012
[A successful case of a super-elderly breast cancer patient treated with hormone therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12

    Topics: Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Biopsy, Large-Core Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Neoplasm Staging; Nitriles; Quality of Life; Triazoles; Ultrasonography

2012
A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06).
    International journal of clinical oncology, 2014, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fractures, Bone; Humans; Japan; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles

2014
What is the optimal endocrine therapy for postmenopausal women with hormone receptor-positive early breast cancer?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-10, Volume: 31, Issue:11

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Practice Guidelines as Topic; Receptors, Estrogen; Tamoxifen; Time Factors; Triazoles

2013
Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4

    Topics: Anastrozole; Anticonvulsants; Aromatase Inhibitors; Gene Expression Regulation, Enzymologic; Genotype; Glucuronosyltransferase; Humans; In Vitro Techniques; Inactivation, Metabolic; Lamotrigine; Microsomes, Liver; Nitriles; Polymorphism, Single Nucleotide; Sapogenins; Triazines; Triazoles

2013
Acupuncture for the treatment of hot flashes in patients with breast cancer receiving antiestrogen therapy: a pilot study in Korean women.
    Journal of alternative and complementary medicine (New York, N.Y.), 2013, Volume: 19, Issue:8

    Topics: Acupuncture Therapy; Analysis of Variance; Anastrozole; Breast Neoplasms; Estrogen Antagonists; Female; Hot Flashes; Humans; Middle Aged; Nitriles; Prospective Studies; Republic of Korea; Severity of Illness Index; Tamoxifen; Treatment Outcome; Triazoles

2013
[A case of crescentic glomerulonephritis developed under oral anastrozole treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:2

    Topics: Administration, Oral; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Female; Glomerulonephritis; Humans; Nitriles; Triazoles

2013
Alleviating anastrozole induced bone toxicity by selenium nanoparticles in SD rats.
    Toxicology and applied pharmacology, 2013, Apr-15, Volume: 268, Issue:2

    Topics: Alkaline Phosphatase; Anastrozole; Animals; Aromatase Inhibitors; Bone and Bones; Cells, Cultured; Female; Humans; Nanoparticles; Nitriles; Osteoblasts; Osteoporosis; Rats; Rats, Sprague-Dawley; Selenium; Triazoles

2013
Anastrozole-associated joint pain and other symptoms in patients with breast cancer.
    The journal of pain, 2013, Volume: 14, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Arthralgia; Breast Neoplasms; Cohort Studies; Female; Humans; Incidence; Middle Aged; Models, Statistical; Nitriles; Pain Measurement; Triazoles

2013
Should all postmenopausal patients with hormone receptor-positive breast cancer receive initial therapy with aromatase inhibitors?
    Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Letrozole; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2013
Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, May-15, Volume: 19, Issue:10

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Biopsy; Breast; Breast Neoplasms; Cluster Analysis; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunity; Ki-67 Antigen; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Triazoles

2013
[Three patients with local recurrence of ER-positive breast cancer for whom anastrozole was clinically effective].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:3

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Receptors, Estrogen; Triazoles

2013
Effect of selumetinib on the growth of anastrozole-resistant tumors.
    Breast cancer research and treatment, 2013, Volume: 138, Issue:3

    Topics: Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; MAP Kinase Kinase 1; Mice; Mice, Nude; Nitriles; Ovariectomy; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Triazoles; Xenograft Model Antitumor Assays

2013
Protective role of testosterone in ischemia-reperfusion-induced acute kidney injury.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2013, Jun-01, Volume: 304, Issue:11

    Topics: Acute Kidney Injury; Anastrozole; Animals; Aromatase Inhibitors; Cell Adhesion Molecules; Creatinine; Male; Nitriles; Orchiectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Reperfusion Injury; Testosterone; Triazoles; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2013
Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor.
    International journal of cancer, 2013, Oct-01, Volume: 133, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Estrogen Receptor alpha; Female; Heterocyclic Compounds, 3-Ring; Humans; MCF-7 Cells; Neoplasm Recurrence, Local; Nitriles; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Receptor, ErbB-3; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Triazoles

2013
[Therapy concept: herceptin in combination with arimidex].
    Onkologie, 2002, Volume: 25 Suppl 5

    Topics: Anastrozole; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Germany; Humans; Neoplasm Staging; Nitriles; Prognosis; Receptor, ErbB-2; Trastuzumab; Triazoles

2002
Effect of aromatase inhibitors on bone mineral density in a Japanese breast cancer population.
    Drug metabolism and pharmacokinetics, 2013, Volume: 28, Issue:5

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Asian People; Bone Density; Breast Neoplasms; Diphosphonates; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Triazoles

2013
Two-step activation prodrugs: transplatin mediated binding of chemotherapeutic agents to vitamin B12.
    Organic & biomolecular chemistry, 2013, May-21, Volume: 11, Issue:19

    Topics: Anastrozole; Antineoplastic Agents; Binding Sites; Cell Proliferation; Cell Survival; Cisplatin; Cytarabine; Dacarbazine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; K562 Cells; Molecular Structure; Nitriles; Prodrugs; Structure-Activity Relationship; Triazoles; Vitamin B 12

2013
Anastrozole and RU486: Effects on estrogen receptor α and Mucin 1 expression and correlation in the MCF-7 breast cancer cell line.
    Acta histochemica, 2013, Volume: 115, Issue:8

    Topics: Anastrozole; Estrogen Receptor alpha; Humans; Immunohistochemistry; MCF-7 Cells; Mifepristone; Mucin-1; Nitriles; Software; Triazoles

2013
Investigation of the effect of active efflux at the blood-brain barrier on the distribution of nonsteroidal aromatase inhibitors in the central nervous system.
    Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:9

    Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; ATP Binding Cassette Transporter, Subfamily B; Blood-Brain Barrier; Brain; Cell Line; Humans; Letrozole; Male; Mice; Nitriles; Triazoles

2013
Posterior reversible encephalopathy syndrome: more than meets the eye.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-10, Volume: 31, Issue:20

    Topics: Anastrozole; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Electroencephalography; Fatal Outcome; Female; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Multiple Primary; Nitriles; Posterior Leukoencephalopathy Syndrome; Risk Assessment; Triazoles

2013
Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report.
    World journal of surgical oncology, 2013, Jun-04, Volume: 11

    Topics: Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Bone Neoplasms; Breast Neoplasms; Cancer Vaccines; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Diphosphonates; Epirubicin; Female; Fixatives; Fluorouracil; Formaldehyde; Humans; Imidazoles; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prognosis; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon; Triazoles; Zoledronic Acid

2013
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Aug-01, Volume: 31, Issue:22

    Topics: Anastrozole; Breast Neoplasms; Female; Gene Expression Profiling; Humans; Neoplasm Recurrence, Local; Nitriles; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Risk; Tamoxifen; Triazoles

2013
Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor.
    Fertility and sterility, 2013, Volume: 100, Issue:4

    Topics: Academic Medical Centers; Administration, Cutaneous; Adolescent; Anastrozole; Aromatase Inhibitors; Cryopreservation; Drug Therapy, Combination; Hormone Replacement Therapy; Humans; Klinefelter Syndrome; Male; Nitriles; Retrospective Studies; Semen Preservation; Sperm Retrieval; Spermatogenesis; Testosterone; Time Factors; Treatment Outcome; Triazoles

2013
Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study.
    Breast cancer research and treatment, 2013, Volume: 140, Issue:2

    Topics: Anastrozole; Biomarkers, Tumor; Breast Neoplasms; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Ki-67 Antigen; Lymph Nodes; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Transcription Factors; Treatment Outcome; Triazoles

2013
Management of prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: from aromatase inhibitors to subcutaneous mastectomy.
    Aesthetic plastic surgery, 2013, Volume: 37, Issue:5

    Topics: Adrenal Glands; Anastrozole; Aromatase Inhibitors; Child; Combined Modality Therapy; Comorbidity; Diseases in Twins; Gynecomastia; Humans; Lithiasis; Male; Mastectomy, Subcutaneous; Nitriles; Peutz-Jeghers Syndrome; Recurrence; Testicular Diseases; Testis; Triazoles; Ultrasonography, Mammary

2013
Application of multiple regression analysis in optimization of anastrozole-loaded PLGA nanoparticles.
    Journal of microencapsulation, 2014, Volume: 31, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Delayed-Action Preparations; Lactic Acid; Models, Chemical; Nanoparticles; Nitriles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Regression Analysis; Triazoles

2014
Combination endocrine treatments unproven in breast cancer.
    The Lancet. Oncology, 2013, Volume: 14, Issue:10

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Nitriles; Triazoles

2013
Sperm retrieval in adolescents with Klinefelter syndrome.
    Fertility and sterility, 2013, Volume: 100, Issue:4

    Topics: Anastrozole; Aromatase Inhibitors; Hormone Replacement Therapy; Humans; Klinefelter Syndrome; Male; Nitriles; Sperm Retrieval; Spermatogenesis; Testosterone; Triazoles

2013
Prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: clinical and surgical management.
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2013, Volume: 66, Issue:12

    Topics: Anastrozole; Aromatase Inhibitors; Breast; Child; Combined Modality Therapy; Disease Progression; Diseases in Twins; Gynecomastia; Humans; Male; Mastectomy; Nitriles; Organ Size; Peutz-Jeghers Syndrome; Testis; Triazoles; Twins, Monozygotic

2013
Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor.
    Fertility and sterility, 2013, Volume: 100, Issue:4

    Topics: Anastrozole; Aromatase Inhibitors; Hormone Replacement Therapy; Humans; Klinefelter Syndrome; Male; Nitriles; Sperm Retrieval; Spermatogenesis; Testosterone; Triazoles

2013
Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer.
    British journal of cancer, 2013, Sep-17, Volume: 109, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Estradiol; Female; Humans; Letrozole; Middle Aged; Nitriles; Obesity; Postmenopause; Prospective Studies; Receptors, Estrogen; Survival Analysis; Triazoles

2013
Endometrial Intracrinology--generation of an estrogen-dominated microenvironment in the secretory phase of women.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:11

    Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Cellular Microenvironment; Decidua; Endometrium; Estradiol; Estrone; Female; Gene Expression Regulation, Enzymologic; Humans; Menstrual Cycle; Multienzyme Complexes; Nitriles; Ovary; Pregnancy; Pregnancy Trimester, First; Primary Cell Culture; Progesterone Reductase; RNA, Messenger; Steroid Isomerases; Stromal Cells; Triazoles

2013
Tardive dyskinesia associated with anastrozole.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Summer, Volume: 25, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Movement Disorders; Nitriles; Triazoles

2013
Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study.
    Maturitas, 2013, Volume: 76, Issue:4

    Topics: Adult; Aged; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Estrogen Replacement Therapy; Female; Hormone Replacement Therapy; Humans; Incidence; Menopause; Middle Aged; Nitriles; Patient Compliance; Prospective Studies; Qualitative Research; Testosterone; Triazoles

2013
Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer.
    Journal of nursing measurement, 2013, Volume: 21, Issue:2

    Topics: Activities of Daily Living; Adult; Aged; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chi-Square Distribution; Factor Analysis, Statistical; Female; Humans; Middle Aged; Neuropsychological Tests; Nitriles; Postmenopause; Prospective Studies; Psychometrics; Quality of Life; Reproducibility of Results; Triazoles

2013
A polymorphism at the 3'-UTR region of the aromatase gene is associated with the efficacy of the aromatase inhibitor, anastrozole, in metastatic breast carcinoma.
    International journal of molecular sciences, 2013, Sep-13, Volume: 14, Issue:9

    Topics: 17-Hydroxysteroid Dehydrogenases; 3' Untranslated Regions; Adult; Aged; Aged, 80 and over; Alleles; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Anastrozole; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Gene Frequency; Genotype; Humans; Middle Aged; Nitriles; Polymorphism, Single Nucleotide; Proteins; Retrospective Studies; Survival Analysis; Triazoles

2013
Concordant effects of aromatase inhibitors on gene expression in ER+ Rat and human mammary cancers and modulation of the proteins coded by these genes.
    Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:11

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Mammary Neoplasms, Experimental; Nitriles; Oligonucleotide Array Sequence Analysis; Rats; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles

2013
Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion.
    The journal of sexual medicine, 2014, Volume: 11, Issue:1

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Drug Implants; Drug Therapy, Combination; Follicle Stimulating Hormone; Gonadotropins; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Nitriles; Off-Label Use; Retrospective Studies; Sex Hormone-Binding Globulin; Testosterone; Triazoles; United States

2014
Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:6

    Topics: Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Implants; Female; Humans; Mammary Glands, Human; Neoadjuvant Therapy; Nitriles; Testosterone; Triazoles; Ultrasonography

2014
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.
    British journal of cancer, 2013, Dec-10, Volume: 109, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Differentiation; Cell Growth Processes; Clinical Trials, Phase III as Topic; Female; Gene Expression Profiling; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitriles; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Signal Transduction; Tamoxifen; Treatment Outcome; Triazoles

2013
Extra virgin olive oil potentiates the effects of aromatase inhibitors via glutathione depletion in estrogen receptor-positive human breast cancer (MCF-7) cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2013, Volume: 62

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aromatase Inhibitors; Cytochromes c; Female; Glutathione; Humans; Letrozole; MCF-7 Cells; Nitriles; Oleic Acid; Olive Oil; Plant Oils; Reactive Oxygen Species; Receptors, Estrogen; Triazoles

2013
Bone mineral density and response to treatment in men younger than 50 years with testosterone deficiency and sexual dysfunction or infertility.
    The Journal of urology, 2014, Volume: 191, Issue:4

    Topics: Age Factors; Anastrozole; Androgens; Aromatase Inhibitors; Bone Density; Clomiphene; Deficiency Diseases; Estrogen Antagonists; Humans; Infertility, Male; Male; Middle Aged; Nitriles; Retrospective Studies; Sexual Dysfunction, Physiological; Testosterone; Triazoles

2014
Physiological testosterone levels enhance chondrogenic extracellular matrix synthesis by male intervertebral disc cells in vitro, but not by mesenchymal stem cells.
    The spine journal : official journal of the North American Spine Society, 2014, Mar-01, Volume: 14, Issue:3

    Topics: Adult; Aggrecans; Anastrozole; Aromatase Inhibitors; Cell Differentiation; Cell Survival; Cells, Cultured; Chondrogenesis; Collagen Type II; Extracellular Matrix; Female; Humans; In Vitro Techniques; Intervertebral Disc; Male; Mesenchymal Stem Cells; Middle Aged; Nitriles; Sex Factors; Testosterone; Transforming Growth Factor beta; Triazoles

2014
Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness.
    PloS one, 2013, Volume: 8, Issue:11

    Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Biomarkers, Tumor; BRCA1 Protein; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Regulation, Neoplastic; Genetic Markers; Humans; Hydroxyprostaglandin Dehydrogenases; Letrozole; Middle Aged; Nitriles; Receptors, Progesterone; ROC Curve; Tamoxifen; Treatment Outcome; Triazoles

2013
The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidance.
    PharmacoEconomics, 2014, Volume: 32, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Female; Humans; Models, Economic; Models, Structural; Nitriles; Quality-Adjusted Life Years; Survival Analysis; Tamoxifen; Triazoles; Uncertainty

2014
Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole.
    Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:1

    Topics: Anastrozole; Aromatase Inhibitors; Body Mass Index; Bone and Bones; Breast Neoplasms; Collagen Type I; Estradiol; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Obesity; Overweight; Peptide Fragments; Peptides; Postmenopause; Procollagen; Receptors, Estrogen; Triazoles

2014
Computational studies on the anastrozole and letrozole, effective chemotherapy drugs against breast cancer.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2014, Mar-25, Volume: 122

    Topics: Anastrozole; Antineoplastic Agents; Breast Neoplasms; Carbon-13 Magnetic Resonance Spectroscopy; Computer Simulation; Female; Humans; Letrozole; Models, Molecular; Molecular Conformation; Nitriles; Proton Magnetic Resonance Spectroscopy; Static Electricity; Triazoles; Vibration

2014
Breast cancer chemoprevention: little progress in practice?
    Lancet (London, England), 2014, Mar-22, Volume: 383, Issue:9922

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Humans; Nitriles; Triazoles

2014
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:2

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Prognosis; Proportional Hazards Models; Receptor, ErbB-2; Retrospective Studies; Risk; Risk Assessment; Tamoxifen; Transcriptome; Treatment Outcome; Triazoles

2014
Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: the impact of comorbidity and demographics on initial choice.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Australia; Breast Neoplasms; Cohort Studies; Comorbidity; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Nitriles; Postmenopause; Practice Guidelines as Topic; Premenopause; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles; Tumor Burden

2014
Tumour grade on core biopsy and evidence of axillary involvement on ultrasound predicts response in elderly co-morbid patients treated with primary hormone therapy for oestrogen receptor positive breast carcinoma.
    The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2015, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Axilla; Biopsy, Large-Core Needle; Breast Neoplasms; Female; Humans; Letrozole; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Nitriles; Receptors, Estrogen; Retrospective Studies; Tamoxifen; Triazoles

2015
Treatment of ovarian anaplastic ependymoma by an aromatase inhibitor.
    Obstetrics and gynecology, 2014, Volume: 123, Issue:2 Pt 2 Sup

    Topics: Anastrozole; Aromatase Inhibitors; Ependymoma; Female; Humans; Middle Aged; Nitriles; Ovarian Neoplasms; Triazoles

2014
Efficacy and safety of Trastuzumab added to standard treatments for HER2-positive metastatic breast cancer patients.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:12

    Topics: Anastrozole; Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Letrozole; Meta-Analysis as Topic; Nitriles; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Taxoids; Trastuzumab; Triazoles

2013
Does obesity interfere with anastrozole treatment? Positive association between body mass index and anastrozole plasma levels.
    Clinical breast cancer, 2014, Volume: 14, Issue:4

    Topics: Aged; Aged, 80 and over; Anastrozole; Androgens; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Chromatography, Liquid; Cross-Sectional Studies; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Middle Aged; Nitriles; Obesity; Postmenopause; Prognosis; Tandem Mass Spectrometry; Tissue Distribution; Triazoles

2014
New trials highlight breast cancer therapy and prevention.
    JAMA, 2014, Feb-05, Volume: 311, Issue:5

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Risk; Triazoles

2014
Anastrozole may aid breast cancer prevention.
    Cancer discovery, 2014, Volume: 4, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Nitriles; Triazoles

2014
Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:6

    Topics: Aged; Anastrozole; Androgens; Aromatase; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Letrozole; Middle Aged; Nitriles; Outcome Assessment, Health Care; Postmenopause; Triazoles

2014
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.
    Annals of surgical oncology, 2014, Volume: 21, Issue:5

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Letrozole; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Nitriles; Postmenopause; Prognosis; Receptor, ErbB-2; Retrospective Studies; Survival Rate; Tamoxifen; Time Factors; Triazoles

2014
Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Insulin Receptor Substrate Proteins; Ki-67 Antigen; Letrozole; Middle Aged; Neoplasm Recurrence, Local; Nitriles; PTEN Phosphohydrolase; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Stathmin; Tamoxifen; Triazoles

2014
Prevention: targeted therapy-anastrozole prevents breast cancer.
    Nature reviews. Clinical oncology, 2014, Volume: 11, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Molecular Targeted Therapy; Nitriles; Postmenopause; Triazoles

2014
Graphene oxide based magnetic nanocomposites for efficient treatment of breast cancer.
    Materials science & engineering. C, Materials for biological applications, 2014, Apr-01, Volume: 37

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Survival; Drug Carriers; Female; Graphite; Humans; Magnetite Nanoparticles; MCF-7 Cells; Nitriles; Oxides; Particle Size; Triazoles

2014
The bone substudy of MA.27: does bone make a difference?
    The Lancet. Oncology, 2014, Volume: 15, Issue:4

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Female; Humans; Neoplasms, Hormone-Dependent; Nitriles; Triazoles

2014
Testosterone, anastrozole, factor V Leiden heterozygosity and osteonecrosis of the jaws.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2014, Volume: 25, Issue:3

    Topics: Anastrozole; Bisphosphonate-Associated Osteonecrosis of the Jaw; Factor V; Humans; Male; Middle Aged; Nitriles; Osteonecrosis; Testosterone; Triazoles

2014
[A case of postmenopausal breast cancer becoming HER2 positive after neoadjuvant hormone therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:4

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Female; Humans; Mammography; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Postmenopause; Receptor, ErbB-2; Triazoles

2014
Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.
    Journal of pediatric endocrinology & metabolism : JPEM, 2014, Volume: 27, Issue:7-8

    Topics: Adolescent; Adult; Age Determination by Skeleton; Anastrozole; Aromatase Inhibitors; Body Height; Bone Development; Dwarfism; Growth Disorders; Humans; Male; Nitriles; Puberty; Retrospective Studies; Sexual Maturation; Treatment Outcome; Triazoles

2014
Influence of aromatase inhibition on the bone-protective effects of testosterone.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2014, Volume: 29, Issue:11

    Topics: Anabolic Agents; Anastrozole; Androgens; Animals; Aromatase; Aromatase Inhibitors; Heptanoates; Male; Muscle, Skeletal; Nitriles; Orchiectomy; Osteoporosis; Rats; Rats, Inbred F344; Testosterone; Trenbolone Acetate; Triazoles

2014
[Effect of genistein combined with anastrozole on mammary tumors in ovariectomized rats].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2014, Volume: 34, Issue:4

    Topics: 17-Hydroxysteroid Dehydrogenases; Anastrozole; Animals; Cell Line, Tumor; Cell Proliferation; Estradiol; Female; Genistein; Mammary Neoplasms, Experimental; Nitriles; Ovariectomy; Postmenopause; Rats; Rats, Sprague-Dawley; Triazoles

2014
The effects of hormonotherapy administered concurrent radiotherapy and trastuzumab on cardiac toxicity in rats.
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2014, Volume: 14, Issue:4

    Topics: Anastrozole; Androstadienes; Animals; Antibodies, Monoclonal; Aromatase Inhibitors; Combined Modality Therapy; Drug Administration Schedule; Female; Heart; Humans; Letrozole; Nitriles; Radiotherapy; Rats; Rats, Wistar; Trastuzumab; Triazoles; Tumor Protein, Translationally-Controlled 1

2014
Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
    Climacteric : the journal of the International Menopause Society, 2015, Volume: 18, Issue:1

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Bone Density; Bone Remodeling; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Longitudinal Studies; Luteinizing Hormone; Middle Aged; Nitriles; Postmenopause; Sex Hormone-Binding Globulin; Single-Blind Method; Testosterone; Triazoles

2015
Aromatase inhibition in relapsing low malignant potential serous tumours of the ovary.
    BMJ case reports, 2014, Jun-12, Volume: 2014

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Carcinoma, Ovarian Epithelial; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Nitriles; Ovarian Neoplasms; Peritoneal Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Splenectomy; Splenic Neoplasms; Triazoles

2014
A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer.
    BMJ open, 2014, Jun-12, Volume: 4, Issue:6

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Attitude to Health; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Medication Adherence; Middle Aged; Nitriles; Qualitative Research; Quality of Life; Tamoxifen; Triazoles

2014
Another pill for breast cancer prevention.
    The Johns Hopkins medical letter health after 50, 2014, Volume: 26, Issue:1

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Postmenopause; Triazoles

2014
Drug cuts breast cancer risk by more than half.
    Harvard women's health watch, 2014, Volume: 21, Issue:7

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Health Promotion; Humans; Middle Aged; Nitriles; Postmenopause; Triazoles; Women's Health

2014
Remission of metastatic primary mucinous carcinoma of the skin with anastrozole.
    Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:1

    Topics: Adenocarcinoma, Mucinous; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Female; Head and Neck Neoplasms; Humans; Mohs Surgery; Neoplasm Recurrence, Local; Nitriles; Remission Induction; Scalp; Skin Neoplasms; Treatment Failure; Triazoles

2014
Sex-dependent influence of endogenous estrogen in pulmonary hypertension.
    American journal of respiratory and critical care medicine, 2014, Aug-15, Volume: 190, Issue:4

    Topics: Anastrozole; Animals; Aromatase Inhibitors; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Estrogens; Female; Humans; Hypertension, Pulmonary; Hypoxia; Lung; Male; Mice; Mice, Inbred C57BL; Nitriles; Polymerase Chain Reaction; Rats; Rats, Wistar; Sex Factors; Triazoles

2014
Silk fibroin rods for sustained delivery of breast cancer therapeutics.
    Biomaterials, 2014, Volume: 35, Issue:30

    Topics: Anastrozole; Animals; Antineoplastic Agents; Biodegradation, Environmental; Breast Neoplasms; Drug Delivery Systems; Female; Fibroins; Kinetics; Microscopy, Electron, Scanning; Nitriles; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Time Factors; Triazoles

2014
Gonadotrophin-independent precocious puberty associated with later diagnosis of testicular embryonal carcinoma.
    Hormone research in paediatrics, 2014, Volume: 82, Issue:4

    Topics: Adolescent; Anastrozole; Androgens; Antineoplastic Agents, Hormonal; Carcinoma, Embryonal; Child; Chorionic Gonadotropin, beta Subunit, Human; Growth; Humans; Male; Nitriles; Orchiectomy; Puberty, Precocious; Testicular Neoplasms; Testis; Treatment Outcome; Triazoles

2014
[Pulmonary metastasis from breast cancer 38 years after mastectomy; report of a case].
    Kyobu geka. The Japanese journal of thoracic surgery, 2014, Volume: 67, Issue:7

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Mastectomy; Nitriles; Time Factors; Tomography, X-Ray Computed; Triazoles

2014
Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats.
    Steroids, 2015, Volume: 99, Issue:Pt A

    Topics: Anastrozole; Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Brain; Cognition Disorders; Estrone; Female; Flutamide; Maze Learning; Menopause; Nitriles; Ovariectomy; Rats, Inbred F344; Receptors, Androgen; Triazoles; Uterus

2015
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.
    Breast cancer research and treatment, 2014, Volume: 147, Issue:3

    Topics: Anastrozole; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; MCF-7 Cells; Nitriles; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptors, Androgen; Tamoxifen; Triazoles

2014
Use of aromatase inhibitors in large cell calcifying sertoli cell tumors: effects on gynecomastia, growth velocity, and bone age.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:12

    Topics: AMP-Activated Protein Kinase Kinases; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Bone Development; Calcinosis; Carney Complex; Child; Child, Preschool; Growth; Gynecomastia; Humans; Infant; Letrozole; Male; Nitriles; Peutz-Jeghers Syndrome; Protein Serine-Threonine Kinases; Sertoli Cell Tumor; Treatment Outcome; Triazoles

2014
Case report: anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland.
    BMC cancer, 2014, Sep-23, Volume: 14

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Carcinoma, Ductal; Disease-Free Survival; Female; Humans; Neoplasm Metastasis; Nitriles; Parotid Neoplasms; Tamoxifen; Treatment Outcome; Triazoles

2014
Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:17

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Chemotherapy, Adjuvant; Estrogens; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Letrozole; Middle Aged; Musculoskeletal Pain; Nitriles; Prospective Studies; Tamoxifen; Triazoles

2014
Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison.
    Journal of clinical pharmacy and therapeutics, 2015, Volume: 40, Issue:1

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Australia; Breast Neoplasms; Developed Countries; Drug Utilization Review; England; Female; France; Humans; Internationality; Letrozole; Longitudinal Studies; Netherlands; Nitriles; Scandinavian and Nordic Countries; Tamoxifen; Triazoles

2015
Primary Hormonal Therapy for Elderly Breast Cancer Patients: Single Institution Experience.
    Gynecologic and obstetric investigation, 2015, Volume: 80, Issue:1

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Letrozole; Nitriles; Receptors, Estrogen; Retrospective Studies; Spain; Tamoxifen; Treatment Outcome; Triazoles

2015
Effects of modified Shu-Gan-Liang-Xue decoction combined with anastrozole on osteoblastic proliferation and differentiation of MC3T3-E1 cells.
    Molecular medicine reports, 2015, Volume: 11, Issue:3

    Topics: Alkaline Phosphatase; Anastrozole; Animals; Calcification, Physiologic; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Gene Expression; Humans; Mice; Nitriles; Osteoblasts; Osteocalcin; RNA, Messenger; Triazoles

2015
Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in Kazakhstan.
    Journal of medical economics, 2015, Volume: 18, Issue:3

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cost-Benefit Analysis; Disease Progression; Everolimus; Female; Humans; Kazakhstan; Letrozole; Nitriles; Postmenopause; Receptor, ErbB-2; Triazoles

2015
Characterization of anastrozole effects, delivered by an intravaginal ring in cynomolgus monkeys.
    Human reproduction (Oxford, England), 2015, Volume: 30, Issue:2

    Topics: Administration, Intravaginal; Anastrozole; Animals; Aromatase Inhibitors; Delayed-Action Preparations; Dose-Response Relationship, Drug; Down-Regulation; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Implants; Estradiol; Feasibility Studies; Female; Follicle Stimulating Hormone; Half-Life; Infusions, Intravenous; Macaca fascicularis; Menstrual Cycle; Metabolic Clearance Rate; Nitriles; Solubility; Triazoles

2015
Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1.
    Nature communications, 2014, Dec-08, Volume: 5

    Topics: Anastrozole; Androstadienes; Animals; Aromatase Inhibitors; Behavior, Animal; Calcium; Calcium Channels; Cysteine; HEK293 Cells; Humans; Inflammation; Letrozole; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuropeptides; Nitriles; Pain; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Steroids; Transient Receptor Potential Channels; Triazoles; TRPA1 Cation Channel; TRPC Cation Channels

2014
No pain, no gain: a fallacy so far.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Jan-20, Volume: 33, Issue:3

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Musculoskeletal System; Nitriles; Triazoles; Vasomotor System

2015
An unusual cause of jaundice in a patient with breast cancer.
    BMJ case reports, 2014, Dec-24, Volume: 2014

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Fatty Liver; Female; Humans; Jaundice; Liver; Liver Function Tests; Middle Aged; Nitriles; Triazoles

2014
Case records of the Massachusetts General Hospital. Case 1-2015. A 66-year-old woman with metastatic breast cancer after endocrine therapy.
    The New England journal of medicine, 2015, Jan-08, Volume: 372, Issue:2

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Class I Phosphatidylinositol 3-Kinases; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Mastectomy, Segmental; Mutation; Nitriles; Phosphatidylinositol 3-Kinases; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Triazoles

2015
[A case of hyoid bone metastasis from breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12

    Topics: Aged; Anastrozole; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Denosumab; Female; Humans; Lymphatic Metastasis; Nitriles; Triazoles

2014
Antiproliferative effects of anastrozole on MCF-7 human breast cancer cells in vitro are significantly enhanced by combined treatment with testosterone undecanoate.
    Molecular medicine reports, 2015, Volume: 12, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Nitriles; Receptors, Androgen; Signal Transduction; Testosterone; Triazoles

2015
Management of Premenopausal Women with Neoadjuvant Endocrine Therapy: A Single-Institution Experience.
    Annals of surgical oncology, 2015, Volume: 22, Issue:12

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Gonadotropin-Releasing Hormone; Humans; Letrozole; Middle Aged; Neoadjuvant Therapy; Nitriles; Premenopause; Receptors, Estrogen; Response Evaluation Criteria in Solid Tumors; Tamoxifen; Triazoles

2015
Aromatase inhibitor (anastrozole) affects growth of endometrioma cells in culture.
    European journal of obstetrics, gynecology, and reproductive biology, 2015, Volume: 188

    Topics: Anastrozole; Aromatase Inhibitors; Cell Proliferation; Cells, Cultured; Endometriosis; Estradiol; Female; Humans; Nitriles; Testosterone; Triazoles

2015
PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
    Journal of liposome research, 2016, Volume: 26, Issue:1

    Topics: Anastrozole; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Liposomes; MCF-7 Cells; Nitriles; Particle Size; Polyethylene Glycols; Rats; Rats, Wistar; Structure-Activity Relationship; Surface Properties; Triazoles

2016
The effect of estrogen synthesis inhibition on hippocampal memory.
    Psychoneuroendocrinology, 2015, Volume: 56

    Topics: Aged; Anastrozole; Estradiol; Female; Gyrus Cinguli; Hippocampus; Humans; Letrozole; Long-Term Potentiation; Longitudinal Studies; Magnetic Resonance Imaging; Memory; Memory, Short-Term; Middle Aged; Nitriles; Postmenopause; Prefrontal Cortex; Psychomotor Performance; Steroid Synthesis Inhibitors; Surveys and Questionnaires; Triazoles; Verbal Learning; Word Association Tests

2015
Breast cancer risk reduction therapy: the low-hanging fruit.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2015, Volume: 13, Issue:4

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast; Breast Neoplasms; Carcinoma in Situ; Female; Humans; Hyperplasia; Nitriles; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles

2015
Solitary uterine metastasis of invasive lobular carcinoma after adjuvant endocrine therapy: a case report.
    Journal of medical case reports, 2015, Feb-14, Volume: 9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Lobular; Carrier Proteins; Combined Modality Therapy; Female; Glycoproteins; Humans; Leiomyoma; Membrane Transport Proteins; Middle Aged; Nitriles; Triazoles; Uterine Neoplasms

2015
Patterns of change in cognitive function with anastrozole therapy.
    Cancer, 2015, Aug-01, Volume: 121, Issue:15

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Educational Status; Female; Humans; Longitudinal Studies; Memory; Middle Aged; Nitriles; Postmenopause; Triazoles

2015
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Lymph Nodes; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Postmenopause; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Risk Assessment; Tamoxifen; Triazoles

2015
The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees.
    Journal of the National Cancer Institute, 2015, Volume: 107, Issue:8

    Topics: Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cohort Studies; Drug Costs; Drugs, Generic; Evaluation Studies as Topic; Female; Humans; Letrozole; Medicare; Medication Adherence; Nitriles; Non-Randomized Controlled Trials as Topic; Poverty; Triazoles; United States

2015
Anastrozole is a dose-specific superovulator and favors implantation in rats: a prospective study.
    Cell and tissue research, 2016, Volume: 364, Issue:1

    Topics: Anastrozole; Animals; Dose-Response Relationship, Drug; Embryo Implantation; Female; Nitriles; Ovulation; Pregnancy; Rats; Rats, Wistar; Triazoles

2016
Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study.
    Journal of affective disorders, 2015, Aug-15, Volume: 182

    Topics: Adult; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Depressive Disorder; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Letrozole; Middle Aged; Nitriles; Population Surveillance; Proportional Hazards Models; Retrospective Studies; Risk; Taiwan; Tamoxifen; Trastuzumab; Triazoles

2015
Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:7

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Letrozole; MCF-7 Cells; Molecular Structure; NF-E2-Related Factor 2; Nitriles; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Triazoles; Ubiquitination

2015
Multiple gene aberrations and breast cancer: lessons from super-responders.
    BMC cancer, 2015, May-29, Volume: 15

    Topics: Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Class I Phosphatidylinositol 3-Kinases; Disease-Free Survival; Everolimus; Female; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Middle Aged; Mutation; Neoplasm Proteins; Nitriles; Phosphatidylinositol 3-Kinases; TOR Serine-Threonine Kinases; Treatment Outcome; Triazoles

2015
Marketed Drugs Can Inhibit Cytochrome P450 27A1, a Potential New Target for Breast Cancer Adjuvant Therapy.
    Molecular pharmacology, 2015, Volume: 88, Issue:3

    Topics: Adjuvants, Pharmaceutic; Anastrozole; Anilides; Animals; Antifungal Agents; Antineoplastic Agents; Breast Neoplasms; Cholestanetriol 26-Monooxygenase; Dexmedetomidine; Enzyme Inhibitors; Fadrozole; Female; Hypnotics and Sedatives; Mice; Mice, Inbred C57BL; Nitriles; Protein Binding; Thiazoles; Tosyl Compounds; Triazoles

2015
Healthcare professionals' preferences for surgery or primary endocrine therapy to treat older women with operable breast cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:9

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Attitude of Health Personnel; Breast Neoplasms; Female; Geriatrics; Humans; Letrozole; Mastectomy; Nitriles; Oncology Nursing; Patient Preference; Receptors, Estrogen; Surgeons; Surveys and Questionnaires; Tamoxifen; Triazoles; United Kingdom

2015
A case of anastrazole-related drug-induced autoimmune hepatitis.
    Clinical journal of gastroenterology, 2014, Volume: 7, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Chemical and Drug Induced Liver Injury; Female; Hepatitis, Autoimmune; Humans; Nitriles; Triazoles

2014
Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary.
    Acta obstetricia et gynecologica Scandinavica, 2015, Volume: 94, Issue:11

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Female; Goserelin; Granulosa Cell Tumor; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Ovarian Neoplasms; Ovariectomy; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Salpingectomy; Tamoxifen; Triazoles

2015
Picking the optimal endocrine adjuvant treatment for pre-menopausal women.
    Breast (Edinburgh, Scotland), 2015, Volume: 24 Suppl 2

    Topics: Age Factors; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Goserelin; Humans; Letrozole; Nitriles; Ovary; Premenopause; Tamoxifen; Triazoles

2015
Neoadjuvant endocrine therapy: Patient selection, treatment duration and surrogate endpoints.
    Breast (Edinburgh, Scotland), 2015, Volume: 24 Suppl 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Ki-67 Antigen; Letrozole; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Patient Selection; Prognosis; Tamoxifen; Time Factors; Triazoles

2015
Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring.
    Biomedical chromatography : BMC, 2016, Volume: 30, Issue:4

    Topics: Anastrozole; Antineoplastic Agents; Chromatography, Liquid; Drug Monitoring; Humans; Letrozole; Limit of Detection; Nitriles; Tandem Mass Spectrometry; Triazoles

2016
Insights into biology of luminal HER2 vs. enriched HER2 subtypes: Therapeutic implications.
    Breast (Edinburgh, Scotland), 2015, Volume: 24 Suppl 2

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Female; Humans; Lapatinib; Letrozole; Molecular Imaging; Neoadjuvant Therapy; Nitriles; Precision Medicine; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Trastuzumab; Triazoles

2015
Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.
    International journal of clinical oncology, 2016, Volume: 21, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Humans; Joint Diseases; Middle Aged; Neoplasm Staging; Nitriles; Patient Outcome Assessment; Postmenopause; Prognosis; Prospective Studies; Quality of Life; Risk Factors; Surveys and Questionnaires; Triazoles

2016
Nanomedicine of anastrozole for breast cancer: Physicochemical evaluation, in vitro cytotoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat model.
    Life sciences, 2015, Nov-15, Volume: 141

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Compounding; Drug Evaluation, Preclinical; Drug Stability; Female; Humans; MCF-7 Cells; Nanomedicine; Nanoparticles; Nitriles; Particle Size; Rats; Triazoles

2015
Aromatase Inhibition and Capecitabine Combination as 1st or 2nd Line Treatment for Metastatic Breast Cancer - a Retrospective Analysis.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:15

    Topics: Adult; Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Capecitabine; Diarrhea; Disease Progression; Disease-Free Survival; Fatigue; Female; Follow-Up Studies; Hand-Foot Syndrome; Humans; Letrozole; Middle Aged; Nitriles; Receptors, Estrogen; Receptors, Progesterone; Retreatment; Retrospective Studies; Survival Rate; Triazoles

2015
Hypervitaminosis B12 As an Additional Prognostic Indicator in Elderly Adults with a Neoplastic Disease: Report of a Case and Review of the Literature.
    Journal of the American Geriatrics Society, 2015, Volume: 63, Issue:10

    Topics: Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Geriatric Assessment; Humans; Life Expectancy; Mammography; Neoplasm Staging; Nitriles; Predictive Value of Tests; Prognosis; Triazoles; Vitamin B 12

2015
Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report.
    Journal of medical case reports, 2015, Oct-20, Volume: 9

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Sarcoma, Endometrial Stromal; Survivors; Tomography, X-Ray Computed; Triazoles; Young Adult

2015
The Effects of Adjuvant Endocrine Treatment on Serum Leptin, Serum Adiponectin and Body Composition in Patients with Breast Cancer: The Izmir Oncology Group (IZOG) Study.
    Chemotherapy, 2016, Volume: 61, Issue:2

    Topics: Adiponectin; Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Body Composition; Body Mass Index; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Leptin; Letrozole; Middle Aged; Nitriles; Tamoxifen; Triazoles

2016
The impact of Anastrazole and Letrozole on the metabolic profile in an experimental animal model.
    Scientific reports, 2015, Dec-01, Volume: 5

    Topics: Anastrozole; Animals; Female; Letrozole; Lipid Metabolism; Liver; Nitriles; Rats; Rats, Wistar; Triazoles

2015
Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer.
    Anticancer research, 2015, Volume: 35, Issue:12

    Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Endpoint Determination; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Interleukin-2; Isotretinoin; Leuprolide; Nitriles; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Triazoles; Triple Negative Breast Neoplasms

2015
[Efficacies of aromatase inhibitors in the treatment of hormone dependent metastatic breast cancer in postmenopausal women: a report of 148 cases].
    Zhonghua yi xue za zhi, 2015, Jun-09, Volume: 95, Issue:22

    Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Hormones; Humans; Letrozole; Neoplasm Metastasis; Nitriles; Postmenopause; Triazoles

2015
Ginkgo biloba extract EGb 761-mediated inhibition of aromatase for the treatment of hormone-dependent breast cancer.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2016, Volume: 87

    Topics: Anastrozole; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Aromatase; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Ginkgo biloba; Humans; Mammary Neoplasms, Animal; MCF-7 Cells; Mice; Neoplasms, Experimental; Nitriles; Plant Extracts; RNA, Messenger; Triazoles

2016
Effect of imatinib on growth of experimental endometriosis in rats.
    European journal of obstetrics, gynecology, and reproductive biology, 2016, Volume: 197

    Topics: Anastrozole; Angiogenesis Inhibitors; Animals; Aromatase Inhibitors; bcl-2-Associated X Protein; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Imatinib Mesylate; Nitriles; Ovarian Follicle; Peritoneal Diseases; Peritoneum; Proto-Oncogene Proteins c-kit; Rats; Transplantation, Autologous; Triazoles; Vascular Endothelial Growth Factor A

2016
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors.
    Cancer research, 2016, Mar-15, Volume: 76, Issue:6

    Topics: Anastrozole; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Estrogens; Female; Glycolysis; Hexokinase; Humans; Letrozole; MCF-7 Cells; Mice; Mice, Nude; MicroRNAs; Neoadjuvant Therapy; Nitriles; Phosphorylation; Receptors, Estrogen; Triazoles

2016
[A Case of Locally Advanced Breast Cancer Treated with Modified Radical Mastectomy with Immediate Reconstruction Using a Tissue Expander after Endocrine Therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biopsy, Large-Core Needle; Breast Implants; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Humans; Mastectomy, Modified Radical; Middle Aged; Nitriles; Tissue Expansion Devices; Triazoles

2015
Exemestane-induced radiation recall dermatitis and morbilliform rash.
    The Journal of dermatology, 2016, Volume: 43, Issue:5

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Arthralgia; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Eruptions; Eosinophilia; Epidermis; Exanthema; Female; Humans; Nitriles; Radiodermatitis; Radiotherapy, Adjuvant; Triazoles; Withholding Treatment

2016
Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene.
    Journal of clinical research in pediatric endocrinology, 2015, Volume: 7, Issue:3

    Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Genetic Predisposition to Disease; Humans; Infant; Ketoconazole; Male; Mutation; Nitriles; Puberty, Precocious; Receptors, LH; Sequence Analysis, DNA; Testosterone; Tosyl Compounds; Triazoles

2015
A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada.
    Journal of medical economics, 2016, Volume: 19, Issue:6

    Topics: Anastrozole; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Canada; Cost-Benefit Analysis; Disease Progression; Female; Health Services; Humans; Lapatinib; Letrozole; Markov Chains; Models, Econometric; Neoplasm Metastasis; Nitriles; Quality-Adjusted Life Years; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Terminal Care; Trastuzumab; Triazoles

2016
Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer.
    Nature communications, 2016, Feb-09, Volume: 7

    Topics: AC133 Antigen; Anastrozole; Androstadienes; Animals; Antigens, CD; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Line, Tumor; Cell Self Renewal; Drug Resistance, Neoplasm; Estradiol; Female; Flow Cytometry; Fulvestrant; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; In Vitro Techniques; Interleukin-6; Letrozole; Leuprolide; MCF-7 Cells; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Nitriles; Oxidative Phosphorylation; Peptides; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, Estrogen; Receptors, Notch; Signal Transduction; Tamoxifen; Triazoles

2016
Long-Term Disease-Free Survival in a Young Patient With Hormone Receptor-Positive Breast Cancer and Oligometastatic Disease in the Brain.
    Clinical breast cancer, 2016, Volume: 16, Issue:3

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carmustine; Chemoradiotherapy; Craniotomy; Cyclophosphamide; Decanoic Acids; Disease-Free Survival; Doxorubicin; Female; Humans; Leuprolide; Nitriles; Paclitaxel; Polyesters; Radiosurgery; Receptors, Estrogen; Triazoles; Young Adult

2016
The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:8

    Topics: Affect; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cognition; Employment; Female; Humans; Middle Aged; Nitriles; Postmenopause; Self Report; Surveys and Questionnaires; Survivors; Triazoles

2016
Analysis of 17β-estradiol (E2) role in the regulation of corpus luteum function in pregnant rats: Involvement of IGFBP5 in the E2-mediated actions.
    Reproductive biology and endocrinology : RB&E, 2016, Apr-12, Volume: 14

    Topics: Anastrozole; Androgen Antagonists; Animals; Aromatase Inhibitors; Cell Proliferation; Corpus Luteum; Estradiol; Female; Flutamide; Gene Expression; Gene Expression Profiling; Insulin-Like Growth Factor Binding Protein 5; Nitriles; Oligonucleotide Array Sequence Analysis; Pregnancy; Rats; Triazoles

2016
A microsomal based method to detect aromatase activity in different brain regions of the rat using ultra performance liquid chromatography-mass spectrometry.
    The Journal of steroid biochemistry and molecular biology, 2016, Volume: 163

    Topics: Amygdala; Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Brain Chemistry; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A1; Estradiol; Female; Hippocampus; Kinetics; Limit of Detection; Male; Microsomes; Nitriles; Ovary; Preoptic Area; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Testosterone; Triazoles

2016
Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Oct-15, Volume: 22, Issue:20

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Gene Expression Profiling; Health Status Indicators; Humans; Lymph Nodes; Neoplasm Recurrence, Local; Nitriles; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Risk Factors; Tamoxifen; Triazoles

2016
Aromatase inhibitors decrease radiation-induced lung fibrosis: Results of an experimental study.
    Breast (Edinburgh, Scotland), 2016, Volume: 28

    Topics: Anastrozole; Androstadienes; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Chemotherapy, Adjuvant; Female; Letrozole; Nitriles; Pulmonary Fibrosis; Radiation Injuries, Experimental; Radiotherapy; Rats; Rats, Wistar; Tamoxifen; Triazoles

2016
Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers.
    The Journal of steroid biochemistry and molecular biology, 2017, Volume: 165, Issue:Pt B

    Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; DNA Mutational Analysis; Drug Administration Schedule; ErbB Receptors; Estrogen Receptor alpha; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Letrozole; Mutation; Neuregulin-1; Nitriles; Receptor, ErbB-2; RNA, Messenger; Treatment Outcome; Triazoles

2017
Hypercalcemic crisis associated with anastrozole use in a patient with breast cancer and primary hyperparathyroidism.
    Endocrine, 2016, Volume: 53, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Carcinoma In Situ; Breast Neoplasms; Calcium; Female; Humans; Hypercalcemia; Hyperparathyroidism; Middle Aged; Nitriles; Parathyroid Hormone; Parathyroidectomy; Treatment Outcome; Triazoles

2016
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy.
    Journal of the National Cancer Institute, 2016, Volume: 108, Issue:11

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Likelihood Functions; Lymph Nodes; Lymphatic Metastasis; Nitriles; Predictive Value of Tests; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Risk Assessment; Tamoxifen; Triazoles; Tumor Burden

2016
Multiparametric Genomic Assays for Breast Cancer: Time for the Next Generation?
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Oct-15, Volume: 22, Issue:20

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biological Assay; Breast Neoplasms; Disease-Free Survival; Female; Homeodomain Proteins; Humans; Nitriles; Postmenopause; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Interleukin-17; Receptors, Progesterone; Tamoxifen; Triazoles

2016
Anastrozole-induced subacute cutaneous lupus erythematosus.
    Cutis, 2016, Volume: 98, Issue:2

    Topics: Aged; Anastrozole; Antibodies, Antinuclear; Arm; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Lupus Erythematosus, Cutaneous; Nitriles; Thorax; Triazoles

2016
Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study.
    Menopause (New York, N.Y.), 2016, Volume: 23, Issue:10

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Breast Neoplasms; Female; Humans; Lasers, Gas; Middle Aged; Nitriles; Retrospective Studies; Surveys and Questionnaires; Tamoxifen; Treatment Outcome; Triazoles; Vagina; Vaginal Diseases; Vulva

2016
Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:3

    Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Arthralgia; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Nitriles; Polymorphism, Single Nucleotide; Postmenopause; Protective Factors; Proto-Oncogene Proteins; Risk Factors; Treatment Outcome; Triazoles

2017
Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.
    The oncologist, 2017, Volume: 22, Issue:1

    Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Circulating Tumor DNA; Disease-Free Survival; Estradiol; Female; Fulvestrant; Humans; Letrozole; Mutation; Neoplastic Cells, Circulating; Nitriles; Nuclear Proteins; Piperazines; Postmenopause; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Transcription Factors; Triazoles

2017
Response to Anastrozole Treatment in a Case with Peutz-Jeghers Syndrome and a Large Cell Calcifying Sertoli Cell Tumor.
    Journal of clinical research in pediatric endocrinology, 2017, Jun-01, Volume: 9, Issue:2

    Topics: Anastrozole; Aromatase Inhibitors; Child; Gynecomastia; Humans; Male; Nitriles; Peutz-Jeghers Syndrome; Sertoli Cell Tumor; Testicular Neoplasms; Treatment Outcome; Triazoles

2017
Mechanism of Bushen Jianpi decoction in preventing and treating osteoporosis caused by aromatase inhibitors in breast cancer treatment.
    Cancer biomarkers : section A of Disease markers, 2017, Volume: 18, Issue:2

    Topics: Alendronate; Alkaline Phosphatase; Anastrozole; Animals; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Disease Models, Animal; Drugs, Chinese Herbal; Female; Mice, Inbred BALB C; Nitriles; Osteoporosis; Ovariectomy; Triazoles

2017
Abemaciclib Shows Promise for Early Breast Cancer.
    Cancer discovery, 2017, Volume: 7, Issue:2

    Topics: Aminopyridines; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Clinical Trials, Phase II as Topic; Disease-Free Survival; Female; Humans; Ki-67 Antigen; Nitriles; Receptor, ErbB-2; Survival Analysis; Treatment Outcome; Triazoles

2017
Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer.
    Cancer medicine, 2017, Volume: 6, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cognitive Dysfunction; Female; Humans; Middle Aged; Neuropsychological Tests; Nitriles; Prognosis; Receptor, ErbB-2; Triazoles

2017
Growth Hormone With Aromatase Inhibitor May Improve Height in CYP11B1 Congenital Adrenal Hyperplasia.
    Pediatrics, 2017, Volume: 139, Issue:2

    Topics: Adolescent; Adrenal Hyperplasia, Congenital; Anastrozole; Aromatase Inhibitors; Growth Disorders; Growth Hormone; Humans; Hydrocortisone; Male; Nitriles; Triazoles

2017
Letrozole not superior to anastrozole for early breast cancer.
    The Lancet. Oncology, 2017, Volume: 18, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Letrozole; Nitriles; Prognosis; Triazoles

2017
Estrone and Estradiol Levels in Breast Cancer Patients Using Anastrozole Are Not Related to Body Mass Index.
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2017, Volume: 39, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Cohort Studies; Estradiol; Estrone; Female; Humans; Middle Aged; Nitriles; Triazoles

2017
Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Apr-01, Volume: 35, Issue:10

    Topics: Adult; Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Cytoreduction Surgical Procedures; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Letrozole; Leuprolide; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Nitriles; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum Compounds; Survival Rate; Tamoxifen; Triazoles; Watchful Waiting; Young Adult

2017
Ki-67 antigen expression in the mammary epithelium of female rats in persistent estrus treated with anastrozole.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:5

    Topics: Anastrozole; Animals; Cell Proliferation; Epithelium; Estrus; Female; Ki-67 Antigen; Mammary Glands, Animal; Nitriles; Rats; Rats, Wistar; Testosterone; Triazoles

2017
High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I-III Breast Cancer Patients Treated in a Safety-Net Healthcare System.
    Journal of women's health (2002), 2017, Volume: 26, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Ethnicity; Female; Humans; Insurance, Health; Medicaid; Medically Uninsured; Neoplasm Staging; Nitriles; Safety-net Providers; Tamoxifen; Treatment Outcome; Triazoles; United States

2017
Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?
    BMC cancer, 2017, 03-28, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Biomarkers; Body Mass Index; Breast Neoplasms; Estrogens; Female; Gonadotropins; Humans; Middle Aged; Neoplasm Staging; Nitriles; Obesity; Postmenopause; Prognosis; Triazoles

2017
Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor.
    Medical hypotheses, 2017, Volume: 101

    Topics: Administration, Topical; Anastrozole; Androstadienes; Aromatase Inhibitors; Estrogens; Female; Genetic Predisposition to Disease; Humans; Hyperpigmentation; Letrozole; Male; Melanosis; Neovascularization, Pathologic; Nitriles; Pregnancy; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles; Ultraviolet Rays; Vascular Endothelial Growth Factor A

2017
MAMMARY GLAND ADENOCARCINOMA IN A MALE BORNEAN ORANGUTAN (PONGO PYGMAEUS).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2017, Volume: 48, Issue:1

    Topics: Adenocarcinoma; Anastrozole; Animals; Antineoplastic Agents, Hormonal; Ape Diseases; Male; Mammary Neoplasms, Animal; Neoplasms, Hormone-Dependent; Nitriles; Pongo pygmaeus; Tamoxifen; Triazoles

2017
Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells.
    Saudi medical journal, 2017, Volume: 38, Issue:4

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Apoptosis; Aromatase; Aromatase Inhibitors; Cell Membrane Permeability; Cell Survival; Cytochromes c; Doxorubicin; Hep G2 Cells; Humans; MCF-7 Cells; Mitochondrial Membranes; Nitriles; Triazoles

2017
A novel long-acting biodegradable depot formulation of anastrozole for breast cancer therapy.
    Materials science & engineering. C, Materials for biological applications, 2017, Jun-01, Volume: 75

    Topics: Absorbable Implants; Anastrozole; Animals; Breast Neoplasms; Drug Implants; Female; Humans; Lactic Acid; Nitriles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Triazoles

2017
Hydroxychloroquine toxicity and aromatase inhibitors.
    The British journal of dermatology, 2017, Volume: 177, Issue:3

    Topics: Anastrozole; Aromatase Inhibitors; Dermatologic Agents; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Middle Aged; Nitriles; Retinal Diseases; Triazoles

2017
Identification of endocrine disrupting chemicals acting on human aromatase.
    Biochimica et biophysica acta. Proteins and proteomics, 2018, Volume: 1866, Issue:1

    Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Benzhydryl Compounds; Biological Assay; Endocrine Disruptors; Enzyme-Linked Immunosorbent Assay; Estrone; Gene Expression; Humans; Ketoconazole; Ligands; NADP; Nicotine; Nitriles; Phenols; Protein Binding; Recombinant Proteins; Resveratrol; Sildenafil Citrate; Small Molecule Libraries; Stilbenes; Triazoles

2018
Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 82

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Fatty Liver; Female; Humans; Incidence; Letrozole; Lipids; Middle Aged; Nitriles; Propensity Score; Retrospective Studies; Tamoxifen; Triazoles

2017
Cost-effectiveness analysis of fulvestrant versus anastrozole as first-line treatment for hormone receptor-positive advanced breast cancer.
    European journal of cancer care, 2017, Volume: 26, Issue:6

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; China; Cost-Benefit Analysis; Drug Costs; Estradiol; Female; Fulvestrant; Humans; Markov Chains; Nitriles; Quality-Adjusted Life Years; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2017
Anastrozole-induced Autoimmune Hepatitis: A Rare Complication of Breast Cancer Therapy.
    Anticancer research, 2017, Volume: 37, Issue:8

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Biopsy; Breast Neoplasms; Female; Hepatitis, Autoimmune; Humans; Liver; Neoplasm Staging; Nitriles; Triazoles

2017
Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
    Gynecologic oncology, 2017, Volume: 147, Issue:1

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystadenocarcinoma, Serous; Cytoreduction Surgical Procedures; Female; Humans; Letrozole; Medical Overuse; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Ovarian Neoplasms; Retrospective Studies; Survival Analysis; Tamoxifen; Triazoles

2017
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.
    The European respiratory journal, 2017, Volume: 50, Issue:2

    Topics: Anastrozole; Animals; Bone Morphogenetic Protein Receptors, Type II; Disease Models, Animal; Echocardiography; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hemodynamics; Humans; Hypertension, Pulmonary; Insulin Resistance; Lung; Mice; Mice, Knockout; Mutation; Nitriles; Signal Transduction; Tamoxifen; Triazoles

2017
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer.
    Journal of the National Cancer Institute, 2018, 02-01, Volume: 110, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; Humans; Lymphocyte Count; Lymphocytes, Tumor-Infiltrating; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Receptors, Estrogen; Risk Factors; Tamoxifen; Triazoles

2018
Comparative pharmacokinetics study of anastrozole after single administration and combination with celecoxib.
    Xenobiotica; the fate of foreign compounds in biological systems, 2018, Volume: 48, Issue:3

    Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Chromatography, Liquid; Cyclooxygenase 2 Inhibitors; Female; Limit of Detection; Nitriles; Rats, Sprague-Dawley; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles

2018
Working at the membrane interface: Ligand-induced changes in dynamic conformation and oligomeric structure in human aromatase.
    Biotechnology and applied biochemistry, 2018, Volume: 65, Issue:1

    Topics: Anastrozole; Aromatase; Humans; Ligands; Molecular Dynamics Simulation; Nitriles; Protein Structure, Quaternary; Triazoles

2018
Isolated Retinal Metastasis From Breast Cancer.
    Retina (Philadelphia, Pa.), 2017, Volume: 37, Issue:11

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Humans; Middle Aged; Nitriles; Radiosurgery; Receptors, Estrogen; Receptors, Progesterone; Retinal Neoplasms; Triazoles

2017
Effect of aromatase inhibitors on learning and memory and modulation of hippocampal dickkopf-1 and sclerostin in female mice.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Anastrozole; Androstadienes; Animals; Aromatase Inhibitors; Cognition; Female; Glycoproteins; Hippocampus; Intercellular Signaling Peptides and Proteins; Letrozole; Maze Learning; Memory; Mice; Nitriles; Triazoles; Wnt Signaling Pathway

2017
Preparation of anastrozole loaded PEG-PLA nanoparticles: evaluation of apoptotic response of breast cancer cell lines.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Anastrozole; Apoptosis; Aromatase Inhibitors; Breast Neoplasms; Cell Survival; Drug Delivery Systems; Female; Gene Expression Regulation, Neoplastic; Half-Life; Humans; MCF-7 Cells; Mitogen-Activated Protein Kinase 3; Myeloid Cell Leukemia Sequence 1 Protein; Nanoparticles; Nitriles; Particle Size; Polyesters; Polyethylene Glycols; Proto-Oncogene Proteins c-myc; Solubility; Triazoles

2018
[A Case of Breast Cancer with Local Recurrence in the Reconstructed Breast Tissue].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12

    Topics: Adult; Anastrozole; Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Mammaplasty; Mastectomy; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nitriles; Treatment Outcome; Triazoles

2017
[A Case of Stage IV Breast Cancer with Extensive Metastasis Successfully Treated with S-1 plus Anastrozole Therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12

    Topics: Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Drug Combinations; Female; Humans; Lymphatic Metastasis; Nitriles; Oxonic Acid; Tegafur; Triazoles

2017
Correlation of Serum Estradiol and Duration of Anastrazole Therapy with Treatment Related Adverse Effects Among Postmenopausal Breast Cancer Women: A Cross-sectional Study.
    Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria, 2017, Dec-30, Volume: 32, Issue:2

    Topics: Aged; Anastrozole; Breast Neoplasms; Cross-Sectional Studies; Estradiol; Female; Hot Flashes; Humans; Middle Aged; Nitriles; Postmenopause; Quality of Life; Triazoles

2017
Beneficial role of biochanin A on cutaneous and renal tissues of ovariectomized rats treated with anastrozole.
    Life sciences, 2018, May-15, Volume: 201

    Topics: Acute Kidney Injury; Anastrozole; Animals; Antineoplastic Agents, Hormonal; Antioxidants; Cytokines; Female; Genistein; Kidney; Nitriles; Ovariectomy; Rats; Rats, Wistar; Skin; Triazoles

2018
RE: "Cost-effectiveness analysis of fulvestrant versus anastrozole as first-line treatment for hormone receptor-positive advanced breast cancer," by Ding H., et al.
    European journal of cancer care, 2018, Volume: 27, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cost-Benefit Analysis; Estradiol; Fulvestrant; Humans; Nitriles; Postmenopause; Receptors, Estrogen; Triazoles

2018
A Case of Psoriasis Complicated by Breast Cancer after Systemic Treatments Including Biologics.
    Acta medica Okayama, 2018, Volume: 72, Issue:2

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Biological Products; Breast Neoplasms; Female; Humans; Immunosuppressive Agents; Nitriles; Psoriasis; Triazoles

2018
[Determination of anaprazole in human plasma by LC-MS/MS in pharmacokinetic study].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2016, Volume: 51, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Area Under Curve; Chromatography, Liquid; Diet, High-Fat; Humans; Nitriles; Plasma; Reproducibility of Results; Tablets, Enteric-Coated; Tandem Mass Spectrometry; Triazoles

2016
[Evaluation of Patient Adherence to Anastrozole Therapy for Breast Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Humans; Middle Aged; Nitriles; Patient Compliance; Retrospective Studies; Triazoles

2018
Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women?
    BMC palliative care, 2021, Feb-05, Volume: 20, Issue:1

    Topics: Aged; Aged, 80 and over; Anastrozole; Endometrial Neoplasms; Female; Humans; Nitriles; Palliative Care; Pilot Projects; Quality of Life; Tamoxifen; Triazoles

2021
Combination Vistusertib and Anastrozole Shows Benefit in Endometrial Cancer.
    Cancer discovery, 2022, 07-06, Volume: 12, Issue:7

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Benzamides; Breast Neoplasms; Endometrial Neoplasms; Female; Humans; Morpholines; Nitriles; Pyrimidines; Triazoles

2022
Anastrozole and related glucuronic acid conjugate are electrophilic species.
    Xenobiotica; the fate of foreign compounds in biological systems, 2022, Volume: 52, Issue:4

    Topics: Anastrozole; Animals; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Female; Glucuronic Acid; Humans; Nitriles; Rats; Triazoles

2022
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group.
    Molecular oncology, 2023, Volume: 17, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Endometrial Neoplasms; Female; Humans; Nitriles; Ribosomes; TOR Serine-Threonine Kinases; Triazoles

2023
Effects of
    Pharmacogenomics, 2023, Volume: 24, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Estradiol; Female; Fulvestrant; Genotype; Humans; Nitriles; Triazoles

2023
Breast Tumor Cells Evade the Cytotoxic Action of Anastrozole, Aspirin, and Clopidogrel Cocktail.
    Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada, 2023, 06-09, Volume: 29, Issue:3

    Topics: Anastrozole; Animals; Antineoplastic Agents; Aspirin; Breast Neoplasms; Clopidogrel; Female; Humans; Mammary Neoplasms, Animal; Nitriles; Tamoxifen; Triazoles

2023